An investigation into the effect of the decision-making process and human factors in prescribing errors within an inpatient mental health setting by Scott, Hilary Frances
 
 
 
 
An investigation into the effect of the decision-
making process and human factors in 
prescribing errors within an inpatient mental 
health setting. 
 
Hilary Frances Scott 
BSc (Hons), MPhil, MBA, MRPharmS 
 
This thesis is submitted in partial fulfilment of the requirements for the award of the 
degree of Doctor of Philosophy of the University of Portsmouth. 
 
         
 
 
School of Pharmacy and Biomedical Sciences,  
Faculty of Science, University of Portsmouth 
in collaboration with 
Essex Partnership University NHS Foundation Trust 
 
September 2018 
 
 i 
 
Abstract  
 
Introduction 
Research on the prevalence and causes of prescribing errors has concentrated on 
the acute sector, with little published in relation to mental health. Studies into dual 
process theory in healthcare have tended to concentrate on its role in diagnosis and 
no studies have looked at whether there is a relationship between thinking style and 
prescribing errors. 
The purpose of this research was to investigate the effect of rational and experiential 
thinking and other human factors on the occurrence of prescribing errors. 
Methods 
The research was carried out in one mental health trust and consisted of four 
interrelated elements. Firstly, a prospective, quantitative study investigated the 
prevalence and nature of prescribing errors. Secondly, semi-structured qualitative 
interviews were undertaken with a sample of clinicians who had made errors to 
explore the causes and factors contributing to them.  Thirdly, prescribers’ decision-
making characteristics were profiled using validated scales and the relationship with 
prescribing errors explored. Finally, the impact of an educational intervention about 
clinical decision making on prescribing errors was measured.  
Key Findings 
The overall error rate was 4.6%, with significantly higher rates of prescribing errors 
observed at those stages in the patient’s journey involving transitions of care, (on 
admission 6.2%; discharge 7.7%), and for early career prescribers, with foundation, 
core and GP trainees having the highest error rates (≥ 5.6%). A weak, but significant, 
inverse relationship was found between experience and error rates. Nearly two-thirds 
of errors (61.1%) were intercepted before any dose was administered and few errors 
were considered to be potentially severe. 
Rule-based mistakes were the most common, and all prescribers reported that they 
were unaware of their error(s) until contacted as part of the research. Factors cited by 
interview participants were generally similar to those found in previous studies, 
however some factors raised had not been identified in previous research. Electronic 
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prescribing is more commonly used in acute trusts, particularly teaching hospitals; as 
a result, junior doctors may enter a psychiatry rotation with little or no experience of 
using paper drug charts. Furthermore, despite the recommendation of the EQUIP 
study for a standard national drug chart across the NHS, individual trusts continue to 
use drug charts that vary widely which can contribute to errors due to both design and 
lack of familiarity. Lack of access to information about a patient’s primary care 
medication regimen, compounded by the tendency of community pharmacists to label 
the secondary, outer container of medicines such as inhalers, also contributed to 
prescribing errors. Access to the Summary Care Record for all prescribers would help 
prevent such errors, particularly out-of-hours, when other resources such as the GP 
surgery and hospital pharmacy team are not available. 
Participants generally demonstrated a preference for rational thinking and a tendency 
to organise, abstract and evaluate information. No statistically significant relationship 
was found between performance on any of the decision-making scales used and 
prescribing errors. An educational intervention on clinical decision making did not 
result in a reduction in prescribing errors.  
Conclusions 
It is likely that multifaceted interventions are needed to improve the quality of 
prescribing and reduce errors. These should be designed to target both the rational 
and experiential processing preferences of individuals. An educational approach 
which addresses the theory of clinical decision making, error-prone types of 
prescribing, and systems to support prescribing reduce errors, should be 
accompanied by on-going feedback on prescribing errors to facilitate learning. Clinical 
and educational tutors have a crucial role to play in reinforcing the importance of 
prescribing as a clinical task and strategies to minimise errors. 
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Chapter 1. Introduction 
1.1 Background and context 
Medicines play a significant part in the care of patients with mental health problems. 
The vast majority (around 85%) of patients with a mental health problem will be 
prescribed medication for their condition.1,2 Almost half of mental health patients will 
have been prescribed a new medication during the previous twelve month period.2 
Patients with the most complex mental health needs are more likely to require time in 
hospital; use of medicines in this group of patients is higher at approximately 99%, 
with more than 90% of patients taking two or more medicines.1   
Figure 1.1, which shows the results of a ward-level audit of medication use, 
demonstrates that whilst the modal number of medicines taken by patients was three, 
a large number of patients were taking many more than this; older people represented 
a greater proportion of those taking high numbers of medicines.  
 
Source: 2005/2006 medicines management review audit of clinical pharmacy services1 
Figure 1.1:   Number of medicines taken by service users admitted to mental health wards 
Globally, medication errors are estimated to cost US$ 42 billion each year.3 In 2017 
the World Health Organisation (WHO) launched its third Global Patient Safety 
Challenge which addresses medication safety and aims to reduce the global level of 
severe, avoidable harm due to medication by 50% over the next 5 years. The WHO 
highlights that errors occur when weak medication systems and/or human factors 
affect the various stages of the medication pathway, including prescribing, and that 
such errors can result in severe harm, disability, and death.4,5 To support the WHO 
campaign the Department of Health and Social Care (DHSC) commissioned a rapid 
review of the evidence base on medication errors in England,6 and established a short 
life working group.7  The rapid literature review estimated that in England, 237 million 
1. INTRODUCTION 
2 
 
medication errors occur at some point in the medication use process each year, of 
which 21.3% are prescribing errors, and 20% occur in secondary care.6   
1.1.1 Prescribing errors 
Six to ten per cent of acute hospital admissions are thought to be drug-related,8–10 
and between 2005 and 2010 over 526,000 reports of medication errors were made to 
the National Reporting and Learning System (NLRS).11 Studies looking at the 
incidence of medication errors have found that adverse incidents due to drugs most 
commonly occur during the prescribing stage, involving the wrong dose, wrong drug 
choice, prescribing when a known allergy is present, wrong frequency and drug-drug 
interactions.12–16 It has been estimated that more than four million prescribing errors 
occur in secondary care in England each year.6 A significant proportion are 
preventable, with the likelihood of an incident having been preventable being greater 
for more serious incidents.12  
Nearly one-fifth of the errors reported to the NLRS related to the prescribing of 
medicines.11 A systematic review of the literature on the prevalence, incidence and 
nature of prescribing errors in hospital inpatients identified that errors occurred in a 
median of 7% of medication orders, affecting 2% of patient days and 50% of hospital 
admissions, although a lack of standardisation between the definitions and data 
collection methods used in different studies made it difficult to combine data 
confidently.17 Data collected in 20 acute hospital trusts, as part of the EQUIP study 
commissioned by the General Medical Council (GMC), identified a mean error rate of 
8.8% across all grades/types of prescribers, with the highest error rates observed in 
Foundation Year 2 (FY2) doctors.18,19 Other studies have also identified that most 
prescribing errors are made by junior medical staff, however, this may also reflect the 
fact that they are responsible for the majority of prescribing.14,20   
Prescribing errors are therefore a common problem with the potential to affect patient 
safety.  However, understanding the epidemiology of such errors is problematic due 
to poorly defined numerators and denominators, and a range of designs, methods 
and error definitions.21,22 Aronson and Ferner proposed definitions and a classification 
system for medication errors based on psychological principles with three broad 
types: knowledge-based and rule-based errors (‘mistakes’), action-based (‘slips’) and 
memory-based errors (‘lapses’). These fit with the model of human error types 
described by Reason.23 Aronson also distinguished between faults which occur during 
the decision-making process involved in deciding what to prescribe and naming it, 
involving  irrational, inappropriate or ineffective prescribing, over-prescribing and 
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under-prescribing;  and those that are made during the act of writing a prescription, 
describing these as ‘prescribing faults’ and ‘prescription errors’ respectively.24 Dean 
et al used a two-stage Delphi technique to arrive at a practitioner-led definition of a 
prescribing error which was tested against a number of clinical scenarios.25  
Issues identified as contributing to prescribing errors include  factors relating to 
organisation and management, working environment, team, task, patient, individual, 
defences built into systems13,18,19,26,27 calculations, use of units, nomenclature, and 
characteristics relating to the declining patient16  as well as themes relating to learning 
curves and use of knowledge, taking instruction and patient safety.28  
Research into the prevalence, incidence, and nature of adverse drug events and drug-
related hospitalisation has been taking place since the 1960s.29 In 1962 in the US, 
Barker and McConnell published what was arguably the first study which 
demonstrated that medication errors occurred more frequently than anticipated.30 
Whilst literature at that stage mainly focused on errors involving the administration of 
medicines, in 1975 a UK study of hospital inpatient prescription charts demonstrated 
that 36% of prescriptions contained at least one prescribing error of either drug use 
or prescription writing.31 A decade later Betz and Levy proposed an interdisciplinary 
method for classifying medication errors by type and practitioner group, to allow 
monitoring and performance improvement by prescribers and pharmacists.32  
However, it is only in the last two decades that the role of negligence and errors in 
relation to medication-related patient safety has received much attention. During the 
1990s a series of studies were published which raised interest in the issue of patient 
safety. The Harvard Medical Practice Study, a study of medical injury and malpractice 
litigation published in 1991, demonstrated that adverse events and injuries caused by 
medical care occurred in 3.7% of admissions and that 27.6% of the adverse events 
were due to negligence,33 with drug complications the most common type of adverse 
event (19%), with 8.9% due to errors, and 52.8% judged to be negligent.34 Results on 
a similar scale were found in further studies published during the 1990s for hospital 
patients in New South Wales and South Australia,35 Utah and Colorado,36 and 
London.37,38 
During the same period, a number of researchers including Bates,12,39–41 Classen42,43 
and Lesar16,20,44,45 in the US started to investigate the incidence of adverse drug 
events, potential adverse drug events, medication errors and prescribing errors, 
followed towards the end of the decade by Dean and Barber in the UK.46   
1. INTRODUCTION 
4 
 
As the 1990s progressed professional interest in patient safety increased. Whereas 
at the beginning of the decade the editor of the British Medical Journal had been 
criticised for suggesting the need for a study of the incidence of adverse events,47 in 
2000 the journal published an entire themed issue on patient safety,48 including a key 
article about human error and the systems approach to accident causation by James 
Reason.49  
In 1999 the US Institute of Medicine report To Err is Human increased public, 
professional and political awareness of patient safety.50 In the UK, the Chief Medical 
Officer published An Organisation with a Memory, the report of an expert group on 
learning from adverse events in the NHS, which stressed the need to understand the 
underlying causes of adverse events and learn from them, and drew parallels with 
other high risk industries which had improved safety records.51  
This report was followed in 2001, with two implementation documents setting out the 
Government’s plans for promoting patient safety. The first, Building a Safer NHS for 
Patients, set out the blueprint for a new national system for learning from adverse 
events and near misses (the NRLS), created the National Patient Safety Agency 
(NPSA) and provided clarity on investigations into major service failures, serious 
public concerns, and complaints by patients.  The report also targeted a number of 
areas for specific action, including a reduction of 40% in the number of serious errors 
in the use of prescribed drugs by the end of 2005.52 In 2004, the Chief Pharmaceutical 
Officer published a supporting report exploring the causes and frequency of 
medication errors. highlighting drugs and clinical settings that pose a particular risk, 
and identified models of good practice to reduce risks.53  
It is against this backdrop that work to improve patient safety related to the use of 
medicines, and specifically prescribing errors has continued to develop since the 
beginning of this century. 
1.1.2 Clinical decision making 
Clinical decision making, or clinical reasoning, has been extensively studied by health 
professionals, education specialists, cognitive psychologists, and sociologists over 
the last 40 years. It is an essential aspect of professional practice, encompassing the 
evaluation and management of a patient’s medical problem, and a major determining 
factor in clinical competence.54 However, as noted by Maskrey et al, whilst healthcare 
professionals seek to become excellent decision makers, neither undergraduates nor 
postgraduates are exposed to the evidence about how humans make decisions.55  
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Although a small number of studies have looked at clinical decision making in the 
context of prescribing decisions,56–61 the majority of work in the healthcare field has 
concentrated on diagnostic decision making rather than therapeutic management.  
A series of papers on human judgement published in the 1960s and 1970s by Tversky 
and Kahneman extend beyond academic psychology across a range of disciplines 
including medicine. Inspired by biased real-world judgements, they challenged the 
previously held view that rational choice was based on an assessment of the 
probability and utility of all possible outcomes.62 At a similar time, Simon was 
challenging the view that such full rationality was an unrealistic expectation given the 
processing limitations of the human mind, describing what became known as 
“bounded rationality”.63 Tversky and Kahneman proposed that judgement was subject 
to mental “short-cuts” or “rules of thumb”, termed heuristics, that may produce 
systematic biases64 and which are associated with intuitive judgement.62 However, 
researchers disagree about the reliability of intuition and the degree to which 
heuristics lead to errors.54,64,65 On one side of the debate, work by Croskerry, Graber 
and others has shown that use of cognitive heuristics may contribute to errors66–69 On 
the other, work by Eva and Norman has suggested that heuristics can lead to a 
decrease in diagnostics errors and that they should not necessarily be considered a 
bad thing.70–73 As both sides provide examples in which heuristics have led to more 
or less errors, it has been suggested that the research agenda needs to move forward 
beyond this debate to identify factors that improve accuracy.65 
1.2 Thesis outline 
This thesis consists of seven chapters. Following the introduction, chapter one 
provides a review of the literature and theory relating to prescribing errors and clinical 
decision making, including the historical context, definitions, terminology and 
epidemiology of prescribing errors, human error theory and causes of prescribing 
errors.  Chapter two describes the methods used in all four sections of this study, 
whilst the results and implications of each section of the study are presented in 
chapters three to six. Chapter seven summarises the key findings, discusses what 
the research adds, along with its strengths and limitations, and makes 
recommendations for future work. 
1.3 Definitions and terminology 
Studies have reported widely varying rates of medication errors.17  Although these 
differences may be partially explained by the setting of the study, nature of the 
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population, specialty, or health system studied, differences in the definitions and 
terminology used as well as methods of data collection have a significant impact on 
the reported prevalence of medication errors.74 As well as many individual 
interpretations of the same terms, multiple terms are also used for the same situation. 
For example the terms “near miss”, “potential adverse drug event” and “potential error” 
appear to be used interchangeably; whilst the term “near miss” can be used to refer 
both to an error that was intercepted before it reached the patient and one that 
reached the patient but did not cause patient harm.75 
In 2005, Yu et al explored the differences in functional meaning of medication safety 
terms defined on the websites of 33 organisations involved in medication safety.75 
Little uniformity was seen between organisations’ definitions of the same or related 
terms. The greatest diversity was seen with the group of terms representing ‘near 
miss’, with 12 definitions remaining even after similarly worded definitions were 
combined. The authors applied these 12 different definitions to four clinical scenarios 
involving a penicillin hypersensitivity reaction in order to determine the functional 
meaning of each definition. The same two scenarios were considered to fit within ten 
of the definitions. Only one scenario was considered to fall within each of the 
remaining two definitions, but in each case the included scenario was different. 
Therefore, three functional meanings were identified from the scenario assignments. 
This demonstrates the practical difficulties for clinicians and researchers in deciding 
whether or not an incident involving medication meets a particular definition, which 
has operational implications for incident reporting systems and highlights the 
importance of arriving at a universal language when communicating issues of 
medication safety. 
Five years later, Lisby et al published a systematic review of studies in hospital 
settings relating to medication errors or adverse drug events (ADEs).74 The 
researchers identified 203 potentially eligible studies relating to medication errors and 
ADEs; only 45 of which contained a generic definition of medication error, although a 
further 34 contained stage-specific error definitions relating to the tasks of prescribing, 
dispensing or administration. Surprisingly, the vast majority of studies (124/203; 61%) 
gave no definition.  Of the 45 definitions, 26 differed in wording and/or content. In 15 
the word ‘error’ occurred in the definition; yet one of the essential attributes of a 
definition is that it avoids circularity. A further 10 used the words ‘failure’ or ‘deviation’ 
whilst 17 studies used the definition developed by the National Coordinating Council 
for Medication Error Reporting and Prevention (NCC MERP).76 
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In 2012, Pintor-Marmol et al published a further systematic review of original studies 
and review articles which contained terms used in medication-related patient safety.77 
Sixty terms with 189 different definitions were identified referring to the process of 
medication use (23 terms), clinical outcomes of medication use (31 terms) or a 
combination of process and outcome (13 terms). The term most commonly used was 
medication error (22.7%), and the most frequently used definition of medication error 
was that proposed by the NCC MERP.76  
1.3.1 Definition of a medication error 
In 1993, as part of guidelines on preventing medication errors, the American Society 
of Hospital Pharmacists (ASHP) defined medication errors as: 
“episodes in drug misadventuring that should be preventable through 
effective systems controls involving, physicians and other prescribers, 
nurses, risk management personnel, legal counsel, administrators, 
patients and others in the organizational setting, as well as regulatory 
agencies and the pharmaceutical industry.”78    
The guidelines identified a short list of medication error types, but the definition, whilst 
listing elements of the system which may have a role in the progeny of an error, failed 
clearly to describe the role of individual practitioner’s actions, or the nature and 
consequences of an error.  
Other authors have defined medication errors in terms of a difference between what 
was ordered and what was administered.46,79–82 However, these fail to acknowledge 
that errors may occur in the process of prescribing and dispensing, as well as 
administration. In addition, were the person administering the drug to correct an error 
made by the prescriber, for example, to administer 250 micrograms of digoxin when 
the prescriber incorrectly ordered 250 mg, this would be considered an error with 
these definitions.  
The National Coordinating Council for Medication Error Reporting and Prevention 
defines a medication error as:  
"A medication error is any preventable event that may cause or lead to 
inappropriate medication use or patient harm while the medication is in 
the control of the health care professional, patient, or consumer. Such 
events may be related to professional practice, health care products, 
procedures, and systems, including prescribing; order communication; 
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product labeling [sic], packaging, and nomenclature; compounding; 
dispensing; distribution; administration; education; monitoring; and use."76  
This definition is comprehensive, taking into account all aspects of the processes 
involved in the use of medicines. The Council recommends that their definition is used 
by medication errors researchers, software developers, and institutions to identify 
errors. A systematic literature review of the definitions used in studies relating to 
medicines errors in hospitals, conducted by Lisby et al, found that the majority of the 
studies which contained a definition (17/45; 38%) used the NCC MERP definition, 
suggesting that it has been widely adopted, at least by researchers.74 The NCC MERP 
definition has now been adopted by the ASHP.83 
Ferner and Aronson have critiqued many of the existing definitions of medication 
error,83,84 including providing a detailed analysis of the essential attributes of a 
definition, and the methods by which a definition may be derived.24  They proposed a 
definition of medication error which is both stipulative and intentional, and has the 
advantage of being brief:  
“a failure in the treatment process that leads to, or has the potential to lead 
to, harm to the patient.”83  
The treatment process involves the use of any medicinal product for treatment, 
investigation or prevention of disease or physiological change. Medication errors can 
occur in any stage of the process involved in choosing a medicine, writing the 
prescription, manufacturing the formulation to be used, dispensing the product, 
administering or taking the medicine and monitoring therapy.85 
However, two systematic reviews which investigated the terminology used in relation 
to medication errors have found little evidence that the Ferner and Aronson definition 
is widely used.74,77  Indeed the only study cited by Pintor-Marmol et al77 as quoting 
their definition was one of their own articles.83 
Following their earlier systematic review of medication error definitions used in the 
literature,74 Lisby et al used a modified electronic Delphi technique to arrive at a 
consensus definition of medication error.86  Using five definitions derived from the 45 
generic definitions found in the systematic review, and including the Aronson and 
Ferner83 and NCC MERP76 definitions, a panel of experts drawn from 13 Danish 
healthcare organisation or chosen by the project group, reached consensus on the 
following definition:  
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“An error in the stages of the medication process - ordering, dispensing, 
and administering and monitoring the effect - causing harm or implying a 
risk of harming the patient” 
The expert panel also assessed the relevance as medication errors of 76 contextual 
or behavioural scenarios taken from the 282 different error type expressions identified 
during the literature review.74 Consensus was achieved with the majority of these, 
resulting in an index of 60 error types. The researchers applied the definition and error 
type index to the results of a previous study they had undertaken investigating the 
frequency, type and clinical consequences of medication errors in a Danish hospital.87 
Their original study identified 655 errors in 1,942 opportunities for error (34%). These 
were classified using a 4-point scale as potentially non-significant, potentially 
significant, potentially serious, or potentially fatal. As the newly agreed definition 
required harm or potential harm to have occurred for an incident to be considered a 
medication error, those incidents which had been categorised as potentially non-
significant and potentially significant were excluded. This resulted in a substantial 
reduction in the error rate to 7% (144/1,942). The authors suggest that the reduction 
seen in the reported error rate when using this definition and index of error types is of 
benefit allowing concentration on those errors which have the potential to cause harm. 
1.3.2 Other related terms 
Various authors have looked at the relationship between adverse events, adverse 
drug events/reactions and medication errors.24,40,83,88–91  
Adverse events 
An adverse event is an adverse outcome for the patient which, whilst it may occur 
while a patient is taking a drug, may or may not be attributable to it. Aronson and 
Ferner proposed the following definition:88 
“An adverse event is any abnormal sign, symptom, laboratory test, 
syndromic combination of such abnormalities, untoward or unplanned 
occurrence (e.g. an accident or unplanned pregnancy), or any unexpected 
deterioration in a concurrent illness.” 
Adverse drug reactions (ADRs)  
An adverse drug reaction, also sometimes referred to as an adverse drug event 
(ADE), is an adverse outcome which can be attributed to an action of a drug, with 
reasonable certainty. All adverse drug events are adverse effects, but not all adverse 
events are adverse drug events.  
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Although the WHO definition92 of an adverse drug reaction is widely accepted, it has 
been highlighted by some authors as having defects. The inclusion of the word 
‘noxious’ effectively excludes minor adverse effects which may be inconvenient but 
not harmful, and other definitions have been suggested.93,94 Aronson and Ferner 
highlight that the WHO definition and others exclude error as a source of adverse 
effect, and suggest the following definition:88 
“An appreciably harmful or unpleasant reaction, resulting from an 
intervention related to the use of a medicinal product; adverse effects 
usually predict hazard from future administration and warrant prevention, 
or specific treatment, or alteration of the dosage regimen, or withdrawal 
of the product”. 
Medication error 
Although multiple definitions have been suggested, the most concise was proposed 
by Ferner and Aronson:83  
“A medication error is a failure in the treatment process that leads to, or 
has the potential to lead to, harm to the patient.” 
This suggests that the treatment process has fallen below some attainable standard. 
The treatment process is intended to start from the point of the decision to treat and 
includes the processes of prescribing, transcribing (where relevant), manufacturing 
and compounding, dispensing and administration of a drug, and the monitoring of its 
effect.24,83  
Medication errors are considered to be preventable, and most do not result in harm 
to the patient. Errors may be intercepted before they reach the patient, may reach the 
patient unnoticed, and often go unreported even if they do reach the patient or are 
considered insignificant.53 In non-healthcare settings, it has been estimated that there 
is a ratio of one major injury and 29 minor injuries to 300 no-harm incidents.95  
The relationship between adverse events, adverse drug reactions, and medication 
errors is shown in Figure 1.2. Prescribing errors represent a subset of medication 
errors. 
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Source: Aronson & Ferner24,83,88 
Figure 1.2:   The relationship between adverse events, adverse drug reactions, and 
medication errors 
1.3.3 Definition of a prescribing error 
In order to be able to compare published evidence concerning the prevalence, 
incidence, and nature of prescribing errors consistent terminology is necessary. In a 
systematic review of literature from 1985 to 2007, Lewis et al identified 63 
publications, detailing 65 unique studies, which reported on the detection and rate of 
prescribing errors in adults and/or child hospital inpatients.17 Nearly a quarter of these 
(15/65; 23%) provided no definition of prescribing error, whilst nearly half (27/65; 42%) 
developed their own definition or modified definitions used in other studies. The most 
commonly used definition was that developed by Dean et al,25 which was used in 11 
of the studies (17%).  
Dean et al used a two-stage Delphi technique96,97 to arrive at a practitioner-led 
definition of a prescribing error which was tested against a number of clinical 
scenarios. A panel of physicians (9), surgeons (3), pharmacists (12), nurses (7), 
clinical pharmacologists (2) and an anaesthetist was purposively selected to include 
a wide range of healthcare professionals of different grade and clinical specialty. 
Individuals were also included based on their expertise in risk management or 
involvement in the study of prescribing errors. Use of the Delphi technique maximised 
the opportunity to identify consensus using a structured but flexible approach,  without 
the problems which can be associated with group decision making where the views 
of one or two participants dominate.98  The views of each panel member have equal 
weighting and each participant is anonymous to the rest of the panel. 
1. Adverse effects that are not reactions to a medicine 
2. Adverse drug reactions that 
are not due to errors 
4. Medication errors that 
cause events that are not 
ADRs 
 
5. Medication errors that 
don’t cause adverse 
events 
3. Adverse drug 
reactions due to 
medication errors 
2 + 3 = all adverse drug 
reactions 
 
3 + 4 + 5 = all medication 
errors 
 
3 = adverse drug reactions 
due to medication errors 
1. INTRODUCTION 
12 
 
Each panel member was asked to rate, using a numerical scale, a preliminary 
definition of prescribing error developed by the researchers and to suggest 
improvements. The median score (7.0) and interquartile range (6.5 - 8.0) suggested 
acceptance of the researchers’ preliminary definition. Panel members’ comments 
could be divided into three categories: whether prescribing decision-making errors 
should be included or considered part of the broader concept of clinical decision 
making; use of the word “significant” and differentiation between clinically meaningful 
errors and optimisation of treatment; and the need for a comparator when considering 
the risk of harm.  
Having taken the panel’s comments into account their finally adopted definition of a 
prescribing error was: 
“A clinical meaningful prescribing error occurs when, as a result of a 
prescribing decision or prescription writing process, there is an 
unintentional, significant (1) reduction in the probability of treatment being 
timely and effective or (2) increase in the risk of harm when compared 
with generally accepted practice”. 
Panel members were also asked to indicate agreement on whether or not 42 general 
scenarios represented a prescribing error. These were based on incidents from 
previous prescribing error studies and included a range with incident types that had 
been included in some studies but excluded from others and some with potential 
ambiguity. Panel members were asked to justify or qualify the scores they assigned 
with text. This first stage of the Delphi process resulted in consensus for 11 of the 
scenarios. 
In the second stage, panel members were asked to re-score those scenarios where 
no consensus had been reached. They were provided with the comments made by 
other panel members, and the median score and interquartile range for each scenario. 
This second stage resulted in consensus for a further 25 scenarios and partial 
agreement for the remaining six. The 27 situations that should be included as 
prescribing errors, seven which may be prescribing errors depending on the individual 
clinical situation, and eight that should not, are shown in Table 1.1, Table 1.2 and 
Table 1.3 respectively. Those situations which were considered to be prescribing 
errors involved prescribers not taking into account the patient’s clinical status or 
pharmaceutical issues, failing to communicate essential information, or making 
transcription errors. 
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Table 1.1:   Situations that should be considered prescribing errors 
Scenario 
Errors in 
decision 
making 
Prescription inappropriate for the patient 
Prescribing a drug for a patient for whom, as a result of a co-existing clinical condition, that drug is 
contraindicated 
Prescription of a drug to which the patient has a documented clinically significant allergy 
Not taking into account a potentially significant drug interaction 
Prescribing a drug in a dose that, according to the British National Formulary or data sheet 
recommendations, is inappropriate for the patient’s renal function 
Prescribing a drug with a narrow therapeutic index, in a dose predicted to give serum levels 
significantly above the desired therapeutic range 
Writing a prescription for a drug with a narrow therapeutic range in a dose predicted to give serum 
levels significantly below the desired therapeutic range 
Not altering the dose following steady-state serum levels significantly outside the therapeutic 
range 
Continuing a drug in the event of a clinically significant adverse drug reaction 
Prescribing two drugs for the same indication when only one of the drugs is necessary 
Prescribing a drug for which there is no indication for that patient 
Pharmaceutical issues 
Prescribing a drug to be given by intravenous infusion in a diluent that is incompatible with the 
drug prescribed 
Prescribing a drug to be infused via an intravenous peripheral line, in a concentration greater than 
that recommended for peripheral administration 
Errors in 
prescription 
writing 
Failure to communicate essential information 
Prescribing a drug, dose or route that is not that intended 
Writing illegibly 
Writing a drug’s name using abbreviations or other non-standard nomenclature 
Writing an ambiguous medication order 
Prescribing “one tablet” of a drug that is available in more than one strength of tablet 
Omission of the route of administration for a drug that can be given by more than one route 
Prescribing a drug to be given by intermittent intravenous infusion, without specifying the duration 
over which it is to be infused 
Omission of the prescriber’s signature 
Transcription errors 
On admission to hospital, unintentionally not prescribing a drug that the patient was taking prior to 
their admission 
Continuing a GP’s prescribing error when writing a patient’s drug chart on admission to hospital 
Transcribing a medication order incorrectly when rewriting a patient’s drug chart 
Prescribing “milligrams” when “micrograms” was intended 
Writing a prescription for discharge medication that unintentionally deviates from the medication 
prescribed on the inpatient drug chart 
On admission to hospital, writing a medication order than unintentionally deviates from the 
patient’s pre-admission prescription  
Source: Dean et al25  
The panel members identified a number of situations where the individual patient’s 
clinical situation was a deciding factor in whether a prescribing error had occurred or 
not. The role of conscious decision making and a reasoned rationale in arriving at the 
medication order was of particular importance, along with its potential consequences.  
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Table 1.2:   Situations that may be considered prescribing errors, depending on the 
individual clinical situation 
Scenario 
Prescribing a drug in a dose above the maximum dose recommended in the British National Formulary or 
datasheet 
Misspelling a drug name 
Prescribing a dose that cannot readily be administered using the dosage forms available 
Prescribing a dose regime (dose/frequency) that is not that recommended for the formulation prescribed 
Continuing a prescription for a longer duration than necessary 
Prescribing a drug that should be given at specific times in relation to meals without specifying this information on 
the prescription 
Unintentionally not prescribing a drug for a clinical condition for which medication is indicated 
Source: Dean et al25  
For example, the panel suggested that major misspelling of a drug, where there was 
a risk of ambiguity, should be a prescribing error, whereas minor misspelling should 
not. Other researchers have quantified this by considering misspelling to be a 
prescribing error if two or more letters are incorrect.99–101Non-adherence to local or 
national guidelines or the drug’s product licence were not considered prescribing 
errors. 
Table 1.3:   Situations that should be excluded as prescribing errors 
Scenario 
Prescribing by brand name (as opposed to generic name) 
Prescribing a drug without informing the patient of its uses and potential side effects 
Prescribing a drug for which there is no evidence of efficacy because the patient wishes it 
Prescribing for a child a drug that has no product license for use in children 
Prescribing a drug that is not in the hospital formulary 
Prescribing contrary to hospital treatment guidelines 
Prescribing contrary to national treatment guidelines 
Prescribing for an indication that is not in a drug product’s license 
Source: Dean et al25  
Ferner and Aronson24,83,102 were critical of the use of the Delphi technique to arrive at 
a definition, highlighting that it was designed to predict events rather than decide facts, 
is a “form of committee” and “allows consensus … by attrition”. However as Avery et al 
pointed out, validity is provided to the definition by its development involving the 
consensus of professionals, and it does not lack the credibility of some definitions, 
such as that of Betz and Levy32 which includes as a prescribing error “prescribing a 
medication without sufficient education of the patient” which would not be recognised 
by most practitioners. Ferner and Aronson also suggested that by including “clinically 
meaningful” in their definition, Dean et al were excluding errors which occurred during 
the decision-making or prescription writing process but do not result in harm, 
highlighting that it is desirable to detect all errors so that they can be examined for 
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potential systems weaknesses, which on another occasion may lead to a clinically 
relevant outcome. However, inclusion in their definition of the terms “reduction in the 
probability…” and “increase in the risk…” suggest that Dean et al intended it to include 
no-harm errors, and this is reflected in the list of situations which are, or may be, 
considered prescribing errors. 
Ferner and Aronson questioned the appropriateness of comparing against “generally 
accepted practice” as this may be poor, preferring instead an “attainable standard”.83 
However unless this is defined there is no baseline against which to compare practice. 
Finally, Ferner suggested that the hope that the definition would be taken up by others 
had not been realised,102 basing his claim on a survey of ADE reporting in US 
intensive care units.103  However, adverse drug events and prescribing errors are not 
the same and the requirements of incident reporting and research differ.104 The 2009 
systematic review of research investigating the prevalence, incidence, and nature of 
prescribing errors in hospital inpatients,17 identified that the Dean et al definition was 
the most commonly used; albeit in only 17% of studies, and their original paper 
continues to be regularly cited in more recent articles. In a systematic review of the 
literature on prescribing errors made by junior doctors, Ross et al described this 
definition as a “strong contender for the ‘ideal’ definition”21. 
1.4 The epidemiology of prescribing errors 
1.4.1 The prevalence and incidence of prescribing errors 
As part of a programme of research commissioned by the GMC (the EQUIP study18) 
into the rates of prescribing errors in hospitals and what might cause them, Lewis et al 
undertook a systematic review exploring the prevalence, incidence, and nature of 
prescribing errors in hospital inpatients.17 The authors searched a number of 
electronic databases for the period from 1985 to October 2007 for studies that 
reported the rate of prescribing errors in handwritten prescriptions written for adults 
and/or children. They restricted studies to those published in English but included 
systematic reviews, comparative and observational studies and abstracts which 
contained sufficient data to calculate prescribing error rates.  
They identified 65 studies, most of which were conducted in the US (25/65; 38%) or 
the UK (22/65; 34%). Despite performing a literature search covering more than 20 
years, more than two thirds of the studies (44/63; 70%) were published during the last 
seven years of the search period, demonstrating that interest in understanding the 
nature and scale of prescribing errors increased significantly after the publication of 
key documents50–53 on the subject of patient safety; this can be seen graphically in 
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Figure 1.3 which shows the chronological incidence of the studies found. A more 
recent systematic review of literature published since 2007 identified a further 12 
studies investigating prescribing errors in secondary care.6 
 
Figure 1.3:   Chronological incidence of prescribing error studies cited by Lewis et al 
Although the studies identified were extremely varied, the authors grouped them by 
the type of denominator in order to calculate median error rate and interquartile range. 
Most studies were prospective (58/65; 89%) rather than retrospective (7/65; 11%); 
and process-based (54/65; 83%), whereby data were collected by healthcare 
professionals reviewing prescriptions as part of their normal work. Only two studies 
were wholly outcome-based measuring actual patient harm (2/65; 3%). A proportion 
included process and outcome-based elements (9/65; 14%). 
Most of the studies analysed (33/65; 51%) reported the percentage of erroneous 
medication orders, with a median of 7% and an interquartile range of 2 - 14%. Just 
under one third (19/65; 29%) used errors per admission to describe the error rate, 
with a median of 52 and interquartile range of 8 - 227. The authors highlight that this 
wide range can be partially explained by the different means used for error detection, 
with very low rates identified by incident reporting and the highest rate as a result of 
combining three methods of error detection. Eleven studies (11/65; 17%) reported the 
incidence of errors in terms of patient days, with a median of 24 errors per 1000 patient 
days and an interquartile range of 6 - 212. Again, low incidence rates were detected 
by studies using incident reporting as the collection method. 
The study by Lewis et al was the first systematic review of the prevalence, incidence, 
and nature of prescribing errors in hospital inpatients, and demonstrated that errors 
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occurred in a median of 7% of medication orders, affecting 2% of patient days and 
50% of hospital admissions. However, Franklin et al105 expressed concern that the 
summary error rates produced in the review may be misleading due to the inclusion 
and exclusion criteria adopted, and the mixing of different methodologies when 
calculating the three grouped error rates. Franklin et al argued that conference 
abstracts and letters, which are unlikely to contain adequate information, along with 
studies based on incident reporting, which is known to result in very low error rates 
that significantly under-represent the problem,106,107 should be excluded. They also 
expressed surprise at the exclusion of studies which used an estimated 
denominator14,100,108,109 (including their own14,108), and the grouping of studies looking 
at different types of medication orders, as error rates may differ depending on the 
nature of the prescribing. Finally, they questioned the decision to conflate five different 
methods of identifying errors and ascertaining denominators and provide their own 
recalculation of the data on error rates with different inclusions and exclusions and 
grouping similar studies together (Table 1.4). 
Table 1.4:   Incidence of erroneous handwritten medication errors for hospital inpatients 
Denominator Numerator No of studies 
in this 
category 
Median 
error rate  
% (range) 
All medication orders entered into 
computer system by pharmacy staff (in a 
system where all medication orders have 
to be sent to pharmacy prior to 
administration) 
Errors identified in these 
medication orders by 
screening pharmacists 
11 2.7%  
(0.3 - 20.3) 
New medication orders screened for the 
first time by ward-based pharmacists 
(does not include medication orders that 
are not seen by ward pharmacists) 
Errors identified in these 
medication orders by 
ward-based pharmacists 
4* 9.9% 
(7.7 - 14.6) 
Medication orders (both new and 
existing) screened by ward-based 
pharmacists on the day(s) of the data 
collection. Each medication order may 
be counted more than once 
Errors identified in these 
medication orders by 
ward-based pharmacists 
4 4.6%  
(2.2 - 27.0) 
All medication orders written during the 
study period that were retrospectively 
reviewed by researchers 
Errors retrospectively 
identified by researchers in 
the medication orders 
reviewed 
2 8.0% 
(7.4 - 8.6) 
All medication orders written during the 
study period regardless of whether or not 
they were seen by ward pharmacists 
Errors identified by ward 
pharmacists 
2 2.7% 
(1.5 - 3.8) 
Figures in this table include studies excluded by Lewis et al on the basis of using an estimated denominator but 
exclude studies in which the methods used are unclear, those focussing only on discharge medication, those 
where it is not clear whether or not each medication order can be associated with more than one error, and those 
published only as abstracts or letters to the editor. 
*One reference included two separate studies 
Source: Franklin et al reworking of data from studies identified in Lewis et al systematic review17,105 
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However, the authors were agreed on the fact that “prescribing error research is an 
emerging research area”, and that there is “enormous methodological variation in the 
research being conducted to date”.110 
Further studies have looked particularly at the prevalence and causes of errors made 
by junior doctors, as in the acute hospital setting they account for a significant 
proportion of all prescriptions written.21,28,111–114  
1.4.2 Prescribing errors in mental health 
Compared with the extensive literature on the epidemiology and causes of prescribing 
errors in general acute, specialist acute, and to a lesser degree, primary care, very 
little research has been undertaken into medication errors in a psychiatric setting, and 
still less into prescribing errors.  
Six published literature reviews have attempted to summarise the evidence.115–120  
Grasso et al searched MEDLINE from 1966 to 2002 for articles relating to medication 
errors, ADRs and ADEs in psychiatry, as well as undertaking a hand search of 
bibliographies. Although unable to find any reports on medication error rates amongst 
psychiatric inpatients other than their own study published the same year,121 the 
authors noted that some of the key studies of ADEs in general acute medical/surgical 
settings identified instances associated with psychotropic medicines.39,42,44,122 In 2006, 
Grasso published a further review, commissioned by the US Institute of Medicine, to 
“review the results of studies in peer-reviewed journals over the last 10 years” relating 
to the incidence, severity, and costs of medication errors.116 Despite searching six 
citation databases, the author only identified two studies reporting medication errors; 
the earlier one led by himself and one by Senst et al from 2001.121,123 
Maidment et al undertook two systematic reviews, each searching the same five 
electronic databases for studies written between 1966 and the mid-2000s.117,118 The 
earlier review sought studies which investigated the incidence or cause of medication 
errors occurring as part of the medication management process in community or 
hospital-based mental healthcare services.117 The authors identified nine studies,99–
101,121,124–128 all of which were process-based, with significant differences in the rate of 
reported errors depending on the methods used to collect data. They found that most 
studies reported errors relating to the clerical aspects of prescribing, rather than those 
related to errors of clinical judgement or decision making. Of the nine studies 
identified, one investigated administration, dispensing, prescribing and transcription 
errors,121 and another only administration errors,126 two investigated administration, 
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dispensing and prescribing errors,124,125 and five investigated prescribing errors 
alone,99–101,127,128 one of which looked only at psychotropic prescribing.127 The authors 
noted that they found no studies which systematically examined the cause of 
medication errors in a mental health setting.117 
In their second review, Maidment et al concentrated on studies which investigated 
medication errors in older people with mental health problems.118 Eight studies were 
identified,99,101,124–127,129,130 of which six had also been included in the earlier 
review.99,101,124–127 Two studies related exclusively to administration errors,126,129 whilst 
prescribing errors, either alone or in combination with other error types were 
considered in the remaining six.99,101,124,125,127,130 The authors concluded that the use 
of very different definitions, denominators and methods made it impossible to produce 
overall error rates, although they did note that most of the data related to clerical 
prescribing errors, and administration errors of limited clinical significance.  
A more recent review, published in 2010 by Procyshyn et al,119 used four electronic 
databases to look at studies from 1999 onwards, using a variation on Cochrane’s 
Highly Sensitive Search Strategy131 in an attempt to retrieve a greater proportion of 
high-quality peer-reviewed publications.  This review identified a further four 
studies132–135 which were not retrieved in the Grasso or Maidment reviews, only one 
of which related to prescribing errors.133 
The most recent review, published in 2017 by Alshehri et al120 searched 10 electronic 
databases for studies published between 1999 and October 2016, identifying 14 
studies reporting data on prescribing errors. The review identified a further six 
studies,136–141 although two of these were abstracts from conference 
proceedings.137,141 
Primary studies 
Twenty-three publications report research into prescribing errors in mental 
health,99,100,134,136,137,139,140,142–146,101,147–149,121,124,125,127,128,130,133 whilst two others have 
looked specifically at discrepancies in the information held on medicines between 
primary and secondary care,150,151 and one publication considered discrepancies at 
the time of discharge.152  One study was published as both a conference abstract139 
and a journal article; only the article has been considered in detail.148  
Details of the 22 papers relating to prescribing errors are provided in Appendix 1 and 
described briefly below. Two papers reported on the same Japanese study,125,134 
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appearing to investigate errors in prescribing, dispensing and administration; 
however, all the reported data related to administration errors. Another Japanese 
study concentrated mainly on adverse drug events but measured medication errors 
as a secondary outcome; this provided only an overall rate of medication errors with 
the proportion due to prescribing.142  Of the remaining 19 studies, four were conducted 
in the USA,121,130,133,145 two in India,140,146 and one in each of Denmark,149 Pakistan,136 
Thailand,137 and Japan.144 Apart from differences in healthcare systems which may 
make it inappropriate to apply their findings to the UK, in the US in particular systems 
for prescribing differ from those in the UK. US prescribers write a medication order 
within the patient’s healthcare record, which is then transcribed by a nurse or aide to 
the medication administration record (MAR) before the supply is requested from the 
pharmacy.46,115,116 Therefore, the opportunities for errors are different to those in the 
UK. The remaining nine studies99–101,124,127,128,143,147,148 were conducted in the UK, with 
three99,100,143 undertaken within an exclusively private hospital setting.  
Three studies collected no denominator data so did not report an error rate.99,128,146 
Jhanjee et al reviewed 648 outpatient prescriptions in Delhi, using the WHO 
guidelines for prescription writing153 as a standard, and calculated the number that 
demonstrated each of 13 error types. However, no information was provided about 
the overall number of prescriptions containing at least one error, nor the overlap in 
errors seen.146 In 2002, Paton et al prospectively collected details of prescribing errors 
identified by psychiatric pharmacists within 12 NHS mental health trusts during the 
period of one month.128 Of the 557 errors detected, 58% were considered to be clinical 
(decision-making) errors, whilst 27% were clerical (prescription writing) in nature. 
Approximately twice as many errors involved psychotropic drugs as non-psychotropic 
drugs and 11% of all errors were considered to be potentially serious. A similar study 
was undertaken by Stubbs et al the following year and attributed 23%, a much lower 
proportion of errors, to decision making. They found an almost equivalent number of 
errors relating to psychotropic and non-psychotropic medication.99  
Another study, undertaken during 2002 at the same UK private hospital, identified 
only 13% of errors due to decision making, with 60% of errors relating to non-
psychotropic drugs. In that study, Haw et al used the total medication order numbers 
checked by pharmacists on four sample days to identify a denominator and calculated 
that errors were detected in 2.2% of prescribed items.100  
Nirodi et al127 in the UK, Rothschild et al130 in the US and Sahithi et al140 in India used 
patient episode and number of admissions to express prescribing errors. Nirodi et al 
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undertook a retrospective review of a sample of 112 patient records from two 
psychiatric units for the elderly and identified that only 18% of patient records were 
legible and error free.127 Rothschild et al prospectively collected data over a six-month 
period and found a prescribing error rate of 7.2 errors per 1000 patient days and 7.4 
errors per 100 admissions. They found a similar balance between errors involving 
psychotropic (70%) and non-psychotropic drugs (30%) to Paton et al.128 Sahithi et al 
prospectively collected data over a six-month period on medication errors in inpatients 
and outpatients who were receiving at least one psychotropic drug, and identified 72 
prescribing errors  affecting 59 patients, from a total study population of 166 patients 
giving an error rate of 0.4 prescribing errors per patient.140  
Shawahna and Rahman explored prescribing errors in psychiatry in a small sample 
of 15 inpatient cases.154 They identified 33 errors in the 84 medications prescribed for 
these patients, giving an error rate of 39.3%. However, the most common categories 
of errors that they found related to “order to break a delivery system that shouldn’t be 
broken” (9/33; 27.3%), and polypharmacy (7/33; 21.2%), factors that are unlikely to 
have been included in other studies of prescribing errors.  
A further study by Stubbs et al, involving eight NHS mental health trusts and one 
private hospital is one of only two multi-centre studies to provide a prescribing error 
rate.101 Pharmacists prospectively recorded prescribing errors detected as part of their 
routine work over 5 working days, as well as the total number of medication orders 
checked. The overall error rate found was 2.4%, with prescription writing errors 
accounting for 77% of errors and decision making for 23%. Almost equivalent 
proportions of psychotropic drugs (55%) and non-psychotropics (40.5%) were 
involved in errors, similar to at least one of the earlier studies.99 
The two most recent studies, by Keers et al, involved three NHS mental health 
trusts.147,148 In the first, data were prospectively collected on prescribing errors and 
omitted items in newly written prescriptions by pharmacists as part of their routine 
work over 10 data collection days.147 An overall error rate of 6.3% was found, with 
medicines omitted on admission to hospital the most common type of errors (12.5%). 
The authors analysed frequency of errors by prescriber grade and prescribing stage, 
identifying that specialty trainees had the highest prescribing error rate (6.8%), but 
were also responsible for the majority of newly written items; whilst junior doctors had 
error rates lower than their senior colleagues (FY1 5.1%; FY2 4.9%). Medication 
orders written on admission to hospital were associated with higher error rates 
(10.7%) than those written at other stages during the patient stay, including discharge. 
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In their second study, Keers et al identified prescribing errors, clerical errors, and 
communication issues occurring in discharge prescriptions screened during a six 
week period.148 They found that 81% of discharges were affected by at least one error, 
with 5.1% of individual medication orders containing an error, more than half of which 
(52.9%) were considered to be clinically relevant, and 5.4% to be potentially serious. 
The two remaining UK studies,124,143 one Japanese study,144 and one US study145 
analysed medication events reported via the organisations’ incident reporting 
schemes. All reported very small numbers of prescribing errors which, on the basis of 
studies that compared errors detected by active methods with spontaneous reporting 
schemes,121,155 are likely to be very significant under-estimates. 
The results of the key UK studies are summarised in Table 1.5. 
Table 1.5:   Prescribing errors identified in studies within UK mental health facilities 
 Overall 
error rate 
(%) 
Decision-
making 
errors  
(%) 
Prescription 
writing 
errors 
(%) 
Errors 
involving 
psycho-
tropics 
(%) 
Errors 
involving 
non-
psycho-
tropics 
(%) 
Haw et al, 2003100 2.2% 12.5% 87.5% 39.8% 60.1% 
Paton et al, 2003128 - - - 67.7% 32.3% 
Stubbs et al, 200499 - 23.7% 76.3% 52.6% 47.4% 
Stubbs et al, 2006101 2.4% 22.6% 77.4% 55.3% 40.5% 
Keers et al, 2014147 6.3% - - - - 
Keers et al, 2015148 
(discharge prescriptions only) 5.1% - - - - 
1.5 Human error theory 
Human error can be defined as the failure of planned actions to achieve their desired 
ends - without the intervention of some unforeseeable event.23 It is routinely cited as 
the main cause or a contributing factor in accidents in a diverse range of industries, 
with the person or people most obviously linked to the incident blamed. However, this 
oversimplifies the real situation; detailed analysis of an incident usually reveals a 
number of events and deviations from safe practice, each influenced by the working 
environment and wider organisational context.156 
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Reason’s model of organisational accident causation23,157 was originally developed 
for use in complex industrial systems and is one of the most influential and frequently 
cited models of systems safety.158 It has been successfully adapted156,159,160 and 
expanded161,162 to take into account the unique characteristics of healthcare systems. 
The aetiology of organisational accidents is described in terms of four contributory 
concepts23,47,49,157,163 (see Figure 1.4): 
• Active failures 
• Latent failures 
• Error-producing conditions 
• Defences/barriers 
Accidents in healthcare, other industries, and our personal lives do not happen in 
isolation and need to be viewed from a comprehensive systems perspective if they 
are to be understood. Whilst the actions and failures of an individual person or group 
of people may play a fundamental part, their thinking and behaviour are influenced by 
their immediate work setting and wider organisational policies and procedures.  
 
Sources: Reason, Vincent, Taylor-Adams47,160,164  
Figure 1.4:   Organisational accident causation model 
1.5.1 Active failures 
In his analysis of error types, Reason divided active failures into those which result 
from unintended actions and those which result from intended actions. These are 
represented graphically in Figure 1.5. Effectively, intended actions (mistakes and 
violations) are the result of a conscious decision, whether or not that decision was 
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based on incorrect or incomplete information, or motivated by specific circumstances. 
Unintended actions (slips and lapses) tend to occur during the largely automatic 
performance of a routine task, usually in familiar surroundings.47  
 
Figure 1.5:   Error types 
Slips and lapses 
Slips are errors of observable action; where there is an error in executing a perfectly 
good plan, resulting in an action that was not what was intended (such as ‘slip of the 
tongue’ or ‘slip of the pen’). Everyone is prone to slips of this kind in everyday life, 
such as putting the cereal box in the fridge instead of the cupboard, and usually realise 
the slip very quickly. They are associated with attentional failure, arising either from 
the surroundings, or the individual’s internal preoccupations with something else. 
Medication-related examples of slips and lapses are given in Table 1.6 
Errors of this type caused by distractions and interruptions are generally difficult to 
eliminate completely but can be controlled. For example, many hospitals now provide 
the nurse undertaking the drug administration round with a coloured tabard to remind 
others not to disturb them during this important task.165  
Technical errors are a failure of skill, and as such are errors in executing a plan, e.g. 
inserting a cannula or making up an infusion. Therefore, they are a subset of slips. 
Lapses are covert slips, involving errors of internal action, and are associated with 
failures of memory. They may only be apparent to the person who makes the lapse.  
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Table 1.6:   Error types with medication-related examples 
Type of error Examples 
Mistakes 
Knowledge-based 
 
 
 
 
 
 
 
 
Rule-based 
mistakenly applying a good  
rule 
 
 
 
 
 
 
 
 
 
 
 
applying a bad rule or failing to 
apply a good rule 
 
- Giving penicillin, without having established whether the patient is 
allergic 
- Knowing that the patient is allergic to penicillin but not knowing that co-
fluampicil contains a penicillin 
- Being unaware of the value of sodium bicarbonate in amitriptyline 
poisoning 
- Continuing to give amiodarone at the loading dose after 2 weeks 
- Initiating pregabalin at 75 mg daily when severe renal impairment 
required a dose reduction to 25 mg daily 
 
- Injecting diclofenac into the lateral thigh (the usually preferred site for 
intramuscular injections) rather than the buttock (which is preferred for 
diclofenac) 
- Following a treatment regimen for a 10 to 15-year-old child for a child 
who is just 10 and very small for age resulting in an effective overdose 
which causes an adverse effect 
- Prescribing oral treatment for a patient with dysphagia  
- Prescribing trimethoprim in a patient whose mid-stream urine sample 
suggested resistance to the drug 
- Prescribing ciprofloxacin for a urinary tract infection without 
considering the interaction with duloxetine which is already prescribed 
- Prescribing tramadol in a brain injury patient with seizures without 
considering the seizure lowering potential 
 
- Using excessive doses of captopril (as was done during early use of 
the drug) 
- Prescribing amoxicillin for sore throat 
- Prolonging antibacterial treatment unnecessarily 
- Duplicating the prescription for co-amoxiclav 
- Prescribing medication based on a patient’s previous admission, so the 
prescription was invalid 
Skill-based errors 
Action-based (slips) 
 
 
 
 
 
 
 
 
 
 
     technical errors  
 
Memory-based (lapses) 
 
- Intending to write ‘chlorpromazine’ but instead writing the more familiar 
chlorpropamide 
- scrawling ‘chlorpromazine’ which is misread as ‘chlorpropamide’ 
- picking a pack containing chlorpromazine from the pharmacy shelf 
when intending to take one containing chlorpropamide 
- A prescriber who habitually uses pethidine 100 mg for postoperative 
analgesia automatically writing morphine 100 mg 
- 150 tablets selected instead of 150 mg during computerised drug 
selection 
- selecting ceftriaxone instead of cefuroxime 
 
- Putting the wrong amount of acetylcysteine in an infusion 
 
- Giving penicillin, knowing the patient to be allergic, but forgetting 
- A nurse, having already added potassium chloride 20 mmol/l to an 
infusion bag, forgetting having done so and adding more potassium 
chloride 
- Omitting a date on which to stop treatment 
- Intending to stop doxycycline but unintentionally continuing it. 
Sources: Ferner, Aronson, NPSA24,83,166,167 
Mistakes 
Whilst slips and lapses are errors in executing a correctly planned action, mistakes 
are errors in planning the action in the first place. Here the plan is inadequate to 
achieve its intended outcome, and the failure lies at a higher level: the mental 
processes involved in assessing the available information, planning, formulating 
intentions and judging the likely consequences.23,47  
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Mistakes can be subdivided into those that result from ignorance (knowledge-based 
errors), and those that are the result of a failure to apply a rule, guideline or procedure 
(rule-based errors). Mistakes are therefore more subtle, more complex, less well 
understood, harder to detect, and generally constitute a greater danger.47 Medication-
related examples of mistakes are given in Table 1.6. 
Knowledge-based errors usually occur in novel situations, where the solution to the 
problem is not already stored in memory or has lapsed due to lack of use and has to 
be worked out from first principles. 
Violations 
As Vincent states, errors are, by definition, “unintended in the sense that we do not 
want to make errors”.47 By contrast, violations are deliberate deviations from safe 
operating practice, procedures or standards. In relation to human error theory Reason 
defines violations as “deliberate, but not necessarily reprehensible, deviations from 
those practices deemed necessary to maintain the safe operation of a potentially 
hazardous system”.23,157 
Violations fall into three main categories157,164: 
• Routine - taking short-cuts in skill-based performance whenever the 
opportunity arises, such that over time the violation tacitly becomes accepted 
practice  
• Optimising - taking actions to further personal rather than task-related goals 
(violating for the thrill of it) 
• Situational - flouting the rules when it is seen as the only way of getting the job 
done because the rules or procedures seem inappropriate for the present 
situation. They may occur in exceptional situations, may involve situations 
where the opportunity for harm is foreseeable and ignored, and may become 
accepted practice over time. 
In contrast to errors, which are related to attentional and informational problems, 
violations tend to be associated with motivational issues such as low morale, poor 
role models and inadequate management.156 
Malicious violations are not errors, but occur where the intention is to cause harm, 
such as deliberate sabotage. These are uncommon but the outcome can be 
devastating, e.g. the actions of Harold Shipman,168 Beverley Allitt,169 and Victorino 
Chua.170 
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1.5.2 Latent failures 
Latent failures are the organisational processes that create an environment where 
active failures and error producing conditions are more likely to result in errors; they 
influence staff performance and may precipitate errors.156 Examples include poor 
design, gaps in supervision, undetected maintenance failures, unworkable 
procedures, clumsy automation, training shortfalls, inadequate equipment, and 
organisational processes (i.e. decisions relating to planning, scheduling, forecasting, 
designing, policy making, communicating, or regulating).164  
Reason compares them to resident pathogens within the human body as these latent 
failures “may be present for many years before they combine with local circumstances 
to penetrate the systems many layers of defences.”23,157 He acknowledges that 
management and organisational decisions are shaped by economic, political and 
operational constraints and that the healthcare system involves many interdependent 
organisations including government agencies, professional and patient organisations 
which have an influence on the operation of an individual organisation.164 
1.5.3 Error-producing conditions 
Latent failures created by organisational processes and management decisions 
impact on operations within the workplace to create the conditions necessary to 
promote the occurrence of errors and violations - for example, understaffing, high 
workload or poor communication.164  
Vincent et al extended Reason’s model and adapted it for use in a healthcare 
environment,156,159,160 classifying error-producing conditions and organisational 
factors (latent failures) into a single broad framework of factors affecting clinical 
practice which they refer to as the “seven levels of safety” (see Table 1.7).  
Table 1.7:   Contributory factors that influence clinical practice 
Factor type Contributory influencing factor 
Patient factors Condition (complexity and seriousness) 
Language and communication 
Personality and social factors 
Task and technology factors Task design and clarity of structure 
Availability of protocols 
Availability and accuracy of test results 
Decision-making aids 
Individual (staff) factors Knowledge and skills 
Competence 
Physical and mental health 
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Table 1.7:   Contributory factors that influence clinical practice (continued) 
Factor type Contributory influencing factor 
Team factors Verbal communication 
Written communication 
Supervision and seeking help 
Team leadership 
Work environment factors Staffing levels and skill mix 
Workload and shift patterns 
Design, availability, and maintenance of equipment 
Administrative and managerial support 
Physical environment 
Organisational and management factors Financial resources and constraints 
Organisational structure 
Policy, standards, and goals 
Safety culture and priorities 
Institutional context factors Economic and regulatory context 
National Health Service Executive* 
Links with external organisations 
Source: Vincent et al 47,156 
1.5.4 Defences/barriers 
Defences are the ways in which systems ensure safety. These are usually particular 
administrative, physical or other barriers that protect or guard against deviations from 
normal practice. For example, the checking of medicines by a second nurse before 
administration or the checking of prescriptions by a ward pharmacist to intercept 
prescribing errors. 
In an ideal world, all layers of defence would be intact, preventing penetration by 
possible accident trajectories (see Figure 1.4). However, each layer of defence may 
contain gaps or weaknesses, which are in constant flux. Particular defences may be 
removed deliberately during maintenance or testing, or due to errors or violations.157 
These ‘holes’ in the system provide an opportunity for incidents to occur without being 
prevented by the defensive system.  
This “Swiss Cheese” metaphor is commonly used to describe defensive 
systems.47,49,157 Like slices of Swiss cheese, each defensive layer has many holes, 
although these are constantly opening, closing and shifting position. The holes in one 
“slice” do not usually result in an incident as the presence of intact defences in other 
“slices” prevent it. However, when the holes in many layers of defence temporarily 
align to permit a “trajectory of accident opportunity” an incident can occur49 (see 
Figure 1.6). 
                                               
* Relevant at the time of publication but would now be Department of Health and Social Care and/or NHS 
England 
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Source: Vincent (adapted from Reason)47 
Figure 1.6:   ‘Swiss Cheese’ model 
Vincent used this analogy47 to describe the circumstances, in 2001, which led to the 
death of a patient as a result of the correct administration by the intrathecal route of 
the chemotherapy drug cytosine, being erroneously followed by injection of a second 
chemotherapy drug, vincristine, which must only be given intravenously.47,171 
Defences and barriers existed; cytosine and vincristine were usually administered on 
separate days, the drugs were stored separately in pharmacy and sent separately to 
the ward from the pharmacy, with two doctors checking labels and doses prior to 
administration. However, on this occasion, a series of defences and barriers were all 
breached at one time with disastrous consequences.  
1.6 Causes of prescribing errors 
Although considerable quantitative research has been undertaken looking at the 
prevalence of prescribing errors, relatively little has explored the reasons that underlie 
errors. As part of a programme of research commissioned by the GMC (the EQUIP 
study)18 into the rates of prescribing errors in hospitals and what might cause them, 
Tully et al undertook a systematic review exploring the causes of and factors 
associated with prescribing errors in hospital inpatients.172 The authors searched a 
number of electronic databases for the period from 1985 to July 2008 for studies that 
reported on the causes of and/or factors associated with prescribing errors in 
handwritten prescriptions. They restricted studies to those published in English and 
excluded studies where causality or associated factors were surmised, restricting 
those included to studies which containing empirical data. They identified 17 
publications, detailing the findings of 16 studies, most of which were conducted in the 
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US (7/16; 43%) or the UK (3/16; 19%). Despite performing a literature search covering 
more than 20 years from 1985, more than two-thirds of the studies (11/16; 69%) were 
published since 2000. Seven studies reported on the causes of prescribing 
errors15,26,27,173–176 and nine on factors associated with them.16,44,174,177–184  Other 
studies investigating the causes of prescribing errors and factors contributing to them 
in a hospital setting have been published since the Tully et al review.28,113,114,185–190  
1.6.1 Contributory factors  
Whilst the opinion of researchers or a general cross-section of healthcare 
professionals has been used in some studies to categorise an assumed cause for 
errors,13,28,111 those that have interviewed the prescriber him/herself about a specific 
prescribing error are likely to have gained the greatest insight into the causes of error. 
For example, only the person who made the error will know whether they were 
distracted resulting in a slip in attention or lacked the knowledge which led to a 
mistake.   
Studies which have conducted an in-depth analysis of the causes of a particular error, 
through qualitative interview with the prescriber or by direct observation, have 
identified that for each error there are often multiple causes.18,26,27,113,175,188,189 These 
can be categorised using the ‘seven levels of safety’ model developed by Vincent et al 
(see Table 1.8), based on Reason’s model of accident causation.23,157 
Prescribers have reported lack of knowledge about the patient,15,18,26,104,190 their 
condition,26,27,113,185,189,190 and medication15,28,104,113,174,185,187–190 as contributory factors to 
making errors. Much of the research has been undertaken with junior 
doctors,18,19,26,28,113,185,187,189 and this has been reported to be particularly the case 
when they move to a new training rotation or are on call.18,27,187,188 Individual factors 
such as hunger and thirst,18,26,27 tiredness,18,27,185,187–190 and excessive workload18,26–
28,104,113,185,187–190 have all been reported in connection with errors.  
There is far less literature available on the causes of error than on their epidemiology.  
What has been published may not be fully representative of the situation in a mental 
health setting. Much of the work has been undertaken with junior doctors who 
represent a much smaller proportion of the medical workforce in a mental health 
setting than in acute care. Existing studies have been undertaken within acute hospital 
settings12,18,26–28,113,185,187–189 or primary care190 environments which may contain 
different contributory factors. No study has investigated the causes of and factors 
contributing to prescribing errors in a mental health setting.  
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Table 1.8:   Contributory factors identified in qualitative prescribing error studies 
Factor type Contributory influencing factor 
Patient factors ‘Difficult’ patients27,190 
Clinically complex cases/polypharmacy26,27,104,113,185,189,190 
Language/communication problems26,27,189 
Unfamiliar patients15,18,26,104,190 
Pressure from patient/relatives18,28 
Poor/wrong information provided by patient18,113 
Task and technology 
factors 
Unavailability of protocols/guidelines/reference sources27,185,188,189 
Task outside normal routine27,185 
Another person’s error/violation (‘following orders’)18,26,28,113,185,187 
Inadequate patient information (e.g. weight, pre-admission drugs, test results)113,185,189 
Fragmentation of tasks/poor completion by the previous person113 
Individual (staff) 
factors 
Physical health 
• Tired18,27,185,187–190 or hungry/thirsty18,26,27 
• Unwell27 
Mental well being27 
• Feeling flustered/confusion18,185 
• Boredom, lack of concentration18 
• Stress/anxiety18,104,188–190 
• Low morale/poor motivation26,185,189 
Personal issues188 
Skills and knowledge15,28,104,113,174,185,187–190 
• Lack of training15,26,27,185 
• Lack of experience/expertise18,26,27,187 
• Calculations27 
• Familiarity with brand names27 
• Not double checking/“thought they knew”18,187 
• Unaware of role of pharmacy services18,187 
Multitasking18,26,113,187,188 
Ignoring ePrescribing alerts18 
Rule violations15,18,104,174,185 
Team factors Poor communication15,104,113,190 
• Poor handwriting27 
• Not documenting/wrong allergy information 18,27 
• Inept crossing off of prescriptions27 
• Absence of documentation in the patient’s notes27,113 
• Wrong documentation in the patient’s notes18 
• Missing drug charts27 
Inadequate supervision/senior support18,26–28,187,188 
Poorly defined responsibilities18,27,28,104,190 
Pressure from nurses/other staff18,104,113,188 
Work environment 
factors 
Staffing issues 
• Inadequate staffing levels18,27,189 
• New or locum staff27,189 
• Dealing with another doctor’s patient/on-call18,27,187,188 
Heavy workload/working longer than rostered/time pressures18,26–28,104,113,185,187–190 
Physical environment (cramped, hectic, noisy, distractions, interruptions)26–28,104,185,188–190 
Design of ePrescribing system18,104,175,190/drug chart18,26,28 
Unfamiliar setting/new post18,28 
Organisational and 
management factors 
Lack of importance placed on the task of prescribing18,27 
Transcription (re-writing charts) not seen as prescribing27,113 
Culture of not questioning decisions/instructions of senior doctors26,27,187 
Culture of not asking for clarification if unsure26,27,187 
Institutional context 
factors 
Communication between healthcare settings104 
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1.7 Clinical decision making 
Work in the field of cognitive psychology over the last 15-20 years has led to the 
development of a number of models for clinical reasoning and decision making known 
collectively as ‘dual process theories’.54 Various research groups have identified the 
existence of dual processing models of reasoning, although some researchers have 
argued for a three-stage model.191,192 Although the terminology varies between the 
proposed models, all have a strong resemblance to each other and all propose two 
cognitive modes, types or systems of information processing underlying 
reasoning.192–198   
1.7.1 Dual process theory 
Whether referred to as ‘experiential’ and ‘rational’,199,200 ‘associative’ and ‘rule-
based’,193 ‘heuristic’ and ‘analytical’,195 ‘Type 1’ and ‘Type 2’,201 or ‘System 1’ and 
‘System 2’,202–205 the characteristics of the two processes are similar (see Table 1.9), 
although Sloman warns that it may not be easy to decide which system is responsible 
for a given answer.193  
Table 1.9:   Characteristics of System 1 and System 2 decision-making processes 
 System 1 System 2 
Cognitive style Heuristic, intuitive, 
associative, concrete 
Analytical, normative, 
deductive, abstract 
Processing Parallel, multiple Serial, linear 
Responsiveness Passive Active 
Cognitive awareness/control Low High 
Action Reflexive, skilled Deliberate, rule-based 
Rate Fast Slow 
Effort Minimal Considerable 
Automaticity High Low 
Vulnerability to bias Yes Less so 
Sources: Croskerry,202–204 Evans205 
Dual process theory-based models distinguish between two cognitive systems – the 
fast, intuitive and automatic thinking of ‘System 1’ and the careful, rational and 
analytical thinking of ‘System 2’.204,206 System 1 and System 2 approaches are used 
in all areas of clinical decision making from diagnosis to decisions about clinical 
management, including drug therapy. Simplistically, routine problems, where there is 
a higher level of certainty, will more often be dealt with by the intuitive System 1, 
especially if time is short. The analytical System 2 will be engaged when the situation 
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is complex, time is available, the decision maker faces ambiguity or a non-routine 
situation, there are high-stakes outcomes, or in a context of uncertainty.54 
Functional magnetic resonance imaging (fMRI) has shown that System 1 and System 
2 thinking are associated with different areas of the brain, and patients with certain 
neurological disorders associated with damage to specific areas of the brain show 
difficulty with intuitive thinking. Neurophysiological studies in monkeys have shown 
similar functional distinctions.72,204 Hruska et al observed differences in the neural 
areas activated in novices and experts during clinical decision making when 
diagnosing hard, but not easy, clinical cases. Novices demonstrated activation of 
neural regions associated with factual rule-based knowledge, whereas experts 
demonstrated activation of neural regions associated with experiential knowledge. 
They also observed that novices demonstrated increased activation of the neural 
regions associated with working memory compared with experts.207,208 Melo et al 
using fMRI found similarities between the responses during diagnosing disease, 
prescribing,  and naming animals and objects based on written stimuli, suggesting 
involvement of similar pathways.209  
Affect is also intrinsically linked to the ability to process information and make 
decisions - stress, fatigue, personal problems, and other factors have all been 
demonstrated to impact decision making,18 as can organisational processes and 
error-provoking conditions.23,26 Croskerry notes that affect is inseparable from thinking 
and that there are numerous affective ‘biases’ that influence decision making, 
including overconfidence, self-deception, disillusionment, complacency and lack of 
motivation (see Appendix 2).54,204,210 Masicampo and Baumeister demonstrated that 
the two thinking modes are not simply a psychological theory but has a physiological 
basis, showing that the ingestion of sugar can reduce reliance on intuitive, heuristic-
based decision making and result in more analytical processing.211  
Croskerry has written extensively about the role of cognition66,67,210,212,213 and dual 
process theory in diagnosis,202–204,214 describing the principal modus operandi of the 
dual process theory model as pattern recognition204 (see Figure 1.7). He postulates 
that repeated presentations of the same problem to System 2 will eventually lead to 
the decision being relegated to System 1 - the development of automaticity through 
familiarity and practice. System 2 can exert an executive function and override the 
impulsive output of System 1; however, System 1 can also override System 2 leading 
to decisions against one’s better judgement (“dysrationalia”).214 He states that most 
errors in decision making occur when System 1 processing takes place.  
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Source: Croskerry,202–204 
Figure 1.7:   Model for reasoning based on dual process theory 
However, researchers do not agree about the culpability of intuitive System 1 in 
relation to errors.  Norman et al challenge the view that analytical reasoning is ‘good’ 
and intuitive reasoning is ‘bad’ which they state is dominant in diagnostic error 
literature, citing studies which have shown that analytical approaches can be inferior 
to System 1 methods and that both can be prone to errors. They caution against 
encouraging clinicians to avoid any form of System 1 or heuristic thinking, stating that 
System 1 thinking is both efficient and effective and that analytical thinking, because 
of its cognitive load, may lead to inferior solutions.71,72,215  Groves et al reported that 
expert general practitioners (GPs) made more errors in data gathering and 
interpretation than novices, but were more accurate overall because they generated 
a better hypothesis. He postulated that this was because these clinicians reasoned 
intuitively using relatively few clinical data, whilst the less experienced appeared to 
adopt a more thorough, but less efficient and intuitive, approach to the clinical 
reasoning process.216 Norman et al suggest that a critical component of expert and 
novice diagnostic reasoning is a similarity to previously encountered examples. 
Context 
Ambient conditions 
Task difficulty 
Task ambiguity 
Affective state 
Modular responsivity 
Intellectual ability 
Education 
Training 
Critical thinking 
Logical competence 
Rationality 
Feedback 
Patient 
Problem 
System 
1 
System 
2 
Pattern 
Processor 
Repetition 
Pattern 
Recognition 
NOT 
RECOGNISED 
RECOGNISED 
Rational 
override 
Dysrationalia 
override Calibration Solution T 
The model is linear, running from left to right. The initial presentation of 
illness is either recognised or not by the observer. If it is recognised, the 
parallel fast, automatic processes of System 1 engage, whereas if it is 
not, the slower, analytical processes of System 2 engage instead. 
Determinants of System 1 and 2 processes are shown in dotted line 
boxes. Repetitive processing in System 2 leads to recognition and default 
to System 1 processing. Either system may override the other. A 
System 1 response may proceed directly to a diagnosis, or the outputs 
from both systems pass into a calibrator where interaction occurs to 
produce the final diagnosis. A ‘cognitive miser’ function prevails – the 
tendency to default to a state that consumes fewer cognitive resources. 
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However, they acknowledge that reasoning cannot be non-analytic all the time, and 
that use of both non-analytical reasoning, and analytical knowledge can lead to 
improved accuracy over either used alone.217 They have also suggested that the 
challenge for clinicians is to determine when they should trust their intuition and when 
to slow down and think deliberatively.218 
Similar views have been expressed by Evans,205 who has also highlighted the link 
between System 2 and working memory capacity which varies between individuals, 
and is linked to general intelligence and cognitive ability, increases with age during 
childhood and declines in old age.194 He suggests that “whereas the heuristic system 
supplies hypothesis, it is the task of the analytic system to evaluate them, and if need 
be, modify or replace them” highlighting that a key issue is whether systems are 
parallel, sequential or interactive,195 and whether there are actually multiple kinds of 
type 1 processes.205  
Choosing the correct therapy for a patient is an essential component of the medical 
activities that lead to an effective, safe and suitable treatment. Bissessur et al describe 
therapeutic reasoning as the step in clinical reasoning that pertains to the choice of 
therapy and highlighted that it has received little attention,219 whilst various 
researchers have highlighted deficiencies in the teaching of therapeutic reasoning, or 
the abilities of newly qualified doctors to demonstrate it.59,220–224 In less experienced 
prescribers, such as medical students or newly qualified doctors, slow and relatively 
time-consuming analytical reasoning is carried out consciously and systematically, 
often with reference to the evidence base. As experience grows with repeated 
exposure to situations, pattern recognition leads to the development of rapid and 
subconscious non-analytical reasoning. However, even an experienced practitioner 
will need to revert to analytical reasoning  when faced with a complex or novel case.59 
The interactions between System 1 and System 2 are referred to as ‘calibration’, with 
the opportunity for System 2 to override the automatic responses of System 1. As 
Fagan in the musical Oliver! demonstrates when finding impulsive System 1 ideas 
appealing but rejecting them by “reviewing the situation”.214 Various strategies have 
been suggested to improve clinical reasoning, including improving knowledge about 
cognitive processes, metacognition (the ability to stand back from one’s own thinking, 
observe it, and recognise opportunities to use interventional thinking strategies, or to 
literally stop, think and mentally challenge the first impression formed before finally 
committing to a decision), and cognitive forcing strategies.212,225 
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1.7.2 Validated scales 
Notwithstanding the exact construct of dual process theory, or whether it is correct, 
an individual’s tendency towards rational vs. experiential (intuitive) type thinking can 
be measured using personality tests.200,226 In the early 1990s Epstein and fellow 
researchers developed a theory of personality termed the Cognitive-Experiential Self-
Theory (CEST) which proposed that information is processed by two parallel, 
interacting systems: one rational and the other experiential.199 Although both systems 
are used by people when making a decision, which system individuals use 
predominantly differs.227 The tools used in this study are described below. 
1.7.2.1 Cognitive Reflection Test 
The ‘Cognitive Reflection Test’ (CRT)226 is designed to test participants’ ability to 
suppress the intuitive, spontaneous answer which springs ‘impulsively’ to mind, in 
favour of a more reflective or rational response. Although it has been criticised as 
being influenced by numerical ability,228 it has been found to be a better predictor of 
rational thinking that either intelligence measures or measures of executive 
functioning.229  
The original version of the CRT presented three problems found to frequently yield 
‘intuitive’ wrong answers: 
• A bat and a ball cost $1.10 in total. The bat costs $1.00 more than the ball. How much 
does the ball costs?  ______ cents 
• If it takes 5 machines 5 minutes to make 5 widgets, how long would it take 100 
machines to make 100 widgets?  _______ minutes 
• In a lake, there is a patch of lily pads. Every day, the patch doubles in size. It takes 
48 days for the patch to cover the entire lake, how long would it take the patch to 
cover half of the lake? _____ days 
These three items have become increasingly well known – especially the bat-and-ball 
problem, which has been used in many classroom situations and appeared in many 
books and journals. 
1.7.2.2 Rational Experiential Inventory 
The ‘Rational Experiential Inventory’ (REI-40)200 is a 40-item instrument designed to 
measure an individual’s propensity for rational and experiential decision making, 
which link to the two types of thinking postulated in dual process theory. It has been 
used in various populations of healthcare professionals including cardiologists,230 
physicians,231–234 paramedics and student paramedics,235 student pharmacists,236,237 
and doctors, nurses and managers.238  
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The instrument contains subscales for ability and engagement with rationality and 
experientiality, each measured by 10 questions: 
• Rational ability refers to how well people believe they use logical and 
analytical thinking (e.g. “I have a logical mind.”) 
• Rational engagement refers to perceived reliance on and enjoyment of using 
local and analytical thinking (e.g. “I enjoy intellectual challenges.”) 
• Experiential ability refers to how well people believe they use their intuitive 
impressions and feelings (e.g. “I believe in trusting my hunches.”) 
• Experiential engagement refers to perceived reliance on and enjoyment of 
using feelings and intuitions (e.g. “I tend to use my heart as a guide for my 
actions.”) 
Ability subscales assess how well people believed they use each disposition, while 
engagement subscales assess reliance on and enjoyment of the disposition. Each 
item is measured on a 5-point Likert scale ranging from “strongly disagree” (1) to 
“strongly agree” (5) with a balanced number of positively and negatively worded items 
on each scale, and some items requiring reversed scoring. Scores are averaged to 
provide a composite score for each scale and subscale, with a higher score reflecting 
a greater tendency to endorse the thinking style.  
1.7.2.3 Need for Cognition Scale 
The ‘Need for Cognition Scale’ (NCS) contains items that focus on engagement in, 
and enjoyment of, cognitive activity, and is a measure of information processing, 
thinking, and judgement. Thus the scale relates to individual differences in rational 
processing and is considered to be predictive of the way in which people deal with 
tasks and social information. 239 The short, 18-item, form of the scale was used.240 
Each item is measured on a 9-point Likert scale ranging from “very strongly disagree” 
(-4) through “neither disagree nor agree” (0) to “very strongly agree” (+4) with half of 
the items reverse scored. Scores from the 18 items are aggregated to give a single 
score. High scores indicate an individual’s tendency to organise, abstract and 
evaluate information.239  
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1.8 Research overview 
1.8.1 Gaps in the research literature 
The incidence and causes of medication errors have been extensively studied in 
hospitals,8,12–15,21,26,27,38,108,113,172,187,241–245 and to a lesser extent in primary care.190,246–
248  
Few studies have investigated medication errors occurring within mental health 
settings. Nineteen studies have investigated prescribing errors in mental health 
settings.99,100,137,140,143–149,101,121,124,127,128,130,133,136 Of these, 10 were conducted 
overseas121,130,133,136,137,140,144–146,149 where differences in healthcare systems may 
make their findings less applicable to the UK. Three UK studies were undertaken 
within an entirely private hospital setting,99,100,143 which may also mean that their 
results are less generalisable as systems may be different. Three studies collected 
no denominator information, only reporting the number of errors identified,99,128,146 
whilst three others used patient cases and admission numbers as 
denominators.127,130,140 Four studies124,143–145 analysed medication events reported via 
incident reporting schemes; all reported very small numbers of errors, and are likely 
to significantly underestimate the actual number of errors. 
Only three studies have calculated the proportion of prescriptions affected by 
errors,100,101,147 and one of these used a proxy for the total number of medication order 
numbers checked by pharmacists.100 Therefore, there is a paucity of published data 
currently available on the prescribing error rate in a mental health setting. 
In his review of publications, Maidment et al noted that there had been no systematic 
study of causes of medication errors in mental healthcare associated with deficits in 
knowledge or decision making.117  
Studies have demonstrated some success with interventions to encourage dual 
processing and improve decision making, although they have largely related to the 
decision making involved in diagnosis.67,249,250 Research specifically around initiatives 
to reduce prescribing errors has tended to look at academic detailing, decision support 
and addressing human factors.251 
Although findings from acute hospital-based studies may be transferable, the most 
frequently used drugs in a mental health setting are very different with more than 90% 
of drugs (by cost) being for the treatment of conditions affecting the central nervous 
system.252 Not surprisingly, the familiarity, knowledge, and experience of mental 
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health prescribers with drugs used for the treatment of physical healthcare conditions 
will also contrast due to different levels of exposure. 
Therefore, the aims and objectives of this research contribute to gaps in the existing 
research literature. 
1.8.2 Importance and contribution of the proposed research 
This research adds to the limited information available about the epidemiology and 
pathophysiology of prescribing errors in mental health inpatient settings and 
contributes to the overall body of knowledge about prescribing errors. It also provides 
data on whether there is a link between prescribers’ cognitive preferences and their 
tendency to make prescribing errors, and whether this can be influenced by raising 
awareness of the principles underpinning clinical decision making. 
While there are robust definitions and methods for assessing the prevalence and 
nature of prescribing errors in a range of healthcare settings, this chapter has 
highlighted that in a mental health setting little research of this kind has been 
undertaken, and that the methods in use may not be universally fit for purpose. In 
addition, to the author’s knowledge, there has been no research undertaken exploring 
the causes of prescribing errors in a mental health setting, or whether there are any 
links between prescribing errors and the thinking styles of individual prescribers. 
These areas are therefore the subject of the author’s research. 
1.8.3 Aims of the research 
The purpose of this research was to investigate prescribing errors, their causes, and 
whether the two types of cognitive process (those executed quickly with little 
conscious deliberation and those that are slower and more reflective) have any impact 
on the occurrence of prescribing errors in a mental health setting.  
1.8.4 Research objectives 
• To investigate the prevalence and nature of prescribing errors in inpatients. 
• To explore the causes of prescribing errors in hospital inpatients. 
• To determine the decision-making characteristics of prescribers and whether 
there is a correlation between cognitive style and making prescribing errors. 
• To investigate whether exposing prescribers to evidence about how humans make 
decisions affects the prevalence or nature of prescribing errors made. 
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Chapter 2. Methods 
2.1 Literature review 
The literature was searched for studies that reported on the occurrence of prescribing 
errors, causes of prescribing errors, dual process theory, and cognitive psychology. 
Searches were undertaken in February 2014 using the following databases: 
EMBASE, MEDLINE, CINAHL, and PsycINFO. Search terms, combined using 
Boolean operators, included the following: ‘medication’; ‘prescribing’; ‘error(s)’; 
‘mental health’; ‘psychiatr*’; ‘thinking’; ‘psychology’; ‘dual process’; ‘health’; ‘cognitive 
psychology’ (see Appendix 3). Search outputs were filtered for duplicates, and citation 
titles and/or abstracts reviewed for relevance. Full papers were obtained for 
potentially relevant articles, reviewed and annotated, and a short summary prepared 
for each. Electronic (PDF) copies of all papers were stored using Mendeley© 
version 1.19.1 (Mendeley Ltd, London), with additional physical copies filed and 
indexed.  
Reference lists of reviewed studies were hand searched for additional relevant 
publications. Citation alerts were set up for articles considered to be of importance, 
and subscriptions set up to receive the electronic table of contents of relevant journals 
and/or email alerts for articles published online. These were regularly checked, and 
appropriate articles added to the list of references held in Mendeley©. More than 1100 
publications were reviewed, of which approximately 200 were considered to be 
important texts, with a further 250 of minor interest, reviewed for background 
information.  
2.1.1 Development of methodology 
To facilitate decisions about the methods to be used in this study, an options appraisal 
was undertaken for each aspect of the research design. This was based on a detailed 
analysis of the methods used in existing studies of a similar nature, and the strengths 
and limitations of each (see Appendix 4). The selected methods are summarised in 
Table 2.1. 
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Table 2.1:   Development of methods 
Required 
decision 
Detail Chosen option 
Prevalence and nature of prescribing errors 
Study 
population 
Wards All 
Data items Medication orders containing errors 
(Numerator) 
Newly prescribed items (not 
previously screened by a 
pharmacist) 
Definition Dean et al practitioner-led 
definition25 
Denominator Number/proportion of new 
medication orders in which a 
prescribing error found 
Errors per order Multiple prescribing errors per 
order allowed 
Sample size Adequate to allow 95% confidence 
with 1% - 5% margin of error 
Method Drug chart review 
Data collector Ward/dispensary pharmacist 
Data analysis Classification of error type Based on type of discrepancy 
Classification of error origin 
(decision making vs. prescription 
writing) 
By researcher 
Severity scale Dean & Barber tool (established 
reliability for prescribing errors)253 
Severity assessment By data collector with sample 
assessed by panel of ‘experts’ 
Causes of prescribing errors 
Study 
population 
Prescribers Sample of prescribers who have 
made non-serious and serious 
errors 
Data collection Format Semi-structured interview 
Time limit on contacting prescribers 96 hours 
Type of interview Face to face 
Sample Until saturation 
Data analysis Classification Reason’s model of accident 
causation 
Decision-making characteristics 
Data collection Method Electronic/paper survey 
Participants All prescribers 
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2.2 Setting 
2.2.1 Study organisation 
The study was undertaken within South Essex Partnership University NHS 
Foundation Trust (SEPT) which provided mental health, learning disabilities, social 
care and community health services within Essex and Bedfordshire.   
Table 2.2:   Data collection sites 
Ward Service type Location 
Alpine Adult - Forensic (Medium Secure) Brockfield House, Wickford 
Assessment Unit Adult - Assessment Mental Health Unit, Basildon Hospital 
Aurora Adult - Forensic (Medium Secure) Brockfield House, Wickford 
Beech Older People - Assessment Rochford Hospital 
Byron Court Learning Disability Billericay 
Causeway Adult - Forensic (Low Secure) Brockfield House, Wickford 
Cedar  Adult - Acute Rochford Hospital 
Clifton Lodge Older People - Continuing Care Westcliff-on-Sea 
Dune Adult - Forensic (Low Secure) Brockfield House, Wickford 
Forest Adult - Forensic (Medium Secure) Brockfield House, Wickford 
Fuji Adult - Forensic (Medium Secure) Brockfield House, Wickford 
Gloucester Older People - Assessment Mental Health Unit, Basildon Hospital 
Grangewaters Adult - Acute Mental Health Unit, Basildon Hospital 
Hadleigh Unit Adult - Psychiatric Intensive Care Mental Health Unit, Basildon Hospital 
Lagoon Adult - Forensic (Medium Secure) Brockfield House, Wickford 
Maple Older People - Assessment Rochford Hospital 
Mayfield  Older People - Continuing Care Thurrock Hospital 
Meadowview Older People - Assessment Thurrock Hospital 
Mountnessing Court Older People - Continuing Care Billericay 
Poplar Child & Adolescent - Assessment  Rochford Hospital 
Rawreth Court Older People - Continuing Care Rayleigh 
Thorpe (was Westley) Adult - Acute Mental Health Unit, Basildon Hospital 
CRHT† Team (East) Adult – Acute (virtual ward) Rochford Hospital 
CRHT† Team (West) Adult – Acute (virtual ward) Mental Health Unit, Basildon Hospital 
Section 136 Suite Adult - Assessment Rochford Hospital 
 
The study sites for this project were the Essex mental health and learning disability 
wards within the mental health division of the organisation as detailed in Table 2.2. 
On 1st April 2017 SEPT merged with the neighbouring mental health trust, North 
Essex Partnership University NHS Foundation Trust, to form a new legal entity - 
                                               
† CRHT – Crisis Resolution and Home Treatment  
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Essex Partnership University NHS Foundation Trust (EPUT). Any aspects of the study 
completed after that date were undertaken only within the boundaries of the former 
SEPT. 
2.2.2 Prescribing arrangements 
Prescribers within these services were predominantly medical staff, but also included 
a small number of nurse and pharmacist prescribers. Details of prescriber types are 
shown in Table 2.3. 
Table 2.3:   Types of prescribers in hospital services 
Prescriber type Description 
Foundation year 1 
(FY1) 
Newly qualified doctors in their first year of post-graduate 
training who have provisional registration with the GMC 
Foundation year 2 
(FY2) 
Doctors in their second year of post-graduate training who have 
full registration with the GMC 
Core trainee 
(CT1-3) 
Doctors who have completed two years of foundation training 
and are now undertaking three years of basic specialty training 
in psychiatry 
GP trainee 
(GPST1-3) 
Doctors who have completed two years of foundation training 
and are now undertaking a 6-month psychiatry placement as 
part of a 3-year training programme to become a general 
practitioner. 
Higher specialty trainee 
(ST4-6) 
Doctors working as part of a higher training programme which 
leads to independent practice in a psychiatric specialty (general 
adult psychiatry, child & adolescent psychiatry, old age 
psychiatry, forensic psychiatry, medical psychotherapy, 
psychiatry of intellectual disability). This usually takes 3 years. 
Staff grade Doctors appointed to a permanent position as a senior doctor 
without completing their consultant training, but with at least two 
years of post-foundation training. Includes Staff Grade, 
Associate Specialist, and Specialty Doctors (SAS doctors) 
Consultant Doctors who hold a Certificate of Completion of Training which 
is the highest level in a specialty (usually after at least 8 years) 
Pharmacist prescriber Pharmacists registered with the General Pharmaceutical 
Council (GPhC) as a supplementary or independent prescriber 
Nurse prescriber Nurses registered with the Nursing and Midwifery Council 
(NMC) as a supplementary or independent prescriber 
Others Sometimes elements of the care of some patients are provided 
by visiting general practitioners, or consultants from another 
hospital trust, for example, geriatricians. 
Sources: BMA, RCPsych254,255 
The process used within the trust for prescribing medicines follows normal UK 
practice. Medication orders are handwritten onto a six-page, tri-fold, paper 
prescription and administration chart; ordinarily referred to as the “drug chart”. An 
example of the drug chart in use at the time of data collection can be found in 
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Appendix 5. The front page contains mainly patient information, including name, NHS 
number, date of birth, and allergy status.  
 
Figure 2.1:   Extract from trust drug chart 
Each individual medication order is written into a template which prompts for details 
of drug name, route, dose, frequency and administration times, then signed and dated 
by the prescriber (see Figure 2.1). Brief instructions on prescribing are contained on 
the front sheet.   
Nurses use the same form to identify when medication doses are due to be 
administered and to document their administration. One page is designed for 
prescriptions for home leave. Discharge medications are prescribed on a separate 
paper prescription form, which doubles as the immediate notification form supplied to 
the patient’s GP at discharge.  
2.2.3 Pharmacy services 
Wards receive a typical UK hospital pharmacy service; each ward has an allocated 
pharmacist who visits the ward on a regular basis to assess the patients’ drug charts. 
The frequency of visits is determined by the nature of the ward and the likely length 
of stay of patients. For example, the Assessment Unit, which has a high turnover of 
patients, is visited daily, whilst wards with a longer average length of stay will be 
visited less frequently. The pharmacist screens each patient’s drug chart to ensure 
that all medication orders are clear, legal, and clinically appropriate, resolve any 
problems identified, and initiates supply of medicines which are not held as stock on 
the ward or are intended for the patient to take home for leave or on discharge.  
As part of their routine duties, ward pharmacists identify any prescribing ambiguities 
and errors. If a medication order is ambiguous or has information missing, but the 
pharmacist can determine the intended medication, the drug chart is annotated to 
clarify the intention; for example, by adding the approved name where the medication 
had been ordered using the brand name or clarifying the formulation such as where 
tablets had been prescribed but the product was only available as capsules. If the 
pharmacist is not certain of the prescriber’s intention, or the medication order contains 
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more significant errors, the prescriber is contacted to clarify and/or discuss what the 
medication order should contain. Such clinical pharmacy interventions are routinely 
recorded for in-house analysis, however, only about half of pharmacy interventions 
tend to involve prescribing errors.241,256  
2.3 Prevalence and nature of prescribing errors 
This prospective quantitative part of the study investigated the prevalence and nature 
of prescribing errors in inpatients in a mental health setting. 
2.3.1 Definition  
The practitioner-led definition of prescribing error developed by Dean et al25 which 
was used in this study (see Section 1.3.3) has been used by the Department of 
Health53 and  extensively in other similar research studies.13,14,17–19,99–101,104,257–259  
As this definition was developed for use in an acute hospital setting, the list of 
situations that should be included or excluded as prescribing errors was extended, 
based on other studies,99–101  to include scenarios relevant to mental health. These 
included compliance with the ‘Consent to Treatment’ requirements of the Mental 
Health Act (MHA) and appropriate monitoring for high-risk psychotropic drugs such 
as lithium and clozapine. 
2.3.2 Data collection 
Fourteen ward pharmacists, none of whom had prescribing responsibilities for 
inpatients, were involved in the collection of prescribing error data as part of their 
routine prescription monitoring duties. To ensure consistency and optimise accurate 
data collection, all participating pharmacists underwent one-to-one or small group 
training, delivered by the researcher, in advance of their first episode of data 
collection. This covered the background, objectives, and data collection methods of 
the study, including full details of the prescribing error definition being used, advice 
on what should and should not be included as prescribing errors, and step-by-step 
instructions on how to complete the data collection forms.  
Pharmacists were advised to include all prescribing errors that met the definition, 
regardless of their severity, including ‘minor’ errors that they corrected by endorsing 
the chart, and those that were not changed by the prescriber following an intervention, 
as they would be reviewed by the researcher. 
Each pharmacist was provided with an explanatory handbook, written by the 
researcher, for reference during the study (see Appendix 6). This covered the items 
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discussed during the training session, and included examples of completed data 
collection forms, These were based on instructions provided to data collectors in 
previous studies.260,261 
Because the data routinely collected within the trust on pharmacy interventions were 
not designed for research purposes, during the study period ward pharmacists were 
asked to collect additional information about the prescribing errors that they identified. 
Data collection for the study did not replace the need to report errors through the 
trust’s incident reporting system as normal. In order that it was clear that the 
procedures involved were outside their routine ward activities, and their participation 
was voluntary, pharmacists were asked to complete a consent form which advised 
that they had the right not to take part in data collection for the research project if they 
preferred (see Appendix 7). 
2.3.3 Sampling and data collection 
Pharmacists prospectively checked prescription charts for newly prescribed or 
rewritten items, or items omitted. Prescriptions written on admission, during the 
inpatient stay, and for leave or discharge, including once-only and when required 
medicines were included. Data were collected between 09.00 and 17.30, Monday to 
Friday and 09:30 to 12.30 Saturday, but included medication orders written outside 
those hours. Data were collected every fourth week between August 2015 and June 
2016, and again between October 2016 and August 2017. 
Where omitted items were identified during medicines reconciliation following 
admission, or by comparison with previous drug charts (leave, discharge or re-written 
prescriptions) the pharmacist determined whether the items were intentionally omitted 
before recording them as a prescribing error. 
Data on the number of newly prescribed or omitted items and the resultant number of 
errors identified were captured using two standard forms, which were piloted within 
one service type (forensic wards – see Table 2.2) during December 2014. For each 
newly prescribed/omitted item the pharmacist recorded the prescriber type (see Table 
2.3), stage of patient stay, whether the item was a psychotropic or non-psychotropic 
drug, and for regular or when required use (see Appendix 8). These data provided the 
denominator for calculating prescribing error rates.   
For each prescribing error, the pharmacist recorded prescriber details along with the 
nature of the prescribing error, whether any doses had been administered/omitted 
before the error was detected, whether harm was experienced by the patient, and 
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potential clinical significance (see Appendix 9). These data provided the numerator 
for calculating prescribing error rates. Each medication order could be associated with 
more than one prescribing error. 
2.3.4 Classification of errors 
Pharmacists classified errors using the categories shown in Table 2.4, which were 
based on error types identified by Lisby et al during a systematic literature review of 
203 studies into the definition and characteristics of medication errors.74,86 All 
completed data collection forms were checked by the researcher to verify that errors 
met the study’s definition and that they were correctly classified, with exclusion or re-
classification as necessary. Medicines involved in errors were also categorised 
according to the relevant chapter and section of the legacy British National Formulary 
(BNF).262 
Table 2.4:   Error categories 
Allergy information missing Omission of route of administration 
Allergy to prescribed drug Omission of signature 
Ambiguous drug name Omission of strength/unit 
Calculation error Omission of treatment time 
Decimal place error PRN without maximum dose limit 
Drug-disease interaction PRN without minimum dose interval 
Drug-drug interaction Wrong concentration 
Drug-lab test interaction Wrong dose 
Duplication of drug(s) Wrong dosing interval 
Illegible handwriting Wrong drug 
Omission of date Wrong formulation 
Omission of dose Wrong duration of treatment 
Omission of dosing interval Wrong route of administration 
Omission of drug Wrong strength/unit 
Omission of formulation Wrong transcription 
Omission of indication for PRN Other 
 
2.3.5 Assessment of clinical significance 
Ward pharmacists were asked to assess the potential clinical significance of each 
error, using a validated method originally developed for assessing the severity of 
medication errors,253 which had previously been adapted for use with prescribing 
errors.263,264 
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This involved a visual analogue 0 to 10 scale with anchors of ‘no potential effect’ and 
‘death’ (Figure 2.2). Errors with a score of less than 3 were considered to be minor, 
those with a score between 3 and 7 (inclusive) considered to be moderate, and errors 
with a score above 7 to be severe.  
 
Figure 2.2:   Clinical significance scale 
Pharmacists needed to use their professional judgement, taking into account the 
specific circumstances of the patient, their drug regimen, their condition and co-
existing morbidities. Examples from previous studies 16,20,44,180,261 were provided in the 
explanatory handbook (Appendix 6) to help pharmacists assess clinical significance, 
and this was discussed during the training. 
2.3.6 Validation 
The assessments of severity given by the ward pharmacists were verified by a multi-
professional panel of four experienced health care professionals. The panel consisted 
of two mental health clinical pharmacists (who were from other organisations, and 
therefore not involved in data collection), one consultant psychiatrist, and one senior 
nurse (who was also qualified as an independent non-medical prescriber). Between 
them, the panel members had more than 80 years of relevant professional 
experience. 
A brief description of each error was produced describing the drug, dose, and strength 
and presented to the panel alongside a copy of the visual analogue scale (see 
Appendix 10). Legal issues were assumed to have no clinical significance and were 
excluded from this process. Where the same or very similar errors had been identified 
more than once, only one occurrence was assessed to minimise workload for the 
panel, and the resulting score applied to all errors of that type.  
For each error description, the mean score across the four members of the panel was 
calculated and used as the index of clinical significance.  
2.3.7 Data analysis 
Descriptive statistics were applied to analyse the frequency of error by prescriber type 
and the nature of prescribing errors identified (e.g. stage, route, severity, drug class). 
No effect                  death 
            
            
0 1 2 3 4 5 6 7 8 9 10 
              Minor                                Moderate                                  Severe 
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Analysis was undertaken using the software program SPSS® version 22 (IBM 
Corporation, Armonk, NY, USA).  
The denominator for calculating prescribing error rates was the number of newly 
prescribed medication orders screened by pharmacists and omitted items. The 
numerator was the number of such medication orders which contained one or more 
prescribing error. All confidence intervals (CIs) were calculated at 95%. 
2.3.8 Sample size calculation 
Sample size calculations were undertaken by Select Statistics‡ (personal 
communication; 15 May 2015) to determine the number of medication orders needed: 
• to estimate the overall prescribing error rate, with 95% confidence, to within a 
margin of error of ±1% to ±5% 
• to estimate the prescribing error rate for each prescribing stage, with 95% 
confidence, to within a margin of error of ±1% to ±5% 
• to estimate the prescribing error rate for each prescriber type (grade) with 95% 
confidence, to within a margin of error of ±1% to ±5% 
Sample sizes based on estimates for the expected proportions of medication orders 
with an error, taken from previously published studies by Haw & Stubbs,100 Stubbs 
et al,101 and Keers et al,147 are shown in Table 2.5. 
Table 2.5:   Sample size estimate for overall prescribing error rate  
 Reference Expected error rate 
(%) 
Estimated Sample Size 
1% margin of error 5% margin of error 
Haw & Stubbs, 
2003100 
2.2% 827 34* 
Stubbs et al, 2006101 2.4% 900 36* 
Keers et al, 2014147 6.3% 2,268 91 
* np <5 so sample size should be treated with caution as may be insufficient to achieve the required precision. 
For example, it was calculated that a sample size of 2,268 medication orders was 
required to estimate the overall prescribing error rate with 95% confidence and to 
within a margin of error of ±1%, based on an expected rate of 6.3%, whilst smaller 
sample sizes would be adequate if the prescribing error rate was actually lower. 
                                               
‡ Select Statistics, Exeter, UK. www.select-statistics.co.uk  
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In order to allow sub-analysis based on various parameters, similar sample size 
calculations were undertaken for prescribing stage and prescriber type, based on the 
results found by Keers et al.147 These are shown in Table 2.6. 
Table 2.6:   Sample size estimate for sub-analysis prescribing error rates 
  Expected error 
rate 
Estimated Sample Size 
1% margin of error 5% margin of error 
Prescribing Stage    
On admission 10.7% 3,671 147 
During stay 6.5% 2,335 94 
Re-write 3.6% 1,334 54* 
Leave 4.5% 1,651 67* 
Discharge 6.5% 2,335 94 
Prescriber Grade    
Foundation year 1 5.1% 1,860 75* 
Foundation year 2 4.9% 1,791 72* 
Specialty trainee 6.8% 2,435 98 
Staff grade 6.5% 2,335 94 
Consultant 5.8% 2,099 84* 
* np <5 so sample size should be treated with caution as may be insufficient to achieve the required precision. 
For example, it was calculated that a sample size of 3,671 medication orders written 
on admission was required to estimate the prescribing error rate for that type of 
medication order, with 95% confidence and to within a margin of error of ±1%, whilst 
a sample size of 2,435 medication orders written by specialty trainees was required 
to estimate the prescribing error rate for that group of prescribers with the same level 
of confidence and precision. 
Based on the relative proportions of overall medication orders falling into each 
category within the Keers et al study147 it was estimated that a total sample size of 
approximately 11,000 medication orders was required to allow sub-analysis with a 
±1% margin of error; a lower sample size would achieve a margin of error between 
±1 and ±5%. The sample size was reviewed during data collection to achieve a 
balance between scientific rigour in relation to the margin of error and workload for 
the data collectors.   
2.4 Causes of prescribing errors 
This qualitative, interview-based part of the study explored the causes of prescribing 
errors in hospital inpatients in a mental health setting. 
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2.4.1 Sampling and data collection 
A purposive sample of prescribers was identified. During each third data collection 
week between August 2015 and August 2016, all prescribers who made a prescribing 
error were given a letter by the ward pharmacist inviting them to participate in a semi-
structured qualitative interview about the error made (see Appendix 11) and asking 
them to contact the researcher. The letter was accompanied by a participant 
information sheet (Appendix 12) and consent form (Appendix 13). Potential 
participants were assured that all information collected during the interview would 
remain private and that any verbatim quotes used would not be attributed to named 
individuals. Details of the prescriber and prescribing error were provided to the 
researcher by the ward pharmacist, omitting any information about the patient for 
whom the item(s) had been prescribed. Written consent was obtained from each 
interview participant. 
2.4.2 Interview design 
Where possible, semi-structured interviews were conducted within 96 hours of the 
error to aid recall. Interviews were guided by an interview schedule (see Appendix 14) 
which included mainly open-ended questions about the prescriber, the prescribing 
error, circumstances in which the error occurred, and perceived contributing factors 
to the error.  Interviews were up to 60 minutes duration, conducted face-to-face by 
the researcher, and in a place convenient to participants to ensure privacy. 
2.4.3 Transcription and thematic analysis 
All interviews were audio-recorded with the participant’s consent (see Appendix 13) 
and participants were assured that they would not be named in any resulting reports 
or publications. In case of device failure, interviews were recorded using two digital 
recorders, wherever possible in venues intended to ensure appropriate sound quality, 
for example, the participant’s office, or seminar/meeting rooms. The audio-recordings 
were transcribed by the researcher as a ‘clean verbatim’ transcription, excluding non-
verbal utterances (e.g. uhm, uh, stutters, laughter and false starts) or confirmatory 
interruptions by the interviewer or interviewee (e.g. “I see”, “yes”, “uh-huh”). External 
sounds such as “sound of door opening” were excluded from the transcription, as 
were names of patients or staff members mentioned during the interview. All 
transcripts were proofread for accuracy before analysis. A sample of 20% of audio 
recordings and transcripts were checked by a third party for accuracy and 
completeness. Transcriptions were de-identified. 
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Transcripts were analysed using the six-step process of inductive thematic analysis 
described by Braun and Clark265 with the aid of NVivo© qualitative data analysis 
software (v11; QSR International Pty Ltd, Melbourne, Australia) to organise the data. 
Once the accuracy of transcripts had been confirmed, initial codes were generated on 
a line by line basis. Words, phrases, and sections of text that could be considered to 
have a specific meaning were assigned to codes within each transcript. Coding was 
reviewed across transcripts to ensure that they had been consistently applied, with 
each transcript being reviewed three times. Codes were grouped, and themes were 
identified from them, again being reviewed for consistency across the dataset. 
Themes were then grouped into categories. Codes, themes, and categories were 
based on the words and phrases used by the interviewees. Anonymised quotations 
are used to illustrate themes in the results section (see Chapter 4).  
2.5 Decision-making characteristics of prescribers 
This part of the study sought to determine the decision-making characteristics of 
prescribers and whether there was a correlation between cognitive style and making 
prescribing errors. 
2.5.1 Sampling and data collection 
Between October 2015 and November 2016, trust staff with the potential to prescribe 
within the study sites identified in Table 2.2 were invited by email to participate in this 
part of the study. A web-based survey tool (SurveyMonkey Inc. Palo Alto, California, 
USA) was used to communicate with most participants, although some completed a 
paper-based version. The opening page of the web-based survey contained a 
participant information sheet and consent form, with participants asked to select “I 
agree” to participate, or “I do not agree” to leave the survey.  
The survey included questions about demographics (i.e. age, gender, number of 
years in practice, level of training, sub-specialty), as well as three validated scales in 
which individual differences in thinking style can be demonstrated (see Appendix 15). 
Non-responders received up to four follow-up requests by email. 
2.5.2 Scales and measures used 
The three scales used were the Cognitive Reflection Test (CRT),226 Rational 
Experiential Inventory (REI-40),200 and Need for Cognition Scale (NCS).239 Separately 
and collectively these tools are designed to identify the preference of prescribers for 
rational or experiential (intuitive) thinking and are described in more detail in 
Section 1.7.2. 
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Cognitive Reflection Test 
An 8-item version was used in this study containing five additional problems kindly 
supplied by Professor Frederick (personal communication; 05 May 2014); two of 
which have subsequently been validated as part of an expanded 7-item CRT.266  
Scores were calculated on the number of correct items. In order to ascertain that 
respondents who answered incorrectly were lured by the ‘intuitive’ incorrect answers, 
a second coding system split responses into correct, ‘intuitive’ incorrect, and other 
incorrect answers.  
Rational Experiential Inventory 
The 40-item version of the ‘Rational Experiential Inventory’ (REI-40)200 was used, 
which contained subscales for ability and engagement with rationality and 
experientiality. Each item was measured on a 5-point Likert scale ranging from 
“strongly disagree” (1) to “strongly agree” (5) with a balanced number of positively and 
negatively worded items on each scale, and some items reverse-scored. Scores were 
averaged to provide a composite score for each scale and subscale, with a higher 
score reflecting a greater tendency to endorse the thinking style.  
Need for Cognition scale 
The short, 18-item, form of the ‘Need for Cognition Scale’ (NCS) was used as a 
measure of information processing, thinking and judgement.239,240 Each item was 
measured on a 9-point Likert scale ranging from “very strongly disagree” (-4) to “very 
strongly agree” (+4) with half of the items reverse-scored. Example questions include 
“I would prefer complex to simple problems” and “I only think as hard as I have to”. 
Scores from the 18 items were aggregated to give a single score, with the possible 
range of scores from 72 to -72. High scores indicate an individual’s tendency to 
organize, abstract and evaluate information.239 
2.5.3 Data analysis 
Two datasets were produced from the survey responses. The first provided an 
evaluation of the decision-making characteristics of prescribers working in a mental 
health setting. For the second, data on decision-making characteristics were 
correlated with information collected in an earlier stage of the study on prescribing 
errors.  
Data were analysed using SPSS® version 22 (IBM Corporation, Armonk, NY, USA). 
Descriptive statistics were produced for the first dataset. For the second dataset, 
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descriptive and inferential statistics were produced. The following hypotheses were 
tested: 
H0 – there is no statistically significant difference in the prevalence of 
prescribing errors made by prescribers with a preference for the two cognitive 
styles (those who execute tasks quickly and with little conscious deliberation, 
and those who take a slower and more reflective approach). 
H1 – there is a statistically significant difference in the prevalence of 
prescribing errors made by prescribers with a preference for the two cognitive 
styles (those who execute tasks quickly and with little conscious deliberation, 
and those who take a slower and more reflective approach). 
and 
H0 – there is no statistically significant difference in the nature of prescribing 
errors made by prescribers with a preference for the two cognitive styles. 
H1 – there is a statistically significant difference in the nature of prescribing 
errors made by prescribers with a preference for the two cognitive styles 
(those who execute tasks quickly and with little conscious deliberation, and 
those who take a slower and more reflective approach). 
Analysis was undertaken using the software program SPSS® version 22 (IBM 
Corporation, Armonk, NY, USA). 
2.5.4 Sample size calculation 
Sample size calculations were undertaken by Select Statistics (personal 
communication; 15 May 2015) to determine the number of medication orders needed: 
• to carry out a test for a difference in the prescribing error rates by thinking style 
(rational vs. experiential), with 95% confidence and 80% to 90% power 
• to carry out a multiple logistic regression analysis, including each relevant 
explanatory variable used in the study (excluding type of error) 
As no research has been conducted regarding the association between thinking style 
and prescribing error rates, sample size calculations were based on “small”, “medium” 
and “large” effect sizes,267 and a Chi-squared test for association. For example, it was 
calculated that a total sample size of 1,051 medication orders was required to test for 
a difference in the prescribing error rate by thinking style, with 95% confidence and 
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90% power, based on a “small” expected effect size (see Table 2.7). The smaller the 
expected difference between the two groups, the larger the number of medication 
orders were needed to ensure statistical rigour. 
A generally accepted rule-of-thumb for multiple logistical regression is that 10 ‘events’ 
(i.e. prescribing errors) are needed per coefficient.268 In order to include each 
explanatory variable collected in the study (see Appendix 8 and Appendix 9), and 
assuming an error rate of approximately 6% required a sample size of at least 3,000 
medication orders.   
Table 2.7:   Sample size estimate for testing a difference in prescribing error rates by 
thinking style  
 Effect size267 Estimated Sample Size 
80% power 90% power 
“Large” (w = 0.5) 32 43 
“Medium” (w = 0.3) 88 117 
“Small” (w = 0.1) 785 1,051 
 
2.6 Educational intervention 
This quantitative part of the study sought to investigate whether exposing prescribers 
to evidence about how humans make decisions affected the prevalence or type of 
prescribing errors made. 
2.6.1 Participants 
A convenience sample of participants was recruited to attend a 3-hour educational 
session on clinical decision making. This was provided as part of the normal weekly 
postgraduate education programme to which all medical staff are invited, and which 
doctors in training posts are expected to attend. Participation was voluntary. 
2.6.2 Delivery 
The session was delivered over one half-day in October 2016 by a recognised expert 
in this field - Professor Neal Maskrey, Professor of Evidence-informed Decision 
Making at Keele University and former Director of Evidence-based Therapeutics at 
the National Prescribing Centre, where he was involved in producing a video for 
prescribers on making better decisions.269 
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2.6.3 Content 
The session started with a short introduction and preliminary findings from the first 
phase of the quantitative data collected on prescribing errors within the trust. This was 
followed by the main theories involved in information mastery and decision making, 
including practical demonstrations of heuristics and biases, an introduction to the dual 
process theory of decision making, including bounded rationality, and the impact of 
affect on decision making. Learning was then reinforced through the application of 
decision-making theory in small group discussion of participant-generated examples 
of real-life errors. 
The session continued with a discussion of some of the techniques available to 
improve performance in clinical decision making, including metacognition and 
cognitive forcing strategies, and how these processes of calibration fit with dual 
process theory. Finally, some elements of the Cognitive Reflection Test were used to 
highlight personal thinking styles.  
2.6.4 Sampling and data collection 
A short questionnaire was developed to evaluate the session. Participants were asked 
to rate 11 statements about the theory, applied theory and practice of decision making 
before the session started and again at the end.270 These measured participants 
understanding of decision-making processes, using a 5-point Likert scale, as well as 
collecting demographic and role-based information, and providing the opportunity to 
comment on the session generally (see Appendix 16). Pre- and post-session scores 
were compared using a paired samples t-test. 
2.6.5 Data analysis 
Although ideally, paired analysis would be used comparing the before and after 
prescribing error rate of the same prescribers, prescriber turnover made this unviable. 
Sample size was based on unpaired analysis to assess whether there was a 
statistically significant difference. Statistical analysis was used to test the following 
hypotheses: 
H0 – there is no statistically significant difference in the prevalence of 
prescribing errors made before and after exposing prescribers to an 
educational intervention. 
H1 – there is a statistically significant difference in the prevalence of 
prescribing errors made before and after exposing prescribers to an 
educational intervention. 
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and 
H0 – there is no statistically significant difference in the nature of prescribing 
errors made before and after exposing prescribers to an educational 
intervention. 
H1 – there is a statistically significant difference in the nature of prescribing 
errors made before and after exposing prescribers to an educational 
intervention. 
2.6.6 Sample size calculations 
Sample size calculations were undertaken by Select Statistics (personal 
communication; 15 May 2015) to determine the number of medication orders needed 
to carry out a test for a difference in the prescribing error rates pre- vs. post- an 
educational intervention, with 95% confidence and 80% to 90% power. 
As it was recognised that dropout rates might be relatively high due to prescriber 
turnover and that a full set of paired observations was unlikely, the sample size 
calculations were based on unpaired observations, using the Chi-squared test to 
assess whether a statistically significant difference in prescribing error rate was 
present post-intervention. Estimates were calculated based on a reduction in the 
prescribing error rate from 6% pre-intervention to between 1% and 5% post-
intervention (see Table 2.8). 
Table 2.8:   Sample size estimates for testing a difference in prescribing error rates following 
an educational intervention  
 Effect  Estimated Sample Size 
80% power 90% power 
Reduction from 6% to 1% 425 568 
Reduction from 6% to 2% 754 1,009 
Reduction from 6% to 3% 1,500 2,007 
Reduction from 6% to 4% 3,729 4,992 
Reduction from 6% to 5% 16,318 21,845 
 
For example, it was calculated that a total sample size (pre- and post-intervention) of 
2,007 medication orders was required to test, with 95% confidence and 90% power, 
for a reduction of 50% from a pre-intervention prescribing error rate of 6% (i.e. a post-
intervention error rate of 3%). The smaller the difference in error rate seen as a result 
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of the educational intervention the greater the sample size required for statistical 
rigour.  
2.7 Ethical issues 
2.7.1 Confidentiality 
Patients’ personally identifiable data (PID) were not collected by the researcher.  
Details of potential errors were provided to the prescriber by the ward pharmacist who 
detected it as part of their normal daily duties in a form which did not identify the 
patient involved. 
Interview participants were asked to avoid naming patients during the semi-structured 
qualitative interviews. Any personally identifiable data mentioned during the interview 
were removed at the transcription stage. Only anonymised audio-recordings and 
transcripts were validated by any third party. 
No interview participants were named in the report or during any dissemination of 
findings. Any verbatim quotes were not attributed to named individuals.  
Audio recordings and transcripts were anonymised and given file names which did 
not identify the interviewee, and the key to coding was kept in a separate, password 
protected document. 
2.7.2 Risks to participants 
The qualitative semi-structured interviews addressed the subject of making errors, 
and as such presented the potential to cause psychological distress or anxiety to 
participants. However, the participants were assumed to be confident, articulate 
healthcare professionals making this unlikely. The interviews were conducted 
sensitively, and participants were assured that no blame was being attributed to them.  
If the error being discussed had resulted in significant patient harm or was potentially 
the result of a serious breach of practice, the researcher asked whether the error had 
been reported via the trust’s incident reporting scheme and encouraged the 
interviewee to do so if it had not. However, any error with the potential to cause patient 
harm was likely to have already been reported by the member of staff who first 
discovered it, which might be the original prescriber, another prescriber, administering 
nurse or pharmacist.  
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In order that the decision to participate in the study was not influenced by the 
researcher, the risk of coercion was minimised by sending details about the study 
through ward pharmacists.  
2.7.3 Ethical approval 
Guidance on the conduct of research within the NHS indicated that NHS Research 
Ethics Committee review was not required as the research involved only NHS staff.271 
The research protocol, including copies of all material to be used during the study 
(e.g. consent forms, letters, participant information leaflets), was submitted to the 
University of Portsmouth Science Faculty Ethics Committee (SFEC) in March 2015. 
The first ethical review led to a request for more information. Re-submission in April 
2015 resulted in a favourable ethical opinion with one condition - to use a standard 
template consent form with the pharmacists who collected data, which was met 
(Reference: SFEC 2015-015 SCOTT). This can be found in Appendix 17.  
In parallel to the SFEC submission, an application was made to the SEPT Research 
Governance Group (RGG) for permission to undertake the research within the 
organisation. This involved submission of the online Integrated Research Application 
System (IRAS) dataset and research protocol. Research Governance approval was 
provided on 27th March 2015, subject to amendments discussed at the RGG meeting 
to the IRAS research and development form. These related to sections 54 - 62 and 
covered the primary and secondary outcome measures, sample size and statistical 
analysis. An amended version of the IRAS form containing the required amendments 
was provided to the research manager in May 2015. 
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Chapter 3. Prevalence and nature of prescribing errors: 
results and discussion 
3.1 Introduction 
Between August 2015 and August 2017, 13,684 newly written medication orders were 
assessed by pharmacists for errors or omissions for this study. A total of 690 errors 
were recorded; 60 of which were excluded for not meeting the prescribing error 
definition being used25 or because insufficient information was provided. Although four 
reported errors were excluded because insufficient information had been provided by 
the ward pharmacist to categorise the error, the majority (45/60; 75%) were errors 
that related to the entire prescription chart rather than to one medication order, with 
most (42/60; 70%) as a result of the patient’s allergy status being omitted from the 
drug chart. Other whole-chart issues included the prescribers name not being printed 
(in addition to the signature), not prescribing in line with the format specified in trust 
policy, and the wrong ward, NHS number, or date of birth entered on the drug chart. 
Errors affecting the whole chart were also detected in large numbers in a previous 
multi-centre psychiatric study where 324/880 detected errors were whole chart errors 
and excluded from analysis; 78% (252/324) of those related to a failure to record the 
patient’s allergy status.101  
National Institute of Health and Clinical Excellence (NICE) guidance on the diagnosis 
and management of drug allergy recommends that people’s drug allergy status should 
be documented in the medical records using standard nomenclature and recording 
details of any drug allergies documented. Patient safety incidents reported to the 
NRLS between 2005 and 2013 identified over 18,000 incidents involving drug allergy, 
the majority of which involved a patient with a previously known allergy to the drug or 
class of drug, and more than a quarter of which caused harm.272 
The definition of a prescribing error used in this study25 was developed many years 
prior to this guidance being issued and it is possible that if the same Delphi exercise 
was repeated now, the absence of documented allergy status would be considered 
as a prescribing error. Omission of the general allergy information for a patient, as 
opposed to errors involving prescribing of a drug to which the patient has a specific 
allergy, has been included in studies of prescribing error incidence by several 
researchers.18,121,187,257,273,274   
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Therefore, 630 newly prescribed items were affected by one or more prescribing error 
or omission, giving an overall error rate of 4.6% (95% CI 4.3 - 4.9%). Fifty-nine 
medication orders were affected by two errors, and 19 orders by three errors, resulting 
in a total of 727 errors. The inclusion of the 42 allergy errors excluded in the analysis 
of this study would have increased the overall prescribing error rate to 4.9% (95% CI 
4.6 - 5.2%). 
The overall prescribing error rate of 4.6% identified in this study was lower than that 
found in a similar study involving three mental health trusts in the North West147 but 
was higher than found in earlier studies conducted in three private psychiatric 
hospitals,100 and in a sample of eight NHS and one private psychiatric hospitals 
respectively.101 It was also lower than the median rate of 7% reported in a systematic 
review of prescribing errors in general hospitals.17  
Keers et al conducted the first study to prospectively identify the prevalence, nature, 
and predictors of inpatient prescribing errors for newly written or omitted prescriptions 
in a mental health setting. They found 6.3% (288/4,427) of medication orders to be 
affected by one or more error compared with the error rate of 4.6% (630/13,684) found 
in this study. The overall prescribing error rate in both the current study and found by 
Keers et al147 were higher than previously found by Haw and Stubbs in 2003100 (2.2%) 
and Stubbs, Haw and Taylor in 2006101 (2.4%) in UK psychiatric studies. However, 
there were methodological differences which are likely to have contributed to the lower 
error rates found. Haw and Stubbs calculated a denominator from a sample of four 
days rather than collected denominator data throughout the study’s duration.  In 
addition, errors were scrutinised independently by a three-person panel and only 
included in the study if two or more panel members agreed an error had occurred.100   
3.1.1 Denominator 
Some studies16,20,189,274 have used all medication orders written during the study 
period as the denominator from which to calculate prescribing error rates. However, 
in the US all medicines are individually dispensed for each patient and the pharmacy 
computer system can be used to easily identify the total number of medication orders 
written.16,20 Due to the routine use in the UK of ward stock medicines rather than 
individually dispensed items this is not possible. Similarly, where electronic 
prescribing is in place data can more easily be extracted on the total number of 
medication orders processed.274 An alternative approach used has been to estimate 
the number of medication orders written during the study period from a sample of 
healthcare records,14 but this is resource intensive and provides only an estimate.   
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However, most studies restrict data collection to newly prescribed items which have 
not previously been screened by a pharmacist.13,101,147,245,259,275 This has the 
advantage of ensuring that errors cannot be double counted, reduces the amount of 
extra work required by ward pharmacists, and does not require reference to other data 
sources.241 In a study which compared four methods of detecting prescribing errors in 
the same patient cohort, the authors concluded that only prospective data collection 
by ward pharmacists and retrospective healthcare record review were usable for 
research purposes.155 A comparison of pharmacy, medical and nursing students 
found that pharmacy students showed a significantly higher prescribing error-
identification rate, which the authors suggested may have been due to the greater 
time spent studying pharmacology and pharmacotherapeutics.276 This supported the 
use of pharmacists to identify prescribing errors.  
3.1.2 Using ward pharmacists for data collection 
The main disadvantage of collecting data during routine clinical practice, rather than 
as a specific review with the primary aim of collecting research data, was that the 
number of errors that pharmacists miss, and the number that they identify but fail to 
record, was unknown.241 A recent Australian study, involving two teaching hospitals, 
found that of more than 12,000 prescribing errors identified during retrospective 
record review, there was evidence that only 10.2% (1,282/12,567) had been detected 
by hospital staff or patients. A correction or annotation made by the doctor, nurse or 
pharmacist to the drug chart, a note made in the healthcare records, or existence of 
a pharmacist’s intervention report were considered to be evidence of detection. A 
greater proportion of those prescribing errors considered to be clinically important 
were detected by staff (118/539; 21.9%). Very few errors were reported to the 
hospitals’ incident reporting systems - 1.3% of clinically important prescribing errors 
and 0.12% of all prescribing errors.107 A Dutch study of prescribing errors added to 
the medication of test patients also showed that not all errors were detected, with 57% 
correctly identified by hospital pharmacist and pharmacy technicians.277 However, the 
specialist knowledge and training of pharmacists in pharmacology, 
pharmacotherapeutics and pharmacokinetics makes them ideally placed to identify 
errors in both practice and research scenarios.276 
In a study involving one UK teaching hospital, Tully and Buchan identified that the 
likelihood of senior pharmacists identifying errors was greater than junior pharmacists, 
and that errors were least likely to be identified on the busiest days, with 40% fewer 
errors identified on days when the number of drug charts to be clinically checked was 
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in the upper quartile. They also identified a ‘Friday effect’ affecting some, but not all, 
specialties with 16% fewer errors identified on Friday compared with other days of the 
week, regardless of workload or pharmacist seniority.275  
Meanwhile, Lesar et al commented that the errors detected in their study of 
prescribing errors in a US teaching hospital over a 9-year period were likely to be “a 
minimum estimate” because of the lack of adequate patient-specific information to the 
centralised (dispensary-based) pharmacists who collected data.44 This supports the 
view that, even with the potential problems highlighted above, collection of data by 
ward pharmacists is likely to be more accurate than collection of data by dispensary-
based pharmacists, where more errors will go undetected as staff do not have access 
to the patient or to their clinical information.241  
Ward-based pharmacists had access to full data on indications and concurrent 
medical conditions (via patients’ paper-based healthcare record and/or the electronic 
unified record) and were more likely to know both the patient and the prescriber. This 
method also resulted in larger quantities of data than could have been collected by a 
single researcher. Donyai et al identified that 52% of pharmacist interventions relate 
to prescribing errors.256 Data collection by staff who were routinely present on the 
ward was also less likely to confound the study by what some have called the 
‘Hawthorne effect’, and likely to improve the identification of prescribers.278 
Two studies which took a similar approach of using ward pharmacists to collect data 
during their routine ward activities quantified the additional time required for data 
collection. One found that an average of nine minutes per ward per day was required 
to collect the data,245 whilst the other reported that the completion of data collection 
forms for research purposes was found to be insignificant.147 Whilst this suggests that 
the results found in this study may still be an underestimate of the true prescribing 
error levels, the fact that the ward pharmacists were aware that data were being 
collected for a specific purpose meant that during data collection weeks, their 
incentive to accurately record all errors found was high.  
3.1.3 Number of prescribers making errors  
Medication orders were written by 212 individual prescribers; nearly two-thirds of 
prescribers (135/212; 63.7%) made at least one prescribing error during the study 
period. The number of prescribers in each staffing category and the number who 
made at least one prescribing error is shown in Figure 3.1. Amongst medical 
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prescribers, 57% of higher specialty trainees made at least one error, whilst 88% of 
GP trainees did so.  
 
Figure 3.1:   Proportion of prescribers who made at least one error 
3.1.4 Doses given or omitted before detection 
During data collection, pharmacists recorded the number of doses given or omitted 
before the error was identified for 573 of the 727 errors (78.8%). In nearly two-thirds 
of cases (61.1%; 350/573) the error was corrected before any doses were 
administered, with a further 10.6% (61/573) intercepted after one dose had been 
administered.  
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Figure 3.2:   Number of doses administered/omitted before detection 
In those cases where at least one dose was administered or omitted before the error 
was identified and corrected (223/573; 38.9%), the mode of doses administered/ 
omitted was 1.0 and the median 3.0. However, data were skewed by a small number 
of cases (11/573; 1.9%) where the number of doses administered/omitted before 
detection was very high (more than 20 doses) (see Figure 3.2). Seven of these errors, 
including the three with the greatest number of doses prescribed before the error was 
corrected, were prescription writing errors which involved omission of the formulation. 
None were considered to have any clinical significance.  
3.2 Prescribing stage 
Data were collected on the stage during the patient’s journey at which a prescription 
was written. More than two-thirds of items (9,265/13,684; 67.7%) were prescribed 
either as an addition or change to therapy or because the prescription chart needed 
to be rewritten. Almost one-fifth of items were prescribed or omitted, at the time of 
admission, and 12.0% (1,644/13,684) at the time of discharge or when a patient was 
allowed home on short-term leave as part of their therapeutic management plan (see 
Table 3.1). 
Table 3.1:   Items prescribed by stage in the patient journey 
 No. of new prescriptions Proportion of overall new 
prescriptions 
Admission 2,613 19.1% 
During inpatient stay 4,552 33.3% 
Rewritten prescription 4,713 34.4% 
Leave 598 4.4% 
Discharge 1,046 7.6% 
Not known 162 1.2% 
Total 13,684 100.0% 
 
Although the overall error rate was 4.6%, differing error rates were seen for 
medication orders prescribed at different stages in the patient journey. Excluding the 
162 items where the stage of prescribing could not be determined or was not 
recorded, items prescribed on discharge were associated with the highest error rate 
(7.7%; 81/1,046), although these accounted for a small proportion of the total 
prescription volume (7.6%; 1,046/13,684). In contrast, re-written drug charts were 
associated with the lowest error rate (2.1%; 100/4,713) and accounted for the largest 
proportion of prescriptions written (34.4%; 4,713/13,684). The respective prescribing 
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error rates associated with different stages of the patient journey are shown in Figure 
3.3. 
The differences between error rates for the stages in the patient journey were tested 
for statistical significance using the Pearson chi-squared test, with a significance level 
of p < 0.05. This demonstrated a significant difference between the error rates for 
each of discharge prescriptions, prescriptions written on admission, and rewritten 
prescriptions, when compared with those written during all other prescribing stages in 
the patient journey (χ2 (5) = 120.525, p < 0.001).  
 
Figure 3.3:   Prescribing error rate by prescribing stage 
Significantly higher rates of prescribing errors were observed at those stages in the 
patient’s journey involving transitions of care, with the error rate for medication orders 
written on admission 6.2% and on discharge 7.7%. It is well recognised that when 
patients move between care providers there is a substantial risk of miscommunication 
and unintended changes to medicines.279 Significant levels of omission of drugs on 
admission and discharge prescriptions have been found in other studies of prescribing 
errors in general hospitals,13,17–19,257,261 but had not been previously noted in UK 
psychiatric studies99–101,128 until the publication of the Keers et al study in 2014.147  
3.2.1 Prescribing errors on admission 
The admission error rate observed in this study (6.2%) was lower than that reported 
by Keers et al147 who found that 10.7% of medication orders written at that stage in 
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the patient’s journey contained one or more error, with omissions being the main 
contributor.  A 2002 study by Morcos et al identified that when patients were admitted 
to a psychiatric hospital, medication was omitted in 57% of the cases they reviewed.150 
The introduction of medicines reconciliation following guidance issued by NICE/NPSA 
in 2007280 was intended to reduce such discrepancies, and a study by Brownlie et al281  
in 2013 identified that unintentional medication discrepancies, most involving 
omissions, were identified and resolved in 56.2% of mental health admissions 
because of medicines reconciliation. A mean discrepancy rate of 1.5 medicines per 
admission was found.  
Within SEPT, almost all admissions are received into a single Mental Health 
Assessment Unit (MHAU), which allows the staffing resources associated with 
undertaking medicines reconciliation to be concentrated in a single place. This results 
in more than 95% of admissions being able to benefit from a pharmacy-led medicines 
reconciliation.282 This model of service is not implemented in all trusts and may have 
an impact on the timeliness and effectiveness of medicines reconciliation at the point 
of admission. This may explain why the error rate found in the current study was lower 
than found by Keers et al.147  
In a general hospital setting, Franklin et al identified a higher error rate for medical 
admission wards, which was associated largely with the omission of patient’s usual 
medication following admission to hospital,13 whilst Seden et al identified the most 
frequent error in a study of nine hospitals to be unintended medication omission 
following admission.257 Although it has been identified that the majority of medicines 
omitted on admission will result in negligible patient impact, a small proportion will 
result in significant long-term impact, and more in significant short-term impact.283  
In single hospital studies, Tully et al found that 14.5% of medication orders on 
admission contained an error, with the majority (46.8%) associated with the category 
‘need for drug’ which included omissions,275 while Dean et al found an error rate on 
admission of 1.3%.14 However, that study used an estimated denominator and only 
associated one prescribing error with each medication order, so may have reported 
an underestimate of the actual error rate, as it was much lower than found in other 
studies. Ashcroft et al identified that prescribing errors were 70% more likely at the 
time of admission to hospital than during the inpatient stay, with an error rate on 
admission of 13.3%, compared with 7.5% during the hospital stay.284 Further details 
of studies which have explored prescribing error rates at different stages of the 
patient’s journey are shown in Table 3.2. 
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Table 3.2:   Comparative prescribing error rates by prescribing stage  
Study Details 
Prescribing error rate (%)  
(95% CI) 
On 
admission 
During 
stay 
Rewrites Leave Discharge Overall 
General hospital setting 
Dean et al. 
200214 
Prospective study over 4 weeks in one UK hospital. 36,168 
(estimate) medication orders reviewed, and 538 errors identified. 1.3% 1.8% 1.0% - 1.3% 1.5% 
Tully et al, 
2009275 
Prospective study over 18 months in one UK hospital. 33,012 
medication orders reviewed, and 3,455 prescribing errors 
identified for 2,324 patients. 
14.5% 9.0% 7.4% - 12.0% 10.5% 
Seden et al 
2013257 
Prospective study of at least 400 prescriptions* per site in nine 
UK hospitals. 4,238 prescriptions reviewed, and 3,011 
prescribing errors found in 1,857 prescriptions 
56.7% 
 - - - 34.5% 43.8% 
Ashcroft et al, 
201519 
Prospective study over 7 data collection days in 20 UK hospitals. 
124,260 medication orders reviewed, and 11,235 prescribing 
errors found in 10,986 orders 
13.3% 
(12.8 – 0) 
7.5% 
(7.1 – 7.9) 
3.9% 
(3.5 – 4.4) - 
6.3% 
(5.9 – 6.7) 
8.8% 
(8.6 – 9.1) 
Mental health setting 
Keers et al, 
2014147 
Prospective study over 10 data collection days in three UK 
mental health trusts. 4,427 medication orders reviewed, and 288 
prescribing errors found in 281 orders 
10.7% 
(8.6 – 12.7) 
6.5% 
(5.3 – 7.8) 
3.6% 
(2.6 – 4.6) 
4.5% 
(1.9 – 7.0) 
6.5% 
(4.3 – 8.6) 
6.3% 
(5.6 – 7.1) 
Keers et al,  
2015148 
Prospective study over 6 data collection weeks in three UK 
mental health trusts. 1,456 medication orders reviewed, and 74 
prescribing errors found.  
- - - - 5.1% (4.0 - 6.2) 
5.1% 
(4.0 - 6.2) 
This study Prospective study over 24 data collection weeks in one UK 
mental health trust. 13,684 medication orders reviewed, and 
727 prescribing errors found in 630 orders 
6.2% 
(5.3 – 7.2) 
5.3% 
(4.6 – 5.9) 
2.1% 
(1.7 – 2.5) 
5.2% 
(3.4 – 7.0) 
7.7% 
(6.1 – 9.4) 
4.6% 
(4.3 – 4.9) 
* one prescription could contain one or more medication order. 
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3.2.2 Prescribing errors at discharge 
At the opposite end of the patient’s journey, the transition of care on discharge was 
also associated with a significant error rate. Discharge medicines demonstrated the 
highest error rate within the study, with 7.7% of medication orders containing one or 
more error or omission. This finding was slightly higher than found by Keers et al who 
reported a prescribing error rate on discharge of 6.5%.147 In a further study specifically 
investigating the quality and safety of discharge prescriptions in a specialist mental 
health setting, Keers et al found that one in twenty (5.1%) of individual medication 
orders written on discharge contained at least one prescribing error, and one in five 
(20.8%) discharge prescriptions were affected.148 Nelson et al had also previously 
identified 23.3% of discharges from a US psychiatric inpatient facility to have a 
medication discrepancy when the medication discharge plan was compared with the 
medication administration record for the last day of the hospital stay. However, they 
did not quantify an error rate in terms of medication orders.152  
Although Lewis et al in their systematic review of the prevalence and nature of 
prescribing errors in hospital inpatients, undertaken as part of the EQUIP study 
commissioned by the GMC,18,172 did not comment on prescribing errors by stage in 
the patient’s journey, some individual studies have provided this analysis. Tully et al 
studied prescribing errors in a single hospital and found that 12.0% of medication 
orders written on discharge contained an error, with most (49.8%) categorised as 
‘need for drug’ which would include errors relating to omitted medicines.275 In another 
single hospital study, Dean et al found a prescribing error rate of 1.3% for discharge 
medication, although the use of an estimated denominator may have impacted the 
calculations.14 Ashcroft et al undertook a study of prescribing errors in 20 UK hospitals 
and identified an error rate of 6.3% associated with discharge medication.19  
Whilst most studies have explored errors rates for individual medication orders, 
Seden et al investigated complete prescriptions (i.e. all items on a single inpatient 
prescription chart or discharge prescription) citing this as a more realistic estimate of 
the number of patients potentially at risk of harm from prescribing errors. Their study 
identified that 34.5% of discharge prescriptions (containing one or more medication 
order) contained at least one prescribing error.257  
Data by both prescribing stage and prescriber grade/type are shown in Table 3.3. 
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Table 3.3:   Prescribing errors by prescriber grade/type and prescribing stage 
  Prescribing Stage  
Prescriber  On admission During stay Rewritten Leave Discharge Unknown TOTAL 
Foundation Year 1 Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
37 
1 
2.7 (0.0-8.0) 
249 
23 
9.2 (5.6-12.8) 
129 
1 
0.8 (0.7-2.3) 
22 
0 
0 (N/A) 
88 
4 
4.5 (0.2-8.8) 
8 
1 
12.5 (0.0 - 35.4) 
533 
30 
5.6 (3.7-7.6) 
Foundation Year 2 Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
211 
34 
16.1 (11.1-21.1) 
222 
7 
3.2 (0.9-5.5) 
38 
3 
7.9 (0.0-16.5) 
23 
1 
4.3 (0.0-12.6) 
23 
0 
0 (N/A) 
9 
1 
11.1 (0.0-31.6) 
526 
46 
8.7 (6.3-11.1) 
Specialty Trainee Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
787 
64 
8.1 (6.2-10.0) 
1,522 
86 
5.7 (4.5-6.9) 
1,218 
46 
3.8 (2.7-4.9) 
215 
3 
1.4 (0.0-3.0) 
266 
32 
12.0 (8.1-16.0) 
57 
9 
15.8 (6.3-25.3) 
4.065 
240 
5.9 (5.2-6.6) 
Staff Grade  Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
708 
27 
3.8 (2.4-5.2) 
1,195 
58 
4.9 (3.6-6.0) 
2,695 
45 
1.7 (1.2-2.2) 
112 
9 
8.0 (3.0-13.0) 
184 
12 
6.5 (2.9-10.0) 
28 
1 
3.6 (0.0-10.5) 
4,922 
152 
3.1 (2.6-3.6) 
Consultant  Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
329 
20 
6.1 (3.5-8.7) 
1,020 
46 
4.5 (3.2-5.8) 
439 
2 
0.5 (0.0-1.2) 
210 
11 
5.2 (2.2-8.2) 
289 
33 
11.4 (7.4-15.0) 
59 
4 
6.8 (0.4-13.2) 
2,346 
116 
4.9 (4.0-5.8) 
Nurse Prescriber Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
0 
0 
- 
14 
1 
7.1 (0.0-20.5) 
14 
0 
0 (N/A) 
6 
1 
16.7 (0.0-46.5) 
2 
0 
0 (N/A) 
0 
0 
- 
36 
2 
5.6 (0.0-13.0) 
Other Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
467 
15 
3.2 (1.7-4.9) 
252 
12 
4.8 (2.2-7.5) 
180 
3 
1.7 (0.0-3.6) 
0 
0 
- 
190 
0 
0 (N/A) 
1 
0 
- 
1,090 
30 
2.8 (1.8-3.8) 
Unknown  Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
74 
2 
2.7 (0.0-6.4) 
78 
6 
7.7 (1.8-13.6) 
0 
0 
- 
10 
6 
60.0 (29.6-90.4) 
4 
0 
0 (N/A) 
0 
0 
- 
166 
14 
8.4 (4.2-12.7) 
TOTAL Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
2,613 
163 
6.2 (5.3-7.2) 
4,552 
239 
5.3 (4.6-5.9) 
4,713 
100 
2.1 (1.7-2.5) 
598 
31 
5.2 (3.4-7.0) 
1,046 
81 
7.7 (6.1-9.4) 
162 
16 
9.9 (5.3-14.5) 
13,684 
630 
4.6 (4.3-4.9) 
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3.3 Grade/type of prescriber 
Most medication orders were written by middle-grade doctors (staff grade, associate 
specialists and specialty doctors), who were responsible for more than one-third of 
items (4,922/13,684; 36.0%). A further quarter of items (25.0%; 3,423/13,684) were 
prescribed by consultant psychiatrists, visiting consultants (mainly geriatricians) or 
general practitioners. Very few items were prescribed by newly qualified doctors 
during their foundation training years (7.7%; 1,059/13,684), with a larger proportion 
prescribed by junior doctors undergoing specialist psychiatric training or a psychiatry 
rotation as part of GP training (29.7%; 4,065/13,684). The distribution of prescribed 
items by staff grade is shown in Table 3.4. 
Table 3.4:   Items prescribed by prescriber grade 
 No. of new 
prescriptions 
Proportion of overall 
new prescriptions 
Foundation Year 1  533 3.9% 
Foundation Year 2 526 3.8% 
Specialty Trainee 4,065 29.7% 
Core Trainee (Psychiatry) 1,904 13.9% 
GP Trainee 818 6.0% 
Higher Specialty Trainee (Psychiatry) 1,343 9.8% 
Staff Grade 4,922 36.0% 
Consultant Psychiatrist 2,346 17.1% 
Other (Visiting Consultants/GPs) 1,090 8.0% 
Nurse Non-Medical Prescriber  36 0.3% 
Not known 166 1.2% 
Total 13,684 100.0% 
 
3.3.1 Initial analysis by prescriber grade/type 
Junior doctors in their second post-qualification year (FY2), and the first year after 
achieving GMC registration, had the highest error rate at 8.7% (46/526), followed by 
specialty trainees at 5.9% (240/4,065). Junior doctors in their first post-qualification 
year (FY1) (30/533), and nurse non-medical prescribers (NMPs) (2/36) both had an 
error rate of 5.6%, although the number of prescriptions written by nurse NMPs was 
very low and therefore the 95% confidence interval for the error rate was high 
(± 6.52%) by comparison to the other categories. Foundation year trainees prescribed 
less than one in twelve of all medication orders. The error rates for all prescribers by 
grade/type are shown in Figure 3.4.  
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Figure 3.4:   Prescribing error rate by prescriber grade/type 
The error rate was also high for those prescribers whose identity and therefore grade 
could not be determined (8.4%; 14/166) however, the prescriptions written by such 
prescribers represented a very small proportion of the overall number of medication 
orders (1.2%; 166/13,684). These and medication orders where the prescriber was 
unknown have been excluded from further analysis and also from data shown in 
Figure 3.4, Figure 3.5 and Figure 3.6. 
The differences between error rates for different prescriber grade/type were tested for 
statistical significance using the Pearson chi-squared test, with a significance level of 
p < 0.05. This demonstrated that the error rate for foundation year two doctors, 
specialty trainees, staff grade doctors and ‘other’ prescribers (visiting consultants, 
mainly geriatricians, and general practitioners) each differed significantly from other 
prescriber grade/types, (χ2 (7) = 77.954, p < 0.001). The error rate for nurse NMPs 
was not significantly different from any other prescriber grade/type due to the very low 
number of prescriptions (0.3%; 23/7,953) and large 95% confidence interval.  
The results found showed some differences from those reported by Keers et al,147 in 
the only other study in mental health to have investigated prescribing errors by 
prescriber grade. Their study of three mental health trusts in the UK found that 
specialty trainees had the highest prescribing error rate at 6.8%, a similar level to this 
study (5.9%). However, FY2 doctors in the Keers et al study were found to have the 
lowest error rate at 4.9% compared with the highest in this study, at 8.7%. Differences 
also existed in the patterns of prescribing responsibility between the two studies. 
8.7% 5.9% 5.6% 5.6% 4.9% 4.6% 3.1% 2.8%
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
FY2 Specialty
Trainee
FY1 Nurse NMP Consultant Overall Staff Grade Other
*
Proportion of 
prescriptions 3.8%              29.7% 3.9%                0.3%              17.1%                                   36.0%              8.0%
*
**
Bars represent 95% confidence 
intervals
n = 13,518
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Within SEPT, staff grade doctors were found to make significantly fewer prescribing 
errors than their colleagues; they were also responsible for writing the greatest 
proportion of medication orders, accounting for 36.0% of the study sample. In the 
North West trusts studied by Keers et al staff grade doctors were responsible for one 
third the proportion of medication orders (10.5%) that their SEPT counterparts 
undertook. In contrast, specialty trainees in the North West undertook 52.8% of the 
prescribing, compared with SEPT specialty trainees who were responsible for slightly 
more than half the prescribing of their northern colleagues at 29.7%. Foundation year 
trainees in the North West also appeared to be responsible for a greater proportion of 
medication orders at 16.9% compared with 7.6% in South Essex.  
Although few studies have reported prescribing error rates by prescriber grade, 
studies in general hospitals have also demonstrated a considerable difference in the 
proportion of prescribing undertaken by newly qualified, junior and senior doctors, 
from that seen in mental health within both this study and the Keers et al study.147 
Following suggestions that doctors in their first year of practice (FY1) were 
responsible for a significant proportion of prescribing errors, the GMC commissioned 
the EQUIP study,18 which sought to compare the prevalence of prescribing errors 
made by FY1s with that of errors by senior doctors. This study of prescribing in 20 UK 
hospitals identified that more than two thirds of the 124,300 medication orders 
reviewed were written by foundation year trainees. By contrast consultants were 
responsible for writing 2.5% of the medication orders studied, and staff grade doctors 
3.5%.18,19 Similarly, a study in eight hospitals in Scotland identified that whilst 
foundation year trainees were responsible for 64.9% of errors, they were also 
responsible for 63.9% of prescribing, with consultants and staff grade doctors 
responsible for 2.6% and 13.3% of medication orders respectively.189 A systematic 
review by Ross et al of 24 studies addressing prescribing errors by junior doctors 
identified considerable variation in reported error rates reported ranging from 0.2% - 
5.1%; however the authors concluded that inconsistencies in methodology, reporting 
units and error definition made any meaningful conclusions difficult.21 
The current study showed the majority of medication orders (36.0%) to be written by 
staff grade doctors, followed by specialty trainees (29.7%) with consultants 
responsible for 17.1%) and foundation trainees by comparison undertaking very little 
of the prescribing (FY1; 3.9%, FY2; 3.8%). Whilst closer to the pattern seen in North 
West England by Keers et al, this is very different from the pattern seen in studies of 
prescribing in general hospitals (see Table 3.5).  
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Table 3.5:   Comparative prescribing error rates by prescribing grade  
Study Details 
Prescribing error rate (%) 
 (95% CI)  
Proportion of overall prescribing (%) 
FY1 FY2 Specialty 
trainee 
Staff grade Consultants Overall 
General hospital setting 
Ashcroft et al, 
201519 
Prospective study over 7 data collection days in 20 
UK hospitals. 124,260 medication orders reviewed, 
and 11,235 prescribing errors found in 10,986 
orders 
8.6% 
(8.2 – 8.9) 
40.2% 
10.2% 
(9.7 – 10.7) 
27.9% 
8.1% 
(7.5 – 8.7) 
13.5% 
6.4% 
(5.2 – 7.6) 
3.5% 
4.8% 
(3.8 – 5.7) 
2.5% 
8.8% 
(8.6 – 9.1) 
- 
Ryan et al, 
2014189 
Prospective study over 14 data collection weeks in 
eight Scottish hospitals. 44,726 medication orders 
reviews, and prescribing errors found in 3,364 
orders 
7.4% 
- 
52.1% 
8.6% 
- 
11.9% 
8.8% 
- 
13.3% 
4.1% 
- 
16.1% 
6.3% 
- 
3.2% 
7.5% 
- 
- 
Mental health setting 
Keers et al, 
2014147 
Prospective study over 10 data collection days in 
three UK mental health trusts. 4,427 medication 
orders reviewed, and 288 prescribing errors found in 
281 orders 
5.1% 
(2.2 – 8.0) 
4.8% 
4.9% 
(3.0 – 6.7) 
12.1% 
6.8% 
(5.8 – 7.8) 
52.8% 
6.5% 
(4.2 – 8.7) 
10.5% 
5.8% 
(3.9 – 7.7) 
13.2% 
6.3% 
(5.6 – 7.1) 
- 
This study Prospective study over 24 data collection weeks 
in one UK mental health trust. 13,684 medication 
orders reviewed, and 727 prescribing errors 
found in 630 orders 
5.6% 
(3.7 – 7.6) 
3.8% 
8.7% 
(6.3 – 11.1) 
3.9% 
5.9% 
(5.2 – 6.6) 
29.7% 
3.1% 
(2.6 – 3.6) 
36.0% 
4.9% 
(4.0 – 5.8) 
17.1% 
4.6% 
(4.3 – 4.9) 
- 
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This may reflect a greater reluctance on the part of medical supervisors in South 
Essex to allow early career doctors to take on prescribing responsibilities but may 
also be as a result of prescribers in the North West being responsible for signing 
medication orders but not necessarily for making the clinical decisions about what to 
prescribe. In an observational study in a large acute hospital in Scotland, Ross et al 
demonstrated that in 62% of cases where a new medicine was prescribed, the 
decision maker was not the same person as the prescription writer, with the decision 
made by more senior doctors than wrote the prescription. They found that whilst 
doctors in foundation and specialty training grades wrote 97% of the prescriptions, 
they were only responsible for the prescribing decisions in 66% of cases.112    
3.3.2 Detailed analysis by prescriber grade 
Initial analysis aggregated data for all doctors in post-foundation training posts into a 
single category of ‘specialty trainee’. However, this included three distinct categories 
of trainee: 
• Core specialty trainees - in their first three years of basic specialty training 
in psychiatry, and likely to be 3 - 5 years’ post-qualification 
• GP trainees - in a six-month psychiatry rotation during three years of training 
to become a GP, and likely to be 3 - 5 years’ post-qualification 
• Higher specialty trainees - in years 4 - 6 of psychiatry training, and likely to 
be 6 - 9 years’ post-qualification. 
As the category of ‘specialty trainee’ shown in Figure 3.4 could include doctors 
between three and nine years post-qualification and with a wide range of experience, 
further analysis was undertaken to determine whether error rates varied between the 
three categories of trainee (see Figure 3.5).  
GP trainees were found to have the highest error rate at 9.7% (79/818), whilst staff 
grade and ‘other’ prescribers had the lowest error rates at 3.1% (152/4,922) and 2.8% 
(30/1,090) respectively. GP trainees were responsible for writing a small proportion of 
prescriptions (6.0%) compared with either core specialty trainees (13.9%) or higher 
specialty trainees in psychiatry (9.8%) (see Table 3.4). Due to the small proportion of 
overall prescribing performed by these groups of prescribers the 95% confidence 
intervals for FY1, FY2 and GP trainees were also relatively large compared with other 
prescriber groups at ± 1.95%, ± 2.41%, and ± 2.02% respectively. 
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The differences between error rates for the different prescriber grade/types shown in 
Figure 3.5 were tested for statistical significance using the Pearson chi-squared test, 
with a significance level of p < 0.05. This demonstrated a significant difference 
between the error rates for each of GP trainees, FY2 doctors, staff grade and ‘other’ 
doctors in comparison to all other prescriber grade/types (χ2 (9) = 115.391, 
p < 0.000).  
 
Figure 3.5:   Prescribing error rate by prescriber grade/type (detailed) 
In line with the approach taken by other similar studies of prescribing errors in general 
and mental health settings,18,19,147,189,257 initial analysis aggregated data for all doctors 
in post-foundation training posts into the single category of specialty trainee, 
regardless of whether they were undertaking psychiatry or general practice training, 
and across the potential 6 years required for core and higher specialty psychiatric 
training. However, as this grouping could include doctors in a wide range of posts and 
stages of career development, further analysis was undertaken to look at GP trainees, 
core specialty trainees and higher specialty trainees separately. Although sample size 
calculations for the study (section 2.3.8) did not anticipate this level of granularity of 
the data, all grades of prescriber demonstrated a margin of error of less than ±5%. 
This would appear to be the first UK study which has investigated prescribing error 
rates by specialty trainees at this level of detail and demonstrated that as well as FY2 
doctors, GP trainees had a significantly higher prescribing error rate than other 
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doctors, whilst the prescribing error rate of core and higher specialty trainees was not 
significantly different.  
In additional analysis of a study of prescribing errors in oncology patients in a Brazilian 
teaching hospital,285 Ferracini et al considered the prevalence and severity of 
prescribing errors by medical residents in years two, three and four of residency 
training (MR2, MR3 and MR4 respectively).286 They found that 57% of prescriptions 
and 61.1% of errors were written by MR2, 18.1% of prescriptions and 20.5% of errors 
by MR3, and 24.9% of prescriptions and 18.4% of errors by MR4 residents. They 
noted that there was no statistically significant association between error rate and 
year of residency training. However, the authors did not provide prescribing error rates 
in terms of errors per medication order, only commenting on the relative proportions 
of prescriptions (containing multiple medication orders) and errors, therefore no 
comparisons can be made with the data provided in this study. 
In the US, Lesar et al identified prescribing error rates by physician ‘class’ as early as 
1990, classifying prescribers as attending, fellow or postgraduate by year if resident 
house staff (first, second, third, fourth or greater). The authors reported that first-year 
residents (equivalent to British FY1s) had a significantly greater error rate than other 
physicians, with error rates declining progressively with postgraduate years of 
training, suggesting that experience and knowledge were important factors in 
performance. They also noted that, surprisingly, attending physicians (equivalent to 
British consultants) had the second highest error rate, and suggested that infrequent 
writing of medication orders (attendings wrote only 4.3% of medication orders) 
increased the risk of errors.20 A few years earlier Folli et al in a study of prescribing 
errors in two paediatric hospitals, had noted that “the frequency of errant orders 
declined as physicians’ training status increased”.180 
3.3.3 The role of experience 
To explore whether there was any relationship between the time since medical 
qualification and prescribing error rates, further analysis was undertaken separating 
trainees by year within each training role. Whilst this should be considered an 
approximate measure as trainees may have transferred into either psychiatry or 
general practice training following a period working in another specialty, and staff 
grade doctors and consultants may have been working at this grade for many years, 
it was used as a proxy to reflect their level of experience (see Figure 3.6).  
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The differences between error rates for different prescriber grades were tested for 
statistical significance using the Pearson chi-squared test, with a significance level of 
p < 0.05. This demonstrated a significant difference between the error rates for FY2 
doctors and doctors in their first year and second years of core psychiatry or GP 
training, in comparison to all other prescriber grades. Additionally, there was a 
significant difference between the error rate for staff grade doctors and all other 
prescriber grades (χ2 (10) = 129.591, p < 0.000).  
The relationship between error rate and prescriber grade (used as a proxy to reflect 
the level of experience of the individual) was explored using the non-parametric 
Spearman’s correlation coefficient (rs). This demonstrated a correlation coefficient, rs, 
of -0.049 (95% confidence interval -0.030 to -0.067) significant at p < 0.01, indicating 
a weak relationship between increased experience and decreased prescribing error 
rates. 
 
Figure 3.6:   Prescribing error rate by prescriber grade (which reflect level of experience) 
The current study indicated that early career doctors in the years immediately 
following registration demonstrated significantly higher error rates. Whilst this finding 
is similar to other studies which have found that junior doctors are more likely to make 
prescribing errors,18–20 some have looked specifically at prescribing errors made by 
doctors during their foundation training, rather than in any detail at further periods in 
the career pathway of doctors.189,287  
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It is perhaps unsurprising that FY2 and new core/GP specialty trainee doctors had the 
highest rates of prescribing errors, as this is the point in their training when they start 
to work independently, providing out-of-hours cover and operating as the ‘duty’ doctor 
on-call. Despite having telephone access to more senior medical colleagues for 
advice, they are often the only doctor available on-site and are expected to take 
responsibility for the care of both newly admitted patients, and patients normally in 
the care of other doctors. For both groups this may also be their first experience of 
working within psychiatry. 
Taking their lead from high-risk industries, Dearden et al developed a prototype 
taxonomy of non-technical skills required for safe prescribing by junior doctors. They 
highlighted that the application of a similar approach in aviation (termed crew resource 
management) has been used to reduce accidents and could show promise in medical 
fields. Their systematic review of studies analysing prescribing behaviours and errors 
by junior doctors identified a tendency to underestimate the risk to patients from an 
incorrect prescription, difficulty asking for help, and a belief that they make less errors 
than the literature suggests, which others will intercept.  They also found that junior 
doctors do not necessarily have the opportunity to learn the skills that they require to 
become expert prescribers.288   
Evaluation of the essential knowledge, skills and attitudes in clinical pharmacology 
and therapeutics has suggested that, across Europe and elsewhere, final-year 
medical students show an overall lack of essential prescribing competencies, with 
poor knowledge of drug interactions and contraindications, and the inability to choose 
appropriate therapies for common diseases.223,289,290 More than two-thirds of 
European medical schools did not provide students with the opportunity to practice 
real-life prescribing prior to qualification.291 The majority of UK medical students 
reported that they had filled in a hospital prescription chart less than three times prior 
to being required to prescribe for the first time as a junior doctor,292 despite such 
experience being valued by medical students.293 
Students lacked insight into their own strengths and weaknesses in prescribing,114,221 
and often did not feel prepared for prescribing.292,294 Junior doctors have reported 
difficulties in applying knowledge gained at medical school to clinical practice,295 and 
that approachable, available and up-to-date ‘teachers’ (pharmacists, nurses and more 
senior doctors) have a significant impact on practical learning about prescribing.296 
More positively, the vast majority of UK final-year medical students are able to pass 
the prescribing safety assessment (PSA) introduced in 2014.297  
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When faced by unfamiliar and complex situations, humans often rely on heuristics to 
make fast decisions, as rational and deliberative analysis is not always possible.206 
Most of the research about the cognitive processes used by medical staff has 
concentrated on diagnosis, but it is likely that there are transferable concepts to the 
development of treatment plans and prescribing. The concept of “scripts” for arriving 
at a diagnosis has been suggested - incoming information activates a previously 
acquired network of relevant knowledge and experience which directs the selection, 
interpretation and memorisation of new information.  
Reasoning with an “illness script” can be seen as both hypothetico-deductive and 
unconscious, with the activation phase automatic, but the processing phase - the 
search for evidence to rule a hypothesis in or out, controlled and deliberate.298  
Schmidt et al put forward a stage theory for the development of clinical reasoning, 
based on the assumption that experienced physicians operate on the basis of illness 
scripts - knowledge structures which emerge from continuous exposure to patients 
and contain a wealth of clinically relevant information about a disease, its 
consequences and context. Their theory asserts that physicians use memories of 
previous patients while diagnosing (and presumably treating) new cases.299 They 
describe four developmental stages that are characterised by the emergence of four 
different knowledge structures, which remain with them:  
• Stage 1: development of elaborated causal networks - acquired knowledge is 
organised into cognitive models, which provide meaning and structure to 
otherwise chaotic information. These causal networks explain the causes and 
consequences of disease in terms of general underlying pathophysiological 
process and become increasingly elaborate and complex with increased 
learning. 
• Stage 2: compilation of elaborated networks into abridged ones – through 
extensive and repeated application of acquired knowledge and exposure to 
patient problems, the elaborate knowledge base becomes compiled into 
simplified causal models which contain only the higher-level concepts from 
the original pathophysiological networks. 
• Stage 3: emergence of illness scripts – the pathophysiological networks are 
gradually compiled into diagnostic labels or simplified mental models that 
sufficiently explain the phenomena observed. Problem solving in routine 
cases becomes a process of script search, selection and verification. 
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• Stage 4: storing patient encounters as instance scripts – physicians retain 
vivid “autobiographical memory” of cases seen earlier. An important 
component of expertise is the accumulation of countless prior examples and 
their rapid and effortless retrieval when confronted with a similar situation. 
The recollections of prior patients, indexed by the relevant illness script, are 
stored in episodic memory, making them easily accessible. 
The authors contend that this is a reasonably accurate description of the 
development sequence, but also suggest that previously acquired knowledge 
structures remain available and that expert clinicians may move from one to another 
as the complexity of the problem demands. It is likely that this equates to the 
interaction between System 1 and System 2 thinking described as “rational override” 
and “calibration” in the model of reasoning based on pattern recognition and dual 
process theory described by Croskerry (see Figure 1.7).202–204   
It has been suggested that the development of expertise requires intense practice 
extended for a minimum of 10 years,300,301 a concept popularised as “the 10,000-hour 
rule” in Malcolm Gladwell’s book Outliers.302 The result seen in this study that there is 
an, albeit weak, inverse relationship between prescribing error rates and experience 
would appear to support this assertion. The likelihood of errors decreases with 
increasing expertise and knowledge73 with more experienced individuals able to see 
the relevant information in a problem and analyse it in an explicit, logical manner, 
while the inexperienced individual does not recognise the critical information and 
performs worse.303 
3.4 Steps in the drug use process 
Errors most frequently occurred during the step of the prescribing process that related 
to providing instructions for the supply of the medicine (35.9%; 261/727) such as 
specifying the correct strength/unit, formulation or route of administration. However, 
this also included failure to comply with legal requirements such as signing (3.4%) or 
dating (8.3%) the prescription and complying with controlled drug legislation (0.4%). 
Overall, nearly one-quarter of errors related to selecting the dosage regimen 
(23.9%; 174/727), with 10.2% (74/727) of errors due to prescribing an incorrect dose. 
Further detail can be found in Table 3.6. 
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Table 3.6:   Types of prescribing errors by step in the drug use process 
Error type No. % 
Need for drug 117 16.1% 
Duplication of drug(s) 48 6.6% 
Omission of drug on admission 29 4.0% 
Omission of drug on leave/discharge prescription 24 3.3% 
Wrong transcription 8 1.1% 
Omission of drug on rewritten prescription 4 0.6% 
Premature discontinuation 2 0.3% 
Drug not indicated 2 0.3% 
Select specific drug 26 3.6% 
Wrong drug 18 2.5% 
Ambiguous drug name 3 0.4% 
Allergy to prescribed drug 2 0.3% 
Non-compliance with MHA requirements 2 0.3% 
Drug-lab test interaction 1 0.1% 
Select dosage regimen 174 23.9% 
Wrong dose 74 10.2% 
PRN without minimum dose interval 45 6.2% 
PRN without maximum dose limit 22 3.0% 
Omission of duration/review date 14 1.9% 
Wrong duration of treatment 11 1.5% 
Omission of dose 8 1.1% 
Provide administration instructions 149 20.5% 
Wrong dosing interval 64 8.8% 
Omission of dosing interval 37 5.1% 
Omission of indication for PRN 20 2.8% 
Omission of treatment time 16 2.2% 
Wrong route of administration 7 1.0% 
Omission of indication for an antimicrobial 5 0.7% 
Provide instructions for supply of product 261 35.9% 
Omission of formulation 104 14.3% 
Omission of date 60 8.3% 
Omission of signature 25 3.4% 
Omission of strength/unit 25 3.4% 
Wrong formulation 22 3.0% 
Wrong strength/unit 12 1.7% 
Omission of route of administration 7 1.0% 
Illegible handwriting 3 0.4% 
Non-compliance with controlled drug requirements 3 0.4% 
 727 100.0% 
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A greater proportion of the errors made by core/GP trainees and consultants involved 
the process of determining the need for a drug. This step in the process accounted 
for 23.0% (47/204) and 21.3% (37/174) of the errors made by these types of 
prescribers respectively, compared with 19.1% (135/708) overall. Staff grade doctors 
made the most errors involving the process of selecting a specific drug with these 
accounting for 36.5% (65/178) of all errors made by them, compared with 21.2% 
(150/708) of errors overall.  Errors associated with selecting a specific drug were also 
higher amongst FY1 doctors at 27.8% (10/36). More information on the step in the 
drug use process and prescriber grade can be found in Figure 3.7. 
 
Figure 3.7:   Proportion of errors by step in the drug-use process and prescriber grade 
Classification based on the steps in the drug use process was originally used to 
capture clinical pharmacists’ interventions,304 but has since been used to categorise 
prescribing errors in a number of studies.14,19,155,305 However, the proportion of overall 
errors occurring in each step in the drug use process and their respective rankings 
varied between studies. Prescribing errors relating to the selection of a drug where 
the least common category in all of these studies; a situation also seen in the current 
study. However, there were differences in the process step which was most commonly 
involved in errors.  
Errors involving selection of the drug dose were most common in a study of errors in 
a UK teaching hospital which identified 538 prescribing errors. Of these 54% related 
to the process of selecting the drug dose, while 18% related to the need for drug 
therapy.14 The process of selecting the drug dose was also the most common area 
for error in a study comparing prescribing errors before and after the introduction of 
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computerised physician order entry (CPOE) in a single general surgery ward. Pre-
CPOE, dose selection was involved in 38%, with again the second most common step 
involved being the need for therapy (36%)155, although the difference between the first 
and second ranked errors was relatively small compared with the earlier Dean et al 
study.14 In studies by Tully et al305 and Ashcroft et al19 ‘need for drug’ was the step in 
the drug-use process which was most commonly associated with a prescribing error.  
However, although ‘need for drug’ was most common in both studies, the proportions 
of errors identified in this category were quite different. The earlier study, in which 
data were collected in 2003/04, identified 37% of errors which related to the need for 
a drug,305 whilst the later study identified 48.7% of errors in this category.19‘ The more 
recent study identified a greater proportion of errors due to the omission of a drug on 
admission (28.5% compared with 15.2%), which is likely to reflect the improved 
recognition of medication issues which occur at transfers of care, and the greater 
emphasis on medicines reconciliation on admission to hospital which has been in 
place since the NICE/NPSA guidance in 2007.280 
In the current study prescribing errors most commonly occurred during the process of 
providing instructions for the supply of the product (261/727; 35.9%), which was 
ranked as third or fourth in the previous studies. However, a high number of errors 
were identified (104/727; 14.3%) which involved failure to specify the formulation or 
product which have contributed to this position. The second most common step of the 
process involved in errors was selecting the dosage regimen, which is more in line 
with the results from previous studies. The current study found a higher proportion of 
omissions occurring at discharge rather than admission compared with other studies, 
which may be accounted for by the high level of medicines reconciliation which occurs 
at admission within SEPT, or the practice in some trusts of pharmacists writing 
discharge medication orders which has been shown to have very low error rates.306  
Only one study investigated the step in the drug-use process by stage in the patient’s 
hospital stay.275 Tully et al found that errors relating to the need for therapy occurred 
more commonly during admission and discharge, errors relating to drug doses during 
the inpatient stay, and to providing administration and supply instructions when drug 
charts were rewritten. The current study found some similarities and differences. 
Errors relating to the need for therapy (mainly omissions) were more commonly 
associated with discharge, those involving supply instructions when drug charts were 
rewritten, and those involving dosage regimens when drug charts were rewritten and 
during the inpatient stay (see Table 3.7).
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Table 3.7:   Prescribing errors identified at different stages of the patient’s journey by step in the drug-use process 
 Admission During stay Rewriting Leave Discharge Not known Total 
Items written/omitted 
No. with errors 
Error rate (%) 
2,613 
163 
6.2% 
4,552 
239 
5.3% 
4,713 
100 
2.1% 
598 
31 
5.2% 
1,046 
81 
7.7% 
162 
16 
9.9% 
13,684 
630 
4.6% 
Stage of the prescribing process        
Need for drug 
 
39 (20.3%) 36 (12.6%) 10 (9.5%) 4 (11.1%) 26 (28.9%)* 2 (11.1%) 117 (16.1%) 
Select specific drug 
 
3 (1.6%) 6 (2.1%) 2 (1.9%) 11 (30.6%)* 3 (3.3%) 1 (5.6%) 26 (3.6%) 
Select dosage regimen 
 
54 (28.1%) 91 (31.8%)* 10 (9.5%)* 3 (8.3%) 13 (14.4%) 3 (16.7%) 174 (23.9%) 
Provide administration instructions 
 
40 (20.8%) 64 (22.4%) 11 (10.5%) 4 (11.1%) 26 (28.9%) 4 (22.2%) 149 (20.5%) 
Provide instructions for supply of product 
 
56 (29.2%) 89 (31.1%) 72 (68.6%)* 14 (38.9%) 22 (24.4%) 8 (44.4%) 261 (35.9%) 
* Errors of this type occur more commonly in this prescribing stage (p < 0.05) 
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3.5 Nature of errors  
As well as arriving at a practitioner-led definition of a prescribing error, Dean et al 
asked panel members to indicate the extent to which 42 general scenarios 
represented a prescribing error. Consensus was reached on 27 scenarios which 
should be classed as prescribing errors, of which 13 errors were associated with the 
decision making of prescribing whilst 14 related to the process of prescription 
writing.25  A similar approach was taken by Lisby et al, who assessed 40 prescribing 
error types identified in a systematic review74 of 203 studies and reached consensus 
that 28 should be considered prescribing errors; 16 relating to decision making, and 
12 to communication (prescription writing).86 These scenarios/error types were used 
to guide the classification of prescribing errors found in the current study. 
The two systems differed in how drug omissions and incorrect medication orders were 
treated; Lisby et al consider omission and incorrect orders (drug, formulation, dose, 
frequency, route, duration and strength/unit) to be decision-making errors, whilst 
Dean et al consider these to be a prescription-writing error. In the current study 
omitted drugs were classified as a prescription-writing error in line with Dean et al,25 
and incorrect medication orders as decision-making errors in line with Lisby et al.86  
3.5.1 Prescribing error types 
 
Figure 3.8:   Types of prescribing error  
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The most frequent errors types were missing or incorrect administration 
times/frequencies (162/727; 22.3%) including the omission of dosing intervals, 
treatment times, and minimum dosing intervals for PRN medication. The next most 
common categories of errors were missing or incorrect strengths or doses 
(141/727; 19.4%) and missing or incorrect formulations (126/727; 17.3%).  
Errors which involved the omission of a medicine accounted for 8.1% of identified 
errors (59/727). Few errors involved prescription of the wrong drug (23/727; 3.2%), 
although drug selection was involved in those errors that related to duplication of 
drugs (48/727; 6.6%), which was the sixth most common category of error. More 
information is shown in Figure 3.8 and Table 3.8.  
Missing and wrong administration times/frequencies were most commonly found in 
medication orders which had been written during the patient’s stay (43.2%; 70/162) 
or on admission (30.9%; 50/162). This was also the case for errors involving missing 
or wrong strengths and doses with 50.0% (71/142) and 29.6% (42/142) occurring 
during the patient’s stay and on admission, respectively. 
Table 3.8:   Types of prescribing error by stage in the patient’s journey 
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Missing or wrong admin 
times/frequencies 50 70 8 5 24 5 162 
Missing or wrong strengths/doses 42 71 11 2 12 3 141 
Missing or wrong formulations 20 29 59 0 17 1 126 
Undated prescriptions 17 28 4 4 1 6 60 
Omission of medicines 26 5 4 4 20 0 59 
Duplication of drug(s) 11 30 5 0 0 2 48 
Missing or wrong duration/review 
date 4 18 0 0 3 0 25 
Unsigned prescriptions 4 9 3 8 1 0 25 
Missing indication 6 14 5 0 0 0 25 
Wrong drug 3 1 2 10 3 0 19 
Missing or wrong route 6 4 2 0 2 0 14 
Non-compliance with MHA 0 1 0 0 0 1 2 
Other 3 6 2 3 7 0 21 
Total 192 286 105 36 90 18 727 
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Signatures were most commonly omitted from medication orders written during the 
patient’s stay (36.0%; 9/25) or for short-term leave (32%; 8/25). A greater proportion 
of medication orders were left undated (8.3%; 60/727), which occurred most 
frequently during a patient’s stay (46.7%; 28/60), or on admission (28.3%; 17/60).  
The most common error found amongst prescriptions which had been re-written was 
the omission of, or incorrect, formulations. This type of error accounted for 56.2% 
(59/105) of errors occurring during re-writing medication orders, and 46.8% (59/126) 
of errors involving missing/incorrect formulations were in re-written prescriptions. 
Medication orders written at the time of discharge were most commonly affected by 
missing or incorrect administration times/frequencies (26.7%; 24/90) and the omission 
of medicines (22.2%; 20/90). Errors recorded in the category of ‘other’ in Figure 3.8 
included drug-lab test interaction, illegible handwriting, wrong transcription and 
controlled drug errors. 
Each identified error was mapped against the categories defined in Reason’s accident 
causation model (see Table 3.9)23 by the researcher. However, as only a very small 
subset of errors was discussed with the prescriber this represents the researcher’s 
assumptions about likely causation rather than being based on the views of the person 
who made the error about its causes. 
Table 3.9:   Types of prescribing errors by human error theory classification 
Type of active failure No. of errors (%) 
Slips 86 (11.8%) 
Lapses 174 (12.9%) 
Knowledge-based mistakes 220 (30.3%) 
Rule-based mistakes 225 (30.9%) 
Violations 22 (3.0%) 
 727 (100%) 
 
Errors were classified using a system of error types proposed by Lisby et al86 following 
a review of 203 studies, an approach which has been used by researchers in other 
studies.18,19,104,121,189,257,274,307. Most of the errors identified (430/727; 59.1%) related to 
the incomplete or incorrect provision of information (e.g. missing or wrong times, 
strengths, doses and formulations). This differed from the findings of some studies 
conducted in both psychiatry147 and general hospital settings,13,19,189,257 which 
identified omitted medicines on admission to be the most common type of prescribing 
error in their studies. In this study omission of medicines was the fifth most common 
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error type accounting for 8.1% of prescribing errors. However, the findings agreed 
with those of Haw and Stubbs99–101 in a mental health setting, and Bobb et al274 in a 
general hospital setting who also found that incomplete prescriptions were the most 
common type of errors. What is not known is whether this reflects the fact that omitted 
medicines were missed by the ward pharmacists when data were collected, or 
whether the admission and medicines reconciliation processes practiced in SEPT 
truly manage to avoid medicines being omitted at the time of admission.  
Very few errors which were specific to a mental health setting were identified (e.g. 
MHA compliance or correct registration with a clozapine monitoring service; 2/272; 
0.27%). Other UK studies commonly found drugs prescribed for a patient detained 
under the Mental Health Act without completion of the necessary authorisation to treat 
forms (range 16 - 26 cases; 3.1 - 12.3% of prescribing errors),99–101 although in the 
more recent study by Keers et al only four such instances were identified (1.4% of 
errors).147 
3.5.2 Decision making and prescription writing errors 
Overall, prescription-writing errors (452/727; 62.2%) were more common than 
decision-making errors (275/727; 37.8%). The proportions were similar to those found 
in a general hospital setting.14  A greater proportion of prescription-writing errors were 
found in three studies in a mental health setting by the research team of Haw, Stubbs 
and colleagues (76.3%, 87.5% and 77.4% respectively.99–101 However, these studies 
classified errors relating to wrong drug, dose, frequency, formulation, treatment 
duration or route as prescription-writing errors (in line with Dean et al25) rather than 
decision-making errors (in line with Lisby et al86). The Lisby et al classification was 
used in this study and may explain the difference from the results of Haw, Stubbs 
et al. In a similar study Paton et al identified 58% of the errors to be clinical errors 
rather than clerical errors, but it is not clear whether these categories correspond to 
decision-making and prescription-writing errors.128 Other studies investigating the 
prevalence and nature of prescribing errors in either a mental health147 or general 
hospital19,189,257 setting have not analysed the data in terms of these characteristics. 
The highest proportion of decision-making errors were made by FY1 doctors, whilst 
higher specialty trainees and visiting consultants/GPs made a lower portion of errors 
which related to decision-making. The details are shown in Table 3.10. 
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Table 3.10: Errors involving prescribing decisions vs. prescription writing by prescriber grade 
 Decision making Prescription writing  
Foundation Year 1  52.8% 47.2% 
Foundation Year 2 30.5% 69.5% 
Core Trainee (Psychiatry) 42.7% 57.3% 
GP Trainee 41.5% 58.5% 
Higher Specialty Trainee  (Psychiatry) 24.6% 75.4% 
Staff Grade 35.4% 64.6% 
Consultant Psychiatrist 42.5% 57.5% 
Other (Visiting Consultants/GPs) 25.0% 75.0% 
Nurse Non-Medical Prescriber 33.3% 66.7% 
Not known 43.8% 56.3% 
Total 37.8% 62.2% 
 
3.6 Type of medicines 
Despite the study involving a cohort of patients who were primarily being treated for 
a mental health condition, nearly 60% of items prescribed were for non-psychotropic 
drugs (57.7%; 7,895/13,684). Non-psychotropic drugs accounted for nearly two-thirds 
of items which contained at least one error (64.0%; 403/630) but a lower proportion 
of errors overall (58.0%; 422/727) with multiple errors affecting one medication order 
more likely to be psychotropics. The error rate for non-psychotropic medicines was 
higher (5.1%; 403/7,895) than for psychotropic medicines (3.9%; 227/5,789). The 
difference between error rates was tested for statistical significance using the Pearson 
chi-squared test, with a significance level of p < 0.05, demonstrating a significant 
difference (χ2 (1) = 10.648, p < 0.001). The error rate for regular medicines was 
higher (4.9%; 439/9,030) than for ‘as required’ medicines (4.1%; 191/4,654). The 
difference between these was tested for statistical significance using the Pearson chi-
squared test, with a significance level of p < 0.05. This demonstrated that the error 
rates for regular and ‘as required’ medicines were statistically significant 
(χ2 (1) = 4.013, p = 0.045). The respective error rates are shown in Figure 3.9.  
For psychotropic drugs, although there was a difference between the error rates for 
regular and ‘as required’ medicines (4.3% compared with 3.3%), this difference was 
not statistically significant when tested using Pearson’s chi-squared test 
(χ2 (1) = 3.684, p = 0.055). The same was the case for the difference between regular 
and ‘as required’ non-psychotropic drugs (5.1% compared with 5.3%) where the 
difference in error rates was not statistically different (χ2 (1) = 0.828, p = 0.363).  
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Figure 3.9:   Error rates for regular and PRN items, by type of medicine 
Foundation year doctors and those in their early years of core psychiatry or GP 
training, showed large differences between the error rates for psychotropic and non-
psychotropic medication orders, although for non-psychotropic items the 95% 
confidence intervals were particularly large for foundation year 2 (± 3.76%) and year 
one core/GP trainees (± 5.22%). Details are shown in Figure 3.10. 
 
Figure 3.10: Error rate for psychotropic and non-psychotropic medicine, by prescriber type 
Excluding NMPs and unknown prescribers, the differences between error rates were 
tested for statistical significance using the Pearson’s chi-squared test, with a 
significance level of p < 0.05. A significant difference was demonstrated between the 
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error rates for psychotropic medicines for staff grade doctors in comparison with other 
prescriber grade/types (χ2 (9) = 20.195, p = 0.017). A significant difference was 
demonstrated between the error rates for non-psychotropic medicines for FY2 
doctors, core/GP trainees in their first year and second years of training, staff grade 
doctors and consultant/GPs, in comparison to other prescriber grade/types 
(χ2 (9) = 151.446, p = 0.000). 
Table 3.11: Frequency of prescribing error by medicine class 
Category Errors 
No. % 
Psychotropics 305 42.0% 
Antipsychotic drugs 81 11.1% 
Hypnotics & anxiolytics 79 10.9% 
Antidepressants 56 7.7% 
Antiepileptic drugs 38 5.2% 
Drugs used in substance dependence 27 3.7% 
Drugs used in parkinsonism 16 2.2% 
Drugs used in mania & hypomania 4 0.6% 
Drugs for hypersalivation 2 0.3% 
CNS stimulants & drugs for ADHD 2 0.3% 
Non-psychotropics 422 58.0% 
Analgesics 71 9.8% 
Antimicrobials (all routes) 65 8.9% 
Gastrointestinal 58 8.0% 
Respiratory 47 6.5% 
Endocrine 44 6.1% 
Cardiovascular 42 5.8% 
Nutrition & blood 34 4.7% 
Skin (excluding antimicrobials) 24 3.3% 
Eye (excluding antimicrobials) 14 1.9% 
Obstetric, gynaecological & urinary tract 9 1.2% 
Ear, nose & oropharynx (excluding antimicrobials) 7 1.0% 
Musculoskeletal & joints 7 1.0% 
Total errors 727 100.0 
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Errors were most commonly identified in medication orders for antipsychotics (81/727; 
11.1%), hypnotics and anxiolytics (79/727; 10.9%), analgesics (71/727; 9.8%), 
antimicrobials (65/727; 8.9%) and drugs for the gastrointestinal system 
(58/727; 8.0%) The frequency of prescribing errors amongst different classes of 
medicine are shown in Table 3.11. 
Three types of errors accounted for most of those involving antipsychotics (50/81; 
61.7%). Errors most commonly related to incorrect formulations being specified or the 
formulation missed (20/81; 24.7%). This reflects the fact that some antipsychotics, for 
example, quetiapine, are available as both immediate and sustained release 
formulations with different dosing regimens, whilst others, for example, olanzapine, 
are available as standard and orodispersible formulations in different strengths. 
Dosing intervals and treatment times were also commonly omitted or incorrect for the 
formulation specified (15/81; 18.5%), and doses were omitted, incorrect for the 
patient, or exceeded the maximum recommended dose (15/81; 18.5%).  
Hypnotics and anxiolytics were most commonly affected by missing or incorrect 
administration times or frequencies (23/79; 29.1%), particularly the absence of a 
minimum dose interval for ‘as required’ lorazepam and promethazine. Another 
common error was incorrect doses (15/79; 19.0%), particularly doses of lorazepam 
which exceeded the maximum recommended dose for older people. Together these 
accounted for almost half of the errors in this group of drugs (38/79; 48.1%). 
Errors involving analgesics were most commonly associated with duplication of drugs 
(16/71; 22.5%), where paracetamol was added to the patient’s regimen when another 
paracetamol containing preparation was already prescribed, or vice versa. As many 
medication orders for analgesics were for ‘as required’ use, these also were highly 
affected by errors relating to missing or wrong administration times or frequencies 
including no minimum dose interval being provided (15/71; 21.1%). 
Medication orders for antimicrobials (by all routes) most commonly involved errors 
relating to missing or incorrect durations of treatment, or absence of a review date 
(18/65; 27.7%). Also common were incorrect dosing intervals or frequencies, for 
example, trimethoprim prescribed for prophylaxis of urinary tract infection twice daily 
rather than the recommended once daily or co-amoxiclav prescribed twice or four 
times daily rather than the recommended regimen of three times daily.  
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One hundred and seventy different medicines were involved in the 727 errors, with 
more than 40% of medicines (69/170) associated with only one error. Table 3.12 
shows the top 20 medicines most commonly involved in prescribing errors by order of 
prevalence, which between them accounted for half of errors (363/727; 49.9%). The 
medicines most commonly associated with errors were paracetamol-containing 
products and lorazepam. 
Table 3.12: Medicines most commonly involved in a prescribing error (Top 20) 
Medicine Errors 
No. Percentage 
Paracetamol (including combination products) 57 7.8% 
Lorazepam 31 4.3% 
Promethazine 26 3.6% 
Nicotine Replacement Therapy 25 3.4% 
Salbutamol 20 2.8% 
Venlafaxine 19 2.6% 
Mirtazapine 17 2.3% 
Senna 17 2.3% 
Olanzapine 16 2.2% 
Zopiclone 16 2.2% 
Levothyroxine 14 1.9% 
Quetiapine 14 1.9% 
Valproate 14 1.9% 
Calcium carbonate 13 1.8% 
Haloperidol 13 1.8% 
Aripiprazole 11 1.5% 
Chloramphenicol 11 1.5% 
Metformin 11 1.5% 
Risperidone 10 1.4% 
Beclometasone 8 1.2% 
Others 364 50.1% 
Total errors 727 100.0% 
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Errors involving paracetamol accounted for 7.8% of all errors (57/727). Of these nearly 
one-quarter (13/577; 22.8%) related to missing or wrong administration times or 
frequencies including no minimum dose interval being provided for an ‘as required’ 
medicine, with a nearly a further third (16/57; 28.1%) due to duplication where other 
paracetamol-containing products were already prescribed for the patient. Missing or 
wrong administration times or frequencies were also the most common type of error 
affecting medication orders for lorazepam (9/31; 29.0%) either where no minimum 
dose interval had been specified for ‘as required’ dosing, or a minimum dosing interval 
of 1 hour had been specified when the recommended minimum period between doses 
is 2 hours. In 5 cases (16.1%) lorazepam had been duplicated on the prescription, 
either on two separate drug charts or as both regular and ‘as required’ medication on 
the same chart, which together exceeded the maximum recommended dose.  
The majority of prescribing errors involved medicines for oral administration (71.9%; 
523/727), with errors involving medicines for topical use (9.4%; 68/727) and inhalation 
(7.7%; 56/727) also common. This reflects the fact that the intravenous route, often 
involved in errors in a general hospital setting is rarely used in mental health patients. 
Few studies have compared the error rates for psychotropic and non-psychotropic 
medication, and the two studies that have identified different results. One study 
identified a higher error rate for psychotropic medication (2.5% vs. 2.0%)101 whilst the 
other, like the current study, found the error rate to be higher for non-psychotropic 
medication (2.9% vs. 1.5%).100 
Relatively few studies have reported on the individual drugs or drug classes involved 
in prescribing errors.18,99,101,130,148 In the EQUIP study into prescribing errors by 
foundation trainees in a general hospital setting, Dornan et al18 reported that 
analgesics and antibacterial drugs were the two most common group of drugs 
involved in errors, which corresponded with the most common non-psychotropic drug 
groups in this study. In their analysis of more than 11,000 prescribing errors, 
psychotropic drugs were involved in a very small proportion of errors. The two most 
common psychotropic drug groups were hypnotics and anxiolytics, which accounted 
for 1.8% of errors (compared with 10.9% in the current study) and drugs used in 
psychosis and related disorders, which accounted for 0.9% of errors (compared with 
11.7%). In studies undertaken in psychiatric inpatients all have identified 
antipsychotics as most commonly involved in prescribing errors,99,101,130 reflecting the 
high use of these in a psychiatric setting, followed by mood stabilisers130 or hypnotics 
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and anxiolytics.99,101  Non-psychotropic drugs involved in errors were commonly those 
for cardiovascular disease, gastro-intestinal conditions and diabetes.  
Thomas et al worked with a clinical panel with expertise in medication safety to arrive 
at a set of prescribing safety indicators for high-severity and/or high-frequency 
prescribing errors relevant to a general hospital setting.308 Using an electronic Delphi 
consensus process,96,97 80 prescribing errors were identified as being of high or 
extreme risk and relevant to a hospital setting. Although the most frequently named 
drugs were antibiotics, opioids and low molecular weight heparins, 18 of the identified 
indicators related to psychotropic medicines, including lithium, benzodiazepines, 
antipsychotics and antidepressants, with clinical contraindications and drug-drug 
interactions featuring highly (see Appendix 18). Whilst a similar exercise has been 
undertaken to develop paediatric prescribing indicators,309 to date no psychiatric 
prescribing indicators have been developed. None of the psychotropic prescribing 
safety indicators developed by Thomas et al were identified in the current study. 
However, the most commonly identified error - more than one paracetamol-containing 
product prescribed to a patient at a time resulting in the maximum dose being 
exceeded - features in the general prescribing safety indicator list. Equally some of 
the indicators which relate to psychotropic drugs may be considered to be a safety 
issue in a general hospital setting, but less so in a specialist mental health setting 
where the risk/benefit ratio may be different. An example would be the use of 
antipsychotics in the management of extreme behavioural and psychological 
symptoms in dementia or use of long-term antipsychotics to treat psychosis in a 
patient with parkinsonism.310  
Life expectancy for those with serious mental illness is typically 15 - 20 years less 
than for the general population.311  Problems managing long-term conditions and 
additional health risks due to high blood pressure, diabetes and obesity associated 
with psychotropic medicines are often compounded by lack of exercise, poor diet and 
smoking.312 Government policy has set out  that the physical inequalities experienced 
by those with mental illness should be reduced through screening and disease 
prevention, and “parity of esteem” be achieved between mental and physical 
services.313,314 It is therefore important that patients with a mental illness receive 
treatment for physical health conditions that is equal to that which would be received 
by patients who do not have a mental illness, including in terms of instances of 
prescribing errors. 
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3.7 Comparison between sub-specialties 
The highest error rates were identified for wards within learning disabilities (6.5%; 
3/46) and general adult services (6.2%; 258/4,162); however, it should be noted that 
the number of medication orders assessed on the learning disability wards was very 
small, representing only 0.3% of the overall sample, and the confidence interval was 
therefore large (± 7.12%). The lowest error rate was identified within forensic services 
(3.4%; 156/4,577). The differences between error rates for different sub-specialties 
were tested for statistical significance using Pearson’s chi-squared test, with a 
significance level of p < 0.05. This demonstrated that the error rates for each of 
general adult services and forensic services were significantly different from the 
overall sample (χ2 (4) = 40.361, p = 0.000) (see Figure 3.11). 
 
Figure 3.11: Prescribing error rate by sub-specialty 
No other studies have compared prescribing error rates between psychiatric sub-
specialties. As the confidence intervals for two - learning disabilities and CAMHS - 
where large due to small sample sizes it would be inappropriate to draw conclusions 
about their prescribing errors rates. However, for general adult and forensic services 
where the difference in error rates where statistically significant, this may reflect both 
the increasing acuity and fast turnover of general adult patients, and the fact that 
transfers of care within forensic services are relatively rare and carefully planned 
when they do occur.  
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3.8 Clinical significance of errors 
During data collection, pharmacists recorded an opinion on the potential clinical 
significance for 665 of the 727 errors identified (91.5%). Of these 27 (4.1%) were 
classified by the ward pharmacist as falling within the potentially ‘severe’ category, 
using the method described in Section 2.3.5. A panel of four experienced healthcare 
professionals evaluated 625 (86.0%) of the 727 errors identified. Legal issues were 
assumed to have no clinical significance and were excluded from this process to 
reduce the workload on panel members. All panel members failed to evaluate at least 
a small number of errors during the review process with one panel member evaluating 
just under three-quarters of the errors sent to them (72.5%; 454/626). The 
categorisations made by the ward pharmacists and expert panel members are shown 
in Table 3.13. 
Table 3.13: Potential clinical significance scores  
 minor 
(< 3) 
moderate 
(3 - 7) 
severe 
(> 7) 
Ward pharmacist (n=665) 452 (68.0%) 186 (28.0%) 27 (4.1%) 
Expert panel (n=625) 338 (54.1%) 278 (44.5%) 9 (1.4%) 
 
Pharmacists also recorded whether the patient had experienced any harm due to the 
error in 689 of the 727 errors (94.8%). Only three errors (0.4%), detailed below, were 
judged to have resulted in actual patient harm: 
• A patient was prescribed pregabalin capsules 300 mg twice daily, but only the 
10 pm administration time was circled on the drug chart. The dose was 
administered once daily for three days before the error was identified. Nursing 
staff reported that the patient was very aggressive with volatile mood which 
was attributed to the omission of three morning doses of pregabalin. 
• A patient was prescribed promethazine tablets 50 mg up to four times daily, 
as required for aggression and agitation. The maximum dose is 100 mg in 24 
hours and the patient had been complaining of palpitations, which can be a 
side effect of promethazine. 
• A patient was readmitted to a mental health ward following a transfer to the 
acute hospital. The transfer paperwork indicated that the patient should 
receive six days of treatment with co-amoxiclav 625 mg three times daily for 
an infection. This was not prescribed on transfer and six doses (2 days 
treatment) were missed before the error was detected. During this period the 
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patient’s blood glucose levels were erratic requiring additional treatment with  
rapid-acting insulin, which was attributed to the untreated infection. 
The degree of inter-rater agreement between panel members was tested using a two-
way random type C intra-class correlation for those errors where all four panel 
members had provided a clinical significance score. Cronbach’s alpha demonstrated 
good correlation (0.9 > α ≥ 0.8) between the four panel members with α = 0.829 
(n = 443).  
Table 3.14: Number of errors by potential clinical significance and prescriber grade (average 
score)  
Prescriber grade/type (N=716) Potential clinical significance  
Minor Moderate Severe Total 
Foundation Year 1 19 (55.9%) 15 (44.1%) 0 34 
Foundation Year 2 38 (67.9%) 18 (32.1%) 0 56 
Core Trainee (Psychiatry) 65 (59.6%) 43 (39.4%) 1 (0.1%) 109 
GP Trainee 47 (50.0%) 47 (50.0%) 0 94 
Higher Specialty Trainee (Psychiatry) 43 (7.54%) 13 (22.8%) 1 (1.8%) 57 
Staff Grade 109 (61.9%) 64 (36.4%) 3 (1.7%) 176 
Consultant Psychiatrist 74 (56.0%) 53 (40.2%) 5 (3.8%) 132 
Other (Visiting Consultants/GPs) 28 (70.0%) 12 (30.0%) 0 40 
Nurse Non-Medical Prescriber 2 (66.7%) 1 (33.3%) 0 3 
Not known 8 (5.3%) 7 (46.7%) 0 15 
Total errors 433 (60.5%) 273 (38.1%) 10 (14.0%) 716 
 
Inter-rater agreement was also tested for those errors where a clinical significance 
score had been provided by the ward pharmacist and all four panel members. This 
demonstrated acceptable correlation (0.8 > α ≥ 0.7) between ward pharmacists and 
panel members with α = 0.785 (n = 396). As Cronbach’s alpha demonstrated 
acceptable inter-rater agreement between the ward pharmacist and panel members, 
a single average score was used to assess the potential clinical significance of errors 
caused by different prescriber grades, shown in Table 3.14.  
Although absolute numbers were small, errors with the potential for greatest clinical 
significance were generally made by more senior and experienced prescribers, with 
80% (8/10) of severe errors made by staff grade doctors or consultants. However, 
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when the difference between scores assigned by prescriber grade was tested for 
statistical significance using the Pearson chi-squared test, with a significance level of 
p < 0.05, no significant difference was demonstrated (χ2 (18) = 23.983, p = 0.156). 
The differences between scores assigned by stage of prescribing were tested for 
statistical significance using the Pearson chi-squared test, with a significance level of 
p < 0.05. Errors with a minor and moderate potential severity occurring during 
rewriting prescriptions and discharge demonstrated a significant difference from other 
categories (χ2 (10) = 45.614, p > 0.000). The potential clinical significance of errors 
by stage of prescribing is shown in Table 3.15.  
Table 3.15: Number and rate of errors by stage of prescribing 
Stage of prescribing (n=716) Potential clinical significance 
Minor Moderate Severe Total 
Admission 107 (56.6%) 80 (42.3%) 2 (1.1%) 189 
During Stay 172 (61.4%) 105 (37.5%) 3 (1.1%) 280 
Rewriting 84 (80.8%)* 19 (18.3%)* 1 (1.0%) 104 
Leave 22 (61.1%) 12 (33.3%) 2 (5.6%) 36 
Discharge 35 (39.3%)* 53 (59.6%)* 1 (1.1%) 89 
Not known 13 (72.2%) 4 (22.2%) 1 (5.6%) 18 
Total errors 433 (60.5%) 273 (38.1%) 10 (14.0%) 716 
* Errors of this type occur more commonly in this prescribing stage (p < 0.05) 
Prescriptions which were rewritten during the patient’s inpatient stay demonstrated a 
greater proportion of minor errors, and a smaller proportion of moderate errors than 
would be expected. Prescriptions written at discharge demonstrated more errors with 
the potential for a moderate clinical significance, and a smaller proportion than 
expected of minor errors.  
Although acceptable correlation had been demonstrated between ward pharmacists 
and all four panel members the pattern of scores did differ. For nearly four-fifths of the 
errors (79.0%; 574/727 errors), a potential clinical significance score was available 
from both the ward pharmacist and as an average score from the expert panel. The 
distribution of scores assigned by ward pharmacists and expert panel members for 
these errors is shown in Figure 3.12. The difference between scores assigned by ward 
pharmacists and the expert panel were tested for statistical significance using the 
Pearson chi-squared test, with a significance level of p < 0.05. This demonstrated a 
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significant difference between the scores assigned by ward pharmacists and those 
assigned by the expert panel. (χ2 (2) = 26.99, p < 0.000). 
 
Figure 3.12: Clinical significance scores assigned by ward pharmacists and expert panel to 
errors rated by both  
Ward pharmacists assessed significantly more errors as ‘severe’ and ‘minor’ than the 
expert panel, but significantly less as ‘moderate’. Panel members only had details of 
the actual error available to them and did not have information on the context of the 
error in the wider management and circumstances of the patient. The details of those 
errors considered to be ‘severe’ by either group are shown in Appendix 19. Some of 
the differences in scores recorded by the ward pharmacist and the expert panel are 
likely to be due to their different perspectives. Ward pharmacists are able to place the 
individual prescribing error in the context of the patient’s entire medication regimen, 
presenting clinical condition and co-morbidities, and may also have anticipated 
actions of their pharmacy and nursing colleagues in preventing the error from reaching 
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the patient. Expert panel members were looking at each error in isolation, unaware of 
other patient’s condition and other medication. One of the panel members provided 
additional comments with their responses which indicated that they had rated the 
potential significance of the errors based on the assumption that pharmacy would 
intervene with many of the errors.  
“What I found most challenging was that the context was missing. It made me 
realise how much of the ‘bigger picture’ is considered when prescribing, e.g. age 
of patient, clearance, other medications. Without these I think it is possible that 
we may underestimate harm.” 
“Pharmacy would pick up errors and contact the prescriber” 
It has also been suggested that level of clinical seniority, and therefore experience, 
influences clinicians perception of the severity of errors, with the outcome and 
potential consequences the main influences on assessment of severity.315 In the 
current study, whilst the ward pharmacists had more knowledge of the outcome of the 
errors, and were of varying levels of seniority and therefore clinical expertise, panel 
members with greater clinical expertise will have had a greater understanding of the 
likelihood of the resultant harm. It has also been suggested that doctors tend to grade 
clinical impact lower than pharmacists and nurses, whilst nurses grade errors higher 
than pharmacists, which confirms the importance of obtaining a multidisciplinary 
perspective when assessing errors for research purposes.316 
In 1999, Dean and Barber253 sought to develop a reliable, validated method for scoring 
the severity of medication errors based on potential patient outcomes. They 
specifically wanted to identify the minimum number of reviewers needed to produce 
reliable scores along with whether scores were affected by the profession of the 
reviewers. Thirty healthcare professionals were sent brief descriptions of 50 drug 
administration errors, selected from a range of sources, with approximately equal 
numbers of cases considered to be minor, moderate and severe, and including 16 
errors with known clinical outcomes. Scoring was undertaken using a visual-analogue 
scale from 0 to 10, with 0 representing an incident with no potential effect on the 
patient, and 10 with the potential to cause death.  
Using generalisability theory to establish the reliability of the process, Dean and 
Barber found that at least four reviewers were required to achieve a generalisability 
coefficient of 0.8 or above, which was considered to represent an acceptable level of 
reliability. For the 16 medication errors of known outcome, they found a clear 
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relationship between mean severity scores of the reviewers and actual patient 
outcome, confirming the validity of the method. The authors concluded that any four 
reviewers from the population of experienced pharmacists, medical staff and nursing 
staff would be acceptable, as the professional discipline of each judge contributed 
little to the variance in scores between individual reviewers. However, they suggested 
that in practice at least one reviewer be selected from each discipline to facilitated 
ownership of the results. This method253,263 has been extensively used, in its original 
or adapted form, for assessing the severity of prescribing errors.104,260,307,317,318 This 
was the method chosen for assessment of severity in the current study, and 
instructions for ward pharmacists and panel members were supplemented  with 
examples from past research.16,20,44,180,261 
Assessing the severity of prescribing errors increases the clinical relevance of a 
study’s findings compared with studies which only report prevalence or incidence 
rates.319 Methods for severity assessment described in the literature are usually based 
on either actual patient outcome,320–322 potential patient outcomes13,16,20,44,253,323,324 or 
a combination of both.12,180,325–327 Garfield et al undertook a systematic review which 
described the tools used in studies to assess prescribing error severity.319 They 
identified 60 publications which included an assessment of the severity of prescribing 
errors and 40 assessment tools. However, two-thirds of studies (40/60; 67%) made 
use of original or adapted versions of four tools developed by Dean and Barber,253 
Folli et al,180 the UK’s National Patient Safety Agency (NPSA),320 and the US National 
Coordinating Council for Medication Error Reporting and Prevention (NCC MERP).328  
Garfield et al assessed the reliability, validity and acceptability of the tools they had 
identified. The authors proposed that an ideal tool needs to be specific to medication 
error severity, relatively easy and not too time-consuming to administer, reliable and 
validated in different healthcare systems. They concluded that only two of the many 
tools that they reviewed had acceptable validity and reliability: the NCC MERP index 
as adapted by Forrey et al,329 and the tool developed by Dean and Barber.253 
However, the NCC MERP tool, although widely used in the US is not well known in 
the UK, and the Dean and Barber tool was used in the current study.  
Despite using different classification systems, past studies have generally shown that 
a large proportion of the prescribing errors identified are classified as minor. In a 
general hospital setting this proportion has been in the region of 40%,18,19,257,287 whilst 
mental health studies have considered a slightly higher proportion to be minor,147 
insignificant,99,100 or negligible.101 The highest proportion found by Stubbs et al who 
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classified 64.5% of the prescribing errors to be insignificant with a further 24.2% of 
minimal significance.99 A similar proportion of errors were considered to be minor by 
the ward pharmacists (65.0%), whilst the expert panel considered a lower proportion 
to be minor errors (55.2%).   
More variation appears in the proportion of errors considered to be serious and life-
threatening. In one of the early prescribing error studies Lesar et al identified 20.1% 
of errors as ‘potentially fatal or severe or potentially serious’, although they did not 
distinguish between those categories.20 More recent general hospital studies have 
tended to identify a lower proportion (typically less than 10%) as serious or life-
threatening,18,19,257 although two studies by  Dean et al identified serious error rates of 
approximately 20%.13,14 This may reflect the specialties covered by these studies, or 
a difference between teaching and non-teaching hospitals. Studies have noted that 
very few errors cause actual harm or required patient monitoring.189 In their study 
involving three mental health trusts, Keers et al classified 6.6% (19/281) of prescribing 
errors as serious and 0.3% (1/281) as potentially life-threatening.147 Smaller scale 
studies, have found higher levels of serious errors,99,100 and noted that serious errors 
were more likely to be committed by junior than senior doctors.100 However, another 
larger scale study from the same authors, assessed that serious and life-threatening 
errors accounted for 4.3% of errors, noting that more serious errors involved non-
psychotropic than psychotropic drugs.101 This lower level of serious prescribing errors 
may be due to several factors, including less use of drugs in a psychiatric setting by 
the intravenous route where the consequences of errors can be serious, less 
requirement for undertaking calculation of doses, patients who are less physically 
unwell, and use of more restricted range of medicines. Additionally, habitual deviation 
from standard regimens in order to illicit a response in individual patients, may make 
it more difficult to identify potentially serious errors.330 Ward pharmacists assessed 
4.5% of errors as severe, whilst the four members of the expert panel rated 1.4% of 
errors to fall into this category (see Figure 3.12).  
3.9 Pharmacist interventions 
Pharmacists recorded the action they took in response to the error in 84.6% of cases 
(615/727). In most cases (289/615; 47.0%) the pharmacist was able to provide 
clarification or make minor amendments without reference to a prescriber. The 
pharmacist contacted a prescriber in 27.3% (168/615) of cases, leaving a formal 
intervention note asking the prescriber to resolve the error in a further 85 cases 
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(85/615; 13.8%) where either the error did not require an urgent resolution, and/or 
they were unable to contact the prescriber (see Table 3.16). 
Table 3.16: Pharmacy interventions 
Action taken by pharmacist 
No. of 
cases 
Proportion of errors 
where resolution 
detailed 
Resolved by pharmacist 289 47.0% 
Contacted prescriber 168 27.3% 
Left intervention note to resolve 85 13.8% 
Alerted nursing staff 16 2.6% 
Other (including more than one of above) 57 9.3% 
Total 615 100.0% 
 
Where the pharmacist contacted a prescriber, this may not have been the original 
prescriber who made the error. For example, it may have been necessary to ask 
another prescriber to change the prescribing error made by a colleague when the 
original prescriber was not available. 
3.10 Summary of findings 
The overall error rate was lower than the 6.3% seen in a similarly designed study 
published in 2014 by Keers and colleagues147 in three mental health hospitals in the 
North West of England, but higher than rates identified in two earlier studies.100,101 
Relatively newly qualified staff made proportionally more errors. However, prescriber 
grades with the highest error rates prescribed a small proportion of prescriptions, with 
prescriptions written by FY1s and FY2s accounting for less than 8% of all 
prescriptions. Specialty trainees who had the second highest error rates accounted 
for nearly one third of items. 
Higher errors rates were seen in prescriptions written at transitions in care. However, 
prescription types with the highest error rates - those written at discharge and 
admission - also accounted for less than one-third of all prescriptions. 
Errors most commonly involved missing/incorrect doses, frequencies and 
formulations. Most errors involved antipsychotics, hypnotics and anxiolytics and 
analgesics. Only a small proportion of errors were considered to have the potential to 
be serious – less than 5%. Most were promptly intercepted and resolved, with 61% 
before any dose had been administered and a further 11% after only one dose. 
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Chapter 4. Causes of prescribing errors: results and 
discussion  
4.1 Introduction 
A qualitative approach which has been used in other studies to explore the causes of 
prescribing errors was used.26,27,113,167,172 During every third data collection period 
ward pharmacists distributed invitations to participate in an interview to 46 of the 54 
prescribers who had made a prescribing error (see Figure 4.1). Invitations were 
followed up by email or telephone within 96 hours of the initial invitation, and where 
acceptable to the prescriber a mutually convenient time for an interview was agreed. 
Some prescribers were invited more than once, but if they had completed an interview 
already, they were not followed up a second time to minimise disruption to service 
provision. Invitations continued to be issued until a high degree of consistency had 
been achieved between responses, after which no further interviews were conducted. 
 
Figure 4.1:   Participant sampling, recruitment and response rate 
Fifteen of the invitees agreed to take part in a face-to-face, semi-structured interview 
(32.6%). Most interviews (66.7%; 10/15) discussed only one prescribing error, four 
involved two errors, and one involved three errors. Five further errors had been 
highlighted to these prescribers prior to interview but were not covered as time 
constraints on the interviewee did not allow further discussion.  
Interviews lasted on average 22 minutes (range 14 to 36 minutes). Due to the 
availability of either the interviewee and/or researcher, the mean time between the 
error being identified and interview taking place was 11 days (range 1 - 24 days), 
54 prescribers were involved in 
 83 prescribing errors during the relevant data 
collection periods 
46 prescribers involved in 69  
prescribing errors were invited to participate 
15 prescribers were interviewed exploring 21 
prescribing errors in 19 medication orders.  
30 did not respond to the 
invitation; 1 declined 
8 could not be identified or were 
no longer available (e.g. locums, 
visiting staff) 
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which was longer than desirable, and may have influenced recall of the error(s) being 
discussed. Participants included foundation trainees, core and specialty trainees, staff 
grade doctors and consultants representing a cross-section of prescribers. The 
majority (60.0%) were female, and most were in the 40-49 age bracket (40.0%). The 
demographics of those who participated in interviews are shown in Table 4.1.  
Table 4.1:   Demographics of interviewees 
Demographics No. % (n=15) 
Gender   
Male 
Female 
6 
9 
40.0% 
60.0% 
Age (years)   
21 - 29 
30 - 39 
40 - 49 
50 - 59 
> 60 
unknown 
4 
2 
6 
1 
1 
1 
26.7% 
13.3% 
40.0% 
6.7% 
6.7% 
6.7% 
Grade of prescriber   
Foundation trainee (FY1; FY2) 
Core/GP Specialty trainee (CT1-3; GPST1-3) 
Higher Specialty trainee (ST4-6) 
Staff Grade 
Consultant Psychiatrist 
Other Medical 
Nurse Non-Medical Prescriber 
4 
3 
- 
4 
4 
- 
- 
26.7% 
20.0% 
- 
26.7% 
26.7% 
- 
- 
 
In all cases, the prescriber was unaware that an error had taken place until they were 
contacted by the ward pharmacist as part of the study. In all but one case, the 
prescribers agreed that the issue which had been brought to their attention was a 
prescribing error, as exemplified by the following quote:  
“Initially when I thought about it when I first got the email, I kept thinking "so what 
is it I did wrong?" I had to read it a couple of times, and I thought, umm well, “it's 
not an error, it’s an omission”. But then if you are looking at the definition, yeah, 
it’s an error.” (P50, staff grade) 
Of the 21 errors discussed, three (14.2%; 3/21) occurred during the admission 
process, four (19.0%; 4/21) at discharge or when a patient was going on a period of 
leave, and the remainder (66.7%; 14/21) during the patient’s stay, either when the 
drug chart was re-written or when treatment was initiated or altered (see Table 4.2). 
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Table 4.2:   Prescribing errors discussed during the interviews  
Type of 
active 
failure 
Type of 
prescribing 
error 
Brief description of error  Prescriber Stage of 
prescribing 
Underlying themes 
Slips Omission of 
treatment time; 
wrong dose 
Promethazine 8 mg prescribed instead of 50 mg; no 
administration time(s) circled on the drug chart. 
P13 
Consultant 
During stay Workload, staffing levels, distractions, 
stress, team dynamics 
Wrong dose Regular dose of promethazine 25 mg twice daily 
prescribed at discharge when intended to be ‘as required’. 
P35 
Consultant 
Discharge Workload, distractions, stress, lack of 
attention to task 
Wrong dosing 
interval 
Adcal-D3® one tablet daily prescribed at discharge when 
one tablet twice daily was intended.  
P147 
Core Trainee 
Discharge Workload, distractions, lack of attention to 
task, knowledge,  
Wrong dosing 
interval 
Glipizide prescribed as once daily at night, but with three 
administration times circled, when it should have been 
three times daily. 
P148 
GP Trainee 
Admission 
(OOH) 
Workload, distractions, confidence, stress, 
patient characteristics, information from 
patient/carer 
Wrong dosing 
interval 
Co-codamol 8/500 prescribed as twice daily, but four 
administration times circled on the drug chart.  
P175 
Staff Grade 
During stay Patient characteristics, information from 
patient/carer, distractions, stress, tiredness 
Wrong dose Promethazine 50 mg four times daily ‘as required’ 
prescribed, when maximum daily dose is usually 100 mg.  
P167 
Foundation Year 2 
Re-write Workload, working pattern, confidence, lack 
of attention to task, tiredness, stress,  
Wrong dosing 
interval 
Metformin 1 gram twice daily prescribed, but only one 
administration time circled on drug chart.  
P64 
Foundation Year 2 
Admission 
(OOH) 
Workload, working pattern, distractions, 
information from patient/carer, tiredness, 
unfamiliar task, confidence 
Lapses Unsigned 
prescription 
Prescription for dispersible aspirin was unsigned by 
prescriber. 
P96 
Foundation Year 1 
Re-write Workload, staffing levels, Prescribing 
circumstances, distractions, lack of attention 
to task, tiredness,  
Omitted when 
clinically 
indicated 
Ferrous fumarate was unintentionally omitted on 
admission to hospital, despite having been identified 
during medicines reconciliation. 
P13 
Consultant 
Admission Workload, staffing levels, distractions, 
stress, team dynamics, prescribing 
circumstances 
Omitted when 
clinically 
indicated 
Omeprazole was unintentionally omitted from the 
discharge prescription, despite having been prescribed 
during inpatient stay. 
P13 
Consultant 
Discharge Workload, staffing levels, distractions, 
stress, team dynamics, prescribing 
circumstances 
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Table 4.2:   Prescribing errors discussed during the interviews (continued) 
Type of 
active 
failure 
Type of 
prescribing 
error 
Brief description of error  Prescriber Stage of 
prescribing 
Underlying themes 
Knowledge-
based 
mistakes 
Wrong dose; 
wrong maximum 
dose 
Nitrolingual® sublingual spray prescribed with a dose of 
200 micrograms and a maximum daily dose of 
400 micrograms. (NB: one spray = 400 micrograms) 
P17 
Core Trainee 
Admission 
(OOH) 
Working pattern, confidence, tiredness, 
communication, stress, hunger & thirst, 
information from patient/carer, distractions,   
Omission of 
strength; 
omission of 
formulation 
Topical salicylic acid prescribed with no strength, 
formulation or indication for use specified. 
P90 
Foundation Year 2 
During stay Working pattern, knowledge, confidence, 
patient characteristics, prescribing 
circumstances, workload, information from 
patient/carer, training  
Rule-based 
mistakes 
Omitted when 
clinically 
indicated 
Warfarin was unintentionally omitted from the leave 
prescription as prescriber did not refer to all of patient’s 
drug charts when preparing it. 
P50 
Staff Grade 
Leave Workload, prescribing circumstances, drug 
chart design, lack of attention to task,  
Omission of 
indication; No 
minimum dose 
interval 
‘As required’ Zopiclone 3.75-7.5 mg prescribed without 
specifying the minimum dose interval or indication. 
P136 
Staff Grade 
Re-write Workload, prescribing circumstances,  
Duplication of 
drug 
Olanzapine dose increased from 15 mg daily to 20 mg 
daily without prescription for 15 mg being discontinued.  
P124 
Consultant 
During stay Workload, stress, unfamiliar task, drug chart 
design, patient characteristics, tiredness,  
Duplication of 
drug 
Pramipexol 300 micrograms three times daily prescribed 
without prescription for 180 micrograms three time daily 
on another drug chart being stopped.  
P148 
GP Trainee 
Admission 
(OOH) 
Workload, distractions, confidence, stress, 
patient characteristics, information from 
patient/carer 
Omitted when 
clinically 
indicated 
Ipratropium inhaler not prescribed on admission to 
hospital, despite patient’s own inhaler brought into 
hospital with them.  
P25 
Staff Grade 
Admission 
(OOH) 
Confidence, information from patient/carer, 
patient’s own medicines, patient 
characteristics, prescribing circumstances 
Duplication of 
drug 
Paracetamol 1 gram four times daily prescribed as 
regular medication, when already prescribed for ‘as 
required’ administration on the same drug chart.  
P171 
Consultant 
During stay Patient characteristics, prescribing 
circumstances, distractions, staffing levels, 
team dynamics, tiredness,  
Violations Omission of 
duration/review 
date 
Duration of treatment or date on which to review a 
prescription for trimethoprim 200 mg twice daily not 
included on drug chart.  
P25 
Staff Grade 
During staff Distractions, prescribing circumstances, 
working pattern, workload,  
OOH = Out of Hours
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Thirteen of the errors (61.9%) involved non-psychotropic medicines. Four errors, 
made by three prescribers, involved promethazine (19.0%), one of which 
(promethazine prescribed with twice the recommended maximum daily dose), may 
have resulted in actual patient harm as the patient complained of palpations, a known 
side effect of promethazine. None of the others were recorded as causing any patient 
harm.  
The ward pharmacist who identified each error, assessed the clinical significance of 
most to be minor (16/21; 76.2%), whilst the remainder were considered to be of 
moderate clinical significance (5/21; 23.8%). None were classified as severe errors.  
4.2 Active failures 
For each error, an active failure was identified. Rule-based mistakes were the most 
common (8/21; 38.1%), although knowledge-based mistakes (2/21; 9.5%) and skills-
based errors (slips and lapses) also occurred. Slips (7/21; 33.3%) were more frequent 
than lapses (3/21; 14.2%). More details of the prescribing errors discussed are shown 
in Table 4.2. 
4.2.1 Slips and lapses 
Prescribers who made slips or lapses were unaware that they had made them and 
unable to explain why they had happened.  
“I do remember writing down the whole TTA, the discharge notification, but frankly 
I do not remember that I had written down the wrong frequency. I don't remember 
that at all. When I received this, then I realised that I must have, but I couldn't 
remember” (P147, core trainee) 
In another case, the junior on-call doctor was asked to admit a patient who had been 
transferred from a ward on another site, which involved rewriting the prescription 
chart.  
“I wrote up the PRN drugs, including the promethazine, and I, I'm pretty sure that 
this is what happened, I basically copied from the original chart. Partly. So, I think 
what they had put was promethazine 25 mg maximum QDS and I put 25-50 mg 
maximum QDS. What I normally write is promethazine 25-50 mg maximum 
100 mg. So, I mixed up my usual way I would prescribe it, with what had been 
done at … The way I would normally do it was correct but I kind of squished the 
two together and came out with something that was obviously completely 
incorrect.” (P167, FY2) 
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In the quotation above, the prescriber describes making an action-based error in 
executing what would normally have been correctly-planned actions, resulting in a 
prescription with the potential for twice the normal maximum daily dose. 
Prescribers who had made slips and lapses often mentioned that they were busy at 
the time of prescribing (7/10; 70.0%) or interrupted during the process (4/10; 40.0%), 
particularly if they were the only medic on duty out-of-hours. In one instance 
promethazine, which had been prescribed during the patient’s stay on an ‘as required’ 
basis, was written as a regular medication on the discharge prescription. The 
prescriber remembered that she had been writing the prescription in an open plan 
office area, with frequent interruptions, and felt that this contributed to the error.  
“I had the drug chart next to me. I think probably what happened is that somebody 
probably came and asked me something, before I wrote PRN and then said, "are 
those charts ready to take over", it was that kind ... I can remember where I was 
writing it; it was in the hub where everyone is around and usually it would be my 
trainee that would write the discharge TTAs but I can't remember, he was either 
not there that day, or he had already gone out on a visit, and I just thought to save 
time I would just write it out, and urhh, I was being asked lots of other questions 
at the same time, so I think I probably just didn't write the PRN”  (P35, consultant) 
In another instance, the junior on-call doctor wrote up metformin with a frequency of 
twice daily, but only circled one administration time on the drug chart, resulting in the 
drug being given once daily for four days. She recalled that whilst writing the 
prescription she had been called away to deal with another patient who was exhibiting 
violence and aggression and had failed to complete the task when she returned. 
“But the fact that I left the chart midway through to go and deal with it, and I was 
probably gone about half an hour because the patient ended up being, not the 
patient with the error, but the patient who was agitated ended up being restrained. 
There was a whole process that went with that, so I came back to the chart 
probably half an hour later, umm, when you are on-call it's very hard to take 
yourself away and prescribe - bleeps going off, the alarm going off” (P64, FY2) 
Three lapses were noted. One involved a prescription which the prescriber had 
forgotten to sign. As a result, one dose of aspirin 75 mg was omitted before the 
prescription was corrected.   
“I remember rewriting the chart, so it wasn't a new prescription. I was rewriting 
the chart. And she's a lady who has been with us for quite a while and has a lot 
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of medications for her physical health as well as her mental health. So, I think she 
has multiple drug charts and I remember rewriting it. I didn't, in all honesty, realise 
I had missed out my signature on that one.” (P96, FY1) 
The other two involved omitting a medicine from the prescription either when the 
patient was admitted or at discharge. Prescribers mentioned prescribing “on autopilot” 
(P35, consultant) for discharge prescriptions or re-writes categorising them as “a 
boring task, repetitive thing” (P147, core trainee) and perhaps not paying as much 
attention to the task as in other circumstances, which may make them more prone to 
slips and lapses. 
4.2.2 Mistakes 
Two mistakes demonstrated a lack of knowledge or experience and related to 
prescribing, or omitting, the dose, strength and/or formulation. In one instance, the 
junior doctor prescribed a Nitrolingual® glyceryl trinitrate (GTN) pump spray for 
sublingual use ‘as required’ for angina pain, but incorrectly stated the dose to be 
200 micrograms per spray rather than the correct dose of 400 micrograms and gave 
the maximum dose as 400 micrograms in 24 hours, when patients would normally 
receive up to three doses of one-two sprays, after which medical advice would be 
sought if the angina pain had not resolved.   
Another junior prescriber undertaking on-call duties was asked to prescribe treatment 
for a patient’s verrucas just before the end of the shift. She recognised that this was 
an area she was unfamiliar with but, despite referring to the BNF, she left the 
prescription simply as salicylic acid, with no information about strength, formulation or 
brand name, and no indication on the prescription as to the condition being treated, 
hoping that someone else would make the final decision. 
So, the patient I'd seen had verrucas and I had never prescribed anything for 
verrucas before, so I used the BNF to try and work out what would be appropriate 
and under salicylic acid, which they recommended as the first line for verrucas, 
there were a lot of options, umm, in terms of what type, what strength etc. and 
the brand names for each. However, I wasn't sure which would be available within 
the trust and also which one, in particular, was first line ... and I thought that 
prescribing it as salicylic acid would allow the pharmacist to make the choice 
about which type to use, really. (P90, FY2) 
Most of the mistakes (6/8; 75.0%) where rule-based, either due to failing or 
misapplying a good rule, or applying an inappropriate rule. Three rule-based mistakes 
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related to duplication of medication, where the prescriber changed the patient’s dose 
of medication but did not cancel the previous medication order. For example, a 
patient’s dose of olanzapine was increased from 15 mg to 20 mg, without crossing 
through the current 15 mg dose on the drug chart. Potentially the patient could have 
received a dose of 35 mg of olanzapine, which exceeds the maximum recommended 
daily dose; this would have been likely to cause sedation, and in an extreme case, 
could have precipitated neuroleptic malignant syndrome.  
“… there was a deviation from, I suppose, the accepted practice, which would 
have been to delete the preceding prescription, as well as perhaps, by putting a 
line through it, or by putting a line in the box that the nursing staff would have 
signed to administer.” (P124, consultant) 
Another related to omitting a medicine from the leave prescription because only one 
of the patient’s drug charts was referred to when preparing the prescription. As the 
omitted item was warfarin, this could have had serious consequences for the patient.  
“[the] patient was going on leave, and I completed, umm, I was given the cards 
for the patient, but I didn't have the warfarin card. I filled in the back, gave it to ... 
and I think they ran to the pharmacy to make sure. So, the yellow card for warfarin 
was still sitting in the folder” (P50, staff grade) 
4.2.3 Violations 
One violation was discussed during the interviews, where the prescriber had omitted 
to specify the duration of therapy or a review date for an antibiotic course. Such 
practice is recommended by local and national guidelines but is frequently omitted. 
Although only one interview was conducted in relation to this type of error it was found 
in 3.4% (25/727) instances of errors in the overall data set.  
“I remember that I made an entry in his medical records asking the ward doctor 
to review the medication, just stating that I have written this medication as part of 
the advice from the A&E. The patient attended A&E, returned and then this was 
prescribed, and as per plan I put “please review” to Dr … I didn't write duration, I 
just said that, you know,” please review the medication”.” (P25, staff grade) 
As there are no studies which have systematically examined the cause of medication 
errors in a mental health setting all comparisons are made with studies conducted in 
secondary acute or primary care. However, it should be noted that there are 
differences in the types of drugs used and the nature of patients treated in these 
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settings. For example, intravenous medicines are rarely used in mental health, and 
patients in acute care are often more physically unwell.  
Studies have tended to identify knowledge-based mistakes as the most common type 
of prescribing error, due either to lack of knowledge about the drug or about the 
patient.15,26,173,174 Fewer studies have identified rule-based mistakes187 or slips and 
lapses27,113,188 as accounting for most errors. Although ‘inadequate monitoring’ was 
classified by Tully et al in their systematic analysis of the causes of prescribing errors 
as ‘rule violations’ such errors could arguably be considered rule-based mistakes 
(lack of knowledge of a rule or failure to apply a rule) rather than violations (an active 
deviation from safe practice). In common with other studies,27,188 participants often 
reported that they were unaware that they had made errors, particularly slips and 
lapses.  
4.3 Error-producing conditions 
Prescribers frequently described many factors as having contributed to the 
prescribing error. These are presented in the following sections in accordance with 
the error producing conditions used in Reason’s model of accident causation - work 
environment, individual factors, patient factors, task factors and team factors. The 
most frequently cited factors were team factors (15/15; 100.0%) and work 
environment (14/15; 93.3%). 
4.3.1 Individual factors 
4.3.1.1 Physical and mental health 
Individual factors included those pertaining to the wellbeing of the prescriber or 
relating to knowledge, experience or competence, and were mentioned by all but one 
prescriber (14/15; 93.3%). Five prescribers cited issues relating to personal well-being 
such as hunger, thirst and tiredness with comments about the shift length being more 
difficult to manage at night, difficulties moving from days to nights, and about being 
more tired on a night shift as it is difficult to sleep during the day.  
“I was hungry because it was lunchtime, but it was yes, a particular type of ward 
round because there were a few new admissions, so we had to review them” 
(P17, core trainee) 
 
It is generally recognised that people do not perform at their best when hungry and/or 
thirsty, and that the brain depends on the body for fuel in the form of glucose from the 
bloodstream. A meta-analysis of 36 studies reported on the effect of blood glucose 
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on decision making. It found that low blood glucose levels decrease the willingness to 
work in all non-food related situations, make decision makers more impatient, and 
increase the tendency to make decisions intuitively rather than deliberately. The 
authors conclude that low glucose levels motivate feeding-related behaviours at the 
expense of other potential priorities.331 Masicampo and Baumeister tested the 
hypothesis that more blood glucose (brain fuel) was needed for a more effortful, rule-
based task than for a less effortful process, using a specific pattern of intuitive, 
heuristic-based decision making and administration of a glucose-rich snack.211 They 
found that providing a beverage sweetened with sugar restored the capacity for 
System 2 reasoning, and decreased reliance on heuristically based System 1, which 
they suggested was consistent with Kahneman’s view that System 2 operates as a 
monitor of System 1 outputs where these occur as the default.332 
Dehydration can also impact mood, perception of task difficulty, and the ability to 
concentrate leading to deterioration in cognitive performance and short-term memory 
impairment. A UK study of doctors and nurses identified that 36% were dehydrated at 
the start of their shift, increasing to 45% at the end, with 41% oliguric at the shift end. 
Cognitive function tests performed at the beginning and end of the shift were 
significantly impaired in dehydrated participants.333  
One newly qualified doctor (P96, FY1) reported that having been on-call over the 
previous weekend, the day on which the prescribing error occurred was her eleventh 
day at work, whilst others commented about the impact of working at night.   
“And you do get that, you find yourself thinking oh, goodness, I normally wouldn't 
struggle during the day.” (P167, FY2) 
 
“I quite often do feel a bit tired on night shift, because you just don't sleep as 
much during the day, particularly if you are shifting from days to nights.” (P167, 
FY2) 
Hendey et al found that although year one postgraduate doctors had similar day time 
error rates to their year two to five postgraduate colleagues, their overnight on-call 
error rate was significantly higher. The authors suggested that fatigue and sleep 
deprivation may have a more pronounced effect on prescribers early in their career, 
perhaps combined with less supervision during the night, or that more experienced 
doctors may have learned better coping mechanisms181  
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A more experienced colleague highlighted the multiple personal factors that can 
influence performance at work. 
“… we are human, we get distracted, we get hungry, we haven't slept last night 
enough, we got upset by our children before coming to work [laughter], whereas 
a robot would not be affected.” (P175, staff grade) 
Ten prescribers talked about stress in association with the error they had made, 
usually with regard to pressure to complete tasks, either because of needing to move 
on to the next in sometimes a long list of tasks or because someone was waiting for 
it to be completed.  
“It is stressful situation, when I say stressful to you - you're the only doctor and 
there are so many admissions. … Here you are the one, your bleep is going on 
and off, on and off; medical problem, patient admission and specially somebody 
like complex here you have to focus, and it is stressful.” (P148, core trainee) 
“Umm, probably stress and tiredness, to be honest. Kind of, being tired and being 
aware "okay, I have to do this because I've got something else to do, and…"  
you're a bit under pressure sometimes because if you've seen a new patient and 
you know that you've got other things to do on the ward, and then patients start 
going off to bed, and you think "Oh, but I haven't finished yet" and I might not get 
time to do it when they waken up in the morning before I have to hand over.” 
(P167, FY2) 
Level of experience did not appear to make a difference, with staff grade and 
consultants (5/8; 62.5%) as well as more junior grades (5/7; 71.4%) reporting being 
under pressure when prescribing. 
“Maybe it was again the pressure, somebody on your head. Needed immediately 
- you're looking at a second patient.” (P13, consultant) 
“There was a time pressure, yeah, and there generally is somebody needs to take 
them all over [to the pharmacy] and they all need to be written. They don't need 
to be, but obviously, if there's one left over somebody has to go all the way over 
there and back again just for one chart, so you're trying to get them all done to 
go over there in one lot after handover in the morning.” (P35, consultant) 
None of the participants specifically mentioned mental well-being in connection with 
prescribing errors, but this has been reported in other studies.26,27,185,187–189 Burnout 
has been demonstrated to occur in between one-quarter and three-quarters of junior 
doctors,334 with recent data suggesting that it affects both junior and senior doctors.335 
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Despite burnout increasing the likelihood of performing below average in certain 
performance measures336 it does not appear to correlate with an increased rate of 
prescribing errors.186 However, depression has been shown to have an impact on the 
rate of prescribing errors. A study among junior doctors working in paediatrics 
identified that 20% of participants met the criteria for depression and 74% for burnout. 
Doctors who demonstrated depression made significantly more prescribing errors 
than those who were not depressed.186  
In a survey of senior UK-trained doctors, almost half (44%) of doctors (42% of hospital 
doctors) felt that working as a doctor had had an adverse effect on their own health 
or wellbeing. Nearly 80% of these respondents identified “stress/work-life 
balance/workload” as the cause, with episodes of burnout and depression attributed 
to them. Less than a third (28.4%) agreed that the NHS was a good employer when 
doctors become ill themselves.337 High levels of stress have been found amongst 
junior doctors, with one study identifying mental health problems which required 
treatment in 11% of newly qualified doctors,338 which may have negative effects on 
decision making, learning and ultimately patient care.338,339 A longitudinal study which 
followed doctors from the final year at medical school to their tenth postgraduate year, 
found that stress relating to work-life balance increased over the period while stress 
associated with work (emotional pressure, time pressure and fear of complaints and 
criticism) decreased.340 Increased levels of exogenous cortisol have been associated 
with a shift from deliberative, reflective to automatic, reflexive thinking in an 
experimental setting, and stress is associated with the release of cortisol and 
noradrenaline.341 
4.3.1.2 Knowledge, skills and competence 
A lack of knowledge about the specific drug(s) being prescribed was acknowledged 
by prescribers in five cases, two of which have already been described in the earlier 
paragraphs covering knowledge-based mistakes (errors involving Nitrolingual® spray 
and salicylic acid described in Section 4.2.2). Another prescriber admitted that 
working in the specialty of psychiatry if patients are admitted on medication for their 
physical health, he was less likely to know if the doses were correct. 
“when psychiatry, I know more about them probably, and because we are 
concentrating on a specialty, and we think about them, and I would be, because 
we are the ones who are initiating them and monitoring them, so I would be more 
aware ... whereas she came in with all these other physical health medications 
which was kind of, I need to copy them down. In copying down, I wasn't thinking 
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probably, was just copying the thing. Whereas had it been a psychotropic 
medication I would be thinking, this patient should receive this dose, and this, 
yeah.” (P147, core trainee) 
A similar view was expressed by another participant who commented that:  
“Our seniors will have sometimes limited knowledge about common physical 
conditions” (P90, FY1) 
Six prescribers talked about experiencing uncertainty about the item they were 
prescribing, or a lack of confidence in their own knowledge or ability, resulting in them 
following the way someone else had prescribed previously. Perhaps unsurprisingly, 
five of these were prescribers in training grades, with half of these being foundation 
trainees. 
“I've looked at a chart that has come from another mental health hospital, and 
I've thought "oh, that's maybe the way I should be doing it." You know, so just 
lack of confidence with prescribing things that I'm less familiar with.” (P167, FY2) 
“I wasn't confident with his writing, but I checked with the medication and it was 
kind of correct.” (P148, GP trainee) 
“I'm a doctor - I should be more sure of myself, maybe more self-confident instead 
of relying on what other doctors prescribe and maybe they're making errors and 
I make errors myself following their prescription.” (P17, core trainee) 
Lack of knowledge and experience has been reported in other studies as an error-
provoking condition.26–28,113,185,187,188 The preparation of medical students for their 
prescribing role has been criticised as inadequate and in need of updating, particularly 
in relation to the application of theoretical knowledge to clinical practice.258,292,295 It has 
also been suggested that training in prescribing should concentrate on a core list of 
80-100 drugs342 which are those most commonly prescribed in primary and secondary 
care, and demonstrate a strong relationship with prescribing errors.343,344 From a 
mental health perspective this list includes selective serotonin re-uptake inhibitor 
antidepressants (SSRIs), benzodiazepine-like hypnotics (‘z-drugs’), typical (first 
generation) and atypical (second generation) antipsychotics, drugs used in substance 
misuse (methadone, nicotine), phenothiazines, sodium valproate,343 and other 
antidepressants which was added in a 2018 update of the list.344 The authors suggest 
that one role of a core list is to allow prescribers to develop robust System 1, decision-
making processes based on pattern recognition for the safe and effective prescribing 
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of those drugs that make up the majority of their workload. This can be complemented 
by System 2 thinking when dealing with unfamiliar drugs, such as reference to 
information sources or consulting with colleagues.343 During the early stages of 
developing prescribing expertise practitioners’ interaction between System 1 and 
System 2 will occur, as calibration between the outputs may be refined to arrive at the 
final decision.214 Prescribing familiar drugs will use System 1 processes, whilst 
unfamiliar drugs will require the involvement of System 2.343 Calibration will be of 
particular importance in circumstances involving risky drugs, patients or situations and 
where lack of knowledge and experience is likely to result in errors. 
In an attempt to ensure that newly qualified doctors are better prepared for their 
prescribing responsibilities a Prescribing Safety Assessment (PSA) was introduced in 
the UK in 2014, which medical students must pass. Feedback from candidates 
suggest that the process of preparing for the PSA engendered an enhanced sense of 
confidence about their future prescribing, and it is already thought to have improved 
undergraduate training for prescribing.345 Although significant variation in students 
from different medical schools has been noted, the overall pass rate has improved 
during the first three years.297  
Although not significant when adjusted for other variables, Tyssen and colleagues 
identified perceived lack of skills at the end of medical school to be associated with 
stress.338 This resonates with the findings of studies into the causes of prescribing 
errors which have identified that many junior doctors do not feel that they have the 
adequate experience or skills for the task of prescribing18,21,26,28,113,187 supporting the 
view that final-year medical students do not have sufficient prescribing 
competencies,224 feel unprepared,294,346 and that there is poor correlation between 
their own assessment of their prescribing skills and actual competence.221 
In the current study all prescribers were asked about the training they had received in 
therapeutics and the practical aspects of prescribing. Most responded only from a 
clinical pharmacology and therapeutics perspective, talking about lectures they had 
received in the theoretical treatment of specific conditions, or experience gained whilst 
shadowing doctors during the clinical years of their undergraduate medical training. 
Three of the four foundation year doctors mentioned the Prescribing Safety 
Assessment and practical training they had received. 
“But we had a lot of teaching on prescribing and prescribing errors. And a lot of 
practical based teaching sessions - of filling out drug charts and a scenario, what 
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would you prescribe and then discussion of that, and there was a lot, particularly 
in final year, a lot of teaching.” (P96, FY1) 
It has yet to be seen whether the prescribing error rates fall for junior doctors who 
have been exposed to the PSA and if they report more confidence and feel better 
prepared for their prescribing role. 
4.3.2 Work environment 
4.3.2.1 Workload and shift patterns 
With only one exception, all prescribers made comments about the work environment 
in relation to the error being discussed. Workload and time pressures were the most 
regularly cited factors, with 13 prescribers mentioning high workload as contributing 
to the error. When discussing the contributory factors to three errors which he had 
made, one prescriber highlighted that he routinely needed to complete five or six 
multidisciplinary patient reviews during a half-day session, which resulted in 
prescribing being rushed in order to keep up with the schedule.  
“… here you have to see five to six patients sometimes in a half day. This is a lot 
of pressure and upon that there's a lot of families being booked as well. Like 
yesterday I was put under enormous pressure. Three families were already 
booked, and the fourth family was on the phone and the staff brings the phone in 
there … "the family is on the phone and they've been asking that they want to 
see you". How on earth you can say no to them if they're on the phone. … we 
had already got four, three families, four families to see.” (P13, consultant)  
Several of the prescribing errors had occurred around the Easter bank holiday 
weekend and prescribers described the additional workload involved in either trying 
to prepare for the bank holiday or catch up after the four-day break.  
“Because it was a short week before Easter ... those weeks do tend to be a bit 
more intense, in that you are trying to do five days’ work in four, but also patients 
want leave because it’s a long break, so more patients would want leave.” (P50, 
staff grade) 
“Yesterday was very busy because it was post-Easter weekend and I hadn't been 
in for four days. And currently the other FY1 - there are normally two of us here 
that cover [X]'s patients - and she's on annual leave at the moment, so it was just 
me. So yes, yesterday I was very busy.” (P96, FY1) 
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The terms “busy”, “stressful”, “intense” and “pressured” were all used during 
interviews to describe the workload. Workload has been highlighted as contributary 
to prescribing errors in a number of studies,13,26,27,113,187–189  and a “morning dip” seen 
in the appropriateness of antimicrobial prescribing has been contributed to the 
morning rush of ward rounds.347 Low staffing levels have been highlighted as a 
contributory factor to errors in several studies,15,26,27 whilst studies have also found 
that the number of prescribing errors increases with the more medication orders 
prescribed per patient178 or per prescriber.179 Workforce gaps within psychiatry, 
coupled with falling applications for medical school places, foundation and specialty 
training programmes coupled with rising demand, present a significant challenge to 
the provision of safe patient care within the NHS.348 
In a 2018 survey of trainees and trainers, 40% of doctors in training and 66% of more 
senior doctors reported that the intensity of their work was “heavy/very heavy”, with 
many reporting that they work beyond their rostered hours.335 A recent briefing from 
the British Medical Association (BMA)348 has indicated that applications to medical 
school and for foundation programme training places have dropped, and fewer 
doctors are applying for specialty training posts. In 2017, fill rates for core psychiatry 
training posts were 69% nationally and 36% in the East of England, with 53% of higher 
specialty training places nationally filled but only 20% in the East of England.349 
Nationally 13% of consultant psychiatrist and 11% of mental health nursing posts are 
vacant.350 It is therefore unlikely that staffing levels and workloads will improve in the 
near future.  
Working on-call was mentioned by four prescribers, who highlighted being the only 
doctor covering several wards or disparate sites, and as a result, constantly chased 
by staff to see other patients.  
“it would have occurred, around about 4.30 on Friday morning. It was the fourth 
shift, fourth night shift I'd worked. It was an incredibly busy evening, multiple 
admissions. …  When you are on-call it's very hard to take yourself away and 
prescribe - bleeps going off, the alarm going off.” (P64, FY2) 
“I had quite a few, like six, seven admissions and yes, it is a stressful situation for 
one person dealing with all these things.” (P148, GP trainee) 
It has been suggested that the NHS needs to change its attitude to doctors sleeping 
during night shifts with planned naps of less than 30 minutes encouraged to improve 
patient care and safety.351 It has also been noted that, despite the implementation of 
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the European Working Time Directive (EWTD) the working patterns expected of 
doctors would not be accepted in other high risk industries such as rail or aviation.352 
Previous work has identified that pilots are less likely to deny the effects of fatigue on 
performance than healthcare staff; 60% of doctors stated that they perform effectively 
in critical situations even when fatigued, compared with 26% of pilots.353 In the 2018 
annual survey of trainees, one fifth of doctors in training reported that their working 
pattern left them feeling short of sleep during work on a daily or weekly basis, a 
proportion which has remained relatively constant for the last seven years. Perhaps 
surprisingly a similar proportion of the medical training supervisors (i.e. senior doctors) 
also reported the same experience, suggesting that around 20% of doctors are 
struggling with fatigue.335   
Studies of doctors’ performance have shown that acute and chronic fatigue has a 
significant impact on neurobehavioral response times,354 the ability to correctly detect 
adenoma during colonoscopy355 and risk of sustaining a needlestick injury356.  In an 
Australian study, Westbrook et al found that prescribing error rates were significantly 
higher for doctors who reported less than average sleep in the previous 24 hours 
compared with those who reported normal sleep.357 Hendey et al compared the error 
rates for medication orders written overnight by doctors on-call, those written following 
an overnight on-call period, and during normal daytime duties; they found an 
increased error rate for overnight and post on-call prescribing compared to prescribing 
undertaken during the day. The authors suggested that their observations may be due 
to the onset of fatigue during the middle of the night, verbal orders after awakening 
from brief sleep (“sleep inertia”358) or degradation of performance associated with 
circadian nadirs.181 Although most of the research has been undertaken in the US and 
in doctors working much longer hours than are normal in the UK, where the EWTD 
restricts working patterns, the principle that fatigue and sleep deprivation have an 
impact on performance remains valid. 
A recent survey of nearly 8,000 US healthcare workers, which investigated work-life 
balance, teamwork and safety climate, identified that positive work-life balance was 
associated with better teamwork and safety environments. The authors revealed that 
doctors and nurses reported the greatest work-life imbalance, with respondents in the 
bottom work-life balance quartile reporting that during the last week 84.5% had 
skipped a meal, 82.5% had worked through a shift without any breaks, 79.4% had 
changed family plans because of work, 72.6% had difficulty sleeping and 70.4% had 
arrived home late from work.359 The 2017 NHS Staff Survey found that 58.3% worked 
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unpaid additional hours, 38.4% reported stress, and 52.9% reported working while 
being unwell.360  
4.3.2.2 Task switching and distractions 
Prescribers regularly described having to simultaneously deal with multiple tasks and 
experiencing distractions, and not having anywhere quiet that they could use when 
prescribing. 
“And even over here when you are writing a drug chart twenty people are there, 
not twenty, I mean three or four. One is talking about something, somebody is 
coming and just opening the door in the middle. There’s quite a lot of disturbance 
all the time.” (P13, consultant) 
“Distraction is one of the other causes, sometimes we do multiple things together 
so when I do a drug chart I'm talking with a nurse, or you know, thinking that the 
patient was unwell, so it might cause a distraction.” (P17, core trainee) 
“He had the fall when I arrived and was just in the middle of prescribing, so he 
had the fall ... I found him on the floor, so it was a little bit ... And I knew that I was 
expected for a new admission on [another ward].” (P25, staff grade) 
“this does happen quite often that you are sort of trying to write up TTAs and 
somebody, and because I'm the consultant as well, people will come in and ask 
you lots of different things, there will be queries about patients or somebody rings 
up.” (P35, consultant) 
Experimental psychology studies have demonstrated the detrimental effect of 
interruptions and task switching, often referred to as “multitasking” on 
performance.361,362 Observational studies have shown that in the emergency 
department, healthcare professionals are interrupted between 5 and 6 times per hour 
(on average every 11 minutes) by colleagues or telephone and bleeper calls, spend 
as much as 30% of the time dealing with multiple tasks and demands simultaneously, 
and fail to return to nearly one in five tasks.363,364 Negative associations were identified 
between mental workload and perceived quality of care.364 Whilst it is recognised that 
the unique characteristics of the emergency department may exacerbate the rate and 
severity of medication errors,57 task switching and distractions are likely to have an 
impact in all clinical settings.    
4.3.3 Patient factors 
Factors relating to the patient themselves were mentioned by 14 prescribers, the most 
frequent being characteristics of the patient. Several of the patients involved were 
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suffering from dementia and unable to communicate any information about their 
medication, whilst others were uncommunicative due to their mental state. 
Communication issues and unfamiliarity of the prescriber with patients seen out-of-
hours or when working on-call may partially explain the higher incidence of prescribing 
error on admission to hospital seen in this and other studies.  
4.3.3.1 Communication 
Patients admitted to a mental health facility are frequently confused, either as a result 
of organic disease (e.g. dementia) or due to the manifestation of functional mental 
illness such as schizophrenia and bipolar affective disorder, which can present as 
thought disorder, hallucinations, delusional beliefs, disordered speech, impaired 
cognition, bizarre behaviour or inaction, apathy and withdrawal. All can make it very 
difficult to elicit a medication history from the patient.    
Medication brought into hospital with the patient was felt to be both a benefit and a 
hindrance depending on the circumstances. Where patients had either a 
comprehensive list of their repeat medication with them or a set of clearly labelled 
medication, this was used as a basis for prescribing.  
“But if the patients have their drugs with them, and some of them do, then I just 
do it from it, from the box.” (P64, FY2) 
However, some patients or their carers, presented with a handwritten ‘aide-mémoire’ 
or a selection of assorted medication, and this could cause confusion and take 
considerable time for the prescriber to decipher. 
Now, with her case, it was really confusing. I guess I had to spend a lot of time to 
sort out the medication, because her partner got a list of medication with his 
handwriting and I didn't have all the GP letters … and they brought scattered 
medication with them with a box which, and also if you look at her drug charts I 
had to put in three different drug charts because of timing, because no, “I want it 
this time, because I've been told by the neurology consultant.” It was quite 
intense.” (P148, GP trainee) 
One prescriber chose not to prescribe a particular inhaler for a patient because the 
one that they brought with them did not bear a label to identify it as theirs. 
“I was not comfortable prescribing it without being labelled, but I saw that he had 
a history of using it, … I assumed that he was using it, I didn't know why or for 
how long, so I put something PRN in case he needs something to help with the 
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shortness of breath.” (P25, staff grade) 
Prescribers in other studies have highlighted lack of access to systems which should 
aid prescribers, particularly out-of-hours.113 It was clear from interviews that 
prescribers within the trust do not have access to the Summary Care Record (SCR), 
although the trust’s pharmacy team routinely access it to aid medicines reconciliation. 
The SCR is created from GPs’ clinical information systems and kept up to date in real 
time as patients’ GP records are updated, with 98% of practices using the system. It 
holds information about current medication, allergies and adverse reactions to 
medicines; additional information such as significant medical history, care plans and 
patient wishes, or preferences can be added. Access to the SCR is intended to make 
care in non-GP settings safer, reducing the risk of prescribing errors.365 Availability of 
this resource, particularly out-of-hours, would have been likely to prevent the errors 
described above where items were either incorrectly prescribed or omitted due to lack 
of information about the patients’ medication on admission.   
Despite the labelling recommendations of the National Patient Safety Agency,366 
endorsed by the Royal Pharmaceutical Society,367 that the actual container (e.g. 
inhaler, bottle or tube of cream) should be labelled rather than the secondary outer 
container, many community pharmacies continue to label the outer container of such 
medicines, which are then discarded and the labelling information lost. 
Recommended labelling practice by the community pharmacists would have 
prevented the omission of the inhaler in the instance described above. 
4.3.3.2 Patient characteristics 
Prescribers have reported that concerns about whether the patients are providing 
accurate information can contribute to prescribing errors.113  
Two prescribers mentioned the risk of drug-seeking behaviour in patients; in one case 
describing the risks of being misled by information provided by the patient or their 
carer. 
“Sometimes you can get misled from patients, or partner. Somebody says "I'm on 
that" but you don't have the information, so you can fall in trap and then you write 
something which patient may not be, especially mental health … So, I had 
experience like that, so you try to avoid them say "okay, I need a written proof 
from GP or consultant".” (P148, GP trainee)  
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In the other, the error arose due to a slip when reducing the dose of codeine being 
received by a patient with suspected drug-seeking behaviour. The prescriber had 
intended to reduce codeine intake by decreasing from two tablets four times a day 
containing 30 mg codeine/500 mg paracetamol to the same regimen with tablets 
containing 8 mg codeine/500 mg paracetamol, in the hope that the patient would not 
notice the reduction. Inadvertently, the frequency was reduced to twice daily as well 
as the dose.  
Other factors mentioned included patients who were unfamiliar to the prescriber, 
either because they were newly admitted, or normally under the care of other teams, 
especially during on-call duties. Interestingly, one prescriber highlighted the opposite 
situation contributing to an error. He described the patient as someone that he had 
looked after in the community and was well known to him. As a result, there had been 
a jovial ending to the interaction.  
“there had been this bit of banter between us, so I was quite relaxed - perhaps 
not as focused as I might have been in writing it.” (P124, consultant) 
In studies, prescribing for patients who are clinically complex, those who are unhelpful 
or difficult, and those who have language difficulties have been reported to result in 
prescribing errors.172 Experimental research has demonstrated that patients’ 
disruptive behaviours can impair diagnostic reasoning,368 potentially due to limited 
cognitive resources needing to be allocated to processing the emotion-provoking 
behaviours of difficult patients at the expense of processing clinical findings (the 
‘resource depletion’ hypothesis).369 Such affective factors could also influence doctors 
in decision making about treatment options, and it has been suggested that 
knowledge of such issues should be incorporated into clinical training.370  
4.3.4 Task factors 
Factors relating to the task of prescribing were raised by five prescribers; four 
highlighting issues relating to the drug chart and one to access to resources to support 
prescribing. 
4.3.4.1 Prescription charts 
Interviewees talked about various aspects of the drug chart which may have 
contributed to their error. Alongside the main inpatient drug chart, the trust used 
separate charts for insulin, anticoagulants and clozapine initiation, which have a 
removable adhesive strip so that they can be attached to the main chart. One 
prescriber, who had omitted warfarin from a leave prescription because she had not 
4.  CAUSES OF PRESCRIBING ERRORS: RESULTS AND DISCUSSION 
 
 
127 
 
looked at the anticoagulant chart as well as the inpatient chart, commented that there 
needs to be a way of keeping everything together, suggesting the adhesive strip is 
not used.  
Umm, when you think about it afterwards you think well it might not just have 
been warfarin, it could have been insulin couldn't it; anything that is on separate 
charts. I think it would be... I don't know how you'd do it.... if everything was 
clipped together in some way. Umm, but I don't know how you would do that 
because obviously when things get rewritten. (P90, staff grade) 
Another prescriber, who had entered different information into the frequency 
instruction on the drug chart to the number of administration times specified, 
highlighted that in other places he had worked, there had only been one of these 
included on the drug chart. 
“In different - in their charts, they don't have a specific box where you put how 
many times per day a medication will need to be taken. They only have, and it's 
clear from the chart, you circle how many hours and how many lines you put and 
that makes it quite clearly understandable - is it twice daily, three times daily, four 
times daily? But you here, you have that extra box.” (P175, staff grade) 
A third explained that he had previously worked with a drug chart that was designed 
to allow changes to the dose, rather than needing to discontinue the instruction and 
write a new medication order if details of a drug change. 
“you know the medication you prescribe, you can't alter it - you have to cross it 
off. … So, each time the consultant changes the dose you have to block it out, go 
down and that wastes extra page. You be writing again and again same thing, 
whereas … they have one drug chart, kind of like, there is three columns. So, you 
can amend it and you can amend the dose easily and you still keep the same 
recording.” (P148, GP trainee)  
It was clear that prescribers found the variety of prescription charts they encounter in 
different organisations a challenge, and this has been raised in previous studies of 
prescribing errors.13,26 The contribution of prescription chart design and familiarity to 
prescribing errors has been demonstrated experimentally, with differences in design 
associated with significant variations in error rates.371 Both the British 
Pharmacological Society (BPS)  and the authors of the EQUIP report into causes of 
prescribing errors have recommended the introduction of a standard national 
prescription chart throughout the NHS.18,372  
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This approach was taken in Australia in 2006 and,  despite being criticised by some 
as inferior to their previous drug chart,373 significantly reduced prescribing errors,374 
although it has been  recognised that more still needs to be done to address the 
causes of errors and ensure compliance with the National Inpatient Medication Chart 
(NIMC).375 Interestingly, in a randomised cross-over study of prescribing writing, those 
participants who took longer to complete prescriptions under the simulated conditions 
made fewer errors, perhaps suggesting that when prescribing on unfamiliar 
documentation they took extra care and double-checked their prescriptions,371 or that 
slower, more deliberative, System 2 thinking was being employed. However, there 
has been no introduction of a standard NHS drug chart in the UK. Although standards 
have been developed for their content,376 the move has been towards the 
implementation of electronic prescribing systems377 with the aim of a paperless NHS 
by 2020.378 
4.3.4.2 Availability of resources 
One prescriber commented that there can be a lack of awareness about the 
availability of, or how to access, trust prescribing guidelines.  
“I think it can be a combination of, urhh, awareness of resources such as trust 
guidelines. If you don't know they are available or where they're available that 
can stop you writing the medication that's available within the trust. Your own 
training and knowledge limitations, I suppose.” (P90, FY2) 
Access to resource materials has been highlighted in other studies, including 
unavailability of drug reference materials such as the hospital formulary or treatment 
guidelines13,114,185; in some instances prescribers have admitted knowing of a 
protocol’s existence but not bothering to refer to it for the information which would 
have prevented the error.27  
4.3.5 Team factors 
Team factors were mentioned by all interviewees. These included the role of different 
members of the team, incomplete handover of tasks to other staff, and assumptions 
about the role of others in sorting out problems. 
4.3.5.1 Cultural barriers 
Comments from more junior prescribers suggested that there may be a culture of not 
challenging the prescribing of senior staff, even if there is a concern that they may 
have made an error.  
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“A lack of self-confidence from doctor’s point of view. Sometimes even if we are 
right we don't trust in our self and also the fact that we don't challenge, we follow 
others, especially if they come from other specialists or other doctors, we follow 
their instruction without challenging them even if we probably should.” (P17, core 
trainee) 
Similar reluctance to challenge more senior doctors has been observed in other 
studies, due either to a lack of confidence (as here), a reluctance to display 
ignorance,13 or a feeling that it was incorrect for a junior doctor to have a different 
opinion to their superiors,26,185 resulting in errors due to following instructions from 
other staff.113 Although this has been raised in other studies13,26,27,185 none of the 
interviewees mentioned that supervision from superiors was inadequate. However, 
comments were made by two consultants about the ability of junior doctors to 
prescribe:  
“We have junior doctors, but we don't have junior doctors. The junior doctor 
should have been here now, he's not here yet, and nobody's here to ask them. 
When you ask them, and they are doing something, they are doing this or ... 
Because I think I can save more time in that. Because if I ask juniors they take ... 
one script they take ages. So, I mean, I think that "why don't I write it myself" that 
will save me five minutes. Five minutes is a lot here” (P13, consultant) 
“I probably wouldn't ask them to write a prescription if they were like a CT1 or 2, 
maybe a 3 could do it. F1 or F2 I wouldn't ask them to do it. But at the same time, 
they are asked to write prescriptions on admission.” (P124, consultant) 
This may suggest that opportunities are not taken to develop the prescribing skills of 
more junior doctors, with the attitude that it is quicker and easier for senior staff to do 
it themselves; in which case doctors in training are going to struggle to develop the 
knowledge and skills required of them as they progress. 
Very few of the prescribers (4/15; 26.7%) had discussed the error they had made with 
anyone else or formally reflected on it in any way. Three of those who had were 
trainees, who had discussed it with their supervisor or recorded it in their learning 
portfolio.  
I've reflected on it though in my portfolio, and I've discussed it with Dr … so I've 
discussed it with her. (P64, FY2) 
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“there's a few things that I'm thinking that I will write down from this, so, just for 
my own reflection. So, yes, absolutely. I think it's really important to just reflect on 
the fact that it's happened and think myself about why it happened.” (P167, FY2) 
Only one other prescriber indicated that they had discussed the error with medical 
and nursing members of their team to try and prevent a similar occurrence in the 
future.  
“I've spoke to the nurse who I was in ward round with, because I think they 
probably ran down to pharmacy with the drug card, and I've said to them it’s 
something we need to be more aware of. I've spoken to the junior that I had with 
me, so I think it is something we are probably going to be a bit more alert to.” 
(P50, staff grade) 
4.3.5.2 Assumptions about the actions of others 
Interview participants seemed to have an over-reliance on others sorting out errors, 
either by leaving messages for someone to complete a task left unfinished or 
assuming that someone else would identify and rectify the error that they had made.  
One prescriber, who made an error while on-call out-of-hours, suggested that they 
were not really responsible for the error, or that someone else should have identified 
it. 
“so, it is a way of sharing the responsibility with the doctor who looks after the 
patient and the pharmacist who reviews the medication … ward doctor and the 
pharmacist could be more vigilant, with prescriptions out-of-hours especially to 
review the need, the duration, and if they are happy with the medication 
prescribed. … I think prescribing is really shared within the team, the medical 
team, between the duty doctor and ward doctor and pharmacist.” (P25, staff 
grade) 
“I remember that I made an entry in his medical records asking the ward doctor 
to review the medication, just stating that I have written this medication as part of 
the advice from the A&E. The patient attended A&E, returned and then this was 
prescribed, and as per plan I put “please review” to Dr X. I didn't write duration, I 
just said that, you know, “please review the medication”.” (P25, staff grade) 
Ambiguities about responsibility for patients,26,27,189 lack of clarity about who is 
responsible for the different stages of prescribing, with initiation the responsibility of 
senior staff during normal hours, but left to junior staff out-of-hours26 and poor 
communication and handover13,113 have been found in previous studies. 
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4.4 Latent failures 
Latent failures arise due to the organisational decisions about systems and processes 
which create an environment where error-producing conditions and active failures can 
occur. Not all qualitative studies of prescribing errors have considered latent 
conditions as factors associated with errors.172  
4.4.1.1 The importance placed on prescribing 
Two previous studies have found that some doctors take the attitude that prescribing, 
especially rewriting drug charts, is not an important task. Dean et al commented that 
directions from senior staff to “put them on drug X”, leaving out details of dose, form, 
frequency, route and duration, leaves the acquisition of such knowledge in a chasm 
between medical school and employment and sends a message that these aspects 
of treatment are unimportant.27 Meanwhile Coombes et al found that prescribing was 
generally described as a “job” or a “chore”26 indicating the unimportance placed on 
this task as a key element of patient care. 
Some of the prescribers interviewed talked about not always giving their full attention 
to the task of prescribing, especially when rewriting drug charts, or writing discharge 
prescriptions.  
“Sometimes your mind tends to wander off when you're doing something very 
mechanically, and just copying charts. You try to bring yourself back and then 
you have all those other things in your mind - “oh I have to look at this patient, or 
…”  These thoughts start to come in and you might, your attention starts, sort of, 
starts wavering. … Probably there's more scope for error.” (P147, core trainee) 
“I think the risk is that, yeah, you do it on autopilot because it is just transferring 
information from one place to another, and it's quite easy to switch off a bit 
mentally, …” (P35, consultant) 
However, another junior doctor recognised this as an area of risk and described 
consciously trying to think about each item before rewriting it.  
“I'm not just, kind of, blindly, going “ok copy”. It’s a case of that's what they've had 
there, but I'm responsible for what this patient has now. So, I really have to just 
think about it, think about what you are writing. Is this appropriate now? Rather 
than just assuming oh, they're on the same medications so … [interrupted by on-
call phone]” (P167, FY2) 
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One prescriber mentioned that he did not feel confident to ask others not to interrupt 
him while he was prescribing and that this increased the risk of errors.  
“You will start doing something and there will always be people coming and 
starting to talk about something else and it's not fully possible to say, "Let me 
finish this. Wait until I finish, then I'll..." I don't know, I haven't felt that it would 
always be appropriate to take that approach just to make sure I don't make a 
single mistake, because you work in a team and if I start saying to everybody let 
me finish this first and I'll come back… “ (P175, staff grade) 
This may have been an individual perception or may indicate an unhealthy attitude to 
safe practice which has been learned during practice in this or other settings. 
4.4.1.2 Unfamiliar situations 
Prescribers also found themselves in unfamiliar situations which led to errors. One 
FY2 doctor described having to deal with paper prescription charts for the first time in 
an on-call situation. Her four-month psychiatry rotation was in a community-based 
clinic where she was used to writing FP10 prescription forms, and during her FY1 
rotations she had worked at sites that used electronic prescribing systems, yet on-call 
she was faced with an unfamiliar paper drug chart.  
“I have never used paper charts before this. Umm, last year I was on entirely e-
prescribing so when you select BD [twice daily] it forces you to pick two times. I 
don't use it in my normal day-to-day base life, I use FP10s, so actually, I have 
probably … only used fifteen charts in my entire career. … Yes, I've had lessons 
on how to fill in paper charts, yes, I've seen them, I've done them in exams, but I 
wouldn't say that they are particularly part of my day-to-day work at the moment, 
… in the community I have my green pad.” (P64, FY2) 
Another, far more experienced doctor also found himself in unfamiliar territory, when 
he was asked to undertake an emergency review of patients to try and release bed 
capacity. It had been more than five years since he worked as an inpatient consultant 
and changes to the drug chart had occurred in that time. 
“What I remembered was thinking, “Oh, I don't recognise the prescription card", 
because it had changed since I had been on the ward previously, so that threw 
me a bit, because I had to pay attention to the boxes and everything which were 
different to what I had been used to.” (P124, consultant) 
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4.4.1.3 Information systems 
Prescribers who had made errors relating to the dose, strength or administration times 
of medicines mentioned that these errors might not have been possible if they had 
been using an electronic prescribing system, as such systems have inbuilt defences 
which prevent many errors, rather than handwritten drug charts. This was especially 
the case for relatively junior medical staff who had experience of using such systems 
previously.  
“It was helpful because you could double check; while prescribing you could 
double check, you know, the correct dose and that was very helpful.” (P17, core 
trainee) 
“Um, last year I was on entirely e-prescribing so when you select BD it forces you 
to pick two times. … Um, and that, with the hospitals I've trained at most of them 
were on e-prescribing. (P64, FY2) 
“… because it wouldn't, you know, it wouldn't have let me make that error. It 
wouldn't have let me prescribe.” (P167, FY2) 
Electronic prescribing (EP), electronic prescribing and medicines administration 
(ePMA), and computerised physician order entry (CPOE) systems (which may also 
include orders for laboratory tests and radiology) have been introduced as the use of 
technology in healthcare has increased in popularity. Although electronic prescribing 
has existed in primary care for more than 30 years, deployment in secondary care 
remains patchy379 with most acute trusts in 2011 reporting use of paper-based 
prescribing on the majority of wards380 and only 13% using electronic prescribing 
across all adult medical and surgical wards.381 Ahmed et al summarised the evidence 
for the impact of inpatient electronic prescribing on patient safety, considering  
systematic and narrative reviews undertaken between 2000 and 2015. They identified 
that most studies demonstrated a decrease in errors following system introduction, 
although some new errors associated with drop down menus and alert fatigue had 
been introduced by such systems. Few of the primary studies had been conducted in 
the UK with most from the US.379 
Six of the errors covered in interviews occurred at the point of admission. The lack of 
access to clinical information about patients’ medication regimens prior to admission 
was cited by prescribers as a factor, particularly out-of-hours.  
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“I think we don't have access to the GP record our self. We can have access to 
our SEPT [record] if they have been discharged and this kind of thing, but I do 
not have access to the GP record. (P148, GP trainee) 
Despite key patient medication being available via the SCR, none of the prescribers 
had access to this system, which would have allowed them to check what the patient 
should be taking. This has already been discussed in Section 4.3.3.1 on 
communication. 
4.5 Defences 
Pharmacists, nursing staff and other doctors were frequently mentioned as defences 
preventing errors reaching the patient. For 61.9% (13/21) errors discussed in 
interviews, the number of doses reaching the patient had been recorded. In six cases 
(28.6%) the error had been intercepted by a pharmacist before reaching the patient; 
but in the remainder (7/21; 33.3%) at least one dose had been administered or omitted 
before the error was rectified.  
Several prescribers made statements which hinted at others being to blame for not 
intercepting their error, rather than taking responsibility themselves for having made 
an error in the first place, suggesting that they are consciously or subconsciously 
expecting others to act as the barrier to any prescribing error reaching the patient. 
“the ward doctor and the pharmacist could be more vigilant, with prescriptions 
out-of-hours especially, to review the need, the duration, and if they are happy 
with the medication prescribed.” (P25, staff grade) 
“I would presume the patient would have been seen the following morning by a 
consultant or a registrar, but I don't know in what depth they check the charts. I 
don't know, normally that's how on a medical [ward] you would have picked up 
that.” (P64, FY2) 
Even out-of-hours, advice was available from pharmacists which could have helped 
avoid some of the prescribing errors, yet prescribers were not necessarily aware of 
how to contact the on-call pharmacist.   
Few previous studies have commented on the final stage in Reason’s model of 
accident causation - the defences or barriers which prevent the error reaching the 
patient.23 Where defences were mentioned, these included pharmacists, nurses, 
other doctors and prescribers re-checking their own prescribing.13,27,185 In their study, 
Dean et al identified that pharmacists were the principle line of defence, identifying 
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and rectifying all of the errors found and mentioned in 16 of the 44 interviews 
undertaken. They noted that doctors welcomed help from pharmacists both in 
identifying errors and having an educational role to the individuals involved. However 
they noted that this could also lead to complacency as some junior doctors trusted 
the pharmacists so much that they would sometimes not bother to look up doses.27 
Several of the doctors interviewed mentioned that they had put in place changes to 
their own processes as a result of the error. 
“I think that I'm just a little bit more careful. And I think I have probably looked up 
a few more things in the BNF since it happened. Even if I think " I'm 99% sure I 
know what that dose is" I've actually gone "hang on a minute" and I've just gone  
[mimes referring to a book] or I've had a look on the phone just to double check 
with things. And I think with PRNs where you're maybe giving a range of doses, 
I'm kind of double checking if I've given a range that the maximum dose. I haven't 
put it in terms of how many times a day, I've put it in terms of the dose, even with 
things like ibuprofen. Often, I've previously put 400mg TDS or maximum TDS, 
and I've 400, you know, I've put the maximum dose in milligrams. Because I think 
that's probably  bit clearer.” (P167, FY2) 
Similar self-initiated defences were mentioned by study participants in two studies. 
Participants in an Australian study suggested that staff should exercise greater 
personal vigilance and should always check and double check their actions,188   whilst 
one Nigerian prescriber mentioned “silently reading out the order to herself before 
signing it”.185 
Checking and double checking of the type described by participants in these studies 
demonstrates calibration through use of a conscious cognitive debiasing strategy212 
allowing metacognition (thinking about one’s thinking) so that the clinician can 
deliberately detach themselves from the immediate context of the clinical decision, 
and reflect upon the thinking process.382  
4.6 Summary of findings 
The study found almost equal numbers of mistakes involving the planning of actions, 
and skills-based slips and lapses, although mistakes were more commonly 
knowledge-based and action-based slips were more common than memory-based 
lapses. 
As with other studies into the causes of prescribing errors, this study showed that 
errors are usually associated with multifactorial causes.  Factors cited by interview 
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participants did not differ substantially from those identified in other secondary care 
settings. Whilst the complexity of error causation makes it unlikely that simple 
solutions are possible, there is one area where local change could have a significant 
impact on prescribing errors. Providing access to the SCR for doctors working on-call 
and out-of-hours to facilitate access to accurate information about newly admitted 
patients’ medicines would have prevented several of the errors which occurred. 
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Chapter 5. Decision-making characteristics of prescribers: 
results and discussion 
5.1 Response rates 
One hundred and ninety-one questionnaires, in electronic or paper format, were 
distributed to prescribers who had been identified during the quantitative data 
collection exercise. Seventy-two questionnaires were returned either fully or partially 
completed, 12 of which were excluded as only demographic information had been 
provided (response rate 31.4%; 60/191). Table 5.1 provides a breakdown of the 
responses. 
Table 5.1:   Questionnaire responses 
Questionnaires No. % 
Distributed (via SurveyMonkey or on paper) 191 100.0 
Returned (via SurveyMonkey or on paper) 
Recipient did not agree to participate 
Recipient agreed to participate 
81 
9 
72 
42.4 
4.7 
37.7 
Excluded as only demographics provided 12 6.3 
Fully or partially completed response 60 31.4 
Fully completed 
Cognitive Reflection Test 
Rational-Experiential Inventory 
Need for Cognition  
51 
51 
59 
59 
26.7 
26.7 
30.9 
30.9 
 
Analysis was undertaken of 51 fully completed questionnaires and a further 9 in which 
demographics had been provided and at least one other section completed. 
5.2 Participant characteristics 
The majority of participants were male (53.3%) and most commonly within the age 
range 40 - 49 years (36.7%) with consultant psychiatrists (26/60; 43.3%) the most 
highly represented category. Respondents had been a registered healthcare 
professional for a mean of 16.4 years (SD 11.9; range 1 - 45 years) and a prescriber 
for 15.7 years (SD 12.3; range 1 - 50). It is possible that the mean ‘years as a 
registered healthcare professional’ is higher than ‘years as a prescriber’ as some 
respondents who originally qualified overseas may have answered this from the 
perspective of registration in the UK. Further details of the demographic distribution 
of respondents can be found in Table 5.2. 
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Table 5.2:   Characteristics of survey participants 
Demographics No. % (n = 60) 
Gender   
Male 
Female 
32 
28 
53.3% 
46.7% 
Age (years)   
21 - 29 
30 - 39 
40 - 49 
50 - 59 
> 60 
7 
16 
22 
9 
6 
11.7% 
26.7% 
36.7% 
15.0% 
10.0% 
Number of years in practice Mean 
As a registered healthcare professional 
As a prescriber 
16.4 
15.7 
Grade of prescriber   
Foundation trainee (FY1; FY2) 
Core/GP Specialty trainee (CT1-3; GPST1-3) 
Higher Specialty trainee (ST4-6) 
Staff Grade 
Consultant Psychiatrist 
Other Medical 
Nurse Non-Medical Prescriber 
9 
10 
4 
9 
26 
1 
1 
15.0% 
16.7% 
6.7% 
15.0% 
43.3% 
1.7% 
1.7% 
 
Participants mean scores are shown in Table 5.3. The mean number of correct 
answers for the original 3-item version of the Cognitive Reflection Test was 1.6 
(SD 1.1) and for the 8-item version, which included five questions which were less 
likely to have been previously seen by participants, the mean score was 4.1 (SD 2.2). 
Results for the 8-item CRT demonstrated modest internal consistency (Cronbach’s 
alpha 0.7 > α ≥ 0.6) with α = 0.611 (n = 51).  
Table 5.3:   Descriptive data for key variables 
Variable Mean (SD) 
Cognitive Reflection Test (CRT) (n=51)§  
Score (3-item version) 
Score (8-item version) 
1.6 (1.1) 
4.1 (2.2) 
Rational Experiential Inventory (REI-40) (n=59)§  
Rationality (total score) 
Rational ability 
Rational engagement 
Experientiality (total score) 
Experiential ability 
Experiential engagement 
3.7 (0.4) 
3.7 (0.4) 
3.7 (0.5) 
3.1 (0.4) 
3.2 (0.5) 
3.1 (0.4) 
Need for Cognition (NCS) (n=59)§  
Need for Cognition score 16.5 (15.0) 
                                               
§ The CRT was completed by 51 of the 60 respondents who returned full or partially completed 
questionnaires. The REI-40 and NCS were completed by 59 of the 60. 
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For the Rational Experiential Inventory, the mean score on the rationality scale was 
3.7 (SD 0.4) and on the experientiality scale 3.1 (SD 0.4), each out of a maximum 
score of 5. Cronbach’s alpha demonstrated good correlation (0.9 > α ≥ 0.8) for both 
the rationality scale (α = 0.819; n = 59) and the experientiality scale (α = 0.814; 
n = 59). Cronbach’s alpha also demonstrated good correlation for the Need for 
Cognition Scale (α = 0.808; n = 59). The mean score was 16.5 (SD 15.0) on a scale 
running from -72 to 72.  
5.3 Cognitive Reflection Test 
Responses were received from 51 respondents who had completed the Cognitive 
Reflection Test (CRT) element of the questionnaire (51/191; 26.7%). The majority 
were male (51.0%) with a modal age range of 40 - 49 years. Most respondents (22/51; 
43.1%) were consultant psychiatrists.  
Table 5.4:   Comparison of mean CRT score on the basis of demographics 
Sample Mean 3-item 
CRT score (SD) 
p Mean 8-item 
CRT score (SD) 
p 
Gender     
Male (n=26) 
Female (n= 25) 
1.7 (1.1) 
1.5 (1.1) 0.507 
4.3 (2.3) 
3.9 (2.2) 0.436 
Age     
21 - 29 (n=7) 
30 - 39 (n=15) 
40 - 49 (n=18) 
50 - 59 (n=7) 
60 and over (n=4) 
1.4 (1.3) 
1.4 (1.1) 
1.8 (1.0) 
2.0 (1.3) 
1.0 (1.4) 
0.551 
3.3 (2.2) 
4.0 (2.3) 
4.7 (1.7) 
4.4 (2.1) 
2.8 (3.6) 
0.389 
Respondent type     
Foundation trainee (n=9) 
Core/GP trainee (n=10) 
Higher specialty trainee (n=4) 
Staff grade (n=5) 
Consultant/GP (n=22) 
Nurse NMP (n=1) 
1.2 (1.2) 
1.2 (1.0) 
1.8 (1.3) 
1.2 (1.3) 
2.0 (1.1) 
1.0 (  -  ) 
0.310 
3.4 (2.5) 
3.5 (1.7) 
4.8 (2.2) 
3.0 (2.9) 
4.9 (2.0) 
3.0 (  -  ) 
0.317 
 1.6 (1.1)  4.1 (2.2)  
     
Further details on the demographic distribution of respondents can be found in Table 
5.4. Using the non-parametric Kruskal-Wallis test, with a significance level of p < 0.05, 
demonstrated that there was no statistically significant difference in CRT scores by 
gender, age or prescriber grade on either the 3-item or 8-item versions of the test (see 
Table 5.4). Further details about the CRT can be found in Section 1.7.2. 
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Table 5.5:   Distribution of answers given for the CRT  
Item 1. A bat and a ball cost £1.10 in total. The bat costs £1.00 more than the ball. How much 
does the ball cost? 
Correct response (5p) 
Errors  ‘Intuitive’ incorrect answer (10p) 
 Other incorrect answers 
 No response 
20 
27 
4 
- 
39.2% 
52.9% 
7.8% 
- 
Item 2. If it takes 5 machines 5 minutes to make 5 widgets, how long would it take 100 
machines to make 100 widgets? 
Correct response (5 minutes) 
Errors  ‘Intuitive’ incorrect answer (100 minutes) 
 Other incorrect answers 
 No response 
27 
21 
3 
- 
52.7% 
41.2% 
5.9% 
- 
Item 3. In a lake, there is a patch of lily pads. Every day the patch doubles in size. If it takes 48 
days for the patch to cover the entire lake, how long would it take for the patch to cover half 
of the lake? 
Correct response (47 days) 
Errors  ‘Intuitive’ incorrect answer (24 days) 
 Other incorrect answers 
 No response 
34 
13 
4 
- 
66.7% 
25.5% 
7.8% 
- 
Item 4. Mary's mother has four children. The youngest three are named Spring, Summer and 
Autumn. What is the oldest child's name? 
Correct response (Mary) 
Errors  ‘Intuitive’ incorrect answer (Winter) 
 Other incorrect answers 
 No response 
29 
19 
2 
1 
56.9% 
37.3% 
3.9% 
2.0% 
Item 5. If you flipped a fair coin 3 times, what is the probability that it would land "heads" at 
least once? 
Correct response (87.5%; 7/8) 
Errors  ‘Intuitive’ incorrect answer (12.5%; 1/8 or 37.5%; 3/8) 
 Other incorrect answers 
 No response 
11 
6 
34 
- 
21.6% 
11.8% 
66.7% 
- 
Item 6. If John can drink one barrel of water in 6 days, and Mary can drink one barrel of water 
in 12 days, how long would it take to drink one barrel of water together? 
Correct response (4 days) 
Errors  ‘Intuitive’ incorrect answer (9 days) 
 Other incorrect answers 
 No response 
31 
6 
14 
- 
60.8% 
11.8% 
27.5% 
- 
Item 7. Jerry received both the 15th highest and the 15th lowest mark in the class. How many 
students are in the class? 
Correct response (29 students) 
Errors  ‘Intuitive’ incorrect answer (30 students) 
 Other incorrect answers 
 No response 
20 
20 
11 
- 
39.2% 
39.2% 
21.6% 
- 
Item 8. A bear loses 20% of its weight during hibernation. If it weighs 100 kilos after 
hibernation, how many kilos did it weight before? 
Correct response (125 kilos) 
Errors  ‘Intuitive’ incorrect answer (120 kilos) 
 Other incorrect answers 
 No response 
38 
8 
4 
1 
74.5% 
15.7% 
7.8% 
2.0% 
 
Table 5.5 shows the responses given for each of the eight questions. Items one to 
three are the original 3-item version of the CRT. Only one question, item 1, which is 
probably the most well-known of the CRT questions, received more ‘intuitive’ incorrect 
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answers than correct ones, although item seven received the same number of correct 
and ‘intuitive' incorrect answers.  
Responses to item 5 were more likely to be incorrect than correct, but not due to 
respondents providing the ‘intuitive’ incorrect answer. Whilst 15 respondents correctly 
answered all three of the original CRT questions, only three correctly answered all 
eight questions; two of these were consultants, and one was a foundation trainee. 
Two respondents answered all eight questions incorrectly; these were a foundation 
trainee and a staff grade doctor. In both cases, six of their responses were the 
‘intuitive’ incorrect answer. The distribution of responses is shown in Figure 5.1. 
 
Figure 5.1:   Distribution of Cognitive Reflection Test (CRT) scores  
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Frederick226 administered the original 3-item CRT to more than 3,000 respondents in 
35 separate studies, as part of a questionnaire including measures of various 
decision-making characteristics. The mean score was 1.24 with 33% of respondents 
classified as ‘low’ scorers (all questions incorrect) and 17% as ‘high’ scorers (all 
questions correct); most of the subsequent analysis concentrated on the two extreme 
groups rather than ‘intermediate’ scorers (those who achieved one or two correct 
answers). Men scored significantly higher than women (p < 0.0001), with women’s 
incorrect answers tending to be the ‘intuitive’ incorrect answer. Those with high CRT 
scores were found generally to be more patient when time preferences were tested, 
and more willing to gamble when risk taking was tested. Although an 8-item CRT was 
mentioned, no results were provided for that version.  The mean 3-item CRT score of 
the 51 prescribers in the current study was 1.6, higher than found in the original study, 
with a lower proportion of ‘low’ scorers (21.6% cf. 33%), and a higher proportion of 
‘high’ scorers (29.4% cf. 17%). Although the mean scores for both the 3-item and 8-
item versions were higher in male than female participants, the differences were not 
significant.  
Haigh383 noted that the validity of the CRT depends on participants being blind to its 
objectives. If pre-exposed, participants may not answer with their first response but 
be more likely to engage System 2 thinking in arriving at the answer, because they 
recognised them as “trick questions’. Also, with only three questions there is an 
opportunity for participants to memorise the answers if they have seen them before. 
His study, in which more than half of participants reported prior exposure to at least 
one CRT problem, found a significantly higher mean score in those with prior 
exposure than those who had none (2.36 vs. 1.48; p < 0.001). He argued that the 
standard three-item version had become a “victim of its own success”. Similar effects 
have been found in other studies,384,385 and as a result, extended or alternative 
versions of the CRT have been developed with up to seven items.266,384,386 Toplak 
et al266 developed a 4-item version (CRT4) as a substitute for the original CRT as well 
as combining the two to produce a 7-item CRT (CRT7). In their sample of 160 
university recruits the ‘intuitive’ incorrect response was given as the modal response 
for all three of the original questions, accounting for 85.6%, 75.2% and 60.0% of 
answers for the bat and ball, widgets and lily pad problems respectively. It was also 
the modal response for the CRT4 questions, but was less dominant  at 31.1%, 51.9%, 
41.9% and 53.1%.  
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An 8-item version of the CRT was used in the current study with five additional 
questions provided by Professor Frederick (personal communication; 05 May 2014).  
The ‘intuitive’ incorrect answer to the three original questions was provided by 52.9%, 
41.2% and 25.5% of respondents respectively, with only the bat and ball question 
having it as the modal response. The ‘intuitive’ incorrect answer was given for the five 
new questions 37.3%, 11.8%, 11.8%, 39.2% and 15.7% of the time and was only the 
modal answer for the class question (item 7). This may reflect prior exposure to the 
original questions, and/or a greater tendency amongst participants in the current study 
to override the ‘intuitive’ incorrect response.  Using a similar approach to Frederick’s 
of low, intermediate and high scorers with the 8-item version, 25.5% were ‘low’ scorers 
(two or less correct answers) while 31.4% were ‘high’ scorers (six or more correct 
answers), similar proportions to those for the original 3-item CRT. 
It has been claimed that numeric ability is strongly correlated with correctly answering 
CRT questions and that it is actually a measure of calculation rather than cognitive 
reflection. Sinayev and Peters suggested that numeracy is “the key mechanism” that 
explains the association between CRT performance and decision making.228 
However, Liberalli et al concluded that while those with computational ability can 
generate answers to the problems, the finding that CRT correlates with Need for 
Cognition scores but not Faith in Intuition scores supported the interpretation that the 
CRT captures monitoring, inhibition and editing processes.387 This was supported 
more recently by Pennycook and Ross, who stated that “if someone does not have 
the disposition or willingness to think analytically, they will not fully exercise their 
cognitive ability and will not do as well on the problem” and “if someone does not have 
sufficient cognitive ability it will not matter how much time and effort they are willing to 
spend thinking about the problem”.388 They highlighted that the CRT indicates a 
disposition or propensity to think analytically, in addition to having the cognitive ability, 
and not primarily a measure of numeric ability; although it has been reported that 
algebraic cueing improved responses to the bat and ball problem.389  CRT scores 
have also been associated with a range of other variables such as religious disbelief, 
paranormal disbelief, improved scientific understanding and reasoning, and belief in 
evolution.388,390  
All of the participants in the current study were healthcare professionals, all but one 
medically qualified, amongst whom the level of numeracy (i.e. cognitive ability) would 
be expected to be high. Equally, clinical training should introduce a degree of 
analytical ability which together, may explain the lower proportion of ‘low’ scorers and 
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higher proportion of ‘high’ scorers on both the 3-item and 8-item CRTs when 
compared with studies which used largely university undergraduates as the sample 
population. Steiger and Reips demonstrated that educational qualifications were a 
predictor of CRT score, with the potential for a ceiling effect amongst the highly 
educated.385  Studies which administered the CRT to 165 medical trainees and 56 
consultants233,234 and 209 medical undergraduates and doctors391 reported average 
scores of 1.49 and 1.86 respectively, which straddle the mean reported in this study. 
Foundation and core/GP trainees tended to give fewer correct answers (43% and 
44% respectively), whilst the lowest proportion of correct answers (38%) were 
provided by staff grade doctors (see Table 5.6). 
The relationship between the number of correct scores on the 8-item version of the 
CRT and prescriber grade (which in most cases reflects the level of experience of the 
individual) was explored using the one-tailed non-parametric Spearman’s correlation 
coefficient (rs). This demonstrated a correlation coefficient, rs,  of 0.243 (95% 
confidence interval -0.013 to 0.497) significant at p < 0.05 and suggested a weak 
positive correlation between the level of experience and the ability to correctly answer 
the questions which comprise the CRT. 
Table 5.6:   CRT Scores for the 8-item version  
  Proportion of responses that 
were for: 
Respondent Type (n = 51) Mean 
Score 
(SD) 
Mean no. 
“intuitive” 
incorrect 
answers 
(SD) 
Correct 
answer 
‘Intuitive’ 
incorrect 
answer 
Other 
incorrect 
answers 
Foundation trainee (n=9) 3.4 (2.5) 3.7 (2.1) 43% 46% 11% 
Core/GP specialty trainee (n=10) 3.5 (1.7) 2.6 (1.3) 44% 33% 24% 
Higher specialty trainee (n=4) 4.8 (2.2) 1.8 (1.7) 59% 22% 19% 
Staff grade (n=5) 3.0 (2.9) 3.0 (2.1) 38% 38% 25% 
Consultant/GP (n=22) 4.9 (2.0) 1.6 (1.5) 61% 20% 19% 
Nurse NMP (n=1) 3.0 ( -  ) 4.0 ( -  ) 38% 50% 13% 
Overall 4.1 (2.2) 2.4 (1.8) 51% 29% 19% 
 
The relationship between the number of ‘intuitive’ incorrect scores on the 8-item 
version of the CRT and prescriber grade was also explored using the one-tailed non-
parametric Spearman’s correlation coefficient (rs). This demonstrated a weak 
negative correlation coefficient, rs,  of -0.344 (95% confidence interval -0.592 to -
0.0.87) significant at p < 0.01 and suggests a moderate correlation between level of 
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experience and the ability to suppress the ‘intuitive’ incorrect answers. This is 
demonstrated in Figure 5.2. 
 
Figure 5.2:   CRT scores by prescriber grade/type 
Prescribing error data, collected by ward pharmacists as described in Section 2.3, 
were available for 40 of the 51 respondents who had completed the Cognitive 
Reflection Test element of the questionnaire. Respondents had prescribed 3,361 
medication orders containing 155 prescribing errors, exceeding the total sample size 
needed to identify a “small” expected effect size with 95% confidence and 90% power. 
 
Figure 5.3:   CRT scores and prescribing error rates 
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Scatterplots were prepared to show the number of correct answers on the 8-item CRT 
(see Figure 5.3) and the number of ‘intuitive’ incorrect answers (see Figure 5.4) 
against prescribing error rate. A trend towards a lower prescribing error rate as the 
number of correctly answered CRT questions increased was suggested by the 
regression line. However, linear regression demonstrated a correlation of R2 = 0.009 
which suggested that less than one per cent of the variation in prescribing error rate 
can be explained by CRT score alone. The statistical significance of the model was 
tested using ANOVA with a significance level of p < 0.05. This demonstrated that 
there was no significant effect of CRT score on prescribing error (F38,39 = 0.333, 
p = 0.567). 
 
Figure 5.4:   CRT ‘intuitive’ incorrect answers and prescribing error rates 
Scatterplots were also prepared to show the number of correct answers on the 8-item 
CRT (see Figure 5.5) and the number of ‘intuitive’ incorrect answers (see Figure 5.6) 
against the proportion of errors which related to decision making rather than 
prescription writing. Decision-making errors include prescribing a drug which is 
inappropriate for the patient concerned - for example, due to a contraindication, 
documented allergy or drug interaction, and tend to be knowledge-based or rule-
based errors rather than slips and lapses. 
A trend towards a greater proportion of errors being due to decision making as the 
number of correctly answered CRT questions increased was suggested by the 
regression line. However, linear regression demonstrated a correlation of R2 = 0.013 
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errors can be explained by CRT score alone.  The statistical significance of the model 
was tested using ANOVA with a significance level of p < 0.05. This demonstrated no 
significant effect of CRT score on prescribing error type (F38,39 = 0.499, p = 0.484). 
 
Figure 5.5:   CRT scores and proportion of errors relating to decision making  
A trend towards a smaller proportion of errors being due to decision making as the 
number of ‘intuitive’ incorrect CRT questions increased was suggested by the 
regression line. However, linear regression demonstrated a correlation of R2 = 0.015 
which indicates that only 1.5% of the variation in prescribing error rate can be 
explained by the number of incorrect answers given on the CRT alone.   
 
Figure 5.6:   CRT ‘intuitive’ incorrect answers and errors relating to decision making  
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The statistical significance of the model was tested using ANOVA with a significance 
level of p < 0.05. This demonstrated no significant effect of the ‘intuitive’ incorrect CRT 
answers on prescribing error type (F38,39 = 0.577, p = 0.452). 
Kinnear and Wilson hypothesised an association between committing clinical errors 
and settling for the ‘intuitive’ incorrect answer to a cognitive puzzle. They asked 
clinicians to answer a question about drug doses, based on the bat and ball problem 
of the CRT, as a measure of their propensity for “quick and casual” decision making, 
and also to self-report the number of clinical errors committed in the previous two 
weeks. Fifty-nine percent of participants reported that they had committed an error, 
while 67% gave the ‘intuitive’ incorrect answer to the problem. The authors noted that 
as the puzzle had been presented in a medical context, it could be argued that it 
behaved as a surrogate for a drug calculation and reflected the potential for 
committing prescribing errors. As in the current study, the authors found no 
statistically significant difference between correct or ‘intuitively’ incorrect answers and 
clinical errors.392 
To test the hypothesis that clinicians who tended towards greater cognitive reflection 
would be less likely to prescribe antibiotics for acute respiratory infections, Pineros 
et al administered the 3-item CRT to 50 primary care clinicians and compared their 
answers with clinician-level antibiotic prescribing rates. The proportions of ‘high’ and 
‘low’ CRT scores were closer to the original Frederick results226 than for the current 
study, with 31% of clinicians answering all questions incorrectly and 22% answering 
all correctly. Contrary to their expectations, the authors found a U-shaped association 
between cognitive reflection and antibiotic prescribing. They concluded that there may 
be a ‘sweet-spot’ of cognitive reflection for appropriate antibiotic prescribing for acute 
respiratory infections, and suggested that clinicians with low CRT scores may tend to 
give in to patient pressure for antibiotics, demonstrating unreflective decisions; whilst 
high scoring clinicians may overthink the patient’s presentation.393  
A novel computer-mouse cursor-tracking application used to administer the CRT 
demonstrated that participants were often initially drawn towards the ‘intuitive’ 
incorrect answer, even when the correct answer was ultimately chosen, supporting 
the view that intuitive processes are activated and then inhibited in order to provide a 
correct response.394 Similar results have also been found using eye-tracking to 
analyse the attention of participants in conflict problems analogous to the bat and ball 
problem.395 The practice of mindfulness mediation has been shown to positively 
influence analytical thought processes, with individuals who listened to a mindfulness 
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recording answering CRT questions more analytically than those who did not.396 In 
addition, a significant correlation has been found between response times and the 
total number of CRT items correctly answered; longer response times were weakly 
associated with better performance, although different results were seen with each 
CRT item. The authors suggested that although cognitive miserliness (being unwilling 
to go beyond default and invest cognitive effort to solve the problem) is part of the 
explanation, the different CRT items measure different cognitive and dispositional 
constructs, with “slower not always better”. They also recommended that other 
measures, such as the REI and NCS, should continue to be used by researchers to 
provide insight into cognitive processes, rather than relying on the CRT alone to 
differentiate between those whose performance may be changed through training, 
and those who elect not to be analytical and who may not be changed through 
interventions.397  
5.4 Rational Experiential Inventory 
Responses were received from 59 respondents who had completed the Rational 
Experiential Inventory (REI-40) element of the questionnaire (59/191; 30.9%). The 
majority were male (54.2%) with a median age of 40 - 49 years. Most respondents 
(27/59; 45.8%) were consultant psychiatrists or GPs with a special interest in mental 
health. Further detail on the demographic distribution of respondents can be found in 
Table 5.7. The mean rational score for all prescribers was 3.7 (SD 0.4) and the mean 
experiential score was 3.1 (SD 0.4). The difference of 0.6 (95% CI 0.4 - 0.7) between 
these mean scores was shown to be statistically significant using the non-parametric 
Wilcoxon matched-paired signed-rank test (z = -5.64, p < 0.001, r = -0.73). Data 
reliability was good for both the rationality and experientiality scales with Cronbach’s 
α ≥ 0.8 (see Section 5.2), similar to figures of 0.888 for rationality and 0.893 for 
experientiality found by Djulbegovic et al in a sample of doctors233 and of 0.90  and 
0.87 for rationality and experientiality respectively described in the original work on 
the REI-40 by Pacini and Epstein.200 More details about the REI-40 can be found in 
Section 1.7.2. 
The differences in mean rational and experiential scores were compared for each 
category. Both male and female prescribers tended more towards rational decision 
making than towards experiential decision making, with statistically significant 
differences between the two scores calculated using the non-parametric Wilcoxon 
matched-paired signed-rank test (males, z = -4.45, p < 0.001, r = -0.58; female z =  
-3.44, p = 0.001, r = -0.45). Male participants scored higher for rationality (3.8; SD 0.3 
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vs. 3.6; SD 0.4), while female participants scored higher on experientiality (3.2; 
SD 0.4 vs. 3.6; SD 0.4). However, the non-parametric Kruskal-Wallis test, with a 
significance level of p < 0.05, demonstrated that there was no statistically significant 
difference in rational or experiential scores by gender (see Table 5.7). 
Similarly, all age groups apart from one showed a statistically significant difference 
between rational and experiential scores, when analysed using the non-parametric 
Wilcoxon matched-paired signed-rank test, with a tendency towards rational decision 
making. Although prescribers in the age group 21 - 29 years demonstrated a higher 
mean score for rationality than for experientiality, the difference was not statistically 
significant (z = -1.52, p = 0.128, r = -0.57). The non-parametric Kruskal-Wallis test, 
with a significance level of p < 0.05, demonstrated that there was no difference in 
rational or experiential scores by age group (see Table 5.7). 
Table 5.7:   Comparison of mean REI-40 scores on the basis of demographics  
Sample (n=59) Mean rational 
score (SD) 
p Mean 
experiential 
score (SD) 
p 
Gender     
Male (n=32) 
Female (n= 27) 
3.8 (0.3) 
3.6 (0.4) 0.493 
3.1 (0.4)* 
3.2 (0.4)* 0.143 
Age     
21 - 29 (n=7) 
30 - 39 (n=16) 
40 - 49 (n=21) 
50 - 59 (n=9) 
60 and over (n=6) 
3.7 (0.5) 
3.5 (0.5) 
3.7 (0.3) 
3.8 (0.4) 
4.0 (0.2) 
0.097 
3.3 (0.3) 
3.1 (0.3)* 
3.5 (0.5)* 
3.2 (0.5)* 
3.2 (0.3)* 
0.416 
Respondent type     
Foundation trainee (n=9) 
Core/GP trainee (n=10) 
Higher specialty trainee (n=4) 
Staff grade (n=8) 
Consultant/GP (n=27) 
Nurse NMP (n=1) 
3.5 (0.6) 
3.6 (0.4) 
3.6 (0.3) 
3.8 (0.3) 
3.8 (0.3) 
3.7 (  -  ) 
0.539 
3.4 (0.3) 
2.9 (0.2)* 
3.2 (0.3)* 
3.2 (0.5)* 
3.1 (0.4)* 
3.3 (  -  ) 
0.069 
 3.7 (0.4)*  3.1 (0.4)*  
* the difference between rational and experiential scores was statistically significant, p < 0.05 
For all grades of prescriber, there was a tendency towards rational decision-making 
over experiential decision making.  However, when analysed using the non-
parametric Wilcoxon matched-paired signed-rank test, the difference in mean rational 
and experiential scores was not statistically significant for foundation trainees (z =  
-0.771, p = 0.441, r = -0.26). The non-parametric Kruskal-Wallis test, with a 
significance level of p < 0.05, demonstrated that there was no difference in rational or 
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experiential scores by prescriber grade (see Table 5.7). The greatest differences 
between the mean rational and experiential scores were found for male prescribers, 
those aged over 60, and prescribers who were consultants/GPs and core/GP 
trainees.  
Cognitive-Experiential Self Theory (CEST) suggests that reasoning follows a dual 
processing model with the world interpreted through the simultaneous use of two 
systems – rationality and experientiality (see Section 1.7).  The Rational Experiential 
Inventory (REI) was developed to reliably measure an individual’s preference for 
rational or experiential thinking styles.199,200 In a sample of healthcare workers, Sladek 
et al398 described ‘gender differences’ evident across a wide age span, with men 
preferring rational reasoning and women preferring experiential reasoning. A small 
negative association was also found between age and scores on both scales, 
although this was non-significant for overall rationality and rational engagement.  
In the current study’s sample, involving 59 respondents, a similar pattern was found, 
with male participants preferring rational reasoning more than female, and female 
participants preferring experiential reasoning more than males. However, these 
gender differences were not statistically significant, and both genders showed a 
significantly greater score for rationality than experientiality (see Table 5.7). When 
analysed in decile age groups, the difference between mean rational and experiential 
scores was statistically significant for all age groups apart from those aged below 30 
years. The same pattern was found for prescriber type, where there was no statistical 
difference between mean rational and experiential score for foundation trainees. This 
may be an artefact due to the small numbers involved (seven participants in the 21 - 
29 age group, and nine in the foundation trainee category), but may also be due to 
the stage in the pathway from novice to expert, reflecting that much of the thinking in 
these groups is still of the rational, System 2 type which through repetition, may 
become intuitive (System 1) and move to the control of the experiential mode.398 
The Kolmogorov-Smirnov test was used to determine whether the distribution of 
scores differed from a normal distribution.  The rationality scores, D(59) = 0.122, 
p < 0.05 were non-normal and negatively skewed (-1.114 ± 0.519) towards higher 
scores. However, the experientiality scores, D(59) = 0.096, p = 0.200 did not deviate 
significantly from the norm and were not skewed (0.053 ± 0.234). The distribution of 
scores is shown in Figure 5.7. A similar pattern for the distribution of experientiality 
scores was found for a large sample of emergency physicians in Canada; although 
the rationality scores in that study were normally distributed but skewed towards 
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higher scores. The authors noted that emergency physicians who had undergone 
specialty training had higher mean rationality scores that those who had undergone 
emergency training in family medicine, but found no statistically significant difference 
between emergency physicians based on the number of years in practice.232 
 
Figure 5.7:   Distribution of Rational Experiential Inventory (REI-40) scores  
Overall, trust prescribers favoured rational decision making over experiential decision 
making although the differences varied by prescriber grade. For overall rationality 
scores, the scores for doctors in training (foundation, core/GP and specialty trainees) 
were generally lower than those for staff grade and consultants, although, as 
described above, this difference was not significant. This trend was repeated for 
rational ability and to a lesser degree, rational engagement. Consultants and core/GP 
trainees had the lowest overall scores for experientiality, although again, this 
difference was not significant. The lowest score for experiential ability and 
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engagement was seen in core/GP trainees. The full data for the REI-40 sub-scales 
are shown in Table 5.8.  
Table 5.8:   Comparison of detailed REI-40 scores on the basis of prescriber grade  
 Rationality Experientiality 
Sample (n=59) Mean Ability Engagement Mean Ability Engagement 
Foundation trainee 
(n=9) 
3.5 (0.6) 3.4 (0.5) 3.5 (0.8) 3.4 (0.3) 3.4 (0.2) 3.4 (0.4) 
Core/GP trainee (n=10) 3.6 (0.4) 3.7 (0.4) 3.5 (0.5) 2.9 (0.2)* 3.0 (0.3) 2.8 (0.2) 
Higher specialty 
trainee (n=4) 
3.6 (0.3) 3.5 (0.2) 3.7 (0.5) 3.2 (0.3)* 3.2 (0.3) 3.3 (0.5) 
Staff grade (n=8) 3.8 (0.3) 3.8 (0.4) 3.8 (0.4) 3.2 (0.5)* 3.3 (0.6) 3.0 (0.5) 
Consultant/GP (n=27) 3.8 (0.3) 3.8 (0.3) 3.7 (0.4) 3.1 (0.4)* 3.2 (0.5) 3.1 (0.4) 
Nurse NMP (n=1) 3.7 ( -  ) 3.8 ( - ) 3.6 ( - ) 3.3 (  -  )* 3.6 (  - ) 3.0 (  - ) 
 3.7 (0.4) 3.7 (0.4) 3.7 (0.5) 3.1 (0.4)* 3.2 (0.5) 3.1 (0.4) 
* the difference between rational and experiential scores was statistically significant, p < 0.05 
A number of other studies have reported REI-40 scores in samples drawn from 
qualified or student healthcare professionals (see Table 5.9) 230–238 Surprisingly, the 
current study sample contrasts quite markedly from several other samples involving 
doctors, although the results were similar to those found in the original Pacini study 
of undergraduate students.200 Higher mean rationality scores were demonstrated by 
a small sample of trainees and consultants,231 emergency physicians232 and 
cardiologists,230 although lower rationality scores were found in another, much larger, 
sample of trainees and consultants.233,234  
Table 5.9:   Comparison of mean REI-40 scores with other study samples 
Sample Mean rational 
score (SD) 
Mean experiential 
score (SD) 
Physicians (n=221)233,234 2.98 (0.53) 2.29 (0.58) 
College students (n=399)200 3.39 (0.61) 3.52 (0.47) 
This study (n=59) 3.69 (0.39) 3.14 (0.38) 
Senior nurses (n=50)238 3.79 (n/a) 3.40 (n/a) 
Paramedics (n=904)235 3.86 (0.42) 3.41 (0.42) 
Student pharmacists (n=114; n=51)236,237 3.9 (0.5) 3.3 (0.5) 
Doctors (trainees and consultants) (n=32)231 3.91 (0.43) 3.04 (0.54) 
Emergency physicians (n=434)232 3.93 (0.35) 3.33 (0.49) 
Cardiologists (n=74)230 3.93 (0.37) 3.05 (0.53) 
Student paramedics (n=267)235 3.97 (0.42) 3.36 (0.46) 
Consultants (n=49)238 4.00 (n/a) 3.07 (n/a) 
Hospital managers (n=53)238 4.02 (n/a) 3.29 (n/a) 
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There was a smaller difference between the mean rational and experiential scores 
than between the scores for doctors found in other studies,230,233,238 but it was similar 
to that found for emergency physicians,232 pharmacy students,236,237 and student 
paramedics.235 Samples of doctors in other studies were drawn from medical and 
surgical specialties, including cardiology,230,231 emergency medicine,231,232 
geriatrics,231 intensive care,231 orthopaedics,231 paediatrics,231,233,234 obstetrics and 
gynaecology,233,234 radiology,233,234 ophthalmology,233,234 and surgery.231 A very small 
number of psychiatrists (12/221; 5%) were involved in the studies by Djulbegovic 
et al.233,234 In one study, Sladek et al specifically excluded consultants working in 
mental health.231  
The lower rationality scores seen in this study may reflect that psychiatry is practiced 
by a different type of doctor. A qualitative study of decision-making processes in 
psychiatry identified that clinical intuitive (a ‘feeling’ or ‘hunch’)  were important when 
psychiatrists described decisions relating to symptom presentation and diagnosis, but 
less so in relation to medication and treatment choices; the authors highlighted that 
psychiatrists have relatively few objective tools to verify or refute their hypotheses.399  
Bloch argued that the ‘art of psychiatry’ is as important to patient care as the practice 
of evidence-based medicine with the interplay of biology, psychology, social 
circumstances and spiritual life more relevant than in any other medical specialty,400 
a view supported by others.401,402 The difference between the practice of psychiatry 
and other medical specialties may explain the lower rationality scores seen in the 
current study. 
Sladek et al explored the thinking dispositions of key decision makers in hospitals, 
comparing senior consultants, nurses and health managers.  Managers had a 
significantly higher preference for rationality than nurses, while consultants had a 
lower preference for experientiality than either nurses or managers. The authors 
suggested that when addressing multiple professional groups it may be beneficial to 
prepare two versions of any message, with one targeting the rational processing mode 
and the other the experiential processing mode.238  
Following a meta-analysis of 89 studies looking at decision performance and decision 
experience, Phillips et al concluded that decision performance was positively 
associated with reflection and negatively associated with intuition. They also identified 
a significantly stronger positive relationship between thinking style and decision 
performance when the task and the processing system matched with, for example, 
tasks that required logic or analysis, performed better by those who scored highly on 
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rationality. The authors concluded that having strong tendencies to use both types of 
thinking may be an “optimal individual thinking style”; particularly if the individual is 
able to identify the best type of thinking for the task in hand, and adapt their decision-
making approach to match.403 
In the current study, very few respondents provided free text comments in their 
questionnaire responses, but those that did also suggested that they may alter their 
predominant thinking style to suit the situation. Comments are shown below:  
“Cognitive styles may vary depending on situation; I can switch between modes” 
(P31, consultant/GP) 
“As a doctor I like to be able to logically justify but I have learnt that gut instinct 
can support this, especially by highlighting things that need to be considered and 
may otherwise be missed, so long as it is part of an overall logical process” (P42, 
consultant/GP) 
“There appears to be a false dichotomy between intuition and thought. Theories 
of expert problem solving suggest pattern recognition and intrinsic knowledge are 
important which could manifest as intuition but instead reflect processes of 
thought borne of knowledge, awareness and experience” (P47, consultant/GP) 
 
Figure 5.8:   REI-40 rationality scores and prescribing error rates 
Prescribing error data, collected as part of an earlier element of the study (see Section 
2.3), were available for 47 of the 59 respondents who had completed the Rational 
Experiential Inventory element of the questionnaire. Respondents had prescribed 
4,024 medication orders containing 180 prescribing errors, exceeding the total sample 
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size needed to identify a “small” expected effect size with 95% confidence and 90% 
power. Scatterplots were prepared to show the total rationality (see Figure 5.8) and 
total experientiality scores (see Figure 5.9) against the prescribing error rate for each 
individual.  
Trends towards a higher prescribing error rate with higher rationality scores and lower 
experientiality scores were suggested by the regression lines. However, linear 
regression demonstrated a correlation of R2 = 0.021 for the rationality score, and 
R2 = 0.001 for the experientiality score which suggested that only 2.1% of the variation 
in prescribing error rate can be explained by the rationality score and less than one 
per cent by the experientiality scores alone.   
 
Figure 5.9:   REI-40 experientiality scores and prescribing error rates 
The statistical significance of each model was tested using ANOVA with a significance 
level of p < 0.05. These demonstrated that there was no significant effect of either the 
rationality score (F45,46 = 0.948, p = 0.335) or the experientiality score (F45,46 = 0.083, 
p = 0.774) on prescribing error rates. 
A trend towards a greater proportion of errors being due to decision making with 
higher rationality scores was explored. Linear regression demonstrated a correlation 
of R2 = 0.055 which suggested that only 5.5% per cent of the variation in the nature of 
prescribing errors can be explained by rationality score alone.  The statistical 
significance of the model was tested using ANOVA with a significance level of 
y = -0.335x + 4.545
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p < 0.05. This demonstrated that there was no significant effect of rationality score on 
prescribing error type (F45,46 = 2.609, p = 0.113).  
No correlation was suggested by the regression line for the experientiality score which 
demonstrated a correlation of R2 = 0.000. The statistical significance of the model was 
tested using ANOVA with a significance level of p < 0.05. This demonstrated that 
there was no significant effect of experientiality score on prescribing error type 
(F45,46 = 0.001, p = 0.975). 
Research has found that thinking dispositions are related to the decision-making 
behaviours of individual doctors, including the application of clinical guidelines,230 and 
compliance with infection control requirements.231 It has been demonstrated that 
doctors with a higher preference for rational thinking are more likely to be guideline-
concordant, whilst those with a higher preference for experiential thinking are more 
likely to be guideline-discordant.230  
Djulbegovic et al assessed physicians’ individual differences in cognitive style in 
relation to accuracy on a conditional inference task, using six scales measuring 
different aspects of cognitive style. They found that physicians capable of supressing 
an immediate intuitive response (CRT) and scoring higher on rational thinking (REI-
40) made fewer inferential mistakes in the clinical scenarios. Whilst postulating that 
better decision making leads to better patient outcomes, the authors suggested that 
it would be interesting to correlate the cognitive scale scores of doctors with patterns 
of diagnostic testing and treatment prescribing.233 
In the current study, no statistically significant relationship was found between higher 
scores on either the rational or experiential scale and prescribing error rates. This 
may be due to the small sample size, with prescribing data and REI-40 scores only 
available for 47 participants. However, it may indicate that prescribing is a complex 
task involving decisions which may be handled differently in diverse situations and 
may not be easily associated with the prescriber’s dominant decision-making style, 
despite it having been suggested that those who favour rationality may be more 
receptive to evidence-based approaches.404  
5.5 Need for Cognition Scale 
Responses were received from 59 respondents who had completed the Need for 
Cognition Scale (NCS) element of the questionnaire (59/191; 30.9%); one respondent 
completed the NCS who did not complete the REI-40 and vice versa. The majority 
5. DECISION-MAKING CHARACTERISTICS OF PRESCRIBERS: RESULTS AND DISCUSSION   
158 
 
were male (54.2%) with a modal age range of 40 - 49 years. Most respondents (27/59; 
45.8%) were consultant psychiatrists or GPs with a special interest in mental health.  
The mean NCS score for all prescribers was 16.9 (SD 15.2). Further detail on the 
demographic distribution of respondents can be found in Table 5.10. For more details 
about the NCS see Section 1.7.2. The non-parametric Kruskal-Wallis test, with a 
significance level of p < 0.05, demonstrated that there was no difference in mean 
scores by gender, age or prescriber grade (see Table 5.10). 
Table 5.10: Comparison of mean NCS score on the basis of demographics 
Sample (n =  59) Mean NCS score (SD) p 
Gender   
Male (n=32) 
Female (n= 27) 
15.5 (12.1) 
18.6 (18.2) 0.144 
Age   
21 - 29 (n=7) 
30 - 39 (n=15) 
40 - 49 (n=22) 
50 - 59 (n=9) 
60 and over (n=6) 
23.9 (12.0) 
7.9 (18.8) 
17.3 (11.8) 
20. 6 (15.9) 
24.3 (11.1) 
0.085 
Respondent type   
Foundation trainee (n=9) 
Core/GP trainee (n=10) 
Higher specialty trainee (n=4) 
Staff grade (n=8) 
Consultant/GP (n=27) 
Nurse NMP (n=1) 
13.4 (25.2) 
6.6 (12.3) 
11.8 (12.9) 
21.1 (10.0) 
21.6 (11.9) 
12.0 (  -   ) 
0.067 
 16.9 (15.2)  
 
The Kolmogorov-Smirnov test was used to determine whether the distribution of 
scores differed from a normal distribution.  The need for cognition scores, 
D(59) = 0.094, p = 0.200 did not deviate significantly from the norm. However, it 
appeared to be negatively skewed (-1.192 ± 0.311) towards scores greater than zero. 
The distribution of scores is shown in Figure 5.10. 
Unlike the CRT and potentially the REI, the NCS has been found to be gender 
neutral405 and no statistically significant difference was found in the mean scores for 
male and female participants in this study. The relationship between age and need 
for cognition has been examined in a number of studies and a weak association found; 
although small individual-level changes in NCS scores can occur over time.406 No 
difference by age group was found in this study. However, it has been suggested that 
association by age may be confounded by education, as a reliable relationship has 
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been found between need for cognition and educational status. Cacioppo et al queried 
whether this was in fact due to self-selection with those with a high need for cognition 
more likely to pursue education.407 
 
Figure 5.10: Distribution of Need for Cognition (NCS) scores 
Few studies have applied the NCS to samples of doctors. In an investigation of  
thinking styles in physicians, Djulbegovic et al reported a mean score for a sample of 
trainees and consultants of 4.2 (SD 0.7).234 However, they quoted scale dimensions 
for the NCS of 1 to 6 which does not correlate with the original 9-point Likert scale  
(-4 to +4) with reverse scoring developed by Cacioppo and Petty,239 which was used 
in the current study. It is therefore not possible to make comparison between the 
results. 
The NCS has been used in a multitude of studies. In 1996 Cacioppo et al reviewed 
its use in over 100 empirical studies in the little over a decade since it had been 
developed,407 and a meta-analysis by Phillips et al of studies which assessed thinking 
styles and decision making identified many which have used the NCS (abbreviated 
as NFC in their paper).403 Using undergraduate or general population samples, many 
have included the NCS as part of a battery of tasks but reported the association 
between different measures rather than absolute numbers, or used scales adapted to 
match the other tools used. For example, although West et al cited a mean NCS score 
of 69.0 (SD 12.2) their study used a scale of 1 to 6 in order to match the Actively 
Open-Minded Thinking Scale within which questions were intermixed, and no clarity 
was provided about reverse scoring.408 The same scoring approach was adopted by 
Toplak et al which quoted a mean NCS score of 68.6 (SD 10.4).266 
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It has therefore not been possible to make direct comparisons with the mean NCS 
scores found in other studies. However, the distribution found in this study can be 
compared with general findings using the NCS. Significant correlation has been found 
between the 18-item NCS and variables such as high quality and adaptive decision 
making409 and accurate and consistent decision making.410,411 Dunphy et al found that 
obstetricians who scored highly on NCS were more likely to have better maternal and 
neonatal outcomes. They suggested that this may be due to clinicians with high need 
for cognition being linked to higher levels of metacognition, developed thought 
processes, and self-evaluation  being more likely to critically evaluate potential 
strategies before reaching a decision412 Studies have shown that individuals with high 
need for cognition scores recall more of the  information that they are exposed to than 
those with low scores.407  
While the absolute mean score cannot be meaningfully compared with others, this 
study found NCS scores which were normally distributed but  skewed towards scores 
greater than zero, thus suggesting that the study sample showed a tendency to 
organise, abstract and evaluate information.239 
 
Figure 5.11: NCS scores and prescribing error rates 
Prescribing error data, collected previously, were available for 45 of the 59 
respondents who had completed the Need for Cognition element of the questionnaire. 
A scatterplot was prepared to show NCS score (see Figure 5.11) against the 
prescribing error rate for each individual. Respondents had prescribed 3,973 
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medication orders containing 177 prescribing errors, exceeding the total sample size 
needed to identify a “small” expected effect size with 95% confidence and 90% power. 
A trend towards a higher prescribing error rate with lower NCS score was suggested 
by the regression line. However, linear regression demonstrated a correlation of 
R2 = 0.019 which suggested that less than 2 per cent of the variation in prescribing 
error rate can be explained by need for cognition alone.  The statistical significance 
of the model was tested using ANOVA with a significance level of p < 0.05. This 
demonstrated that there was no significant effect of the NCS scores on prescribing 
error (F43,44 = 0.838, p = 0.365). 
A trend towards a greater proportion of errors being due to decision making with 
higher NFC scores was explored. Linear regression demonstrated a correlation of 
R2 = 0.012 which suggested that only 1.2% per cent of the variation in the nature of 
prescribing errors can be explained by NFC score alone.  The statistical significance 
of the model was tested using ANOVA with a significance level of p < 0.05. This 
demonstrated that there was no significant effect of NFC score on prescribing error 
type (F43,44 = 0.547, p = 0.463).  
5.6 Summary of findings 
No significant differences in CRT scores were found by gender, age or prescriber 
grade. The mean score on the classic 3-item version of the CRT was marginally higher 
than found in the original study with less ‘low’ scorers and more ‘high’ scorers as 
would be expected in a sample of highly educated participants. Educational 
attainment has been shown to be a strong predictor of CRT score. Participants may 
have had prior exposure to the original version of the CRT as the ‘intuitive’ incorrect 
was the modal answer in only two of the eight questions, a pattern which differed from 
other studies.   
Few past studies have administered the CRT to medical staff. In those that have, a 
U-shaped relationship was shown in relation to appropriate antibiotic prescribing, but 
no correlation found with self-reported clinical errors. The current study demonstrated 
a weak positive correlation between level of experience and CRT scores. Despite a 
slight trend, there was no statistically significant effect of CRT score or the number of 
‘intuitive’ incorrect answers on either prescribing error rate or the number of 
prescribing errors which related to decision making.  
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Overall, participants demonstrated statistically higher REI-40 scores for rationality 
than experientiality, although this was less pronounced for women than for men. 
Unlike other studies, the difference between men and women was not significant.  
There were no significant differences between rationality or experientiality scores by 
age or prescriber grade, with only the youngest/least experienced categories showing 
a non-significant difference between rationality and experientiality scores. 
This is thought to be the first study to explore REI-40 scores in psychiatrists and the 
patterns found differed markedly from some other studies involving doctors, but less 
so from other sample populations. No relationship was found between REI-40 scores 
on either scale and prescribing error rates. It is also thought to be the first study to 
explore NCS scores in psychiatrists and a high ‘need for cognition’ was demonstrated 
amongst this population. No relationship was found between NCS score and 
prescribing error rates.  
Scores on validated scales designed to measure thinking dispositions do not appear 
to provide a prediction of prescribing error performance, suggesting that accurate and 
appropriate prescribing involves more factors than can be captured by measurement 
of thinking dispositions.  
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Chapter 6. Educational intervention: results and discussion 
6.1 Introduction 
The educational session was attended by 47 medical staff. The breakdown of 
participants by prescriber grade is shown in Table 6.1. The turnover of medical staff 
was such that very few of the participants were working within the trust throughout the 
entire period of pre- and post-intervention prescribing data collection (see Appendix 
20), and prescribing data were collected for only 32 of the session participants.  
Table 6.1:   Prescriber grade of educational intervention attendees 
Participant Grade No. attending session 
No. pre-
session 
prescribing 
data available 
No. post-
session 
prescribing 
data available 
No. pre- & 
post- session 
prescribing 
data available 
Foundation trainee  9 0 4 0 
Core/GP specialty trainee  10 4 8  3 
Higher specialty trainee  8 4  5  2 
Staff grade  3 2  2  1 
Consultant 17 8  7  6 
Overall 47 18 26 12 
 
No prescribing data were collected for 15 participants. For six participants data were 
available only for the first data collection period and for a further 14 participants only 
for the second period.  Data for both periods were available for only 12 participants; 
as a result, limited comparisons could be made.  
6.2 Evaluation of training session by attendees 
Of the 47 attendees, 19 (40.4%) completed a short questionnaire before and after the 
session. The percentage of positive responses ‘agree’ and ‘strongly agree’ to a series 
of 11 statements about decision making increased for 10 of them. All respondents 
agreed or strongly agreed that the programme had provided them with a good 
understanding of decision making, whilst 94.4% (18/19) felt that the content was 
relevant to their training or practice and would be useful to their work. All felt that they 
would be able to apply the knowledge learned.  
The differences in mean pre- and post-session scores were compared for each 
statement using the non-parametric Wilcoxon matched-paired signed-rank test. 
Statistically significant differences between the two scores were identified for 
statements two, six, seven, nine and 10. The difference in overall scores was also 
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statistically significant (z = -3.559, p = 0.000, r = -0.82). The respective scores, on a 
5-point Likert scale and the proportion of positive responses for each statement are 
shown in Table 6.2. 
Table 6.2:   Scores and percentage positive responses to each statement 
 Before session After session 
(n = 19) Average 
score (SD) 
Positive 
responses  
Average 
score (SD) 
Positive 
responses  
Statement 1 - An understanding of decision 
making is important in my clinical practice 4.7 (0.5) 100% 4.8 (0.4) 100% 
Statement 2 - I often make decisions based 
on my intuition 3.8 (1.0) 52.6% 4.0 (0.8)* 73.7% 
Statement 3 - Different people use different 
styles to gather information 4.0 (0.8) 84.2% 4.3 (0.6) 94.7% 
Statement 4 - I understand the way in which 
I gather information to inform decision 
making 
4.0 (0.6) 78.9% 4.2 (0.6) 89.5% 
Statement 5 - If I can't make a decision I 
consult a colleague 4.3 (0.5) 94.7% 4.5 (0.5)  100.0% 
Statement 6 - I don't have enough time to 
stay up-to-date on important clinical topics 3.3 (1.1) 36.8% 3.7 (1.0)* 63.2% 
Statement 7 - Decision making can be 
influenced by cognitive biases 3.8 (0.8) 78.9% 4.5 (0.5)* 100.0% 
Statement 8 - Keeping up-to-date with 
information on clinical topics is a key aspect 
of decision making 
4.2 (0.7) 84.2% 3.8 (1.0) 73.7% 
Statement 9 - I understand the different 
processes involved in decision making 3.5 (0.8) 52.6% 4.3 (0.5)* 100.0% 
Statement 10 - I often make decisions on 
'auto-pilot' 3.2 (0.8) 31.6% 3.7 (0.7)* 68.4% 
Statement 11 - I use the best available 
evidence to inform my decision making 3.6 (1.1) 63.2% 4.0 (0.5) 84.2% 
Overall 3.8 (0.3)  4.2 (0.3)*  
* the difference between the pre- and post-session score was statistically significant, p < 0.05 
The need for a healthy degree of scepticism to be fostered amongst medical students 
has been highlighted413 and several studies have investigated the impact of decision-
making training for undergraduates.382,414,415 Bhatti413 suggested that raising 
awareness of cognitive biases and equipping medical students with cognitive 
debiasing strategies will improve the future quality of care and therefore patient 
outcomes. The author cited the GMC’s view that medical students should be able to 
systematically reflect on their practice and translate that reflection into action,416 
asserting that medical students need to be equipped with the skills of critical thinking. 
A recent survey in the US reported that most students enter undergraduate clinical 
training years with at best a fair knowledge of the key clinical reasoning concepts and 
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that, despite respondents reporting that clinical reasoning should be taught in all 
phases of medical education, it is offered by only a minority.417 It is probable that a 
similar situation exists in the UK.   
Harendza et al implemented a clinical reasoning course, addressing six learning 
outcomes, as part of the final year undergraduate medical training. The course was 
delivered as 16, two-hour seminars using 32 patient cases collected from clinical 
practice to illustrative different cognitive errors. In a self-assessment questionnaire 
completed before and after the course, students assessed themselves significantly 
better at all eight of the skills which play a role in clinical reasoning. Students were 
also assessed on the same clinical case at the beginning and end of the course. 
Although post-course case presentations contained fewer errors and more differential 
diagnosis, the difference was not significant.414 Chew et al noted that cognitive 
debiasing may be “easy in theory yet difficult in practice” and can often slow down the 
whole clinical decision-making process. In a quasi-experimental study, final-year 
medical students completed a 90-minute tutorial on cognitive biases and debiasing 
strategies and were introduced to a checklist to facilitate metacognition. Two weeks 
later, those exposed to the tutorial scored significantly higher than students in a 
control group on five clinical case scenarios, designed to contain common cognitive 
biases.382  However, a study of final-year medical students using observations of 
performance  and semi-structured interviews, concluded that the impact of teaching 
decision-making cognitive theory, during a 6-week ‘Preparation for Practice’ block, 
was not clear in relation to making diagnosis, prioritisation and asking for help.415  
Clinical decision-making training has also been reported in a postgraduate setting. A 
study of GPs, GP trainees and nurse practitioners who participated in decision-
making workshops demonstrated significant self-reported improvements in  the theory 
and applied theory of decision making.270 Meanwhile in Pennsylvania, a curriculum 
consisting of three sessions delivered over one academic year was undertaken by 
year two internal medicine residents (equivalent to FY2 trainees in the UK). Outcomes 
were evaluated using the Diagnostic error Knowledge Assessment Test (D-KAT), 
completed at the beginning and end of the course, and designed to test knowledge of 
cognitive errors and their application in clinical vignettes. Whilst pre- and post-course 
D-KAT results were used as the primary outcome, the D-KAT results from year three 
residents were also used as a control group. Post-course scores on the D-KAT test 
were “modestly” but significantly improved compared with pre-course scores and 
higher than those of the year three control group.418 Houchens et al investigated 
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techniques that are demonstrated by exemplary clinical educators to cultivate clinical 
reasoning in an inpatient setting. From interviews and focus groups with educators 
and learners, and direct observations of clinical teaching they identified four themes:  
• simplification, organisation and prioritisation when dealing with information;  
• accessing prior knowledge and contextualising it using schemas and illness 
scripts;  
• thinking aloud to verbalise thought processes, provide rationale for 
management plans, and share mistakes;  
• medical scholarship, critically analysing and connecting the literature with 
patient presentations, and using evidence to support clinical decision 
making.419  
It is probable that the actions and behaviours of clinical and educational supervisors 
are as important in teaching clinical decision making as formal interventions about the 
theory of clinical decision making.  
As shown above, most studies researching ways to improve clinical decision making 
have concentrated on diagnosis. However, Jenkins and Youngstrom examined the 
impact of a cognitive debiasing intervention on decision-making errors in paediatric 
bipolar disorder, where the outcome measures included treatment decisions as well 
as diagnosis. Participants undertook a brief web-based educational intervention which 
comprised an overview of the condition, education on common cognitive pitfalls and 
corrective strategies; a control group just received the overview of the condition. 
Participants in the intervention group showed significantly better overall judgement 
accuracy and made fewer decision-making errors, even after controlling for 
experience and profession. The authors noted that cognitive error, particularly search 
satisficing (premature discontinuation), appeared to be associated with premature 
treatment decisions, with more accurate judgement leading to a more conservative 
and methodical approach.420  
6.3 Prescribing errors 
Prescribing error data were collected by ward pharmacists before and after the 
educational intervention. A total of 7,953 medication orders were reviewed pre-
intervention (period one), and a further 5,731 post-intervention (period two). Less than 
one-sixth of medication orders (14.4%; 1,974/13,684) were written by the 32 
prescribers who attended the education session, compared with 85.5% 
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(11,710/13,684) which were written by the 180 prescribers who did not (see Table 
6.3). 
For the 32 prescribers who attended the session and for whom data were available, 
the number of medication orders was very slightly less than the calculated sample 
size (pre- and post-intervention) of unpaired observations required to test, with 95% 
confidence and 90% power, for a reduction of 50% from the pre-intervention 
prescribing error rate (see Section 2.6.6).  
Analysis was undertaken for these 32 participants on the basis of unpaired data. For 
the small number for whom pre- and post-intervention data were available paired 
comparisons were also undertaken.  
6.3.1 Analysis of unpaired data 
For those who did not attend the educational session, and all prescribers overall, the 
difference in error rates between the two periods demonstrated no statistically 
significant difference when tested using the Pearson chi-squared test, with a 
significance level of p < 0.05. 
Table 6.3:   Prescribing error rates pre- and post-intervention 
Prescriber 
 Pre-
intervention 
(period 1) 
Post-
intervention 
(period 2) 
Total p 
Did not attend 
educational 
session (n = 180) 
Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
6,826 
348 
5.1 (4.6-5.6) 
4,884 
234 
4.4 (3.8-5.0) 
11,710 
561 
4.8 (4.4-5.2) 
0.066 
Attended 
educational 
session (n = 32) 
Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
1,127 
28 
2.5* (1.6-3.4) 
847 
41 
4.8* (3.4-6.2) 
1,974 
69 
3.5 (2.7-4.3) 
0.005 
All prescribers 
(n = 212) 
Items written/omitted 
No. with errors 
Error rate (95% CI) (%) 
7,953 
376 
4.7 (4.3-5.2) 
5,731 
254 
4.4 (3.9-4.9) 
13,684 
630 
4.6 (4.3-4.9) 
0.415 
* the difference between pre- and post-intervention error rates was statistically significant, p < 0.05 
For the 32 participants for whom prescribing data were available, data were available 
for 18 prescribers for period one, 26 prescribers for period two, and 12 prescribers for 
both periods.  Data collected during the pre-intervention data collection period 
demonstrated a prescribing error rate of 2.5% (28/1,127) compared with a post-
intervention error rate of 4.8% (41/847). Full details are shown in Table 6.3. This was 
tested for statistical significance using the Pearson chi-squared test, with a 
significance level of p < 0.05. This demonstrated a significant difference between the 
error rate pre- and post-intervention (χ2 (1) = 7.958, p < 0.05). 
6. EDUCATIONAL INTERVENTION: RESULTS AND DISCUSSION 
168 
 
Although there was a statistically significant difference between the pre- and post-
intervention prescribing error rates in the group who attended the educational session, 
the error rate was higher in the post-intervention group than in the pre-intervention 
group. This is likely to be explained by the fact that the two samples were not matched 
pairs, and their composition was quite different (see Table 6.1 and Table 6.4).  
Table 6.4:   Comparison of samples for those attending educational session 
 Pre-intervention sample Post-intervention sample 
Participant Grade 
No. medication 
orders  
(% of sample) 
No. medication 
orders with 
errors 
No. medication 
orders  
(% of sample) 
No. medication 
orders with 
errors 
Foundation trainee  - - 34 (4.0%) 0 
Core/GP specialty trainee  249 (22.1%) 8 342 (40.4%) 26 
Higher specialty trainee  273 (24.2%) 7 139 (16.4%) 3 
Staff grade  199 (17.7%) 7 54 (6.4%) 1 
Consultant 406 (36.0%) 6 278 (32.8%) 11 
Overall 1,127 (100%) 28 (2.5%) 847 (100%) 41 (4.8%) 
 
In the group for whom pre-intervention prescribing data were available, 22.1% of the 
medication orders were written by junior doctors likely to be within the first five years 
of practice (foundation, core and GP trainees) whilst 53.7% were written by 
experienced doctors (staff grade and consultants). In the post-intervention group, 
twice the proportion of medication orders (44.4%) were written by junior doctors with 
an associated higher number of errors, as might be expected from the earlier findings 
of this study, where early-years prescribers had the highest error rates amongst 
prescribers.  
In contrast, experienced doctors accounted for a lower proportion of the medication 
orders written in the post-intervention sample. Other reasons that may have led to the 
results observed include the small size of the sample of medication orders written by 
prescribers who attended the educational session (14.4%; 1,974/13,684) compared 
with the overall sample, and the large 95% confidence intervals produced as a result 
(see Table 6.3). During the first data collection period, the highest error rates were 
demonstrated by foundation year 2 (12.3%; 33/269) and GP trainees (9.8%; 59/602), 
with the lowest rates shown by core specialty trainees (3.0%; 34/1,143) and higher 
specialty trainees (2.2%; 14/637). During the second data collection period, the 
highest error rates were demonstrated by core (9.6%; 73/761) and GP trainees (9.3%; 
20/216), with the lowest rates shown by staff grade (1.8%; 42/2,291) and other 
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prescribers (0.5%; 2/389). Error rates by prescriber grade for both periods are shown 
in Figure 6.1.  
 
 
Figure 6.1:   Prescribing error rates by prescriber grade 
During the first data collection period, most errors were associated with discharge 
prescriptions (7.1%; 41/577), followed by prescriptions written on admission (6.5%; 
92/1,414). During the second data collection period, discharge prescriptions were still 
associated with the highest rate of errors (8.5%; 40/469), followed by admissions 
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(5.9%; 71/1,199). Error rates by prescribing stage for both periods are shown in Figure 
6.2.  
 
 
Figure 6.2:   Error rate by prescribing stage 
Analysis of unpaired data demonstrated a statistically significant difference in the 
prescribing error rates pre- and post- intervention, but not a reduction in prescribing 
errors, likely to have been due to the difference in composition of the unpaired 
samples.  
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6.3.2 Analysis of paired data 
Data were only available for 12 prescribers for the periods both before and after 
attendance at the educational session on decision making. Of these, two prescribers 
(prescribers 3 and 93) had no prescribing errors identified during either period, and a 
further five had no recorded prescribing errors in one of the two periods (prescribers 
9, 10, 15, 21 and 83). Pre- and post-intervention data for the 12 prescribers is shown 
in Table 6.5.  
Table 6.5:   Pre- and post-intervention numbers of medication orders with and without errors 
Prescriber Pre-intervention Post intervention  
 
Total 
medication 
orders 
Medication 
orders with 
errors 
Error rate 
(%) 
Total 
medication 
orders 
Medication 
orders with 
errors 
Error rate 
(%) 
Change in 
error rate 
3 87 0 0.0% 20 0   0.0% 0.0 
6 193 6 3.1% 62 1   1.6% -1.5 
9 169 5 3.0% 17 0   0.0% -3.0 
10 74 3 4.1% 12 0   0.0% -4.1 
15 44 0 0.0% 20 1   5.0% +5.0 
21 102 2 2.0% 48 0   0.0% -2.0 
33 117 1 0.9% 50 1   2.0% +1.1 
67 80 1 1.3% 39 3   7.7% +6.4 
83 18 1 5.6% 13 0   0.0% -5.6 
93 22 0 0.0% 20 0   0.0% 0.0 
147 107 4 3.7% 15 4 26.7% +23.0 
171 12 1 8.3% 111 8   7.2% -1.1 
 1,025 24 2.3% 
(1.4 - 3.2) 427 18 
  4.2% 
 (2.3 - 6.1) 1.9 
        
In both this group of prescribers as a whole, and for some individual prescribers, the 
total number of medication orders written in the two periods differed considerably 
(period one, 1,025; period two, 427). For example, prescriber 147 wrote 107 
medication orders during period one, but only 15 in period two. The mean prescribing 
error rate for these 12 prescribers was 2.3% (95% CI 1.39 - 3.21; 24/1,025) for period 
one and 4.2% (95% CI 2.3 - 6.1; 18/427) for period two. This difference in error rates 
was not statistically significant when tested using the Pearson chi-squared test, with 
a significance level of p < 0.05 (χ2 (1) = 1.697, p < 0.193).  
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Whilst the intervention undertaken in the current study did not result in a significant 
reduction in prescribing errors, many other studies have investigated interventions 
aimed at improving prescribing and reducing errors; these suggest that interventions 
need to be more complex than that reported in this study. It has been suggested that 
interventions need to be at three levels to improve prescribing: training, 
standardisation of process and environment, and accompanied by a cultural change 
to recognise prescribing as a complex, technical task.421 Several recent systematic 
reviews have reported on educational interventions to improve prescribing422,423 or 
reduce medication-related harm,424 and the Health Foundation published a rapid 
collation of the evidence for educational approaches, initiatives relating to roles and 
personnel, and tools to reduce prescribing errors.251 Interventions to address the 
occurrence of prescribing errors need to reflect knowledge about both the causes of 
errors and the circumstances in which they occur.425 
Brennan and Mattick considered 64 studies of hospital-based interventions and were 
particularly interested in studies which focused on new prescribers. The authors 
reported that most interventions were multifactorial, using several types of 
intervention, although educational materials were the most popular. They found that 
the same types of strategies, for example, specific feedback to prescribers, were 
successful in some studies but ineffective in others. Therefore, they suggested that 
no firm conclusions could be drawn about the most effective types of intervention, and 
noted that few interventions were tailored to meet the needs of new prescribers.422 
Kamarudin et al identified 47 studies exploring educational interventions to improve 
prescribing competency, although 20 involved medical students rather than qualified 
doctors; 10 were hospital-based. The authors suggested that limited conclusions 
could be drawn due to the quality of the studies reviewed, and noted that high quality 
studies were needed which consider long-term changes in prescribing habits to 
assess the effectiveness of educational interventions.423 Similar conclusions were 
drawn by Bos et al in a recent review, which looked particularly at 15 studies reporting 
an impact on medication-related patient harm. The authors highlighted that studies 
were small, with short follow-up and poor methodology. However, they did note that 
those studies where education was part of a multifaceted approach all reported 
positive outcomes, whilst only four of seven studies involving an educational 
intervention alone were positive. The authors concluded that educational sessions 
should be combined with other approaches to improve medication safety424 Didactic 
approaches do not appear to produce changes in prescribing behaviour.426 
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Studies have identified that prescribers are frequently unaware that they have made 
an error.13,18,27 With feedback considered the “cornerstone of effective teaching”,427 it 
is perhaps unsurprising that prescribers continue to make prescribing errors if they 
rarely know that they have made them. In addition, a culture has been reported 
amongst pharmacists of not using formal incident reporting systems to capture every 
error they encounter because the high prevalence makes this “too cumbersome and 
time consuming”.428  Whilst pharmacists understand the importance of incident 
reporting this is  principally driven by actual patient harm, meaning that most incidents 
are not reported. Therefore, another source of potential feedback to prescribers is 
largely lost. 
Qualitative studies have shown feedback on prescribing to be positively received by 
doctors,429–431 with prescribers describing feedback as “essential in order for them to 
calibrate their prescribing appropriately”.430 However, pharmacists have reported 
anxiety that delivering such feedback will damage interprofessional relationships.432 
Current arrangements for feedback are generally informal, opportunistic, and 
inconsistent, with errors usually corrected by pharmacists without feedback to the 
prescriber.13,431,432 Interviews with prescribers have identified that feedback is most 
beneficial when timely and provides a benchmark against which to compare their own 
behaviours and knowledge. Email feedback was felt likely to be least effective at 
changing prescribing behaviour.430 The findings of a study by Reynolds et al 
supported this assertion. They investigated fortnightly prescribing advice emails that 
addressed a common and/or serious error. Whilst focus group findings suggested 
increased doctor engagement with safe prescribing, no difference was found in 
prescribing error rates compared with a control site, and the authors concluded that 
producing a measurable reduction in prescribing errors needed a multifaceted 
approach.278  
Studies have found that individualised education and feedback improved prescribing 
and reduced errors. In a recent UK study, pharmacists who had received additional 
training on the theory, impact and principles of delivering feedback, provided 
individualised verbal and written feedback on both overall prescribing and specific 
prescribing errors.  Error data for two intervention wards were compared at baseline 
and post-intervention with two comparable control wards. Following feedback, mean 
prescribing error rates were significantly lower in the intervention group than in the 
control group, and lower at the end of the study period than at baseline.433  McLellan 
et al investigated the impact of individualised feedback, including comparative 
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information, in the setting of a feedback workshop on suboptimal antimicrobial 
prescribing (mainly prescription writing). Suboptimal prescribing was found to be 
significantly lower in the intervention group than in a control group.434 In a mental 
health setting, Chaturvedi et al provided feedback to prescribers on the quality of 
prescriptions written within an adult psychiatry unit. There were substantial 
improvements in the proportion of prescriptions which met specified standards after 
feedback.435  
A number of studies have investigated interventions designed specifically to reduce 
antipsychotic polypharmacy rates rather than the occurrence of prescribing errors. 
Ungvari et al found that psychopharmacotherapy lectures, distribution of literature and 
feedback on prescribing reduced the number of patients who were prescribed more 
than one antipsychotic.436 Thompson et al reduced levels of antipsychotic co-
prescribing though use of an educational/cognitive workbook, academic detailing and 
reminder stickers applied to drug charts, compared with control wards which received 
a set of guidelines. Although they found a significantly lower chance of being 
prescribed multiple antipsychotics in the intervention group than the control group, 
there was considerable variation between units involved in the study and in the 
changes seen between baseline and follow-up.437,438  Similar approaches involving 
guideline implementation, education and feedback, and pharmacist interventions 
have also been successful in changing prescribing culture and reducing 
antipsychotics prescribed in combination and/or above the maximum BNF 
recommended dose in other studies439–441; although one study which looked at this 
type of prescribing one year after an intervention found no change in the frequency of 
antipsychotic co-prescribing.442 The authors of this study noted high rates of staff 
turnover during the period and differences in case mix between the baseline and post-
intervention patient groups which may have been contributory. However, it may also 
have indicated that any immediate impact of the intervention was not sustained over 
the period of a year. 
6.4 Summary of findings 
In the current study, a three-hour educational intervention on clinical decision making 
did not reduce prescribing error rates. However, similarly to other research, it did have 
an impact on the self-reported understanding of decision-making processes. 
Statistically significant differences were demonstrated in five of the post- intervention 
evaluation statements, three of which related to participants’ understanding of their 
own decision making, and two to decision-making theory.  
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It is likely that interventions to improve the quality of prescribing and reduce errors 
need to be multifaceted in design in order to recognise the complexity of the 
prescribing process.443 In terms of an educational component, which could be 
delivered as part of the induction process or as part of ongoing postgraduate 
education session, the research undertaken within this study suggests that this needs 
to contain the following elements: 
• the theory of clinical decision making, including awareness of dual process 
theory, incorporating the development of pattern recognition through 
experience and the process of calibration; cognitive biases and the application 
of debiasing strategies to help overcome them. 
• locally identified stages in the prescribing process shown to be error-prone, 
particularly issues relating to errors occurring at care interfaces, and relating 
to particular categories of medication. 
• systems locally which can be used by prescribers to help reduce errors, such 
as medicines reconciliation, technology, (ePMA, SCR), reporting and 
feedback on prescribing errors as an educational tool, how to access 
information sources (e.g. local formulary, guidelines, on-call pharmacist) 
This educational approach should be accompanied by on-going feedback on 
prescribing errors to individuals (about their own errors) and prescribers in general 
(about patterns of prescribing errors) as without feedback prescribers cannot alter 
prescribing habits which they do not know are incorrect.430 For newly qualified 
prescribers this could be provided by ‘buddying’ with a pharmacist.444 Clinical and 
educational tutors have a crucial part to play in reinforcing the importance of such 
feedback as a learning tool. 
Evidence from cognitive psychology also suggests that interventions should be 
designed in such a way as to target both the rational processing and the experiential 
processing preferences of individual participants,238 and that a better understanding 
of the individual differences between doctors can contribute to the design of strategies 
to improve the uptake of new evidence.404 See also the limitations discussed in 
Section 7.4.4. 
 
 
7. OVERALL DISCUSSION AND CONCLUSIONS 
176 
 
Chapter 7. Overall discussion and conclusions 
7.1 Introduction 
The purpose of this study was to investigate the effect of dual process thinking and 
other human factors on the occurrence of prescribing errors in an inpatient mental 
health setting. In order to investigate this, research was undertaken in four areas. 
Firstly, the prevalence and nature of prescribing errors were investigated, including 
exploring the views of prescribers on the causes of errors that they had made. 
Secondly, validated tools were used to explore the decision-making characteristics of 
prescribers, the outcome of which were correlated with the incidence of prescribing 
errors by those prescribers. Finally, the impact of an educational session aimed at 
increasing the knowledge and understanding of prescribers on the theory behind 
clinical decision making was explored by comparing the prescribing error rates pre- 
and post-intervention. This section of the thesis explores the impact and significance 
of the results found.  
7.2 Study objectives 
The four research objectives of this study are shown below, and the key findings in 
relation to each are set out in the following sections: 
• To investigate the prevalence and nature of prescribing errors in inpatients. 
• To explore the causes of prescribing errors in hospital inpatients. 
• To determine the decision-making characteristics of prescribers and whether 
there is a correlation between cognitive style and making prescribing errors. 
• To investigate whether exposing prescribers to evidence about how humans make 
decisions affects the prevalence or nature of prescribing errors made. 
7.3 Key findings 
7.3.1 Prescribing errors 
In a sample of nearly 13,700 medication orders reviewed over 24 months, 4.6% (95% 
CI 4.3 - 4.9%) were found to contain one or more prescribing error. This was lower 
than the finding of 6.3% (95% CI 5.6 - 7.1%) in a recent multi-centre study of similar 
design,147 but higher than two earlier UK studies.100,101  
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Higher error rates were associated with transitions of care, which is consistent with 
evidence suggesting that as patients move between care providers, the risk of 
unintended changes to medicines can be a substantial issue.279 Notwithstanding the 
importance of getting patients’ medicines correct at times of transition, it was noted 
that those prescriptions written at admission and discharge accounted for less than 
one-third of all prescriptions, and that the admission error rate was substantially lower 
at 6.2% (95% CI 5.3 - 7.2%) than found in the major comparator study where the 
admission error rate was 10.7% (95% CI 8.6 - 12.7%).147 It is suggested that this may 
be due to comprehensive processes within the Trust regarding medicines 
reconciliation. 
A substantial body of evidence has identified that junior doctors have higher error 
rates than their more senior colleagues and are responsible for writing a large 
proportion of medication orders.18,19,189 However, in the current study, whilst the 
highest error rates were found amongst early years prescribers, unlike in acute 
settings they were responsible for writing a low proportion of medication orders. A 
weak, but significant, relationship was found between increasing experience and 
decreasing prescribing error rates.   
Prescribing errors more commonly involved prescription writing (62.2%) than decision 
making (37.8%). Errors most commonly involved the step of providing instructions for 
supply of the product, in particular missing or incorrect information about formulations 
and strengths. The error rate for medicines to be administered regularly (4.9%) was 
significantly higher than for ‘as required’ medicines (4.1%). 
Overall, errors were more common in non-psychotropic medicines (5.1%) than in 
psychotropic medicines (3.9%) with the differences most marked in junior doctors. 
This supports the need for junior doctors to have a core formulary of common 
medicines with which they are most familiar; but probably also reflects the fact that 
FY2 and core/GP trainees will often be faced with unfamiliar medication regimens out-
of-hours during the admission of unknown patients. Errors were most commonly 
identified in medication orders for antipsychotics (11.1%), hypnotics and anxiolytics 
(10.9%), analgesics (9.8%) and antimicrobials (8.9%). Twenty drugs accounted for 
nearly half of all errors, with paracetamol accounting for most (7.8%). These patterns 
are similar to those found in other studies. 
A small proportion of errors were considered to be potentially severe and less than 
1% were recorded as causing actual patient harm. Errors with the potential for 
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greatest clinical impact were generally made by more senior and experienced doctors 
although this was not statistically significant. Errors were assessed by an expert panel 
as well as by ward pharmacists. Despite excellent correlation between the scores 
given by these two groups, there were differences, with ward pharmacists more likely 
to assess errors as ‘minor’ or ‘severe’. This is likely to reflect the fact that ward 
pharmacists were able to assess the error in context, whilst the expert panel had no 
access to information about the patient’s complete medication regimen, clinical 
condition or co-morbidities.  
Pharmacists intervened in the majority of cases and resolved the error before any 
doses were administered to the patient (61.1%), demonstrating the importance of 
clinical pharmacy services in a setting in which pharmacy and medicines optimisation 
services have traditionally been under resourced by comparison to acute trusts.1  
7.3.2 Causes of errors 
In all of the 15 interviews undertaken with prescribers who had made prescribing 
errors, no-one was aware of their error until contacted in relation with this study. This 
is in line with the findings of other studies which have indicated that generally 
pharmacists concentrate on identifying and correcting errors rather than providing 
feedback on prescribing, which would allow prescribers to learn lessons and change 
behaviour.13,431,432 If feedback is the “cornerstone of effective teaching”427 this situation 
is undermining the ability of prescribers to learn from their errors. 
In contrast to studies which have investigated the causes of errors in an acute setting, 
rule-based mistakes were the most common (8/21; 38.1%), followed by slips 
(7/21; 33.3%) which were more frequent than lapses. Other studies have tended to 
identify knowledge-based mistakes as the most common type of prescribing 
error.15,26,173,174  
In line with previous studies,13,26,27,113,187–189 prescribers cited being busy, workload, 
time pressures, multitasking, distractions and frequent interruptions as contributory 
factors relating to their work environment which promoted errors. Similarly, personal 
wellbeing including hunger and tiredness, exacerbated by working patterns, unfamiliar 
situations and lone-working were also mentioned. Factors cited by interview 
participants did not generally differ from those identified in earlier studies in other 
secondary care settings. 
However, one point of note from the interviews was that as electronic prescribing 
systems have become more common in acute hospitals, particularly teaching 
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hospitals associated with training medical undergraduates, more junior doctors are 
joining the trust for psychiatry rotations with little or no experience of working with 
paper drug charts. This increases the risk of them making errors in what is an 
unfamiliar task. In addition, the absence of summary care record access for duty 
doctors and those working on-call outside traditional office hours when GP surgeries 
are closed, increases the likelihood of errors relating to the lack of accurate 
information about newly admitted patients’ medicines.  
7.3.3 Decision making characteristics 
Participants in this element of the study correctly answered approximately half of the 
Cognitive Reflection Test questions on both the 3-item and 8-item versions with mean 
scores of 1.6 and 4.1 respectively. There were no statistically significant differences 
by gender, age or prescriber grade, despite gender differences having been found in 
the original CRT study.226 Very few participants correctly answered all questions on 
either version of the tool, although on the 3-item version more were ‘high’ scorers and 
less were ‘low’ scorers. This may have been due to past exposure to some or all of 
the 3-item questions as the proportions of high and low scorers on the 8-item version 
were similar to that found the original study. A significant, but weak, positive 
correlation was found between experience and the number of correct CRT answers, 
whilst a moderate, negative correlation was found between experience and the 
number of ‘intuitive’ incorrect answers. 
Overall, participants had higher mean rationality than experientiality scores measured 
using the Rational Experiential Inventory. Although men tended to have higher scores 
for rationality, and women for experientiality, there was no statistically significant 
differences by gender, age or prescriber grade; although there was a non-significant 
trend towards higher rationality scores with grade. The difference between mean 
rationality and experientiality scores was significant in all groups apart from those 
aged 21 - 29 and foundation trainees. The rationality scores were lower than seen in 
most other studies involving doctors.230–232,238 This may reflect the fact that psychiatry 
relies more heavily on the interplay between biology, psychology, social 
circumstances and spiritual life than other medical specialties; described as the ‘art of 
psychiatry’ by Bloch.400  
It was not possible to make direct comparison between the Need for Cognition Scale 
scores found in this study and in others, as differing scoring systems have been 
employed by various authors. However, the results did show that the participants in 
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this sample generally showed a tendency to organise, abstract and evaluate 
information. 
Despite apparent trends, no statistically significant relationships were identified 
between performance on the CRT, REI or NCS scales and prescribing error rates. 
Therefore, thinking dispositions do not appear to provide a prediction of prescribing 
error performance, suggesting that more factors are involved in accurate and 
appropriate prescribing decisions than can be captured by such measurement.  
The null hypothesis was therefore upheld of there being no statistically significant 
difference in the prevalence or nature of prescribing errors made by prescribers 
depending on thinking style.  
7.3.4 Educational intervention 
Only a small number of those for whom prescribing error rate was available attended 
the educational session on clinical decision making (32/212; 15%). Prescribing data 
were only available for 68% of those who attended, and only for one-quarter of 
participants was it available for both the pre-intervention and post-intervention 
periods. 
Despite a statistically significant difference in the error rates for period one and two, 
these largely represented prescribing by different prescribers. For those that attended 
the educational session and for whom prescribing data were available, the 
composition of the unpaired groups pre- and post-intervention were quite different. 
There was no statistically significant difference in the error rates for the 12 prescribers 
who attended and for whom pre- and post-intervention data were available. 
The null hypothesis was therefore upheld of there being no statistically significant 
difference in the prevalence or nature of prescribing errors made by prescribers after 
exposure to the educational intervention about clinical decision making.  
7.4 Strengths and limitations 
A potential limitation of the literature review which underpinned this thesis was the 
opportunity for omission of relevant publications including those not indexed in the 
standard reference databases. This was minimised by ‘snowballing’ (searching 
references of references), searching the ‘grey literature’, creating automatic citation 
alerts for key papers and subscription to the electronic ‘table of contents’ for many 
journals. Only papers published in English were inspected which may have excluded 
publications of relevance. 
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7.4.1 Prescribing errors 
The main strengths of this aspect of the study were the large number of medication 
orders reviewed (nearly 13,700), that training was provided to ward pharmacists to try 
and minimise variations and subjectivity in data collection, and the inclusion of only 
newly written items, so that medication orders would only be counted once. Data 
collection was limited to one UK NHS trust and results may therefore not be 
generalisable to other organisations or other international settings as the range of 
services and sub-specialties provided can vary substantially between organisations.  
Although medication orders were screened by pharmacists as part of their routine 
work, a method commonly used in prescribing error research,19,147,189 failure to identify 
and/or record errors would result in an underestimate of the actual error rate. 
Completion of data reporting forms for the study may have been seen as additional 
work and not all pharmacists may have been motivated to the same degree. Even 
with training, interpretation of errors by multiple pharmacists could have been 
subjective with variation in error detection due to individual levels of expertise and 
workload,275 and subjectivity in the assignment of severity scores.6 It was not possible 
to include any quality assurance check to identify missed or unrecorded prescribing 
errors, which has been shown to increase error identification.256 Data collection by a 
combination of methods including drug chart and retrospective record review may 
have identified a greater number of errors,107,155 but was beyond the resources 
available. Data collection fatigue was minimised by intermittent data collection one 
week in four.  
Use of pharmacists who were familiar with the doctors working on particular wards 
improved the correct identification of prescribers which is a known problem with 
handwritten prescriptions.278,375 The identity and grade of the prescriber was unknown 
in only 1.2% of medication orders in this study, less than in others studies.19,147,189 
Minimising the number of unknown prescribers is also important if feedback is to be 
provided to improve the quality of prescribing and reduce errors.13,18,422 Pharmacists 
recorded the details of the doctor who had signed the prescription, and there is 
evidence to suggest that other doctors may be involved in making prescribing 
decisions, particularly where junior doctors are involved.112 
Data were collected for core, GP and higher specialty trainees, although this was not 
originally planned when the sample size was calculated, and the target number of 
medication orders were not calculated for this level of granularity.  
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7.4.2 Causes of errors 
A small number of interviews were conducted with prescribers who had made 
prescribing errors within one UK NHS trust. Although this may affect the 
generalisability of the results to mental health settings, the findings were broadly 
similar to qualitative studies in non-mental health settings.26,27,113,185,187,188 The 
distribution of interviews across grade of prescriber was relatively even, so the results 
are not likely to be skewed by the views of either junior or senior doctors. However, 
the self-selected nature of those who agreed to participate in interviews is a limitation 
as the views of those who did not participate may have been different. 
The inclusion of specific incidents in the interviews, rather than asking for views on 
errors in general is a strength of the study. Prescribers who had made errors were 
presenting their own explanation of what had happened to the researcher; it is 
recognised that attribution bias may result in participants minimising their own liability 
in an error and accentuating contributory factors. They may also have answered in a 
manner what will be viewed favourably by the researcher, demonstrating social 
desirability bias. This may have been exacerbated due to the role within the 
organisation of the researcher who, as Chief Pharmacist, may have influenced the 
responses given by some interviewees.   However, an attempt to mitigate against this 
was made by recruitment via the ward pharmacist, assurance of confidentiality, 
participants being reminded that participation was optional and that they could 
withdraw at any point and an attempt on the part of the researcher to remain objective 
and attempt to check for genuine responses through iterative questioning. Whilst it 
would have been ideal to involve a third party in conducting the interviews resource 
was not available to facilitate this option.  The ‘worldview’ of the researcher may have 
influenced the emerging themes from the interviews, although as thematic analysis 
was undertaken against the theoretical framework of Reason’s model of accident 
causation23 this should have been minimised.  
Prescribers were interviewed as soon as practical after the time of their error; 
however, it was often not possible to undertake interviews within the original planned 
timescale of 96 hours. This may have increased the likelihood of recall bias, but also 
allows time for reflection about the incident by the prescriber.  
7.4.3 Decision-making characteristics 
There were a number of limitations to the element of the study relating to the decision-
making characteristics of prescribers. There was a high non-response rate to the 
questionnaire with a number of those who did participate providing partial responses; 
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therefore, the actual response rate was between 26.7% and 30.9% for different 
elements of the questionnaire. The answers of non-responders may have 
demonstrated different results, and voluntary participation may have created a 
selection bias. Due to the need to link responses with prescribing error data, 
questionnaires were not anonymous which may have led respondents to give 
answers which they felt were expected (social desirability bias). As the questionnaire 
was administered to most respondents online there was no opportunity for clarification 
of any misunderstanding in the wording of questions.  
Although a potential strength was that the questionnaire contained established 
validated tools, inclusion of the questions from the original 3-item version of the CRT 
may have given rise to skewed results due to pre-exposure.383 Prior exposure to the 
CRT was not measured and psychiatrists may have a higher likelihood to have come 
across the questions before. Equally, the REI-40 captures self-reported rational and 
experiential ability and preference and therefore may not be an accurate 
representation of how participants think in a clinical setting. 
7.4.4 Educational intervention 
The intervention was undertaken in a single organisation and had a limited number of 
participants, which limits the generalisability of the results. The primary assessment 
method was the number of prescribing errors before and after the educational 
session, but the numbers for whom prescribing data were available both pre- and 
post-intervention were very low, making firm conclusions impossible. This was mainly 
due to this high turnover of junior medical staff, due to psychiatry rotations, such that 
some who attended the educational session had left the organisation by the second 
data collection period. 
7.5 What the research adds 
This study supports recent findings that prescribing errors appear to be more common 
in a mental health setting than early studies suggested.147 Whilst previous studies 
investigating the prevalence of prescribing errors in a UK mental health setting have 
analysed error rates at some level by prescriber grade101,147 and stage in the patient’s 
journey,147 this study has provided a more granular analysis by prescriber grade than 
previous studies. It has looked in detail at prescribing error rates in relation to level of 
experience and identified a relationship, albeit weak, between them. It has also 
identified the steps in the drug use process most prone to error in this setting and 
related that to prescriber grade and stage. In addition, those drugs  most commonly 
involved in prescribing errors have been identified by BNF section and at individual 
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drug level, with perhaps surprisingly in a mental health setting, paracetamol the drug 
most commonly associated with error. The study has confirmed the findings of other 
studies and in other settings that junior doctors are responsible for a higher proportion 
of errors, but has also identified that, in this trust at least, this group of prescribers are 
not responsible for the high proportions of overall prescribing seen in other studies in 
acute hospitals.18,19,189  
In probably the first qualitative study of the causes of prescribing errors in a mental 
health setting, a very similar pattern of factors was seen to contribute to errors, 
confirming that regardless of setting, prescribing errors are associated with 
multifactorial causes, which are unlikely to be solved by simple solutions. However, 
of note was the fact that by generally lagging behind acute trusts in terms of 
implementation of technological advances (ePMA, SCR), junior doctors joining a 
mental health trust on a psychiatry rotation are placed at a disadvantage, with an 
increased potential for errors. 
Whilst few studies have administered decision-making tools to medical staff, this may 
have been the first to use such tools in psychiatry, and to link the responses to the 
occurrence of prescribing errors. No relationship was found between prescribing error 
rates and thinking dispositions as measured by the CRT, REI-40 or NCS, suggesting 
that accurate and appropriate prescribing involves more factors than can be captured 
by measurement of thinking disposition. Of interest however, was the fact that 
participants appeared to have lower rationality scores than those found in other 
groups of doctors, as measured by the REI-40 tool. 
The final element of this study demonstrated that, whilst having an impact on self-
reported understanding of decision making, a brief educational intervention on clinical 
decision making had no impact on reducing prescribing error rates. 
7.6 Recommendations for future research 
Future research which may complement the study described in this thesis includes: 
• adapting the data collection method used to investigate the prescribing error rate 
in community-based mental health services, where there is generally little 
pharmacy infrastructure available to prevent errors reaching the patient. 
• investigating the impact on prescribing errors on admission where staff have 
access to patients’ past medication history via the summary care record. 
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• further work to identify the most effective methods for pharmacists to provide ‘real-
time’ feedback to prescribers on their prescribing to promote on-going active 
learning. 
• a larger study into the thinking dispositions of psychiatrists to identify whether 
there really is a difference in the rationality / experientiality profile of this group of 
professionals which would inform methods for influencing prescribers in the future. 
• further investigations into multifactorial interventions to reduce prescribing errors. 
7.7 Closing thoughts 
In 2004, Edmondson argued that healthcare does not learn from errors as a result of 
two interrelated and powerful organisational issues. Firstly, voicing questions, 
concerns, and challenges that might intercept and prevent errors is often inhibited by 
interpersonal culture, and admission of error is discouraged. Secondly, the responses 
to failure are often workarounds and quick fixes, rather than systematic problem 
solving and root cause analysis. He emphasised that “an organisation learns when its 
teams learn” and that learning from failure requires substantial effort to create new 
beliefs and behaviour that support such learning.445  
These views were expressed not long after the publication of key reports about patient 
safety in both the US50 and the UK,51,52 and the creation of the NPSA in the UK. The 
fact that more than half a million incident reports were submitted to the NRLS for the 
period October to December 2017, a five-fold increase on the number of reports 
during the same quarter in 2005,446 hopefully reflects that in the intervening years 
improvements have been made in relation to these organisational issues. However, 
Edmondson’s views about the role of leaders and team learning remain valuable, and 
feedback on prescribing errors is likely to be a key element in reducing their 
occurrence. 
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Appendix 1:   Summary of primary research into prescribing errors in mental health settings 
Reference Objective(s) Design and details of 
study 
Definition of error and 
type studied 
Number and rate of 
error 
Severity of errors and 
method of rating 
severity 
Ayani N, Sakuma M, Morimoto T, 
Kikuchi T, Watanabe K, 
Narumoto J, et al. The 
epidemiology of adverse drug 
events and medication errors 
among psychiatric inpatients in 
Japan: the JADE study. BMC 
Psychiatry 2016;16(1):303.142 
 
To estimate the incidence and 
nature of ADEs and medication 
errors among psychiatric inpatients 
in Japan. 
• 438 psychiatric inpatient beds in 
one psychiatric hospital and one 
tertiary care teaching hospital, 
Japan 
• Retrospective cohort study of 
psychiatric inpatients admitted 
and discharged from 1 April 2010 
to 31 March 2011 
 
Outcome measured: 
• number of ADEs 
• medication errors 
Definition: 
• Not reported 
 
 
 
Subclass of medication errors 
studied: 
• Ordering 
• Monitoring 
 
Denominator: 
• 1000 patient days 
 
Rate of error: 
• All errors: 398 
o 39% of patients 
o 17.5 per 1000 patient days 
o 88.8 per 100 admissions 
 
Distribution of errors: 
• Ordering 134/398 (34%) 
• Monitoring 155/398 (39%) 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity: 
• Not reported 
 
Method of severity rating: 
• Not reported 
 
Grasso BC, Genest R, Yung K et 
al. Reducing errors in discharge 
medication by using personal 
digital assistants. Psychiatr 
Serv. 2002; 53(10):1325-6133 
To examine whether the number of 
errors in discharge medication lists 
at a psychiatric hospital would 
decrease when the practice of 
transcribing the lists by hand from 
physicians’ discharge orders was 
replaced by the use of personal 
digital assistants (PDAs) to create 
and directly print out such lists. 
• 103 bedded state psychiatric 
hospital, Maine, USA 
• Civil and forensic patients 
admitted 
• Retrospective comparison of 
hand-transcribed and PDA 
discharge medication lists 
o Hand-transcribed data 
collected 1 June to 30 
September 2000 
o PDA-generated data 
collected 1 April to 31 July 
2001 
 
Outcomes measured: 
• Rate of errors found in discharge 
medication lists 
Definition: 
• Erroneous exclusion of a 
currently used medication; 
erroneous addition of a new 
drug; incorrect or incomplete 
dosage, quantity to be 
dispensed, or frequency of 
administration; illegibility; and 
inclusion of usages that are 
prone to misinterpretation. 
 
Subclass of medication errors 
studied: 
• Transcription  
Denominator: 
• Number of discharge medication 
lists 
 
Rate of error: 
• Hand-transcribed: 20/110 (18%) 
• PDA-generated: 7/90 (8%) 
 
Distribution of errors: 
• Not reported 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity: 
• Not reported 
 
Method of severity rating: 
• Not reported 
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Reference Objective(s) Design and details of 
study 
Definition of error and 
type studied 
Number and rate of 
error 
Severity of errors and 
method of rating 
severity 
Grasso BC, Genest R, Jordan 
CW et al. Use of chart and record 
reviews to detect medication 
errors in a state psychiatric 
hospital. Psychiatr Serv. 2003; 
54(5): 677-81121 
To compare the effectiveness of 
using a review team and the usual 
self-reporting method for detecting 
different types of medication errors 
in a state psychiatric hospital 
• 103 bedded state psychiatric 
hospital, Maine, USA 
• Civil and forensic patients 
admitted 
• Retrospective chart review of 
entire hospitalisation of a random 
selection of 31/95 patients 
discharged from 1 June to 15 
October 2001 
• Prospective clinician self-
reporting of medication errors via 
incident reporting system 
 
Outcomes measured: 
• Rate of medication errors 
• Severity of error 
Definition: 
• NCC MERP definition 
 
Subclass of medication errors 
studied: 
• Prescribing 
• Transcription 
• Dispensing 
• Administration 
 
 
 
Denominator: 
• Error per 1000 patient days 
 
Rate of error: 
• Prescribing: 165 
• Transcription: 344 
 
Distribution of errors: 
• Prescribing: 239/2,194 (11%) 
• Transcription: 498/2,194 (23%) 
 
Distribution of medications 
involved: 
• Not reported 
 
Comment: 
The review team detected a total of 
2,194 medication errors compared 
with only 9 self-reported incidents 
for the same patient group (a ratio 
of 244:1) 
Distribution of severity (all error 
types): 
• Low risk of harm: 19% 
• Moderate risk of harm: 23% 
• High risk of harm: 58% 
 
Method of severity rating: 
• Rated by review team with a 
random sample of 15 records 
checked by the medical director 
on two occasions for consistency 
 
Haw C, Stubbs J. Prescribing 
errors in a psychiatric hospital. 
Pharm Pract. 2003; 13(2): 64-6100 
To determine the nature, frequency 
and potential severity of prescribing 
errors detected by pharmacists 
working in a psychiatric hospital 
• 400 bedded private psychiatric 
tertiary referral centre, 
Northampton, UK 
• Adolescent, brain injured, elderly, 
forensic and learning disabilities 
• Prospective recording of 
prescribing errors on a data entry 
form by pharmacists during 
January 2002 
 
Outcomes measured: 
• Rate of prescribing errors 
• Severity of error 
Definition: 
• Dean et al definition25 
 
Subclass of medication errors 
studied: 
• Prescribing 
Denominator: 
• Number of medication orders 
checked recorded on four sample 
days 
 
Rate of error: 
• Overall 50/2,274 (2.2%) 
• Psychotropic 34/1,180 (2.9%) 
• Non-psychotropics 16/1,094 
(1.5%) 
 
Distribution of errors: 
• Prescription writing (clerical): 
272/311 (87.5%)  
• Decision making: 39/311 (12.5%) 
 
Distribution of medications 
involved: 
• Psychotropics: 124/311 (39.8%) 
• Non-psychotropics: 187/311 
(60.1%) 
Distribution of severity (all error 
types): 
• Clinically insignificant: 173/311 
(56%)  
• Minimal clinical significance: 
111/311 (36%) 
• Potentially serious (could cause 
harm): 27/311 (9%) 
• Potentially life-threatening: nil  
 
Method of severity rating: 
• Rated independently by review 
team on scale above. Median 
used if no agreement 
 
Comment:  
Potentially serious errors were 
more likely to be made by junior 
than consultant psychiatrists  
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Reference Objective(s) Design and details of 
study 
Definition of error and 
type studied 
Number and rate of 
error 
Severity of errors and 
method of rating 
severity 
Haw C, Cahill C. A computerized 
system for reporting medication 
events in psychiatry: the first 
two years of operation. J 
Psychiatr Ment Health Nurs. 
2011; 18(4):308-16143 
To describe the first 2 years of 
operation of an electronic system 
for reporting medication events in 
psychiatry 
• 570 bedded private psychiatric 
tertiary referral centre, 
Northampton, Essex & 
Birmingham, UK 
• Forensic & rehabilitation, older 
adults, adolescents and acquired 
brain injury 
• Descriptive analysis of 
medication events reported via 
the electronic system between 1 
March 2008 and 28 February 
2010 
 
Outcomes measured: 
• Number of incidents reported 
• Severity of error 
Definition: 
• Dean et al definition25 
 
Subclasses of medication errors 
studied: 
• Prescribing 
• Dispensing 
• Administration 
 
 
Denominator: 
• Not reported 
 
Rate of error: 
• Prescribing: 30 
 
Distribution of errors: 
• Prescribing: 30/446 (6.7%) 
 
Distribution of medications involved 
(all error types): 
• Psychotropics: 276/377 (73.2%) 
• Non-psychotropics: 133/377 
(35.3%) 
 
Distribution of severity (all error 
types): 
• Insignificant: 88/446 (19.7%) 
• Minor: 330/446 (74.0%) 
• Moderate: 24/446 (5.4%) 
• Serious: 4/446 (0.9%) 
• Life-threatening: nil 
 
Method of severity rating: 
• Rated independently by review 
team with inter-rater reliability 
checked for 20 errors 
 
 
Higuchi A, Higami Y, Takahama 
M, Yamakawa M, Makimoto K. 
Potential underreporting of 
medication errors in a 
psychiatric general hospital in 
Japan. Int J Nurs Pract. 
2015;21(2):2–8.144 
To explore a pattern of 
underreporting by comparing 
medication errors among 17 wards 
in a psychiatric general hospital  
• 948 bedded psychiatric general 
hospital, Osaka, Japan 
• Acute care, dementia care, 
psychiatric long-term care, 
psychiatric general 
• Quantitative analysis of 
prospectively collected incidence 
reports in the fiscal year of 2010 
 
Outcomes measured: 
• Number of incidents reported 
• Number of incidents reported by 
ward 
• Severity of incidents 
Definition: 
• Not reported 
 
 
Subclasses of medication errors 
studied: 
• Prescribing 
• Dispensing 
• Administration 
 
Denominator: 
• 1000 patient-days 
 
Rate of error: 
• Prescribing: 2.6% of all 
medication incidents reported 
online (17 incidents) 
 
Distribution of errors: 
• Not reported 
 
Distribution of medications 
involved: 
• Not reported 
 
  
Distribution of severity (all error 
types): 
• Intercepted near miss: 12.3% 
• Non-intercepted near miss: 
61.6% 
• Minor: 24% 
 
• Moderate: not recorded (assume 
nil) 
• Serious: nil 
• Serious/life-threatening: nil 
 
Method of severity rating: 
• Self-rated by incident reporter 
 
Comment: Majority of reported 
incidents related to administration 
(94%). Main perspective of study 
was differences in reporting rates 
between individual wards. 
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study 
Definition of error and 
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Number and rate of 
error 
Severity of errors and 
method of rating 
severity 
Ito H, Yamazumi S. Common 
types of medication errors on 
long-term psychiatric care units. 
Int J Qual Health Care. 2003; 
15(3): 207-12125 
 
Also reported as Sawamura K, Ito 
H, Yamazumi S, et al. Interception 
of potential adverse drug events in 
long-term psychiatric care units. 
Psychiatry Clin Neurosci. 2005; 
59(4): 379–84.134 
 
To identify the most frequent types 
of medication errors in long-term 
psychiatric care hospitals 
• 85 long-stay units in 44 private 
psychiatric hospitals, Japan 
• Analysis of incident reports 
between 1 October and 30 
November 2000 
 
Outcomes measured: 
• Types of potential adverse drug 
events 
• Severity of error 
Definition: 
• Any event that could be harmful 
to patients on participating units, 
whether the incident was 
intercepted or not 
 
Subclasses of medication errors 
studied: 
• Prescribing 
• Dispensing 
• Administration 
 
Denominator: 
• Error per 1000 patient days 
 
Rate of error: 
• All errors: 221 (0.79 per 1000 
patient days) 
• Prescribing: nil 
 
Distribution of errors: 
• Not reported 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity (all error 
types): 
• Clinically insignificant: 125/221 
(56.6%) 
• Potentially significant: 33/221 
(14.9%) 
• Potentially serious: 63/221 
(28.5%) 
 
Method of severity rating: 
• Self-rated by incident reporter 
 
Comment: 
All reported errors appear to relate 
to administration 
Jayaram G, Doyle D, Steinwachs 
D, et al. Identifying and reducing 
medication errors in psychiatry: 
creating a culture of safety 
through the use of an adverse 
event reporting mechanism. J 
Psychiatr Pract. 2011; 17(2): 81–
9145 
To investigate medication errors on 
inpatient psychiatric units  
• 88-bed psychiatric division of an 
academic, inner-city hospital, 
Baltimore, US 
• Incident report analysis for years 
2003, 2005 and 2007 
 
Outcomes measured: 
• Number of incidents reported 
 
Definition: 
• Not reported 
 
Subclasses of medication errors 
studied: 
• Prescribing 
• Transcription 
• Preparation 
• Administration 
• Monitoring 
 
 
Denominator: 
• Error per 100 patient days 
 
Rate of error (all error types):  
• 2003: 27.9 
• 2005:   5.5 
• 2007:   3.4 
 
Distribution of errors: 
• Prescribing 
o 2003: 12/494 (2.4%) 
o 2005:   5/133 (3.8%) 
o 2007: 15/100 (15.0%) 
• Transcription 
o 2003: 249/494 (50.4%) 
o 2005: 39/133 (29.3%) 
o 2007: 17/100 (17.0%) 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity: 
• Not Reported 
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Number and rate of 
error 
Severity of errors and 
method of rating 
severity 
Jhanjee A, Bhatia M, Oberoi A, 
Srivastava S. Medication errors 
in psychiatric practice - a cross-
sectional study. Delhi Psychiatry 
J 2012;15(1):5–13.146 
To identify and quantify various 
types of medication errors in 
psychiatric prescriptions 
• psychiatry outpatient department 
of tertiary hospital, Delhi, India 
• Cross-sectional study of 
psychiatric outpatient 
prescriptions between 1 March 
2009 and 1 November 2011 
 
Outcomes measured: 
• Frequency of errors 
• Nature of errors 
 
Definition: 
• Dean et al definition25 
• WHO guidelines for prescription 
writing153 
 
Subclasses of medication errors 
studied: 
• Prescribing 
 
Denominator: 
• Not reported 
 
Rate of error:  
• Not reported 
 
Distribution of errors: 
• error categories reported as 
absolute numbers 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity: 
• Not reported 
 
Method of severity rating: 
• Not reported 
 
Keers RN, Williams SD, 
Vattakatuchery JJ, et al. 
Prevalence, nature and 
predictors of prescribing errors 
in mental health hospitals: a 
prospective multicentre study. 
BMJ Open. 2014;4(9):e006084.147 
To determine the prevalence, 
nature and predictors of prescribing 
errors in three mental health 
hospitals 
• Inpatient units in three NHS 
mental health hospitals in the 
North West of England 
• Prospective recording of 
prescribing errors in newly 
written or omitted medication 
orders screened on 10 data 
collection days between January 
and April 2013 
 
Outcomes measured: 
• Frequency of errors 
• Nature of errors 
• Potential severity of errors 
• Predictors of errors 
Definition: 
• Dean et al definition25 
 
Subclasses of medication errors 
studied: 
• Prescribing 
 
Denominator: 
• Number of newly written or 
omitted medication orders 
screened 
 
Rate of error:  
• 281/4,427 (6.3%) items affected 
(288 total errors) 
 
Distribution of errors: 
• by prescribing stage  
o On admission 92/863 (10.7%) 
o During stay 100/1530 (6.5%) 
o Rewritten 46/1273 (3.6% 
o Leave 11/247 (4.5%) 
o Discharge 32/495 (6.5%) 
• by prescriber 
o FY1 11/216 (5.1%) 
o FY2 26/536 (4.9%) 
o Specialty trainee 159/2336 (6.8%) 
o Staff grade 30/465 (6.5%) 
o Consultant 34/586 (5.8%) 
o Pharmacist 0/10 (0%) 
o Nurse prescriber 0/12 (0%) 
o Unknown prescriber 21/266 (7.9%) 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity: 
• Minor: 126/288 (43.8%) 
• Significant: 142/288 (49.3%) 
• Serious: 19/288 (6.6%) 
• Life-threatening: 1/288 (0.3%) 
 
Method of severity rating: 
• Validation undertaken by a 
multidisciplinary panel 
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Reference Objective(s) Design and details of 
study 
Definition of error and 
type studied 
Number and rate of 
error 
Severity of errors and 
method of rating 
severity 
Keers R, Williams S, 
Vattakatuchery J, Brown P, Miller 
J, Prescott L, et al. Medication 
safety at the interface: evaluating 
risks associated with discharge 
prescriptions from mental health 
hospitals. J Clin Pharm Ther 
2015;40(6):645–54.139 
 
 
 
 
 
 
 
 
 
To determine the prevalence, 
nature and predictors of prescribing 
errors affecting discharge 
prescriptions in three mental health 
hospitals 
• Inpatient units in three NHS 
mental health hospitals in the 
North West of England 
• Prospective recording of 
prescribing errors in newly 
written or omitted medication 
orders screened during 6 weeks 
between February and March 
2014  
 
Outcomes measured: 
• prescription writing errors 
• clerical errors 
• inadequate communication 
Definition: 
• Dean et al definition25 
 
Subclasses of medication errors 
studied: 
• Prescribing 
 
Denominator: 
• Number of newly written or 
omitted medication orders 
screened in discharge 
prescriptions 
 
Rate of error:  
• 222/259 (81%) discharges 
affected by at least one error 
 
Distribution of errors: 
• discharge prescriptions: 54/259 
(20.8%)  
• medication orders 74/1,456 
(5.1%) 
• clerical errors: 197/274 (71.9%) 
• communication issues: 44/64 
(68.8%)  
 
 
Distribution of medications 
involved: 
• CNS: 36/74 (48.65%) 
• Respiratory: 21/74 (28.4%) 
• Cardiovascular: 6/74 (8.1%) 
• Endocrine: 4/74 (5.4%) 
• Others: 7/74 (9.5%) 
Distribution of severity (prescribing 
errors): 
• Clinically relevant: 54/74 (52.9%) 
• Serious: 4/74 (5.4%) 
 
Method of severity rating: 
• Validation undertaken by a 
multidisciplinary panel 
 
Maidment ID, Thorn A. A 
medication error reporting 
scheme: analysis of the first 12 
months. Psychiatr Bull R Coll 
Psychiatr. 2005; 29(8): 298-301124 
To analyse all mediation incidents 
reported in the first year of a new 
medication error reporting system 
• Single NHS and Social Care 
Trust, Kent, UK 
• Patient population not specified 
• Incident report analysis 
• April 2003 to March 2004 
 
Outcomes measured: 
• Type of error 
• Site of error 
Definition: 
• Not reported 
 
Subclasses of medication errors 
studied: 
• Prescribing 
• Dispensing 
• Administration 
 
 
Denominator: 
• Error per month 
 
Rate of error (all error types):  
• 5.5 per month 
 
Distribution of errors: 
• Prescribing: 2/66 (3.0%) 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity (all error 
types): 
• Low: 40/66 (60.6% 
• Moderate: 23/66 (34.8%) 
• High: 3/66 (4.5%) 
• Life-threatening: nil 
 
Method of severity rating: 
• Rated by single rater using Likert 
scale of 1-5 
 
Comment:  
Moderate and severe incidents 
occurred disproportionately on 
older adult in-patient wards 
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Number and rate of 
error 
Severity of errors and 
method of rating 
severity 
Nirodi P, Mitchell AJ. The quality 
of psychotropic drug prescribing 
in patients in psychiatric units 
for the elderly. Aging Ment 
Health. 2002; 6(2): 191-6127 
To examine the quality of drug 
prescribing by medical staff for 
elderly patients hospitalised with 
dementia in comparison with 
functional psychiatric illness 
• Two psychiatric inpatient units for 
the elderly (≥ 65 years), 
Yorkshire, UK 
o Unit A - medium size hospital 
with catchment population of 
50,000 
o Unit B - regional psychiatric 
hospital with catchment 
population of 110,080 
• Retrospective review of 
prescription charts for the 
duration of index admission for a 
representative sample of 112 
patients  
 
Outcomes measured: 
• Number of prescription records 
containing errors 
Definition 
• Six measures of prescribing 
quality (psychotropics only) 
 
 
 
Subclasses of medication errors 
studied: 
• Prescribing 
 
Denominator: 
• Patient episode 
 
Rate of error:  
• 92/112 (82%) patient records 
contained an error 
 
Distribution of errors (dementia vs. 
functionally ill): 
• Illegibility 19.9% vs. 11.0% 
• Frequency of administration 
missing: 36.5% vs. 22.5% 
• Dose missing: 25.2% vs. 5.8% 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity: 
• Not reported 
 
 
Comment: 
Prescribing quality was inferior for 
patients with a diagnosis of 
dementia compared to those with 
functional illness. 
Paton C, Gill-Banham S. 
Prescribing errors in psychiatry. 
Psychiatr Bull R Coll Psychiatr. 
2003; 27(6): 208-10128 
To describe prescribing errors 
within psychiatry by analysing 
interventions made by pharmacists 
• Twelve mental health trusts, UK 
• Prospective recording by 
psychiatric pharmacists of the 
details of prescribing errors 
during May 2002 
 
Outcomes measured: 
• Nature of prescribing errors 
• Action taken by the pharmacist 
Definition: 
• Not reported 
 
Subclasses of medication errors 
studied: 
• Prescribing 
 
 
Denominator: 
• Not reported 
 
Rate of error (all error types):  
• 557 interventions reported 
 
Distribution of errors: 
• Prescription writing (clerical): 
155/557 (27.8%) 
• Decision making: 335/557 
(60.1%) 
• Other: 67/557 (12.0%) 
 
Distribution of medications 
involved: 
• Psychotropics: 377/557 (67.7%) 
• Non-psychotropics: 180/557 
(32.3%) 
Distribution of severity: 
• Potentially serious outcome: 
63/557 (11.3%) 
 
Method of severity rating: 
• Not reported 
 
Comment:  
Action taken by pharmacists: 
• Contacted prescriber directly: 
338/557 (60.6%) 
• Left note on prescription 
chart/ward diary: 180/557 
(32.3%) 
• Spoke to nursing staff: 95/557 
(17.1%) 
• Wrote in clinical notes: 5/557 
(0.9%) 
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Rothschild JM, Mann K, Keohane 
CA et al. Medication safety in a 
psychiatric hospital. Gen Hosp 
Psychiatry. 2007; 29(2): 156-62130 
To assess the epidemiology of 
medication errors and adverse drug 
events in a psychiatric hospital. 
• 172-bed academic psychiatric 
hospital, New England, USA 
• Dissociative disorders and 
trauma, schizophrenia and 
bipolar, geriatric, acute 
psychiatric, dementia  
• Acute inpatient satellite unit off 
campus 
• Prospective data collection using 
healthcare record review, staff 
reports and pharmacy 
intervention reports between 1 
September 2004 and 28 
February 2005 
 
Outcomes measured: 
• Types of medication errors 
• Adverse drug events 
Definition: 
• Bates et al definition12 
 
Subclasses of medication errors 
studied: 
• Prescribing 
• Transcription 
• Administration 
 
 
 
Denominator: 
• 1000 patient days  
• 100 admissions 
 
Rate of error (all error types):  
• 10.6 per 1000 patient days 
• 10.8 per 100 admissions 
 
Rate of error (prescribing):  
• 7.2 per 1000 patient days 
• 7.4 per 100 admissions 
 
Distribution of errors: 
• Prescribing: 138/203 (67.9%) 
• Transcription: 40/203 (19.7%) 
 
Distribution of medications 
involved: 
• Psychotropics: 141/203 (69.5%) 
o Antipsychotics: 51/203 (26.1%) 
o Mood stabilisers: 49/203 (24.1%) 
o Antidepressants: 18/203 (8.9%) 
o Anxiolytics/sedatives: 18/203 (8.9%) 
• Non-psychotropics: 62/203 
(30.5%) 
Distribution of severity (all error 
types): 
• Significant: 103/203 (50.7%) 
• Serious: 91/203 (44.8%) 
• Life-threatening: 9/203 (4.4%) 
 
Method of severity rating: 
• Rated by physician raters using 
4-point Likert scale. 
Disagreements resolved by 
discussion 
 
 
Sahithi HK, Mohammad I, 
Manoranjani Reddy J, Nandha 
Kishore G, Ramesh M, Sebastian 
J. Assessment of medication 
errors in psychiatry practice in a 
tertiary care hospital. Int J Pharm 
Sci Res 2015;6(1):226–32.140 
 
To determine the incidence, 
causes, patterns, outcomes and 
predictors of medication errors in 
psychiatric practice 
• 1,200-bed psychiatry 
department, tertiary hospital, 
Mysore district, India  
• Prospective data collection from 
November 2012 to April 2013.  
• Patients aged 18 years and over 
(inpatients and outpatients) 
receiving at least one 
psychotropic agent 
 
Outcomes measured: 
• Number of medication errors 
• Types of medication errors 
 
Definition: 
• NCC MERP definition 
 
Subclasses of medication errors 
studied: 
• Prescribing 
• Administration 
• Dispensing 
 
Denominator: 
• Patients 
 
Rate of error (all error types):  
• 215 errors in 166 patients; 1.3 
errors per patient 
• Prescribing: 72 errors in 59 
patients 
 
Rate of error (prescribing):  
• Not reported 
 
Distribution of errors: 
• Prescribing: 72/215 (33.5%) 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity: 
• Not reported 
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study 
Definition of error and 
type studied 
Number and rate of 
error 
Severity of errors and 
method of rating 
severity 
Sawamura K, Ito H, Yamazumi S, 
et al. Interception of potential 
adverse drug events in long-term 
psychiatric care units. 
Psychiatry Clin Neurosci. 2005; 
59(4): 379–84.134 
 
Also reported as Ito H, Yamazumi 
S. Common types of medication 
errors on long-term psychiatric care 
units. Int J Qual Health Care. 2003; 
15(3): 207-12125 
 
To identify the most frequent types 
of medication errors in long-term 
psychiatric care hospitals 
• 85 long-stay units in 44 private 
psychiatric hospitals, Japan 
• Analysis of incident reports 
between 1 October and 30 
November 2000 
 
Outcomes measured: 
• Types of potential adverse drug 
events 
• Severity of error 
Definition: 
• Any event that could be harmful 
to patients on participating units, 
whether the incident was 
intercepted or not 
 
Subclasses of medication errors 
studied: 
• Prescribing 
• Dispensing 
• Administration 
 
Denominator: 
• Error per 1000 patient days 
 
Rate of error: 
• All errors: 221 (0.79 per 1000 
patient days) 
• Prescribing: nil 
 
Distribution of errors: 
• Not reported 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity (all error 
types): 
• Clinically insignificant: 125/221 
(56.6%) 
• Potentially significant: 33/221 
(14.9%) 
• Potentially serious: 63/221 
(28.5%) 
 
Method of severity rating: 
• Self-rated by incident reporter 
 
Comment: 
All reported errors appear to relate 
to administration 
Shawahna R, Rahman N-U. 
Prescribing errors in psychiatry 
department: an audit from a 
hospital in Lahore. J Pak 
Psychiatr Soc 2008;5(1):31–3.136 
To investigate the incidence of 
prescribing errors in a psychiatry 
ward, and the types of errors 
encountered 
• 15 randomly selected inpatient 
cases from a psychiatry 
department, Lahore, Pakistan 
• Prospective review over a period 
of 15 days from 1 September 
2006 
 
Outcomes measured: 
• Number of prescribing errors 
• Percentage of prescribing errors 
• Types of prescribing errors 
 
Definition: 
• Not reported 
 
Subclasses of medication errors 
studied: 
• Prescribing 
Denominator: 
• Number of medications 
prescribed 
 
Rate of error: 
• 33/84 (39.28%) 
 
Distribution of errors: 
• Not reported 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity: 
• Not reported 
 
Sirithongthavorn S, 
Narkpongphun A, Kamduang N, 
Isarapongs P, Kanjanarat P. 
Common types of medication 
errors of outpatient service in 
pediatric psychiatry care 
[abstract]. Pharmacoepidemiol 
Drug Saf 2009;18(Suppl 1):S245-
6.137 
To identify incidence and types of 
medication errors related to 
paediatric psychiatry outpatient 
services 
• Outpatient unit of a tertiary 
psychiatric care hospital for 
children, Thailand 
• Prospective review of every 
prescription, January to 
December 2007 
Definition: 
• Not reported 
 
Subclasses of medication errors 
studied: 
• Prescribing 
• Pre-prescribing 
• Dispensing 
Denominator: 
• Number of medications 
prescribed 
 
Rate of error: 
• All errors: 2.42% 
• Prescribing: 180/7,444 
 
Distribution of errors: 
• Not reported 
 
Distribution of medications 
involved: 
• Not reported 
Distribution of severity: 
• Not reported 
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Number and rate of 
error 
Severity of errors and 
method of rating 
severity 
Soerensen AL, Lisby M, Neilsen 
LP et al. The medication process 
in a psychiatric hospital: are 
errors a potential threat to 
patient safety? Risk Manage 
Healthc Policy. 2013; 6: 23-31149 
To investigate the frequency, type 
and potential severity of errors in 
several stages of the medication 
process in an inpatient psychiatric 
setting 
• Three psychiatric wards, 
university hospital, Denmark 
• Prospective data collection using 
direct observation, unannounced 
visits and chart review between 
January and April 2010 
 
Outcomes measured: 
• Frequency of errors 
Definition: 
• A planned action which failed to 
achieve the desired 
consequences (including 
deviation from guidelines) 
 
Subclasses of medication errors 
studied: 
• Prescribing 
• Dispensing (≡ decanting by 
nurses) 
• Administration 
• Discharge summaries 
 
 
Denominator: 
• Opportunity for error 
 
Rate of error (all error types):  
• 189 errors in 1,082 opportunities 
for error (17.5%) 
 
Rate of error: 
• Prescribing: 10/267 (3.7%) 
• Discharge summaries: 19/84 
(22.6%) 
 
Distribution of errors: 
• Prescribing: 10/189 (5.3%) 
• Discharge summaries: 19/189 
(10.1%) 
 
Distribution of medications involved 
(prescribing; only with potential to 
be serious/fatal): 
• Antipsychotics: 3/6 (50%) 
• Analgesics: 2/6 (33.3%) 
• Anxiolytic/sedative: 1/6 (16.7%) 
Distribution of severity: 
• Potentially non-significant: nil 
• Potentially significant: 4/10 (40%) 
• Potentially serious: 4/10 (40%) 
• Potentially fatal: 2/10 (20%) 
 
Method of severity rating: 
• Rated independently by two 
clinical pharmacologists using a 
four-point scale. More severe 
category used if disagreement 
between raters. Inter-rater 
agreement of 1.0 for prescribing.  
 
 
Stubbs J, Haw C, Cahill C. 
Auditing prescribing errors in a 
psychiatric hospital. Are 
pharmacists’ interventions 
effective? Hosp Pharm. 2004; 
11(5): 203-699 
To determine the nature and 
severity of prescribing detected by 
pharmacists in a psychiatric 
hospital. 
 
To assess the effectiveness of 
pharmacy interventions for 
correcting these errors 
• 550 bedded private psychiatric 
tertiary referral centre, 
Northampton, UK 
• Adolescent, brain injured, elderly, 
forensic, learning disabilities, 
general psychiatry 
• Prospective recording of 
prescribing errors on a data entry 
form by pharmacists during 
March 2003 
 
Outcomes measured: 
• Rate of prescribing errors 
• Severity of error 
• Nature and effectiveness of 
pharmacists’ interventions 
Definition: 
• Dean et al definition25 
 
Subclass of medication errors 
studied: 
• Prescribing 
Denominator: 
• Not recorded 
 
Rate of error: 
• 211 errors reported 
 
Distribution of errors: 
• Prescription writing (clerical): 
161/211 (76.3%)  
• Decision making: 50/211 (23.7%) 
 
Distribution of medications 
involved: 
• Psychotropics: 111/211 (52.6%) 
o Antipsychotics: 61/211 (28.9%) 
o Hypnotic/anxiolytics: 18/211 (8.5%) 
• Non-psychotropics: 100/211 
(47.4%) 
o GI medications: 21/211 (10.0%) 
o Topical medications: 16/211 (7.6%) 
Distribution of severity (all error 
types): 
• Clinically insignificant: 173/311 
(56%)  
• Minimal clinical significance: 
111/311 (36%) 
• Definitely clinically significant: 
27/311 (9%) 
• Potentially life-threatening: nil  
 
Method of severity rating: 
• Rated independently by review 
team. Median used if no 
agreement 
 
Comment:  
136/211 (64.8%) of cases, the drug 
involved was administered before 
error detected. 183/198 (92.4%) of 
interventions were accepted. 
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Stubbs J, Haw C, Taylor D. 
Prescription errors in psychiatry 
- a multi-centre study. J 
Psychopharmacol. 2006; 20(4): 
553-61101 
To examine and compare the 
nature, frequency and potential 
severity of prescribing errors across 
a range of UK mental health units. 
 
To determine if higher relative 
pharmacy staffing levels were 
associated with higher prescribing 
error detection rates. 
• 8 NHS trusts and 1 private 
psychiatric hospital, England and 
Wales 
• Prospective recording of 
prescribing errors detected by 
pharmacists as part of their 
routine work, over 1 week (5 
working days) in June 2004 
 
Outcomes measured: 
• Rate of errors 
• Type of error 
• Severity of error 
• Comparative detection rates 
Definition: 
• Dean et al definition25 
• Errors relating to the whole 
prescription chart were excluded 
from analysis 
 
Subclasses of medication errors 
studied: 
• Prescribing 
 
 
Denominator: 
• Number of medication orders 
checked 
 
Rate of error:  
• Overall 523/22,036 (2.4%) 
• Psychotropics: 289/11,688 
(2.5%) 
• Non-psychotropics: 212/10,368 
(2.0%) 
 
Distribution of errors: 
• Prescription writing (clerical): 
405/523 (77.4%)  
• Decision making: 118/523 
(22.6%) 
 
Distribution of medications 
involved: 
• Psychotropics: 289/523 (55.3%) 
o Antipsychotics: 89/523 (17.0%) 
o Hypnotic/anxiolytics: 69/523 (13.2%) 
• Non-psychotropics: 212/523 
(40.5%) 
o GI medications: 35/523 (6.7%) 
o Analgesics: 31/523 (5.9%) 
Distribution of severity: 
• Doubtful or negligible 
importance: 250/523 (47.85) 
• Minor importance: 240/523 
(45.9%) 
• Serious effect or relapse: 17/523 
(3.3%) 
• Potentially fatal: 5/523 (1.0%) 
 
Method of severity rating: 
• Rated by mutual agreement of 
authors. Most severe errors 
independently rated by panel of 
psychopharmacologists. 
 
Comment:  
Fourfold variation in error detection 
between sites (range 1.2 - 4.5%) 
but no correlation with time taken to 
check one medication order (used 
as measure of pharmacy workload 
relative to staffing levels) 
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Appendix 2:   Biases and Failed Heuristics 
Ambiguity bias The display of preference for known or certain probabilities over 
uncertain probabilities regardless of the actual benefits. 
Anchoring bias The tendency to be unduly persuaded by features encountered 
early in the presentation of illness, thereby committing to a 
premature diagnosis. 
Availability bias The tendency to overestimate the prevalence of an event which 
has recently been encountered or read about 
Bandwagon effect An accelerating diffusion through a group of a pattern of behaviour, 
the probability of any individual adopting it increasing with the 
proportion who have already done so. 
Bounded rationality A restrictive ‘keyhole’ view of the problem being confronted 
Confirmation bias Attention is directed disproportionally towards observations that 
appear to confirm a hypothesis instead of seeking evidence that 
might disprove it. 
Conjunction fallacy The likelihood of two or more independent instances occurring is 
overestimated through mistakenly linking them in a cause-effect 
relationship 
Hindsight bias Exaggerating what may have been anticipated in foresight and 
overestimating what was known at the time the case was first 
encountered 
Impact bias Failure to anticipate the ability to adapt to new states. The 
tendency to overestimate the long-term impact of both positive and 
negative events. 
Omission bias The tendency to prefer the consequences of inaction (omission) 
rather than commit to doing something that changes the patient’s 
course. 
Outcome bias The tendency to judge the quality of a decision in terms of its 
outcome 
Prevalence bias The tendency to misjudge the true base rate of a disease 
Representativeness 
bias 
Mistaken belief that circumstantial factors are representative of an 
event that the observer is anxious not to miss 
Search satisficing Calling off the search for further information having found the first 
result 
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Appendix 3:   Database Searches 
1. EMBASE, MEDLINE, PsycINFO, CINAHL; (((medication AND error) OR (prescribing AND 
error)) AND (mental health OR psychiatr*)).ti,ab [Limit to: Publication Year 2000-2014]; 329 
results.  
2. EMBASE, MEDLINE, PsycINFO, CINAHL; ((prescribing AND error) AND thinking).ti,ab 
[Limit to: Publication Year 2000-2014]; 0 results.  
3. EMBASE, MEDLINE, PsycINFO, CINAHL; (((medication AND error) OR (prescribing AND 
error)) AND psychology).ti,ab [Limit to: Publication Year 2000-2014]; 21 results.  
4. EMBASE, MEDLINE, PsycINFO, CINAHL; (pathophysiology AND (medication OR 
prescribing) AND error).ti,ab [Limit to: Publication Year 2000-2014]; 49 results.  
5. EMBASE, MEDLINE, PsycINFO, CINAHL; ("dual process" AND (health OR medicine OR 
prescribing)).ti,ab [Limit to: Publication Year 2000-2014]; 125 results.  
6. EMBASE, MEDLINE, PsycINFO, CINAHL; ("cognitive psychology" AND (health OR 
medicine OR prescribing) AND error).ti,ab [Limit to: Publication Year 2000-2014]; 42 results.  
 
5. EMBASE, MEDLINE, PsycINFO, CINAHL; (((prescribing OR prescription) AND error)).ti,ab 
[Limit to: Publication Year 2000-2002]; 242 results.  
7. EMBASE, MEDLINE, PsycINFO, CINAHL; (((prescribing OR prescription) AND error)).ti,ab 
[Limit to: Publication Year 2003-2005]; 438 results.  
9. EMBASE, MEDLINE, PsycINFO, CINAHL; (((prescribing OR prescription) AND error)).ti,ab 
[Limit to: Publication Year 2006-2007]; 350 results.  
12. EMBASE, MEDLINE, PsycINFO, CINAHL; (((prescribing OR prescription) AND 
error)).ti,ab [Limit to: Publication Year 2008-2008]; 203 results.  
14. EMBASE, MEDLINE, PsycINFO, CINAHL; (((prescribing OR prescription) AND 
error)).ti,ab [Limit to: Publication Year 2009-2009]; 309 results.  
16. EMBASE, MEDLINE, PsycINFO, CINAHL; (((prescribing OR prescription) AND 
error)).ti,ab [Limit to: Publication Year 2010-2010]; 312 results.  
18. EMBASE, MEDLINE, PsycINFO, CINAHL; (((prescribing OR prescription) AND 
error)).ti,ab [Limit to: Publication Year 2011-2011]; 399 results.  
21. EMBASE, MEDLINE, PsycINFO, CINAHL; (((prescribing OR prescription) AND 
error)).ti,ab [Limit to: Publication Year 2012-2012]; 392 results.  
23. EMBASE, MEDLINE, PsycINFO, CINAHL; (((prescribing OR prescription) AND 
error)).ti,ab [Limit to: Publication Year 2013-2013]; 358 results.  
25. EMBASE, MEDLINE, PsycINFO, CINAHL; (((prescribing OR prescription) AND 
error)).ti,ab [Limit to: Publication Year 2014-2014]; 34 results.  
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Appendix 4:   Options appraisal of potential methods 
Decision 
Required 
Detail Options Advantages Disadvantages Notes Use Refs 
Prevalence and types of prescribing errors (inpatients only) 
Study 
population 
Wards All • Gives greater chance of finding errors improving 
statistical rigour 
• Full range of sub-specialties  
• Can be reduced later if necessary 
• Involves greater number of data collectors so 
consistency may be lower 
• Larger sample size necessary to retain 
statistical power for sub-specialty analysis? 
• Some wards visited less frequently than 
others (needs to be taken into account in any 
bed-day calculations)  
• Would be impossible for researcher to be 
involved in data collection due to numbers and 
time requirements 
Adult Assessment, OP Assessment, 
Adult Acute, Adult Rehabilitation, OP 
Continuing Care, Forensic, PICU, 
CAMHS 
  
Selection by 
geographic location 
• Easier to collect data 
• Smaller number of data collectors involved so 
consistency may be higher 
• Will take longer to obtain number required for 
sample size 
• Reduces range of sub-specialties involved so 
results less generalisable 
Rochford (OP Assessment, Adult 
Acute, CAMHS) 
Brockfield (Low & medium secure) 
Basildon MHU (Adult & OP 
Assessment, PICU, Adult Acute)  
 
  
Selection by sub-
specialty 
• Easier to collect data 
• Smaller number of data collectors involved so 
consistency may be higher 
• Will take longer to obtain number required 
sample size 
• Some ward types visited daily, so data will be 
faster to collect 
• Geographically dispersed 
• Less generalisable 
   
Data items Medication orders 
containing errors 
(numerator) 
All  • Faster to collect required sample size 
• More work for ward pharmacists 
• Difficult to ensure errors not double counted Approach used by Bobb, Lesar, Ryan  16,20,189,274 
Newly prescribed 
items (not previously 
screened by 
pharmacist) 
• Easy to ensure errors not double counted 
• Workload remains manageable for ward 
pharmacists 
• Will take longer to achieve required sample 
size 
Approach used by Tully, Franklin, 
Ghaleb (implied), Stubbs (implied), 
Dean 
 13,101,245,259
,275,307 
Definition Dean et al25  • Widely used • Criticised by Ferner & Aronson “definition is not the same as 
classification”; development of “case 
law”104 
Used by Avery, Dean, Franklin, Haw, 
Ghaleb  
 13,22,85,89, 
140,245 
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Decision 
Required 
Detail Options Advantages Disadvantages Notes Use Refs 
Data items Denominator Number/proportion 
of new medication 
orders in which a 
prescribing error 
found 
• Measure of risk associated with prescribing 
act318 
• Less extra information for ward pharmacists to 
record 
• Effectively acting as a random sample 
 Approach used by Tully, Franklin, 
Dean 
2% random sample used by Avery 
 13,104,245,275
,307 
Number/proportion 
of all medication 
orders in which a 
prescribing error 
found 
• Measure of risk associated with prescribing 
act318 
Obtain denominator - retrospectively estimate 
number of orders written during study period 
• Resource intensive 
• Time consuming 
• Some notes will be missing 
Dean used 1 in 5 sample to estimate 
total numbers14 
 14,189,260,318 
Obtain denominator - record all medication orders  
• Prohibitively time consuming 
Used by Franklin (one 28-bedded 
ward; 2 x 4 weeks)  
 
 155,260 
Obtain denominator - from pharmacy system 
• Not possible in UK because of use of ward 
stock whereas all IPD in US 
Used by Lesar but different health 
system  
 16,20 
Number of 
medication errors 
per patient day 
• Measure of risk to individual patients318 
• Bed day data should be available for each ward 
Obtain denominator - record all medication orders  
• Prohibitively time consuming 
Used by Franklin (one 28-bedded 
ward; 2 x 4 weeks)  
 
 155,260 
Errors per order One prescribing 
error per order 
allowed 
 • Understates number of errors Approach used by Barber, Dean   14,260,318 
Multiple prescribing 
errors per order 
allowed 
• Better reflection of actual situation  Approach used by Avery, Ghaleb, 
Haw, Seden, Stubbs, Dean, Franklin 
 84,85,89,243, 
245,292 
Data 
collection 
Sample size    Aim to collect >200 errors. Will 
probably need about 10,000 items 
screened overall 
  
Sampling period Continuous until X 
number of items/ 
errors reached 
• Required numbers will be achieved sooner • Open ended which makes planning difficult 
• Risk of data collection fatigue which may lead 
to data not being rigorously collected 
Approach used by Seden (min 400 
items x 9 sites) 
 257 
Defined time period 
(X weeks) 
• Easier to plan dependent steps in the project • Need to make sure that sample size 
accurately calculated at outset to ensure 
statistical power achieved 
Approach used by Barber (4 weeks), 
Franklin, Dean (2 weeks), Ghaleb (2 
weeks per ward x 11 wards i.e. 22 
weeks), Haw, Stubbs (1 month), 
Stubbs (5 days) 
 12,84–86,243, 
246,292 
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Decision 
Required 
Detail Options Advantages Disadvantages Notes Use Refs 
Data 
collection 
Sampling period Census days/weeks • Intermittent data collection days reduces data 
collection fatigue 
• Easier to adjust process as get clearer picture 
of the number of errors being detected 
• Need to ensure all weekdays included 
• Data collectors may forget details if too widely 
spaced 
• As irregular data collectors may forget to 
collect data 
• Need to make sure that sample size 
accurately calculated at outset to ensure 
statistical power achieved 
• May miss wards not visited weekly 
Approach used by Tully (38 randomly 
selected days over 18 months), 
Franklin (1 day per fortnight, 
alternating Mondays & Wednesdays), 
Ryan (1 week each month), Seden (1 
day per week, but different) 
 174,231,244, 
261 
Method Drug chart review • Part of routine clinical pharmacy activities 
• Ward pharmacist has access to information that 
is not in health care record 
• Likely to identify ‘trivial’ deviations which 
would never be harmful102 
• Identifies fewer prescribing errors than 
retrospective review  
• May be deficiencies in documenting errors by 
ward pharmacists (especially for minor errors 
which they rectify) 
• Differences in clinical knowledge 
• Differences in diligence at finding and 
documenting errors 
Approach used by Ajemigbitsi, 
Abbasinazari, Barber, Ben-Yehuda, 
Bobb, Colpaert, Dean, Donyai, 
Dornan, Dutton, Franklin, Haw, Jani, 
Kuo, Paton, Ross, Ryan, Stubbs, Tully 
 13,18,99–
102,104,113,12
8,178,185,189,
244,245,256,26
0,274,275,307,
447–450 
Medical record 
review 
• Identifies more prescribing errors than drug 
chart review 
• More likely to identify omissions 
• Far more time consuming (ten times longer 
per patient) 
• Unlikely to identify all errors as some items will 
have been changed/ceased for other reasons 
than error and where chart amended following 
intervention may not be obvious 
Approach used by Grasso (31 
patients), Leape & Rothschild (both 
real time) 
 15,121,130,155 
Spontaneous 
reporting 
• DATIX system already in place • Dependent on voluntary reporting by staff  
• Poor quality data completion when do report 
• Huge degree of under-reporting 
Not suitable for research purposes  155 
Solicited reporting  • Dependent on recall of staff 
• Unlikely to identify more than a proportion of 
actual errors 
• Resource intensive 
Approach used by Bates (twice daily), 
Leape (at least daily), Rothschild 
 12,15,130 
Trigger tools  • Low identification rate for prescribing errors 
• Many false positives 
• Trigger tools do not exist for the error types 
being investigated 
Not suitable for research purposes  155 
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Decision 
Required 
Detail Options Advantages Disadvantages Notes Use Refs 
Data 
collection 
Data collector Ward pharmacist • Part of routine clinical practice on wards 
• Familiar with patients 
• Familiar with prescribers 
• Has access to healthcare record 
• Able to collect larger quantities of data than a 
single researcher 
• Adds to workload of ward pharmacists  
• Number that fail to be identified is unknown 
• Pharmacists will need training (1:1 ward 
based training suggested by Barber260) 
• Researcher will need to review all reported 
incidence against inclusion criteria 
• Differences in ability of ward pharmacists to 
detect errors 
• Differences in diligence of ward pharmacists 
at recording  
• Errors may be missed  
Franklin identified 9 minutes per ward 
per day to collect the data 
 87,140,227, 
231,246,338 
Researcher • Not adding to workload of ward pharmacists 
• Has access to healthcare record  
• Less likely to detect errors (not clinical 
pharmacist) 
• Not familiar with patients 
• Not familiar with prescribers 
• Quantity of data able to collect will be limited 
   
Researcher 
shadowing ward 
pharmacist 
• Part of routine clinical practice on wards 
• Familiar with patients 
• Familiar with prescribers 
• Has access to healthcare record 
• Quantity of data able to collect will be limited 
• Researcher may be distraction to ward 
pharmacist resulting in normal work of lower 
quality 
• If ward pharmacists work at normal rate 
difficult for researcher to capture necessary 
information 
Approach used by Ghaleb (5 data 
collectors shadowing 10 pharmacists) 
 259 
Data analysis Classification of 
error type 
Components of 
prescribing process 
• Based on stages of the drug use process • Developed for categorising clinical pharmacist 
interventions 
• May be difficult to decide which stage a 
prescribing error occurs in 
Used by Tully, Franklin, Dean, 
Cousins,  
 
Suggested not appropriate by Barber 
 14,155,260,261
,275,304 
Clinical 
consequences 
• May lead to concentration only on errors 
causing ADEs 
• Number of errors which have actually caused 
harm to patient likely to be very small 
   
Psychological cause 
of error 
• Links to Reason’s model and therefore later 
sections of project 
• Unless collecting information from prescribers 
based on assumption  
Used by Leape (termed proximal 
cause), Lesar 
 15,16 
Type of discrepancy • Lisby - developed by consensus from error 
types identified in review of 203 studies 
 Used by Avery, Lisby, Grasso, Lesar, 
Ryan, Seden, Dornan, Franklin, Bobb 
 17,19,71,89, 
106,174,243, 
260,292 
Dean et al 
scenarios25 
• Should be relatively easy to identify categories • “definition is not the same as classification” - 
considered inappropriate for this purpose by 
originator 
Used by Haw & Stubbs (with extra MH 
scenarios) 
 25,99–101 
WHO classification • Should be internationally recognised • Not widely used   162 
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Decision 
Required 
Detail Options Advantages Disadvantages Notes Use Refs 
Data analysis Classification of 
error origin 
(decision making 
vs prescription 
writing) 
Ward pharmacist to 
assess 
 • Researcher would need to validate at least a 
sample so duplicating work 
• Extra work for ward pharmacist 
• Less familiar with concept 
Used by Dean  14 
Researcher to 
assess 
• Reduces workload for ward pharmacists 
• Task only undertaken once 
    
Severity scale NCC MERP 
index452,453 
• Widely used in publications • Developed to assess actual rather than 
potential harm 
• Includes ‘not an error’ category so mixed 
system 
• System not widely used in the UK 
Assessing severity increases clinical 
relevance of findings 
 
Rothschild used as well as 4-point 
severity scale 
 115,174,260, 
303 
NCC MERP index 
as adapted by 
Forrey329 
• Established validity 
• Good interrater agreement when used 
• Widely used in publications 
• System not widely used in the UK   319,329 
Dean & Barber 
tool253 
• Established validity and reliability for 
administration errors 
• Established reliability for prescribing errors 
• Relationship between potential and actual harm 
established 
• Tested on a large sample 
• Continuous scale potentially permits more 
powerful statistical analysis 
• Uses visual analogue scale which is simple to 
use and familiar to most  
• Designed and validated for medication 
administration errors 
• Requires four reviewers to achieve acceptable 
reliability 
• Including pharmacy, nursing and medical 
panel members suggested to facilitate 
ownership253 
• Resource intensive 
• May be more time consuming to use 
Adapted by Kollo for prescribing 
errors263 
 
Used by Avery (grouped to minimise 
workload), Franklin (1 in 5 sample) 
 
Professional discipline of each judge 
less relevant than expected253 
 
Score > 7.0 considered to be ‘serious’13  
Score <3 considered ‘minor’; 3-7 
‘moderate’, >7 ‘severe’104  
 13,104,253,263
,307,319 
Severity 
assessment 
By data collector  • Collected at time error identified 
• Has knowledge of other medicines being taken 
by patient 
• Has knowledge of co-morbidity of patient 
• Has access to lab results and healthcare record 
• Does not require panel of experts who may 
need to evaluate a large number of errors 
• May be difficult to get consistency between 
data collectors 
   
By data collector 
with sample 
assessed by panel 
of ‘experts’ 
• Collected at time error identified 
• Has knowledge of other medicines being taken 
by patient 
• Has knowledge of co-morbidity of patient 
• Has access to lab results and healthcare record 
• Needs at least two reviewers of each of two 
professions to be achieve acceptable 
reliabilitity263 
 
Approach used by Franklin (1 in 5 
sample) 
 
 
20% sample 
 13 
By panel of ‘experts’ • True to the validated method developed by 
Dean & Barber and adapted by Kollo (as using 
that tool) 
• Needs at least two reviewers of each of two 
professions to be achieve acceptable 
reliabilitity263 
• Resource intensive and time consuming 
Approach used by Franklin, Haw, 
Lesar   
 19,51,85,93, 
239,249,292 
  
 
227 
A
PPEN
D
IX 4 
Decision 
Required 
Detail Options Advantages Disadvantages Notes Use Refs 
Causes of prescribing errors 
Study 
population 
Prescribers 
(including NMPs) 
All prescribers who 
have made errors  
• Comprehensive population • Probably prohibitively large numbers involved 
• Will reach saturation anyway 
   
Sample of 
prescribers who 
have made non-
serious and serious 
errors 
• More manageable number of interviews to 
undertake 
• Less resource intensive 
• Need to establish process for choosing non-
serious errors to follow up (balanced 
numbers?) 
   
All prescribers who 
have made serious 
errors  
• More manageable number of interviews to 
undertake 
• Less resource intensive 
• May result in small numbers of participants  
• May take much longer to reach saturation 
• May give biases results as issues involved in 
serious errors may be different from those in 
non-serious errors 
Approach used by Barber, Dean  27,260 
Data 
collection 
Semi-structured 
interview or 
questionnaire 
Semi-structured 
interview 
• Benefit of non-verbal feedback 
• Allows prompting and exploration of answers 
given 
• Resource intensive 
• Time consuming 
• Outcomes may be influenced by experience of 
interviewer at qualitative interviewing 
Used by Barber & Dean and Coombes 
to assess reasons for the error 
 18,26,27,260 
Questionnaire • Faster to administer 
• Could ask participants to complete and bring to 
interview? 
• Questions can act as a prompt  
• Loss of non-verbal feedback  
• Limited to questions as written 
• Generally limited to closed questions 
• Questions may lead the interviewees answers 
Used by Barber & Dean and Coombes 
to investigate potential contribution of 
factors to error production during 
semi-structured interview 
 26,27,260 
Time limit on 
contacting 
prescribers 
72 hours • Short timescale aids recall of incident • Likely to be difficult to achieve, especially 
taking weekends into account 
Approach used by Coombes   
96 hours • Short timescale aids recall of incident • Likely to be difficult to achieve, especially 
taking weekends into account 
Approach used by Barber, Dean, Ross  27,113,260 
1 week • More achievable • Recall likely to be less    
>1 week  • Recall more likely to be impaired Nichols interviewed up to 60 days post 
event (median 8 days) 
 188 
Type of interview Face to face • Benefit of non-verbal feedback  • More travel time involved for researcher    
Telephone • Less resource intensive for researcher 
• May be more attractive to some participants 
• Loss of non-verbal feedback Ideally face to face but may be 
necessary 
  
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Decision 
Required 
Detail Options Advantages Disadvantages Notes Use Refs 
Data 
collection 
 
Sample Until saturation • No new themes emerging  Approach used by Barber, Dean (44 
required) 
 27,260 
Purposive    Approach used by Dornan, Lewis (68 
interviews), Duncan (22 interviews) 
 18,28,187 
Convenience • Prescriber who made the error  Approach used by Franklin (15 
interviews), Nichols (26 interviews), 
Ross & Ryan (40 interviews) 
 13,113,188,189
,307 
Data analysis Classification Reason’s model of 
accident 
causation23,49 
adapted for 
healthcare156,159 
(London Protocol160) 
• Commonly used in this context 
• Makes easier to link findings to previous 
research 
 Approach used by Barber, Dean, 
Dornan, Franklin, Lewis, Ross, Ryan, 
Coombes, Nichols (although not 
stated) 
 12,17,172–
174,246,292, 
25,27,28,56,98,
141,144,145 
Theoretical domain 
framework 
  Approach used by Duncan  28 
Decision making characteristics (Administering CRT226 and REI200 to determine thinking style (~10 minutes)) 
Data 
collection 
 
Paper based or 
electronic survey 
Paper based • Enables coding so that can match any that do 
not identify themselves 
• May be less likely to be returned    
Electronic survey • May be more likely to get responses 
• SurveyMonkey includes tracking options 
• Needs specialist software (e.g. Qualtrics, 
SurveyMonkey) 
   
Timing 
 
Before error data 
collection 
• Easier to match respondents to errors as 
detected 
• May alert prescribers to study and bias results    
After error data 
collection 
     
Who to administer 
to 
All prescribers  • Easier to administer 
• Need to be able to compare results for those 
who have made errors during the study with 
those who have not 
• Could not be anonymous sample as need to 
match scores to whether errors have been 
made 
• May get poor response rate as asking to 
identify themselves 
Need to establish which NMPs 
prescribe for inpatients 
 
 
 
Prescribers who 
have made errors  
  Need data for those for whom errors 
have not be made as well 
  
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Appendix 5:   Prescription and Medicines Administration Chart 
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Appendix 6:   Information booklet for clinical pharmacists 
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Appendix 7:   Participant consent form (Pharmacists) 
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Appendix 8:   Prescribing error data collection form (Ward level) 
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Appendix 9:   Prescribing error data collection form (Patient level) 
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Appendix 10: Prescribing error severity assessment 
APPENDIX 11 
254 
 
Appendix 11: Causes of prescribing error interview invitation letter 
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Appendix 12: Participant information sheet (Interviews) 
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Appendix 13: Participant consent form (Interviews) 
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Appendix 14: Causes of prescribing error interview schedule 
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Appendix 15: Cognitive style questionnaire 
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Appendix 16: Clinical decision-making session evaluation questionnaire 
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Appendix 17: Science Faculty Ethics Committee favourable opinion 
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Appendix 18: Prescribing indicators relevant to mental health 
Prescribing safety indicator title Error type Risk 
Lithium dose not adjusted or omitted in a patient with a lithium 
concentration above the therapeutic range (>1,0 mmol l-1) (risk of 
lithium toxicity) 
Dosing High 
Benzodiazepine or benzodiazepine-like drug prescribed to a patient 
with chronic obstructive pulmonary disease (risk of respiratory 
depression) 
Clinical 
contraindication 
High 
Antipsychotic, other than risperidone, prescribed to a patient for the 
management of behavioural and psychological symptoms of dementia 
(increased risk of stroke) 
Clinical 
contraindication 
High 
Tricyclic antidepressant prescribed to a patient with dementia 
(increased risk of worsening cognitive impairment) 
Clinical 
contraindication 
High 
Selective serotonin reuptake inhibitor prescribed to a patient with 
epilepsy (increased risk of seizure threshold being reduced) 
Clinical 
contraindication 
High 
Selective serotonin reuptake inhibitor prescribed to a patient with a 
history of clinically significant hyponatraemia (non-iatrogenic, sodium 
<130 mmol l-1 in the previous 2 months)  
(increased risk of hyponatraemia) 
Clinical 
contraindication 
High 
Prochlorperazine prescribed to a patient with parkinsonism. 
(risk of exacerbating parkinsonism symptoms) 
Clinical 
contraindication 
High 
Lithium prescribed in conjunction with newly prescribed nonsteroidal 
anti-inflammatory drugs without dose adjustment or increased 
monitoring (increased risk of toxicity) 
Drug-drug 
interaction 
High 
Lithium prescribed in conjunction with newly prescribed loop or thiazide 
diuretics without dose adjustment or increase monitoring (increased 
risk of toxicity) 
Drug-drug 
interaction 
High 
Tricyclic antidepressant prescribed at the same time as a monoamine 
oxidase inhibitor (increased risk of serotonin syndrome) 
Drug-drug 
interaction 
High 
Tramadol prescribed concomitantly with a monoamine oxidase inhibitor 
(increased risk of serotonin syndrome)  
Drug-drug 
interaction 
High 
Selective serotonin reuptake inhibitor prescribed concomitantly with 
tramadol (increased risk of serotonin syndrome) 
Drug-drug 
interaction 
High 
Selective serotonin reuptake inhibitor prescribed concomitantly with 
aspirin without appropriate prophylaxis with antisecretory drugs or 
mucosal protectant (increased risk of gastrointestinal bleeding) 
Drug-drug 
interaction 
High 
Citalopram prescribed concomitantly with other QT-prolonging drugs 
(increased risk of arrhythmias) 
Drug-drug 
interaction 
High 
Benzodiazepines prescribed long term (i.e. more than 2-4 weeks) (risk 
of dependence and withdrawal reactions) 
Duration High 
Benzodiazepine or benzodiazepine-like drug prescribed long term to a 
patient with depression (risk of dependence and withdrawal reactions) 
Duration High 
Benzodiazepine-like drugs (e.g. zopiclone) prescribed long term (i.e. 
more than 2-4 weeks) (risk of dependence reactions) 
Duration High 
Antipsychotic prescribed long term (i.e. > 1 month) to a patient with 
parkinsonism (increased risk of worsening of extrapyramidal side-
effect) 
Duration High 
Source: Thomas et al308 
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Appendix 19: Summary of errors considered to be potentially ‘severe’ by either the ward pharmacist or expert panel 
Type of 
error 
Prescriber  Prescribing 
stage 
Sub-
specialty 
Description Ward 
pharmacist 
assessment 
Expert 
panel 
assessment 
Allergy Consultant Leave Older People Co-Amoxiclav 625 mg three times daily prescribed for a patient with a documented penicillin allergy. severe (8.0) severe (7.9) 
Allergy Staff grade During stay Older People Co-Amoxiclav 625 mg three times daily prescribed for a patient with a documented penicillin allergy. severe (9.0) severe (7.9) 
Dose Staff grade Admission Older People Fluoxetine liquid 20 mg/5 ml prescribed with a dose of 10 ml (40 mg) daily when the dose should 
have been 10 mg (2.5 ml) daily. 
severe (8.0) moderate (4.3) 
Dose Consultant During stay Adult Haloperidol 1 g twice daily prescribed, when maximum daily dose is 20 mg. severe (9.0) moderate (7.0) 
Dose Core trainee Admission Older People Paracetamol 1 g four times daily prescribed for a patient with a weight of 47.3 kg, when transfer 
document from acute trust states dose of 500 mg four times daily. 
severe (8.0) moderate (5.4) 
Dose GP trainee Re-write Adult Quetiapine 800 mg daily prescribed without specifying that formulation should be modified release. severe (9.0) moderate (3.2) 
Dose Core trainee Admission Adult Seretide Accuhaler© twice daily prescribed without specifying strength. Salmeterol/fluticasone 
available as 50/100 mcg, 50/250 mcg and 50/500 mcg strengths 
severe (8.0) moderate (3.3) 
Dose Staff grade Admission Older People Solifenacin 70 mg daily prescribed when dose should have been 10 mg daily. severe (8.0) moderate (6.6) 
Dose GP trainee Admission Adult Symbicort© inhaler twice daily prescribed without specifying strength. Budesonide/formoterol 
available as 100/6 mcg, 200/6 mcg and 400/12 mcg strengths. 
severe (8.0) moderate (3.7) 
Dose Staff grade Re-write Forensic Venlafaxine modified release 225 mg prescribed three times daily when modified release 
formulation should be once daily dose. 
severe (9.0) moderate (6.9) 
Duplication Higher specialty 
trainee 
Not known Older People Warfarin 5 mg daily prescribed on both anticoagulation chart and main drug chart. severe (8.0) severe (7.8) 
Duplication Consultant During stay Adult Lithium carbonate 400 mg twice daily prescribed without discontinuing previous prescription for 
800 mg daily. 
severe (8.0) severe (7.9) 
Duplication Staff grade During stay Adult Co-codamol 30/500 four times daily prescribed when patient already had both co-codamol and 
paracetamol prescribed on other drug charts (i.e. double duplication). 
severe (8.0) moderate (6.3) 
Duplication Staff grade During stay  Older People Co-codamol 8/500, two tablets four times daily as required prescribed when patient already 
prescribed two tablets twice daily as regular medication and two tablets twice daily as required 
medication. 
severe (8.0) moderate (6.3) 
Duplication Foundation year 
1 
During stay Older People Co-dydramol 10/500, one to two tablets four times daily as required prescribed when patient already 
prescribed paracetamol 1 g four times daily as regular medication. 
severe (9.0) moderate (5.6) 
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Type of 
error 
Prescriber  Prescribing 
stage 
Sub-
specialty 
Description Ward 
pharmacist 
assessment 
Expert 
panel 
assessment 
Duplication Consultant During stay Adult New prescription written for olanzapine 25 mg once daily, without discontinuing previous 
prescription for 20 mg daily. 
severe (8.0) moderate (5.6) 
Duplication Consultant Admission Older People Paracetamol 1 g four times daily prescribed when patient already prescribed paracetamol 1 g four 
times daily as required. 
severe (9.0) moderate (5.1) 
Duplication Staff grade During stay Older People Paracetamol 1 g four times daily prescribed when patient already prescribed paracetamol 1 g four 
times daily as required. 
severe (8.0) moderate (5.2) 
Duplication  GP trainee  Admission Older People Paracetamol 500 mg - 1 g six-hourly as required prescribed when patient already prescribed co-
codamol 30/500, two tablets four times daily as regular medication. 
severe (8.0) moderate (5.2) 
Duration Staff grade Discharge Forensic 28 day’s supply of Clozapine 150 mg each morning prescribed. Patient required weekly blood tests 
with a ‘green’ result before release of further weekly supplies. 
minor (0.0) severe (7.4) 
Duration Staff grade Discharge Forensic 28 day’s supply of Clozapine 175 mg at night prescribed. Patient required weekly blood tests with a 
‘green’ result before release of further weekly supplies. 
minor (0.0) severe (7.4) 
Frequency Staff grade Re-write Forensic Zuclopenthixol decanoate 800 mg IM prescribed for weekly administration, when should have been 
prescribed for administration every two weeks. 
minor (0.0) severe (7.2) 
Frequency Core trainee Admission Older People Furosemide 40 mg daily prescribed when patient’s own drugs and discharge summary from acute 
hospital showed frequency of twice daily. 
severe (8.0) moderate (3.9) 
Indication Core trainee Discharge Adult Quetiapine modified release 800 mg daily prescribed at discharge when patient not taking that 
medication 
severe (8.0) moderate (6.7) 
Omission Staff grade Leave Older People Warfarin omitted from leave prescription. not assessed severe (7.5) 
Omission Consultant Admission Older People Co-amoxiclav 625 mg three times daily omitted from prescription on transfer from acute hospital. 
Six doses missed before corrected and diabetic patient experienced erratic blood sugar levels 
requiring Actrapid© insulin PRN which could have been due to infection. 
severe (8.0) moderate (6.9) 
Omission GP trainee  Discharge Adult Mirtazapine 15 mg at night omitted from discharge prescription. severe (8.0) moderate (3.2) 
Omission Consultant Discharge Adult Mirtazapine 45 mg once daily omitted from discharge prescription. severe (8.0) moderate (4.8) 
Omission Staff grade Admission Older People Ramipril 5 mg daily omitted from prescription on transfer from acute hospital. severe (9.0) moderate (4.5) 
Route GP trainee  During stay Adult Pabrinex IV prescribed when should have been Pabrinex IM. Formulations for IV and IM use are 
not interchangeable. 
moderate (3.0) severe (7.3) 
Legal Consultant Admission Older People Prescription for metformin 500 mg twice daily unsigned by prescriber. severe (8.0) not assessed 
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Appendix 20: Data collection by prescriber 
FY= foundation year; CT = core trainee; ST = specialty trainee; GPST = general practice specialty trainee. Missing prescriber codes did not prescribe and/or attend the educational session 
Prescriber code 
& 
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0 Unidentified                          158 
1 Consultant                          48 
2 Staff Grade                          149 
3 Consultant             Yes             107 
4 CT2                          254 
5 CT3                          94 
6 Consultant             Yes             255 
7 FY2                          19 
8 GPST2                          61 
9 ST4             Yes             186 
10 Consultant             Yes             86 
11 GPST2                          64 
12 Consultant                          12 
13 Consultant                          343 
14 Consultant                          220 
15 Consultant             Yes             64 
16 Staff Grade                          128 
17 CT2                          207 
18 GPST2                          166 
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19 FY1                          42 
20 Consultant                          3 
21 Staff Grade             Yes             150 
22 FY2                          1 
23 FY1                          18 
24 Staff Grade                          74 
25 Staff Grade                          34 
26 Visiting GP                          592 
27 Geriatrician                          47 
28 Staff Grade                          153 
29 CT2                          217 
30 Staff Grade                          342 
31 Consultant                          21 
32 Consultant                          45 
33 Consultant             Yes             167 
34 Consultant             Yes             27 
35 Consultant                          79 
36 GPST2                          28 
37 CT3                          14 
38 ST6                          238 
39 CT3                          121 
40 Consultant                          166 
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41 Staff Grade                          1450 
42 Visiting GP                          56 
43 ST6                          229 
44 Consultant                          33 
45 FY1                          51 
46 Consultant                          91 
47 Consultant                          101 
48 FY1                          76 
49 Nurse                          2 
50 Staff Grade                          29 
51 CT2                          12 
52 FY2                          19 
53 Geriatrician                          2 
54 Staff Grade                          1 
55 CT3                          102 
56 Nurse                          8 
57 Consultant                          22 
58 Staff Grade                          142 
59 Staff Grade                          19 
60 FY1                          27 
61 CT3                          152 
63 FY2                          4 
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64 FY2                          9 
65 ST4             Yes             16 
67 ST4             Yes             119 
68 ST6                          79 
69 CT3                          95 
71 ST4             Yes             12 
72 Staff Grade                          71 
73 Staff Grade                          12 
74 FY2                          28 
75 Staff Grade                          90 
76 Nurse                          16 
77 Consultant                4          79 
78 Consultant                          27 
79 Consultant                          12 
80 Consultant             Yes             20 
81 GPST1                          8 
82 Staff Grade                          378 
83 CT3             Yes             31 
84 Consultant                          5 
86 ST6                          1 
87 ST6             Yes             19 
88 FY2                          3 
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89 FY1                          22 
90 FY2                          34 
91 FY1                          9 
93 CT3             Yes             42 
94 FY2                          19 
95 FY1                          31 
96 FY1                          29 
99 ST4                          6 
100 GPST1                          15 
101 FY2                          22 
102 FY2                          12 
103 FY1                          20 
107 Consultant             Yes             0 
110 Consultant             Yes             0 
112 Staff Grade                          36 
113 Consultant             Yes             25 
115 Consultant                          10 
116 Consultant             Yes             0 
118 Consultant                          18 
119 Consultant                          25 
124 Consultant             Yes             3 
125 Consultant             Yes             0 
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127 Consultant             Yes             0 
129 Consultant             Yes             0 
131 Consultant                          4 
132 Consultant             Yes             0 
135 Staff Grade             Yes             0 
136 Staff Grade                          68 
139 Staff Grade                          240 
140 GPST1                          23 
141 Nurse                          1 
142 Consultant                          73 
143 Unknown                          4 
144 Other                          283 
145 GPST2                          94 
146 Staff Grade                          20 
147 CT3             Yes             122 
148 GPST3                          64 
149 GPST1                          8 
150 GPST1             Yes             2 
151 GPST1             Yes             0 
152 FY2                          19 
155 FY2                          34 
156 FY1                          6 
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157 FY2                          17 
158 FY1                          3 
159 CT1                          25 
161 FY1                          16 
162 FY1                          40 
163 GPST2                          66 
165 Unknown                          1 
166 Consultant                          26 
167 CT1                          40 
169 Staff Grade                          353 
170 Staff Grade                          23 
171 Consultant             Yes             123 
172 Staff Grade                          50 
173 GPST1                          3 
174 Consultant                          4 
175 Staff Grade                          80 
177 CT1             Yes             78 
178 ST4             Yes             37 
179 ST4             Yes             27 
180 ST4             Yes             0 
181 CT1             Yes             17 
182 CT1             Yes             143 
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183 CT2             Yes             37 
184 GPST3                          12 
185 FY2             Yes             0 
186 FY2             Yes             1 
187 GPST1             Yes             5 
188 ST4                          3 
189 FY2             Yes             0 
190 FY1             Yes             0 
191 FY1                          17 
192 FY2                          50 
193 GPST1                          7 
194 FY1             Yes             18 
195 FY1                          4 
196 CT1                          16 
197 FY2             Yes             1 
198 FY1             Yes             14 
200 GPST1                          4 
202 FY2             Yes             0 
203 FY1             Yes             0 
205 GPST2                          37 
206 ST4                          367 
207 Staff Grade             Yes             20 
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208 Staff Grade                          79 
210 Staff Grade                          2 
211 Staff Grade                          251 
212 Nurse                          2 
213 FY2                          17 
214 FY1                          8 
215 Consultant                          185 
216 Consultant                          1 
217 Consultant                          4 
218 FY1                          14 
219 GPST2                          46 
221 GPST2                          27 
222 GPST1                          51 
223 FY1                          2 
224 Staff Grade                          26 
225 Staff Grade                          31 
226 FY2                          33 
227 FY2                          1 
228 FY2                          14 
229 FY2                          15 
230 Staff Grade                          10 
231 Nurse                          7 
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232 FY2                          6 
233 Staff Grade                          87 
234 Visiting GP                          107 
235 FY2                          46 
236 Staff Grade                          23 
237 Staff Grade                          1 
238 GPST1                          3 
239 FY1                          2 
240 Staff Grade                          158 
241 FY2                          20 
242 Unknown                          1 
243 FY1                          12 
244 FY2                          11 
245 Unknown                          1 
246 Consultant                          5 
248 FY1                          7 
249 FY1                          4 
250 Consultant                          2 
251 Unknown                          1 
252 Staff Grade                          11 
253 FY1                          6 
254 Staff Grade                          56 
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255 GPST2                          15 
256 FY2                          36 
257 FY1                          10 
258 FY1                          6 
259 FY2                          2 
260 GPST2                          9 
261 FY2                          2 
262 FY1                          19 
263 FY2                          2 
264 Visiting GP                          1 
No of active 
prescribers 37 51 53 53 42 42 45 42 42 51 50 38 
47 
19 30 43 35 35 41 25 45 35 52 43 37 212 
No. of medication 
orders reviewed 477 1,038 1,003 724 615 697 573 558 471 687 651 459 215 464 373 403 484 535 253 633 492 844 552 483 13,684 
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Appendix 21: Research Ethics Review Checklist (Form UPR16) 
 
 
